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R2243 Temporal and geographical analysis of clones involved in
the increase in serogroup 1 pneumococci
J. Van Eldere, P. Vermeersch, K. Van Pelt, J. Verhaegen (Leuven, BE)
Introduction: The national reference centre receives all pneumococci
isolated from invasive infections from more than 100 of 182 laboratories
in Belgium. A marked increase in serogroup 1 (SG1) isolates was
observed from 2003 onwards. Overall prevalence of SG1 increased from
8.2% (1998–2002) to 13.6% (2003–2006). In 2006, 58.7% of blood
isolates in the age group 5–10 years belonged to SG1 and 34.3% of the
isolates in age group 10–19 years. Since 2003 macrolide and tetracycline
resistance has appeared in SG1 isolates.
Methods: For the period 1998–2002 and 2003–2006, we received 6622
and 7021 isolates respectively. Of these, 200 randomly chosen serogroup
1 isolates were analysed via multi-locus sequence typing (MLST) as
described by Enright & Spratt (Microbiol. 1998; 144: 3049). The MLST
data were also compared to available data on strain characteristics
(antibiogram) and patient characteristics (geography, age, clinical data
on diagnosis and treatment) to investigate trends in clonal selection and
spread.
Results: The increase in SG1 was primarily linked to the increase in
two sequence types (ST350 and ST304). A clear temporal-geographical
pattern of spread could be established for these sequence types.
Resistance development was limited to ST350 and was not observed
in the other sequence types. A temporal-geographical pattern could also
be established for resistance development and spread.
Conclusion: The increase in SG1 and the increased resistance in SG1 are
linked to the spread of speciﬁc sequence types throughout Belgium. The
difference in resistance development between the two dominant sequence
types cannot be explained by the available data and needs to be further
examined.
R2244 Prevalence of virulence genes (ctxA, tcpA, zot and ace)
among Vibrio cholerae isolated from outbreaks during 2005
in Iran by multiplex PCR method
N. Sadeghifard, A. Maleki (Tehran, IR)
Objective: The virulence of V. cholerae is related on presence of ctxAB
and tcpA genes. These genes are alleged to be exclusively associated
with clinical strains of O1 and O139 serogroups. In the present study,
we examined the presence of virulence genes ctxA, tcpA, zot and ace
among El Tor variants.
Methods: Thirty nine El Tor variants were obtained from outbreaks
during 2005 in Iran. After detection of isolates by biochemical
methods, and serotyping, chromosomal DNA was extracted by standard
phenol/chloroform method. The oligonucleotide primers for each of the
selected virulence-associated factors were designed based on available
GenBank sequences for V. cholerae O1 E1 Tor for all genes. A multiplex
PCR assay was performed and the PCR product was run and visualised
in 1.5% agarose gels stained with ethidium bromide.
Results: The PCR analysis of the strains revealed that 100, 100, 82.1 and
82.1% carried the ctxA, zot, tcpA and ace genes, respectively. Isolates
with tcpA gene negative had ace gene positive and isolates with ace gene
negative had tcpA positive, so there was not any strain with tcpA gene
negative and ace gene negative and vice versa.
Conclusion: the results of present stydy reveald that 100% strains carry
ctxA and zot genes, but just 82.1% strains had tcpA and ace genes.
R2245 Comparison of Austrian, Hungarian and Macedonian
meticillin-resistant and meticillin-sensitive Staphylococcus
aureus strains in relation to accessory gene regulator type
E. Kocsis, H. Lagler, N. Pesti, K. Stich, K. Kristo´f, K. Nagy, Z. Cekovska,
W. Graninger, F. Rozgonyi (Budapest, HU; Vienna, AT; Skopje, MK)
Objectives: The purpose of this study was to examine the presence of
genes responsible for different accessory gene regulator (agr) types in
Staphylococcus aureus strains isolated from invasive clinical samples,
and compare according to country origin and meticillin resistance.
Methods: Classical microbiological methods were used for the
phenotypical identiﬁcation of the strains. By detecting the genes
encoding thermostabile endonuclease (nucA) and 23S rRNA the genetic
conﬁrmation of the species of the strains was done. According to
the presence of the mecA gene 48 Austrian (AT) meticillin-resistant
S. aureus (MRSA) and 128 meticillin-sensitive S. aureus (MSSA), 110
Hungarian (HU)MRSA and 94 MSSA, 73 Macedonian (MK) MRSA and
29 MSSA strains were studied. The genes responsible for four different
agr types were detected by multiplex polymerase chain reaction. The
pulsed-ﬁeld gel electrophoresis of the strains was also done to conﬁrm
the heterogenic feature of the bacterial groups.
Results: The agr1 gene was detected in 46%, 47% and 93% in AT,
HU and MK MSSA strains, while in 40%, 20% and 97% in AT, HU
and MK MRSA ones, respectively. Both the AT and HU MSSA strains
harboured the agr2 gene in 34%, while the MK MSSA isolates carried
this gene only in 7%. The agr2 gene carriage of the AT, HU and MK
MRSA strains was 58%, 74% and 3%, respectively. The agr3 gene could
be detected in AT, HU MSSA and MRSA strains in 15%, 13% and in
2%, 6%, respectively. The agr4 gene was harboured by only AT and HU
MSSA strains in 5% and 6%.
Conclusion: The presence of the agr1 gene was signiﬁcantly charac-
teristic for the MK MSSA and MRSA strains compared to the AT
and HU ones (p< 0.001). The frequency of the agr2 gene characterised
signiﬁcantly the HU MRSA strains (p< 0.01). Comparing all the MSSA
strains with MRSA ones the prevalence of agr2 gene was signiﬁcant for
the MRSA isolates (p< 0.001). Our results may indicate alterations in
the regulation of virulence factor genes.
Supported by O¨AD and Te´T grant No.: A-19/02 and the Hungarian
National Scientiﬁc Research Fund (OTKA) T046186.
R2246 Correlation of adherence and haemagglutination abilities
of Staphylococcus saprophyticus strains
J. Vranes, V. Leskovar, B. Bedenic, S. Ljubin-Sternak,
A. Mlinaric-Dzepina, A. Zvirotic (Zagreb, HR)
Objectives: Staphylococcus saprophyticus is an important pathogen in
human urinary tract infections, especially in young, sexually active
women. Bacterial adherence to the urinary mucosa is commonly regarded
as the crucial initial step in the pathogenesis of urinary tract infections.
The aim of this study was to compare the adherence ability of
S. saprophyticus strains to the Buffalo green monkey kidney (BGMK)
cell line with the hemagglutination (HA) ability of those strains, isolated
from the middle clean-catch urine samples of 60 young women in Zagreb
Institute of Public Health.
Methods: The strains were divided in two groups: thirty studied strains
were isolated in great number (104 CFU/ml) and pure culture from
women with urinary tract infection, and another thirty strains were
isolated in small number (103 CFU/ml) and mixed culture from urine of
women without urinary tract infection. Examination of the HA activities
with sheep erythrocytes was performed in microtiter plates, and for
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adhesion assay the continuous epithelioid BGMK cell line was used.
Proportions were compared by the chi2-test and for correlation of the
hemagglutination and adherence abilities the Spearman’s coefﬁcient of
correlation was used.
Results: The results of the study showed that the strains isolated in
great number and pure culture from the urine of women with urinary
tract infections mostly expressed hemagglutinin (73% of the strains),
had statistically signiﬁcant (p< 0.01) greater HA capability and adhered
good or excellent to the BGMK cell line in comparison with the strains
isolated in small number and mixed culture which mostly did not
express the hemagglutinin (only 36% of the strains), had statistically
signiﬁcant (p< 0.01) smaller HA capability, and did not adhered or
adhered poorly to the used cell line. In both studied groups of strains
the statistically signiﬁcant correlation (rs=0.556, p = 0.001 and rs=0.543,
p = 0.002, respectively) was observed between the adherence and the HA
ability of strains, as well as the greater adherence capability of strains
with higher HA titers.
Conclusions: This in vitro study showed statistically signiﬁcant
difference in virulence and pathogenicity between the two studied groups
of strains. As the HA ability correlated with the adherence ability of
strains, the simple and easy to perform HA test could be used in clinical
laboratory for estimation of adherence ability and virulence potential of
S. saprophyticus strains.
R2247 In vitro investigation of the intercellular cross-talk between
opportunistic bacteria and eukaryotic cells
C. Bleotu, M. Balotescu Chiﬁriuc, C. Iordache, O. Dracea, M. Bucur,
C. Larion, L. Matei, O. Banu, R. Cernat, V. Lazar (Bucharest, RO)
Objective: to investigate the potential functional responses of eukariotic
mammalian cells to the exposure to Pseudomonas (P.) aeruginosa and
Staphylococcus (S.) aureus.
Material and Methods: HeLa cells were grown in 6 multiwell plates
in DMEM supplemented with 2% foetal calf serum and 24 h later
standardised microbial suspensions were added over the monolayer in an
interior ﬁlter well. The logarithmic phase microbial cultures supernatants
(MLCA) as such/MLCA inactivated at 100 C degrees for 20 minutes/
MLCA diluted 1:2 in fresh culture medium were added directly over
the HeLa cells monolayer. After 24 h of incubation, cells from the
monolayer were harvested, stained with annexin V and propidium iodide
and analysed by ﬂow cytometry. The extra-cellular level of IL-1, IL-2,
II-4, IL-6, IL-8, IL-10, IL-12, TNF-alpha and IFN-gamma produced by
HeLa cells in the presence of bacterial cultures supernatants was assessed
by ELISA.
Results: Our studies have indicated that HeLa cells respond to bacterial
cultures and their respective supernatants in speciﬁc ways. The necrosis
rate of HeLa cells at 24 h was signiﬁcantly increased in the presence
of P. aeruginosa culture supernatants, comparatively with the whole
bacterial culture, demonstrating that the bacterial soluble factors could
accelerate the killing of host cells, probably by inducing a strong pro-
inﬂammatory effect demonstrated by the stimulation of IL-6 production
correlated with the inhibition of IL-10. The killing activity was preserved
after thermic inactivation. In exchange, in the case of S. aureus, the death
rate of HeLa cells was much more increased in the presence of whole
bacterial cultures, comparatively with the respective supernatants. The
decreased necrosis rate is sustained also by the anti-inﬂammatory effect
produced by the soluble staphylococcal antigens and demonstrated by the
increased level of IL-10. However, in both bacterial infection models, the
HeLa cells necrosis rate was signiﬁcantly reduced after decreasing the
soluble mediators concentrations by adding fresh medium.
Conclusion: Our results demonstrate that eukaryotic cells are able to
detect bacterial chemical signals and to respond appropriately. The
understanding of the mechanism of crosstalk between the bacterial
products and host cells may contribute to the elaboration of an efﬁcient
strategy for controlling the severity of tissue damages and autoimmune
diseases, associated or consecutive to bacterial infections.
R2248 Relationship between Helicobacter pylori babA and babB
status with other virulence factors and their correlation
with disease outcome in Iran
S. Saberi Kashani, M. Douraghi, Y. Talebkhan, M. Bababeik,
M. Esmaeili, M.A. Mohagheghi, M. Eshagh Hosseini, M. Mohammadi
(Tehran, IR)
Objectives: Helicobacter pylori (Hp) is an important human pathogen
associated with gastrointestinal diseases such as gastritis, peptic ulcer
disease (PUD) and gastric cancer. A number of pathogenic factors
have been described for this bacterium, and some of them have been
proposed as predictive markers of the clinical outcomes. However, with
the exception of the cag and vacA status, there is no global consensus
regarding the role of the other introduced virulence factors. Therefore,
the aim of this study was to investigate the status of Hp strains regarding
the Hp babA and babB (blood group antigen binding) adhesins and assess
any existing association between the status of these genes and clinical
outcomes in Iranian patients.
Methods: Hp virulence genes were ampliﬁed by means of gene-speciﬁc
polymerase chain reaction in clinical isolates of Hp from 72 Iranian
patients (16 GC, 12 PUD, 44 NUD patients).
Results: Eleven categories of genotypes were identiﬁed with the
following frequencies: Group 1: A+B+/cagA+/s1 (38.0%); Group 2:
A+B+/cag+/s2 (2.8%); Group 3: A+B+/cag−/s1 (1.4%); Group 4:
A+B−/cag+/s1 (7%); Group 5: A+B−/cag+/s2 (2.8%); Group 6: A−B+/
cag+/s1 (22.5%); Group 7: A−B+/cag+/s2 (14.1%); Group 8: A−B+/
cag−/s1 (1.4%); Group 9: A−B+/cag−/s2(4.2%); Group 10: A−B−/
cag+/s 1(2.8%); Group 11: A−B−/cag+/s2 (2.8%). Frequency of Group 1
in GC, NUD and PUD patients is 75%, 27.3% and 27.3% respectively
and Group 7 is prevalent in 36.4% of PUD patients. babA prevalence in
GC, NUD and PUD patients was 75%, 47.7% and 33.3% and babB
prevalence was 93.8%, 77.3% and 91.7% respectively. 75% of Hp
isolates were babA/babB double positive in GC patients.
Conclusion: Frequency of babB is higher among Iranian GC and
PUD cases but babA frequency is limited to GC cases. Infecting
strains from Groups 1 and 7 were found to be associated with GC
and PUD respectively. Co-presence of cagA, s1vacA, babA and babB
may work synergistically in exacerbating the resulting inﬂammation
which may create grounds for development of intestinal metaplasia and
eventually GC, whereas co-existence of cagA, s2vacA, babB may cause
susceptibility to PUD development. In GC cases presence of babA/babB
double positive are signiﬁcantly prevalent (p = 0.044). Application of this
analysis on additional samples will allow for a more concrete conclusion.
R2249 Association of Helicobacter pylori and chronic idiopathic
urticaria
M. Marcano, G. Perez-Perez, M.I. Urrestarazu, N. Serrano,
M.E. Cavazza (Caracas, VE; New York, US)
Objective: The aim of this work was determined the relation of
the infection with H. pylori and the dermatological disease Chronic
Idiopathic Urticaria (CIU).
Methods: We studied 60 patients with CIU diagnosis at baseline and
6 weeks after therapeutic intervention to eradicate H. pylori in the
infected patients. H. pylori status was established by UBT-C14 and
we performed Elisa’s to determinate the antibodies response to CagA
(Cytotoxin-associated gene product) and H. pylori Whole-Cell (WC)
antigens.
Results: 44 patients were UBT-positive and 16 UBT-negative; no
statistically signiﬁcant differences were founded in the mean age, gender,
duration of disease, and symptoms between both groups. No correlation
between H. pylori density (UBT DPM mean value) and symptoms
severity was found. Serology correlated in 88.6% of UBT-positive
patients and 5 (11.4%) of them were false negative for H. pylori WC
ELISA but 4 (80%) of those patients were positive for CagA ELISA. In
contrast, only 5 (31.3%) of UBT-negative patients shows concordance
in the serology (WC & CagA negative); with 4 (25%) false positive for
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H. pylori WC and CagA serology and 9 (43.7%) were false positive
for CagA. A decrease in WC OD net values was ﬁnd in the UBT-
positive patients with clinical improvement after H. pylori successful
eradication (100%) compared with UBT-negative patients (P< 0.05), but
not for CagA OD net values. Severity of symptoms showed a correlation
with increasing OD values of WC and CagA in the UBT-negative group
(P> 0.05).
Conclusion: H. pylori eradication is associated with clinical improve-
ment of CIU. In H. pylori-positive patients, CagA serology is more
reliable than WC serology. Successful eradication of H. pylori correlated
with clinical improvement, but not with the severity of the disease. UBT-
negative group showed increase in the WC and CagA OD values in
relation to severity of the disease. All these ﬁndings strengthen the role
of H. pylori in the maintenance of CIU disease.
Grants: FONACIT S1–2000000408, G-2005000371. LOCTI – IBA-02–
2007 /IBA-03–2007. ALUMNWARE – INALUM.
R2250 Investigation of imipenem efﬁcacy against carbapenem-
susceptible but heteroresistant Acinetobacter baumannii
clinical isolates by experimental pneumonia
G. Michail, A. Ikonomidis, E. Neou, A. Maniatis, S. Pournaras
(Larissa, GR)
Objectives: The clinical consequences of the recently described car-
bapenem heteroresistance of Acinetobacter baumannii remain unknown.
The aim of this study was to investigate the efﬁcacy of imipenem
treatment against apparently carbapenem-susceptible, heteroresistant
Acinetobacter baumannii clinical isolates by experimental infection
model.
Materials: The study included four previously characterised A. bauman-
nii clinical isolates: one apparently carbapenem-susceptible A. baumannii
exhibiting unstable carbapenem heteroresistance, one with stable
heteroresistance, one carbapenem-susceptible without heterogeneity and
one carbapenem-resistant. Approximately 107 CFUs of the isolates
were inoculated intratracheally to cause experimental pneumonia in
Wistar rats. The animals were treated with 30mg/kg body weight
imipenem/cilastatin intraperitoneally q. 6 h for 24 h, sacriﬁced, the
lungs excised and homogenised and cultured with serial dilutions, to
estimate the bacterial counts yielded. Equal numbers of animals remained
untreated as controls of the experimental infection.
Results: No bacterial growth was observed from the animals that
were infected by the two carbapenem-heteroresistant isolates and the
susceptible A. baumannii and treated with imipenem. The carbapenem-
resistant isolate yielded approximately 100 CFU/ml of the lung
homogenate after imipenem treatment. All isolates were grown from
the lungs of the untreated animals, in numbers ranging from 13 x 103 to
125 x 103 CFUs/ml, assuring the success of the experimental infection.
Conclusions: The results of the present study indicate that the
heteroresistant A. baumannii isolates tested may be treated with equal
success as susceptible ones, with the administration of adequate
imipenem dosing regimens.
R2251 Veillonella parvula LPS stimulates cytokine production in
a TLR4-dependent manner
R. Capicotto, M. Vinci, A.G. Lamberti, A. Quirino, G. Matera,
M.C. Liberto, M.G. Netea, L.A.B. Joosten, J.W.M. van der Meer,
A. Foca` (Catanzaro, IT; Nijmegen, NL)
Objectives: Veillonella parvula is a Gram-negative coccus present in
animal and human mouth and gastrointestinal tract. Oral V. parvula is
involved in the development of early periodontal disease. Very little is
known about cellular and molecular mechanisms responsible for innate
immune response following microbial population change inside dental
plaque leading to severe periodontitis. Moreover, the interaction between
oral V. parvula LPS and TLR has not been studied yet. The aim of
this study was to investigate the role of TLR4 for the recognition of
Veillonella parvula LPS in human peripheral blood mononuclear cells.
Methods: Experiments were carried out in peripheral blood mononuclear
cells isolated from healthy volunteers. PBMCs were stimulated with
increasing concentrations of V. parvula LPS, with or without addition
of speciﬁc TLR4 antagonist. IL-6 concentrations were determined in
supernatants by ELISA. Stimulation of PBMCs with E. coli LPS was
used as control for TLR4 engagement.
Results: V. parvula LPS stimulated cytokine release in human PBMC in
a dose-dependent manner. Pretreatment of cells with a TLR4 antagonist
signiﬁcantly reduced IL-6 production in PBMC stimulated both with
Veillonella and E. coli LPS. However V. parvula LPS was 10 to 100 fold
less active than E. coli LPS for cytokine induction.
Conclusions: V. parvula LPS is an active stimulus of cytokine
production, although signiﬁcantly less active than enterobacteriaceae
LPS. Cytokine induction stimulated by V. parvula LPS is mediated by
TLR4 engagement.
R2252 Inhibitory effect of hyperimmune LPS antiserum in attach-
ment of E. coli O157:H7 to HEP-2 cell and murine model
S. Moradi Bidhendi, P. Khaki, S. Pourbakhsh, M. Sattari, M. Heidari
(Karaj, Tehran, IR)
Objective: Enteroheamorragic E. coli(EHEC) strain of serotype
O157:H7 is associated with humans disease. The organism have also
been associated with a spectrum of sporadic and endemic human
illnesses ranging from nonbloody diarrhoea to the haemolytic uremic
syndrome. This work was carried out to study of inhibitory effect of
hyperimmune LPS antiserum in attachment of bacteria to HEP-2 cell
and murine model.
Methods: Bacterial strain was isolated from human. Hyperimmune
LPS antiserum was prepared by injecting to rabbit. Different dilution
of antiserum prepared. These dilution added to the suspension of
bacteria(2×108 cfu/ml) for 30 minutes then added to the HEP-2 cell and
after 3−6 hours the cells examined with staining and light microscope.
For murine model these mixture gave to mice with gavage and the
inhibitory attachment of these dilution attained with staining and electron
microscope of intestinal tract of mice.
Results: The result showed that 1/1280 dilution can prevent the
attachment of the bacterium to HEP-2 cell. For murine model the result
showed 1/640 dilution of antiserum was inhibitory.
Discussion: Our results suggest that the prepared antiserum can use to
prevention of bacterial attachment and may be useful for control of the
disease that cause with this bacteria.
R2253 Risk factors for hospital-acquired Acinetobacter baumannii
bacteraemia
C. Bulut, C. Ataman Hatipoglu, M.A. Yetkin, G. Ertem, G.R. Yilmaz,
A. Ozisik, E. Karakoc, A.P. Demiro¨z (Ankara, TR)
Objectives: Acinetobacters are increasingly detected as aetiological
agents of hospital acquired infections in seriously ill patients, in recent
years. The aim of this study was to evaluate risk factors for Acinetobacter
baumannii bacteraemia.
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Methods: Prospective laboratory-based active surveillance has been
performed in our hospital. Hospital acquired A. baumannii infections
detected between January 2005 and December 2006 were enrolled to
the study. The deﬁnitions of hospital acquired infections were established
by using CDC criteria. Conventional methods were used to identiﬁcate
Acinetobacter isolates. Disc diffusion method was used for antimicrobial
susceptibility testing of these microorganisms.
Results: Total of 117 A. baumannii infections were included in the
study. These infections were detected in 58 male and 59 female patients.
The mean age of the patients was 59±19 years. A. baumannii was
isolated most commonly from the neurosurgery intensive care unit (ICU)
(30%), followed by neurology ICU (22%) and internal medicine wards
(12%). Of the isolates, 28.5% were isolated from pneumonia, 22% from
primary bacteraemia, 21.5% from surgical site infections, 20.4% from
urinary tract infections and 7.6% from other infections. Predisposing
factors detected in the patients with A. baumannii infection were urinary
catheter (81.3%), central venous catheter (41%), mechanical ventilation
(30%) and tracheotomy (15%). The rate of the patients who had coma
was 46%. The mean duration of time between hospitalisation and
occurrence of infection was 18±15 (3–108) days. In seventy patients
(57%) A. baumannii isolates were multi-drug resistant (MDR).
A. baumannii bacteraemia was detected in 51 episodes. Bacteraemia
and other infections due to A. baumannii were compared. Male gender,
insertion of urinary catheter, presence of central venous catheter,
presence of peripheric arterial catheter, mechanical ventilation, total
parenteral nutrition and being an ICU patient were found as risk factors
for A. baumannii bacteraemia (p< 0.05). On multivariate analyses only
mechanical ventilation was found as a risk factor (p< 0.05).
Conclusions: In ICUs, patients with mechanical ventilation, urinary
catheter, central venous catheter, total parenteral nutrition are at risk for
A. baumannii bacteraemia. High mortality rate and antibiotic resistance
of these microorganisms are still important problems.
Animal models including experimental
treatment
R2254 Comparison of Klebsiella pneumoniae virulence in
mammalian and non-mammalian animal models
S. Vilches, N. Jimenez, M. Reyes, S. Merino, M. Salo, J. Tomas
(Barcelona, ES)
K. pneumoniae is an important cause of nosocomial infections occurring
at almost all body sites, but with highest incidence in the urinary and
the respiratory tracts.
The main populations at risk are neonates and predisposed and
immunocompromised hosts. K. pneumoniae typically has both smooth
LPS (O antigen) and capsule (K antigen) on its cell surface, and both
contribute to the pathogenicity of this species. The aim of this study
was to compare using different K. pneumoniae well deﬁned mutants
lacking only the capsule, the O-antigen LPS, several parts of the LPS
core (outer and inner) with or without capsule, several mammalian and
non mammalian animal models.
In K. pneumoniae, the O-antigen LPS is critical for serum resistance,
changes in surface hydrophobicity, adhesion to UEC cells and urinary
tract infection and colonisation in rats. The capsule is essential in the
K. pneumoniae experimental model of pneumonia, while the colonisation
of the urinary tract by K. pneumoniae requires a complete LPS with
O-antigen. The K. pneumoniae virulence tested as LD50 in mice
inoculated intraperitoneally seems to be dependent on the capsule and
the complete LPS (probably full core LPS and O-antigen molecules).
The two non mammalian experimental models used, unicellular
Dictyostelium ameobae and the insect Drosophila melanogaster, renders
similar results to the ones obtained in the experimental model of
pneumonia about the important role of the capsule.
R2255 Efﬁcacy of tigecyclin vs. vancomycin in ampicillin- and
gentamicin-resistant E. faecium experimental endocarditis
E. Vryonis, E. Perivolioti, P. Fanourgiakis, E. Platsouka, M. Samarkos,
M. Katsimpoulas, E. Balafas, N. Kostomitsopoulos, P. Karagianakos,
O. Paniara, A. Skoutelis (Athens, GR)
Objectives: Tigecyclin is the ﬁrst available glycycycline. It is a new
drug exhibiting broad-spectrum activity against aerobic and anaerobic
bacteria including multidrug resistant Gram-positive and Gram-negative
pathogens.
The aim of this study was to evaluate the efﬁcacy of tigecyclin compared
to vancomycin in an animal model of experimental endocarditis due
to an ampicillin (AMP) & gentamicin (GEN) resistant and tigecyclin
glycopeptides susceptible clinical isolate of Enterococcus faecium.
Methods: We used a rabbit model of left sided experimental
endocarditis. One day after the insertion and ﬁxation of a polyethylene
catheter into the left ventricle, animals were inoculated with E. faecium.
Thirty-six hours later they were randomly assigned to a control group (C)
and groups receiving intravenous tigecycline 7mg/kg/q12 h x 5 days (T)
or intravenous vancomycin 50mg/kg/q12 h x 5 days (V). At the end of
treatment all animals were sacriﬁced. Therapy response was determined
by blood cultures and quantitative (log10 cfu/gr of tissue) cultures of
aortic valve vegetations, liver, spleen, kidney and brain.
Results: The results obtained of the different therapeutics groups are
expressed in the Table.
Groups Vegetationa,b Livera,b Kidneya,b Spleena,b Braina,b
C 7.86±0.91 (0/10) 5±2.42 (0/10) 5.8±2.54 (0/9) 5.23±2.67 (0/9) 4.63±1.85 (0/9)
V 5.64±0.25 (0/8) 3.97±0.18 (0/5) 40.3±0.77 (0/5) 3.63±0.4 (0/5) 3.77±0.56 (0/5)
T 5.34±0.32 (0/8) 4.38±1.32 (2/8) 4.33±1.23 (2/8) 4.48±1.29 (2/8) 3.42±0.97 (2/8)
Mann-Whitney
2-tailed test
C vsV p< 0.0001
C vs T p<0.0001
V vs T p = ns
C vsV p = 0.0007
C vs T p = 0.0117
V vs T p = ns
C vsV p = 0.012
C vs T p = 0.0206
V vs T p = ns
C vsV p = 0.004
V vs T p = ns
C vsV p = 0.029
C vs T p = 0.0111
V vs T p = ns
aMean±SD log10 CFU/g of tissue.
bNo. of sterile vegetations/No. of treated animals.
All the blood cultures of the V and T group at the end of treatment were negative.
Conclusions: Although both regiments reduce signiﬁcantly the bacterial
count per gram of vegetations, treatment with V was found to be more
potent than QD. Also animals treated with V had lower bacterial counts
per gram of liver, brain and spleen tissue.
Bioﬁlms
R2256 Bioﬁlm production by clinical strains of Acinetobacter
baumannii isolated from patients hospitalised in two
tertiary care hospitals
M. Wroblewska, A. Sawicka-Grzelak, H. Marchel, M. Luczak, A. Sivan
(Warsaw, PL; Beer Sheve, IL)
Objectives: Bioﬁlm poduction by microorganisms is at present
increasingly recognised as virulence factor, particularly relevant to
opportunistic pathogens, such as Staphylococcus epidermidis, Pseu-
domonas aeruginosa and Candida spp. However, scarse reports could
be found in literature on bioﬁlm formation by clinical strains of
Acinetobacter baumannii isolated from hospitalised patients. The aim of
the study was to evaluate whether factors such as bacterial genotype, site
of isolation, resistance to carbapenems and duration of hospitalisation are
related to bioﬁlm formation by clinical strains of A. baumannii.
Methods: In total 34 randomly selected, clinical strains of Acinetobacter
baumannii, isolated from patients hospitalised in two tertiary care
hospitals (24 strains from hospital A and 10 strains from hospital B),
were examined for bioﬁlm formation. They originated from various
clinical specimens (blood, catheter tip, urine, wound swabs, bronchial
aspirates). Bacteria were cultured according to standard bacteriological
techniques. Susceptibility of the isolates to antibacterial agents was tested
by a disk-diffusion method (according to CLSI recommendations) and
E-tests. The strains were typed retrospectively by RAPD and PFGE
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analysis. Bacterial biomass in bioﬁlms was determined quantitatively
using a spectrophotometer (O.D. 600 nm).
Results: There was a great variability in the ability of the tested
strains to produce a bioﬁlm. Analysis of bioﬁlm formation by the
studied clinical strains of A. baumannii revealed three groups of strains,
regarding their ability to produce a bioﬁlm. However, no relation could
be found between the ability of bioﬁlm production and molecular type,
carbapenem resistance or site of isolation of the clinical strains of
A. baumannii. Interestingly, in two cases an increase in bioﬁlm formation
could be detected in A. baumannii isolates cultured from the same patient
upon prolonged hospitalisation.
Conclusion: A better understanding of bioﬁlm formation by Acinetobac-
ter and genetic basis for control of this process are required to develop
novel strategies for dealing with infections caused by these opportunistic
and often multi-drug resistant nosocomial pathogens.
R2257 Antimicrobial efﬁcacy of commercial dentifrices with
triclosan or stannous ﬂuoride
V. Haraszthy, J. Zambon, P. Sreenivasan, W. DeVizio (Buffalo,
Piscataway, US)
Dentifrices with antimicrobials augment mechanical control of bacteria
in oral bioﬁlms and provide important clinical beneﬁts such as reductions
in gingivitis.
Objectives: This study assessed antimicrobial effects of commercial
dentifrices with triclosan/copolymer (Colgate Total; TCN/copolymer),
stannous ﬂuoride (Crest Pro-Health; SnF2) or ﬂuoride (Crest Cavity
Protection; F). Antimicrobial effects were determined on a battery of 17
oral and non-oral bacterial strains representative of species in the normal
oral cavity, in dental caries, in periodontal disease, and in halitosis. An
ex-vivo test examined the effects of dentifrices on supragingival plaque
from 10 adults as representative of the effects on bacteria in naturally-
occurring bioﬁlms.
Methods: Antimicrobial effects on 17 bacterial strains were determined
by broth-based procedures for minimal inhibitory concentrations
(MIC’s). The lowest concentration of dentifrice inhibiting microbial
growth after incubation is reported. For the ex-vivo study, dental plaque
was collected from all teeth of the 10 subjects. Plaque samples were
dispersed and serial dilutions plated on solid media containing different
concentrations of each dentifrice and on control media without dentifrice.
Bacterial colonies were enumerated following incubation.
Results: The TCN/copolymer dentifrice demonstrated the lowest
MIC’s. Substantial inhibition of oral Gram-negative bacteria (such as
Veillonella sp. and periodontal pathogens including Aggregatibacter
actinomycetemcomitans, Eikenella corrodens, and Fusobacterium nu-
cleatum) and Gram-positive bacteria (Streptococcus sp.) was observed
by the TCN/copolymer dentifrice. Analyses of the ex-vivo studies by
2-way ANOVA with subjects and dentifrice in the model demonstrated
signiﬁcant effects by the dentifrices (p< 0.0005). Post-hoc Tukey
multiple comparison tests indicate signiﬁcantly higher inhibition by
TCN (>80%) than by either of the other dentifrices (p< 0.00005). No
signiﬁcant differences were observed between the SnF2 and F toothpastes
(p = 0.99).
Conclusions: Results demonstrate signiﬁcantly higher antimicrobial
effects from the TCN/copolymer dentifrice against a panel of bacteria
compared to the SnF2 and F dentifrices. TCN/copolymer dentifrice
resulted in signiﬁcantly higher ex-vivo inhibition of dental plaque
bacteria in naturally-occurring bioﬁlms compared to the other dentifrices
(p< 0.0005).
R2258 Antibioﬁlm activity of bismuth ethandithiol, bismuth
dimercaprol, silver nitrate and EDTA on bioﬁlm producing
Pseudomonas aeruginosa
A. Abdi-Ali, F. Khani Juy Abad, M.A. Bahar (Tehran, IR)
Objectives: The purpose of this investigation was to study the effect
of four different biocides against bioﬁlm producing Pseudomonas
aeruginosa.
Methods: Initially, MICs of EDTA, BisEDT (bismuth ethandithiol),
BisBAL (bismuth dimercaprol) and silver nitrate on 2 bioﬁlm producing
strains of P. aeruginosa (strain 214 isolated from clinical specimen
and standard strain 8821M) were determined by microdilution method
according to CLSI standard. Subsequently, bioﬁlm formation of these
strains in the presence of biocides was determined by modiﬁed microtitre
plate method.
Results: Results showed that in the presence of these biocides, bioﬁlm
formation is inhibited on the average up to 80% in MIC concentration.
Our ﬁnding also showed that BisBAL and BisEDT are more effective in
preventing bioﬁlm formation.
We also investigated bactericidal activity of these biocides. The results
showed differences in antibiotic susceptibility of planktonic and bioﬁlm
cell populations. Complete eradication of Planktonic cells were observed
using with 16–32 fold MIC of EDTA, 16 fold MIC of silver nitrate, 64
fold MIC of BisBAL and 16 fold MIC of BisEDT, While bioﬁlm was
completely eradicated by treatment with 32–64 fold MIC of EDTA, 512–
1024 fold MIC of silver nitrate, 1024–2048 fold MIC of BisBAL, and
2048 fold MIC of BisEDT.
Conclusion: Our ﬁnding showed that these biocides were effective in
reducing bioﬁlm formation and can be used for inhibiting of bioﬁlm
formation in industry by cleaning of surfaces and application of catheter
impregnating with biocides in medicine.
R2259 Antibiotic susceptibility of Pseudomonas aeruginosa bioﬁlm
to uliﬂoxacin and other ﬂuoroquinolones
P. Ceccarini, A. Capezzone de Joannon, V. Rossi (S. Palomba, Rome, IT)
Objectives: Pseudomonas aeruginosa is one of the most medically
relevant bioﬁlm forming bacterium and an important causative agent of
many human infections. Since uliﬂoxacin, the active form of the prodrug
pruliﬂoxacin, is a quinolone with a potent antipseudomonal activity, this
study intended to determine in vitro the activity of uliﬂoxacin compared
to other ﬂuoroquinolones (FQs) on P. aeruginosa PAO1 bioﬁlm.
Methods: the activity of uliﬂoxacin, ciproﬂoxacin, levoﬂoxacin and
moxiﬂoxacin on P. aeruginosa PAO1 was studied both using a
polystyrene 96-wells plate bioﬁlm susceptibility assay (MBEC™;
Innovotech) and the standard microdilution method (CLSI). Bioﬁlm was
formed on the pegs of a modiﬁed microtiter lid culturing P. aeruginosa
PAO1 in Trypticase Soy Broth for 7−9 h to obtain a bacterial bioﬁlm
population from 3×106 to 5×107 colonies forming units (CFU) /peg.
Activity of FQs on bioﬁlm was determined after 24 h treatment
with drugs (concentrations range from 1 to 512mg/L) evaluating the
bactericidal activity on bioﬁlm disrupted by sonication and measuring
bacterial regrowth both in fresh broth medium and on agar plates by
CFU determination.
Results: MICs were obtained following the standard microdilution
method using as initial inoculum the broth culture which originated
bioﬁlm. MICs expressed in mg/L were 0.25 for uliﬂoxacin, 0.5 for
ciproﬂoxacin, 2 for levoﬂoxacin and 4 for moxiﬂoxacin.
A complete eradication of sessile cells and the minimum bioﬁlm
eradication concentration (MBEC) on 7.5 h bioﬁlm (3×106 CFU/peg)
was obtained with uliﬂoxacin at 2mg/L and at higher concentrations
with the other tested FQs.
High killing effect was obtained on older bioﬁlm (9 h and 5×107
CFU/peg) at concentrations of about 4 times MIC values for all
FQ. In particular a 5 log reduction was obtained at the following
concentrations: 1−2mg/L of uliﬂoxacin, 2mg/L of ciproﬂoxacin,
4−8mg/L of levoﬂoxacin and 8–16mg/L of moxiﬂoxacin.
Conclusions: FQ antibiotics exerted a remarkable bactericidal activity
against P. aeruginosa PAO1 bioﬁlm. In particular uliﬂoxacin showed the
highest activity at concentrations equivalent to those found in plasma
and tissues after oral treatment.
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R2260 Correlation between antifungal drug susceptibility and
morphological changes of Candida albicans and Candida
parapsilosis bioﬁlms
A. Katragkou, M. Kruhlak, M. Simitsopoulou, A. Chatzimoschou,
E. Georgiadou, C. Cotten, T. Walsh, E. Roilides (Thessaloniki, GR;
Bethesda, US)
Objective: While the effects of older antifungals on Candida bioﬁlms
(BF) are well-documented, less is known about the effects of newer
triazoles and echinocandins against Candida BF. Our objective was to
determine the activities of voriconazole (VRC), posaconazole (PSC),
caspofungin (CAS) and anidulafungin (ANID) against Candida albicans
(CA) and Candida parapsilosis (CP) BF, to compare these activities with
their planktonic (PL) counterparts and to correlate the susceptibility with
the corresponding morphological changes.
Methods: Two CA and 1 CP clinical BF-producing strains were used
for susceptibility testing. A Green Fluorescent Protein-tagged CA strain
was used for microscopy. BF were grown on silicone elastomer disks
in 12-well or 96-well plates at 37ºC under constant shaking for 48–
72 h. Mature BF were incubated in RPMI-1640 containing no drug
(controls), VRC, PSC, CAS or ANID at two-fold dilutions for 24 h.
BF formation and antifungal activities were assessed by XTT assay as
changes in BF metabolic activity. BF MICs were determined as minimum
antifungal concentrations causing 50% reduction in the BF metabolic
activity compared to controls. PL MICs were determined by CLSI M27-
A2 method. Confocal laser scanning microscopy (CLSM) was used to
evaluate the effects of VRC and ANID on BF morphology. ANOVA with
post-test analysis was employed.
Results: PL MICs for CA-M61, CA-GDH2346 and CP-PA/71 were of
VRC 0.01, 4, 0.03, of PSC 0.001, 4;0.001, 0.01, of CAS 0.06, 0.03,
0.06 and of ANID 0.003, 0.003, 0.125mg/l, respectively. By comparison,
the BF MICs of VRC were >256, >256, 256, of PSC >64, >64,
>256, of CAS 0.06, 0.03, 1 and of ANID 0.5, 0.12, 2. The maximum
inhibitory effect of CAS against CA BF was noted for both strains at
2mg/l (37±9% vs. control p< 0.01) and of ANID at 0.5 or 8mg/l
(48.5±3.4% or 40.3±4.1% vs. control, p< 0.001) depending on the
strain. The corresponding values of both CAS and ANID for CP BF
were 16mg/l (41.2±9%, p< 0.001; 47.6±7%, p = 0.01). CLSM showed
that VRC-treated CA BF were morphologically similar to untreated
controls; whereas, ANID-treated CA BF were greatly distorted with
shorter hyphae, looser network and vacuoles on the cell wall. However,
complete sterility of the silicone substrate did not occur.
Conclusions: Echinocandins exhibit relatively low MICs for Candida
BF; whereas, MICs of triazoles are very high. These ﬁndings correlate
with the morphological changes observed in drug-treated BF and provide
insight into mechanisms underlying BF resistance.
R2261 Bioﬁlm-production is strongly correlated with the presence
of accumulation associated protein
M. Karanika, D. Iliopoulos, M. Vergi, C. Koutsia-Carouzou,
K. Angelou, K. Malizos, E. Petinaki (Larissa, Athens, GR)
Objectives: The implication of bioﬁlm in chronic bacterial infection in
many species has triggered an increasing interest in the characterisation
of proteins involved in bioﬁlm formation. The purpose of this study
was to investigate the role of polysaccharide intercellular adhesin (PIA),
accumulation associated protein (Aap) and bioﬁlm-associated protein
(Bap) in bioﬁlm formation among Staphylococcus hominis.
Methods: A total of 50 genetically unrelated Staphylococcus hominis,
recovered from various orthopaedic clinical specimens were tested for
bioﬁlm-production by Christensen, and for the production of PIA,
AAP and BAP. Staphylococcal cells were suspended in 100 mM PBS
containing 5 mM EDTA and 1 mM PMSF. Cells were centrifuged, and
suspended in 1ml digestion buffer [50 mM Tris/HCl pH 7.5, 20 mM
MgCl2 and 30% rafﬁnose (Sigma)]. To each sample protease inhibitors
(Complete cocktail; Roche), and lysostaphin (Sigma) were added, and
the suspension was incubated in a 37ºC water bath for 30 min. After
centrifugation at 6000 g, the supernatant fraction, which contained the
wall-associated proteins, was analysed by SDS-PAGE (4–20% separation
gel). PIA was detected with the PIA-speciﬁc antiserum (1:5,000),
AAP was detected with AAP-antiserum (1:2,500 dilution) and BAP
was detected by anti-Bap serum (1:2,000 dilution). Bound antibodies
were visualised by anti-rabbit immunglobulin G-alkaline phosphatase
conjugate (1:5000; Sigma).
Results: Eighteen out of ﬁfty S. hominis tested (36%) were found to be
bioﬁlm-producers. Among them, 88.8%, 50% and 38.8%, respectively
were found to produce AAP, PIA and BAP. Strong production was
detected in six strains (33.3%) that simultaneously expressed AAP,
PIA and BAP. A week bioﬁlm production was associated with the
combination of AAP and BAP, or AAP and PIA in two independent
strains, while detection alone of PIA was found in two strains.
Conclusions: These results clearly demonstrate that PIA is not the only
protein responsible for bioﬁlm-production, but other proteins, such as
AAP, also play a crucial role.
R2262 Effect of sitC deletion on planktonic and sessile growth of
Staphylococcus epidermidis
C. Massonet, V. Pintens, R. Merckx, J. Van Eldere (Leuven, BE)
Objectives: To investigate the role of the SitABC transporter in bacterial
growth and metal cation uptake during in vitro planktonic and sessile
growth and in an in vivo rat model for foreign body infections.
Methods: A bioﬁlm forming S. epidermidis strain 10b, a PIA negative
strain Tu¨3298 and an existing S. epidermidis sitC deletion mutant
(Tu¨3298 sitC::erm) were used. For in vitro studies bacteria were grown
overnight in RPMI without Fe (fRPMI) or in iron depleted BHI (fBHI)
and re-incubated in different media with iron (25mM FeCl3) and/or
manganese (25mM MnCl2). Siderophore activity was measured with a
Chrome Azurol S Liquid Assay. For in vivo studies a subcutaneous rat
model was used. Catheter fragments, inoculated with a low inoculum
of S. epidermidis, were implanted subcutaneously in rats as described
(Vandecasteele et al. BBRC. 2002; 291: 528). Gene expression was
quantiﬁed by real-time PCR.
Results: S. epidermidis Tu¨3298 sitC::erm was not able to grow in a
Fe-limited environment, in contrast to its wild type strain. Siderophore
production in fBHI and certainly in fBHI plus free Fe demonstrated the
bacterial need for siderophores for growth. For the sitC deletion mutant,
a strong beta-haemolytic activity was observed. All strains tested were
able to adhere to the catheter surface and to form a bioﬁlm in our in
vivo model. SitC was higher expressed in S. epidermidis Tu¨3298 during
initial attachment, whereas in strain 10b expression was highest during
the maturation and persistence phase. One week post-implantation the
number of bioﬁlm adherent bacteria was transiently higher in the sitC
deletion mutant. High expression of fur and a low expression of sirR
were measured in the mutant strain in contrast to their expression levels
in the wild-type strain with lower number of sessile bacteria.
Conclusion: In vitro experiments suggest that the SitABC transporter
favours Fe uptake over Mn2+ uptake. The more pronounced haemolytic
activity of the mutant strain, indicated a switch to Fe uptake from haem
in the mutant strain and the presence of another siderophore-dependent
Fe uptake system(s) for bound Fe. A deletion of sitC had, directly or
indirectly, a negative effect on expression of sirR and a positive inﬂuence
on expression of fur.
R2263 Evaluation of linezolid, vancomycin, gentamicin, and
ciproﬂoxacin activity against Staphylococcus aureus bioﬁlms
using XTT and Resazurin
N. Ferna´ndez-Hidalgo, M.T. Martı´n, P.M. Lo´pez, X. Gomis, J. Gavalda`,
B. Almirante, A. Pahissa (Barcelona, ES)
Objective: S. aureus (SA) bioﬁlms (BF) show reduced susceptibility
to antimicrobials. The activity of linezolid (LNZ), vancomycin (VAN),
gentamicin (GEN), and ciproﬂoxacin (CIP) against SA BF was evaluated
using the tetrazolium salt XTT, and the redox indicator resazurin (RZ).
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Methods: 10 meticillin and quinolone resistant (MRSA) and 7 meticillin
susceptible (MSSA) SA strains isolated from patients with catheter-
related bacteraemia were studied. BF were obtained on ﬂat bottom
microtiter plates inoculated with 106 cfu/mL in Trypcase Soy Broth
(TSB). Growth control (GC) and sterility control (SC) were included.
Plates were incubated (24 h, 37ºC), and then washed and ﬁlled with
Mueller-Hinton broth containing 2-fold dilutions of LNZ, VAN, CIP,
and GEN (2048−0.125mg/L). After incubation (37ºC, 24 h) plates were
washed, and TSB containing 0.2mg/L XTT + 0.1 microM menadione
or RZ 0.0015% as appropriate was added. After 2.45 h of incubation
at 37ºC, the absorbance of XTT (492 nm) or the ﬂuorescence of RZ
(530/590 nm excitation/emission) was read. SC values were subtracted
to those obtained from the BF wells. The % of metabolic activity (MA) of
BF exposed to antibiotics respect to their respective GC was calculated.
Concentrations (mg/L) that inhibited >75 and >90% (CI75, CI90) of
MA were considered; ANOVA was used to compare log10 of CI75 and
90. Studies were run in triplicate.
Results: XTT and RZ rendered similar results. For MSSA, the geometric
mean concentration that resulted in CI90 was 4.9mg/L for VAN, 9mg/L
for GEN, 2.3mg/L for CIP and 50mg/L for LNZ. For MRSA, the
geometric mean that achieved the CI90 was of 8mg/L for VAN, 157.6
for GEN and 1024 for LNZ. Only CIP resulted in 100% of MA
at 2048mg/L. For MSSA the log10 CI90 for VAN, GEN and CIP
were signiﬁcant lower with respect to that of LNZ (p< 0.05). SA. For
MRSA, the log10 CI90 of VAN was signiﬁcant lower than that for GEN
(p< 0.01) and both VAN and GEN showed signiﬁcant lower log10 CI90
respect to LNZ (p< 0.021).
Conclusions: XTT and RZ performed equally for detection of the
activity of LNZ, VAN, GEN, and CIP activity against SA BF. For both
categories of SA LNZ showed signiﬁcant higher log10 CI90 with respect
to the other drugs. 100% inhibition of MA was only seen in BF of CIP-
susceptible SA exposed to high concentrations of CIP.
R2264 Comparison between proliferation intensity of S. aureus on
unmodiﬁed and new C60-modiﬁed polymers
G. Bancescu, E. Preoteasa, A. Bancescu, S. Dumitriu, C. Murariu,
C. Preoteasa, T. Zecheru, C. Zaharia, C. Cincu (Bucharest, RO)
Objectives: The number of new biomaterials in medicine is growing
and it is important to know the ease by which they are colonised by
microorganisms. The aim of the present study was to assess the intensity
of Staphylococcus aureus proliferation on the surface of some new
composite materials modiﬁed with C60 fullerene compared to materials
of unmodiﬁed polymers.
Methods: The conventional test pellets were solid blocks (diameter
= 10mm, h = 1mm) of different materials: polymethylmethacry-
late (PMMA), PMMA-fullerene composites (PMMA-F), poly(2-
hydroxymethylmethacrylate) (PHEMA) and PHEMA-fullerene compos-
ites (PHEMA-F), which were sterilised using UV. The samples were
immersed in a fresh suspension of S. aureus ATCC 25923 in nutrient
broth (with a deﬁned microbial concentration) and incubated at 37ºC for
24 h. Afterwards, the pellets were washed with sterile saline solution
(to remove the nonadherent cells) and dried at 37ºC. Two methods
were used in order to evaluate the microbial proliferation intensity
on the different materials. The ﬁrst consisted in performing imprints
by pressing the surface of the pellets against the surface of three
Mannitol Salt Agar (MSA) plates and counting the bacterial CFUs
after 24–48 h incubation at 37ºC. The second one referred to transfer
(using an automate pipette) deﬁned aliquots of staphylococcal suspension
(obtained by vortex shaking the pellets in a nutrient broth) into a sterile
microplate. After 20 h incubation at 37ºC, the optical densities (OD)
measurements of the staphylococcal cultures were read at 450nm by a
microplate reader (BIO-TEK, Powerwave AS), and the values could be
compared.
Results: In case of the ﬁrst method, no bacterial growth was observed on
MSA at 24 h. The results at 48 h were for: PMMA-F: 3 CFUs, PMMA:
less than 200 CFUs, PHEMA-F: more than 200 CFUs, and PHEMA:
uncountable CFUs. The OD values were in accordance with the results
obtained by the ﬁrst method, regarding the microbial adherence and
proliferation degree on the tested materials.
Conclusion: S. aureus presented higher tendency for proliferation on
PHEMA. Composite materials modiﬁed with C60 fullerene seem to be
less favourable for microbial proliferation than the unmodiﬁed polymers,
but further studies are warranted.
R2265 Pioneer coloniser bacteria in bioﬁlm formation on
galvanised steel in a model cooling tower system
N. Dogruoz, D. Goksay, E. Ilhan-sungur, A. Cotuk (Istanbul, TR)
Objectives: Cooling tower water systems provide an ideal environment
for microbial bioﬁlm. Bioﬁlm in cooling towers is one of the most
common problem that include opportunist pathogens such as Legionella
pneumophila and corrosion agent sulphate reducing bacteria (SRB).
Some bacteria have a higher tendency to produce bioﬁlm than others.
Especially, Pseudomonas and Aeromonas strains are acknowledged to
be the pioneer colonizer and predominant in bioﬁlm formation. But
we have not observed these bacteria in the ﬁrst month in our previous
study related microbial bioﬁlm. The aims of this study were to examine
bioﬁlm formation and to observe the ﬁrst attachment/ detachment of
Pseudomonas spp., Pseudomonas aeruginosa, Aeromonas spp., SRB and
ﬁlamentous fungi on galvanised surfaces during one month in a model
cooling tower water system.
Methods: Galvanized steel was used as test material. Bioﬁlm was
removed from coupon surfaces and resuspended in steril tap water. For
enumeration of heterotrophic bacteria, Pseudomonas spp. Pseudomonas
aeruginosa and Aeromonas spp., bioﬁlm suspensions were spread
plate respectively onto R2A Agar, Pseudomonas Agar Base with CFC
supplement, Pseudomonas Agar Base with CN supplement, Aeromonas
Medium Base with Ampicilin. Postgate medium B and Sabouraud
Dextrose Agar were used for isolation of SRB and ﬁlamentous fungi,
respectively. Glass was used as control.
Results: Colonisation of the galvanised steel and glass by microorgan-
isms occurred very fast from the beginning of the experiment. The
values of heterotrophic bacteria on galvanised steel and glass surfaces
rose during 30 days. Pseudomonas spp., Pseudomonas aeruginosa and
Aeromonas spp. were not determined in the bioﬁlm on both of the
surfaces after 19 days. SRB were determined in the bioﬁlm on both
of the surfaces during the experiment. Filamentous fungi were ﬁrstly
seen on surfaces of galvanised steel and glass at 30 min.
Conclusion: Our results revealed that bioﬁlm was formed on galvanised
steel in spite of its toxic effect on microorganisms. In addition we
established that although Pseudomonas spp., Pseudomonas aeruginosa
and Aeromonas spp. were the pioneer colonizer, they were not
surprisingly determined in bioﬁlm on both of the surfaces after 19
days. The presence of ﬁlamentous fungi on both of the surfaces showed
variable. Also we saw that SRB took part in the bioﬁlm formation from
the beginning of its.
R2266 The prevention of microbial bioﬁlm formation on net
prosthetic appliance for hernioplasty
A. Aﬁnogenova, G. Aﬁnogenov, R. Tikhilov, A. Mironenko, N. Postrelov,
B. Basin, A. Koltsov (St. Petersburg, RU)
Objectives: To evaluate the ability of net prosthetic appliance to prevent
the microbial bioﬁlm formation.
Methods: Net prosthetic appliance is made of lavsan polyﬁlaments.
Antimicrobial effect was attained in vitro when the composition of mixed
high dispersed silver with high-molecular weight polyvinylpyrrolidine
(PVP) was placed on polymeric net. Cell Wells™ 6-Well with Lid
were used. Control – net without mixed composition. The piece of net
was placed on the plate bottom with nutrient medium, then infect with
S.aureus ATCC 6538 was added. The plates were incubated at 37ºC,
1 week, 2 weeks or 3 weeks. The CFU/ml as a testing parameter was
evaluated during the experiment. In vivo the net prosthetic appliances
were placed subcutaneous on guinea-pigs in conditions of microbial
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contamination. Experimental animals were disabled on the 1st, 3d and
5th day of experiment. Then the pieces of net prosthetic appliances
were placed on Petri dishes and incubated at 37ºC, 24 h; after what
the CFU/cm2 of each example were evaluated. The tissue histological
examination was performed in surgical zone in 10–15 days.
Results: In vitro control plates showed solid infect growth after 24 h
and the increasing level of CFU during 3 weeks up to 109 CFU/ml.
Experimental examples showed no CFU in 1 and 2 weeks, during the 3d
week 102 CFU/ml were obtained. In vivo net prosthetic appliance with
tested composition helped to reduce the content of S.aureus in wound.
Control nets possessed 103 CFU/cm2 on the 1st day; 106 CFU/cm2
on the 3d day and 109 CFU/cm2 on the 5th day. The examples of
silver-net tested after 1st, 3d and 5th day were sterile and possessed
antimicrobial effect against S.aureus by agar diffusion method. Their
prolonged antimicrobial effect was obtained after more than 5 days as
well, this is necessary for optimisation of wound reparative processing.
No pus process was in each experimental wound where silver-nets were
placed. Control animals possessed the signs of sub-clinical festering.
Conclusions: High-molecular weight polyvinylpyrrolidine mixed with
silver penetrates to lavsan polyﬁlaments pores leading to pseudo-
monoﬁber formation. Tested composition PVP and silver is biodegrad-
able in 1 week after net application. The net pores cleared that way
are ready for conjunctive tissue growth. Net prosthetic appliance with
antimicrobial composition was successfully applied in different clinics
in Russia.
Antimicrobial pharmacokinetics,
pharmacodynamics and general
pharmacology
R2267 Heterogeneity of the mutant selection window: selection
of resistant Staphylococcus aureus at ciproﬂoxacin constant
concentrations simulated close to the MIC or the mutant
prevention concentration
A. Firsov, I. Lubenko, M. Smirnova, E. Strukova, S. Zinner (Moscow,
RU; Cambridge, US)
Objective: Expected enrichment of resistant mutants at antibiotic
concentrations that fall into mutant selection window (MSW) might
depend not only on the time inside the MSW but also on the position
of the pharmacokinetic proﬁle in the MSW. To test this hypothesis,
the selection of ciproﬂoxacin (CIP)-resistant S. aureus was studied at
CIP constant concentrations (CCs) simulated closer to the bottom of
the MSW (slightly above the MIC – “lower case”) and to the top of
the MSW (slightly below the mutant prevention concentration (MPC) –
“upper case”).
Methods: Two meticillin-resistant strains of S. aureus, one with a wide
MSW (ATCC 6538) and another with a narrow MSW (ATCC 43300)
[respective MPC/MIC ratios are 16 and 4], were exposed to constant-
rate infusion of CIP for 3 consecutive days. With S. aureus ATCC 6538
and ATCC 43300, simulated CCs were 1.3−2 times greater than the
MICs (“lower case”) and 1.5 times smaller than the MPCs (“upper
case”). Bacterial growth on agar plates containing 2×–16×MIC of CIP
was tested daily. Time courses of mutants grown on CIP-containing
plates were expressed by areas under the bacterial mutant kinetic curves
(AUBMCs) measured from the start to the end of the infusion.
Results: Susceptible sub-populations of S. aureus ATCC 43300 were
completely replaced by mutants resistant to 2× and 4×MIC of CIP by
the end of the infusion (both lower and upper cases – CC 0.75 and
1.5mg/L, respectively). Similar replacement occurred with S. aureus
ATCC 6538, but only in the lower case (CC 0.5mg/L). In the upper
case (CC 2.7mg/L), CIP-resistant mutants of S. aureus ATCC 6538
were enriched later and to a lesser extent than in the lower case: for
mutants resistant to 2–16×MIC of CIP, estimated AUBMCs were 2−3-
fold smaller in the upper case than in the lower case. There were no
“position-associated” differences in the enrichment of resistant S. aureus
ATCC 43300, probably due to comparable CCs at both the lower and
upper positions within the MSW.
Conclusion: A more rapid and pronounced enrichment of CIP-resistant
staphylococci occurs with organisms exhibiting a wide MSW. The
possible heterogeneity of the MSW should be considered to better predict
the enrichment of staphylococcal resistance.
R2268 Comparison of vancomycin and teicoplanin trough serum
levels in patients treated for orthopaedic device infections
X. Lemaire, L. Legout, H. Migaud, C. Loiez, Y. Yazdanpanah,
E. Senneville (Tourcoing, Lille, FR)
Introduction: no study has compared the pharmacokinetic performances
of the glycopeptide agents vancomycin (V) and teicoplanin (T) for the
treatment of pts with orthopaedic device infections (ODI).
Objectives: to compare trough serum concentrations of V and T in
patients (pts) treated for with both loading doses and high daily dosages
for ODI.
Methods: medical charts for pts treated with either V or T for ODI
and for which the results of at least 2 trough levels were available were
reviewed. Patients with V or T therapy were compared on the following
parameters: age, weight, renal clearance, protides, fever, white blood
cells, CRP level, and trough serum levels of V or T.
Results: 52 patients hospitalised from May 2000 to December 2005
were eligible for the study. Intravenous loading doses were administered
in 26 pts treated with V (0.5−1g infused during 1 hour) and in 26 pts
treated with T (10mg/kg bid for 5 injections). Following the loading
dose, one-daily10–12mg/kg T infusion and continuous V infusion of
30mg/kg were administered. No signiﬁcant differences in the patients’
demographic parameters were observed between T and V groups.
Trough levels performed at day at day 2±1 and at day 5 ±1 were
signiﬁcantly higher in T than in V patients (26.1 vs 16mg/L, p = 0.01 and
27.8 vs 19.9mg/L, p = 0.01, respectively). When considering an expected
trough value of >25mg/L, this target was reached at day 2+/1 in 1/26 V
pts vs 10/26 T pts (p = 0.002), and at day 5 ±1 in 6/26 V pts vs 13/26
T pts (p = 0.04).
Conclusion: teicoplanin trough serum concentrations obtained during
the ﬁrst week of treatment are signiﬁcantly higher than those of
vancomycin in patients treated with both loading doses and high daily
dosages for ODI.
Mechanisms of action and resistance
R2269 Molecular characterisation of antimicrobial resistance
mechanisms and genotype of Irish Enterobacteriacae
F. Walsh, T. Rogers (Dublin, IE)
Objectives: There is a dearth of information on the development and
spread of antibiotic resistance in Gram-negative hospital-acquired infec-
tions in Ireland. This study aimed to identify the molecular mechanisms
of resistance and the genotypes among Irish Enterobacteriacae.
Methods: Antibiotic susceptibilities were determined by breakpoint agar
dilution method. The resistant isolates were screened for the presence
of b-lactamase and ESBL genes, plasmid mediated ampC genes, qnr
genes, aac(6′)Ib-cr and aminoglycoside genes. The gyr and par genes of
ﬂuoroquinolone resistant isolates were ampliﬁed by PCR and sequenced.
The genetic relatedness of all isolates was performed by PFGE and
analysed using BioNumerics software.
Results: Number of isolates positive for genes/genetic mutations:
Klebsiella pneumoniae: 13 acc-1, 2 dha-1, 1 Shv, 1 CTX-M group 1, 1
aac(6′)-Ib-cr, 2 gyrA and 1 parC mutation.
Enterobacter spp.: 3 dha-1, 5 Shv, 4 Tem, 1 Oxa, 6 CTX-M group 1,
1 group 9, 2 group 26, 3 qnrA, 2 aac(6′)-Ib-cr, 2 aac(6′)-IIc, 9 gyrA
and 5 parC mutation.
Escherichia coli: 1 Shv, 7 Tem, 2 Oxa, 4 CTX-M group 1, 2 group 8,
5 group 9, 1 group 26, 1 qnrA, 1 qnrB, 16 gyrA, 1 parC and 1 parE
mutation.
One of the Enterobacter species isolates, which tested positive for the
aac(6′)-Ib-cr gene, was an Enterobacter aerogenes. This gene has never
been identiﬁed in this genera prior to this study.
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This is the ﬁrst detection of isolates with blaOXA genes (in
Enterobacteriacae), CTX-M groups 8 and 26, the Qnr genes, aac(6′)-
Ib-cr gene, aac(6′)-IIc gene and mutations within the DNA gyrase and
DNA topoisomerase genes in Ireland. A novel amino acid mutation,
L445H, was identiﬁed in the parE gene of an E. coli.
The PFGE patterns analysed by BioNumerics did not suggest the
predominance of a particular clone within any of the bacterial species.
The resistant E. coli isolates 14815 and 28265 appeared to be very
closely related, with only 1 band difference. Isolate 14090 was identical
to 28265. Isolate 14090 was susceptible to ﬂuoroquinolones and
cephalosporins.
Conclusions: These ﬁndings indicate that the transferable antibiotic
resistance genes, which have been associated with outbreaks in other
European countries, are present in Ireland. The PFGE results suggest
that resistance is spreading due to horizontal transfer of resistance genes
rather than vertical transfer of resistant isolates.
R2270 First report of carbapenem-resistant Bacteroides fragilis
strain isolated from an intensive care unit in Italy
G. Lo Cascio, L. Maccacaro, A.R. Centonze, R. Fontana, A. Mazzariol
(Verona, IT)
Objectives: A carbapenem-resistant Bacteroides fragilis strain isolated
in August 2005 from a patient admitted to the intensive care unit of
University Hospital in Verona (Italy) was investigated for carbapenemase
activity and presence of cﬁA genes and activating insertion sequence (IS)
elements.
Methods: The imipenem-resistant B. fragilis, designated BF417, was
identiﬁed with API Rapid ID32A. Metallo-b-lactamase (MBL) produc-
tion was investigated with E-test MBL strips and spectrofotometric assay,
following the imipenem hydrolysis of crude cell extracts. PCR techniques
were used to amplify the cﬁA gene and the insertion sequence (IS)
elements. Sequence was performed by an ABI capillary sequencing
equipment.
Results: The strain BF417 showed high-level of resistance to imipenem
and meropenem (MIC> 32mg/L) and other b-lactam antibiotics:
piperacillin (MIC> 256mg/L); cefoxitin (MIC> 256mg/L); amoxi-
cillin/clavulanate (MIC> 256mg/L).
The MBL E-test showed the presence of a functional metallo-
b-lactamase. The hydrolysis assays showed that the crude cell extracts
from strain BF417 hydrolysed the imipenem at the rate of 4.5×109
moles/min/mg protein.
Sequence analysis of PCR amplicons revealed a cﬁA gene with 99%
of identities to previously described B. fragilis cﬁA-1 and an insertion
sequence (IS) element with 88% of identities to IS614B element.
Conclusions: To our best knowledge this is the ﬁrst carbapenem-resistant
B. fragilis isolated in Italy, bearing a cﬁA gene coding a MBL. The cﬁA
gene ia activated by a new IS element which possesses an overall identity
of 88% to IS614B element.
R2271 Prevalence and efﬂux mechanism of macrolide resistance in
Campylobacter jejuni and Campylobacter coli from different
sources
S. Uzunovic-Kamberovic, M. Kurincic, D. Hodzic, A. Kramar,
T. Zorman, R. Kadribasic, S. Smole Mozina (Zenica, BA; Ljubljana,
SI; Travnik, Sarajevo, BA)
Objectives: The prevalence and efﬂux mechanism of resistance against
erythromycin, azithromycin and clarithromycin in Campylobacter jejuni
and Campylobacter coli isolated from humans, poultry, farm chickens
and water in Zenica-Doboj Canton, Bosnia and Herzegovina during
2001–2006 was investigated.
Methods: Antibiotic resistance phenotypes of Campylobacter jejuni/coli
isolated from humans (n = 222), poultry meat (n = 50), farm chickens
(n = 15) and water (n = 17) were determined by disc diffusion and Etest
methods, and with reference agar dilution and broth microdilution
method with CellTiter-Blue® reagent and automated ﬂuorescence
signal detection. The involvement of efﬂux pumps was evaluated
as well by broth microdilution measurements of MICs with/without
the efﬂux pump inhibitors phenylalanine-arginine beta-naphthylamide
(PAB′N, 20mg/ml) and naphtyl-methyl-piperazine (NMP, 80mg/ml) in
25 selected isolates.
Results: The high proportion of C. coli from humans (119/222), poultry
meat (29/50), farm chickens (8/15) and water (15/17) was found,
56.5%, 56.9%, 53.3% and 88.2%, respectively. Erythromycin resistance
in human, poultry, farm chicken and water isolates was 21.3%, 30.6%,
38.5% and 57.1%, respectively, and it was in the range 17.1%-58.3% and
20.2%-50% in C. jejuni and C. coli isolates. Prevalence of azithromycin
and clarithromycin resistance was similar. The PAB′N and NMP restored
the MICs of two low-level resistant isolates (MICs 8–16 mg/mL, n = 2) to
the level of susceptible strains, and reduced the MICs of all susceptible
strains (n = 14). In high-level resistant isolates (MICs over 32mg/mL,
n = 9) the use of PAB′N increased the susceptibility by 4–16-fold, while
NMP restored the susceptibility of two HLR strains. In the case of
azithromycin and clarithromycin, PAB′N increased susceptibility up to
6- and 128-fold, respectively.
Conclusion: Unusually high prevalence of C. coli and the resistance to
macrolides in both C. jejuni and C. coli isolated from humans, poultry,
farm chickens, and water was noted. Efﬂux activity was conﬁrmed as
involved mechanism at erythromycin, azithromycin and clarithromycin
resistance. However, the results conﬁrm that PAB′N and NMP efﬂux
pump inhibitors are moderately active in reversing macrolide resistance
in Campylobacter isolates. Further studies of mechanisms involved
in macrolide resistance of Campylobacter are required, as well as
monitoring of macrolide resistance of human, animal and environmental
isolates.
R2272 Study on SHV-type extended-spectrum-b-lactamase in
Hunan province
W.E. Liu, H.L. Li, M.X. Zou (Changsha, CN)
Objective: To invesigate the prevalence of SHV-produing Enterobac-
teriaceae isolates in Hunan province. To identify the subtype of SHV
enconding gene and study the epidemiological aspect of SHV-producing
isolates.
Methods: 171 clinical strains of muti-resistant Enterobacteriaceae
isolates were collected from three afﬁliated hospital of Central South
University in the region from October 2004 to July 2005.ESBLs
producing isolates were conﬁrmed by means of phenotypic conﬁrmatory
tests as recommended by the CLSI/NCCLS. PCR and DNA sequencing
were used to determine the genotype of SHV enzymes. The homology
of SHV-producing strains were detected by RAPD.
Results: 26 of 142 ESBLs-producing Enterobacteriaceae isolates were
conﬁrmed to produce blaSHV genes, there are 19 K. pneumoniae,
5 E. cloacae, 1 K.ozaenae and 1 C. freundii. 5 subtypes of SHV-
type b-lactamases were determined, including 9 strains of SHV-28, 7
strains of SHV-12, 7 strains of SHV-1, 2 strains of SHV-11 and 1
strain of SHV-5. There were 6 RAPD types in 19 isolates of SHV-
producing K. pneumoniae, 5 RAPD types in 5 isolates of SHV-producing
E. cloacae.
Conclusions: SHV-12 is the predominant genotype of SHV-type
b-lactamases producing Enterobacteriaceae in Hunan province, and clone
spread has played a certain role in SHV-type b-lactamase producing
K. pneumoniae. SHV ESBLs are not found in Escherichia coli.
R2273 Is Bartonella bacilliformis, endemic pathogen of the Andean
areas, intrinsically resistant to quinolones?
J. Ruiz, L. Flores, M. Vargas, R. Garcia de la Guardia, R. Quispe,
Z.B. Iban˜ez, D. Alvarado, P. Ramirez, L.J. del Valle (Barcelona, ES;
Lima, PE)
Objectives: To characterise the resistance to quinolones and the
sequence of the gyrA and parC gene in Bartonella bacilliformis,
responsible of the Carrion’s disease in the Andean countries.
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Methods: Three B. bacilliformis were included in the study. Two
of them were isolated before of 1957 (CIP 57.17 and CIP 57.18,
Institute Pasteur), previously to the introduction of the quinolones in
the clinical practice, while the third was recovered in 1996. The specie
was conﬁrmed by ampliﬁcation and sequence of the rRNA16S gene.
The QRDR sequence of the gyrA and parC genes was characterised by
PCR ampliﬁcation and posterior DNA sequence. The susceptibility to
nalidixic acid (Nal) and ciproﬂoxacin (Cip) was established both by disk
diffusion and by the E-test method. In all cases the plates were incubated
at 28ºC in a 5% CO2 atmosphere and controlled once to day in order to
avoid contaminations.
Results: The three strains exhibit resistance to Nal by the two tested
methodologies, possessing a MIC> 256mg/L by the E-test method.
While, the two ancient isolates presents a MIC of 0.25mg/L to Cip,
and the remaining isolate has a MIC> 32mg/L to Cip.
In accordance with that is reported in the Gene Bank, the three strains
presents an Ala in the position 85 of the parC gene, equivalent to the
80 of the QRDR of the parC gene of Escherichia coli. Meanwhile, the
two isolates pre-quinolone age presents a Ala in the position 91 of the
gyrA gene, as is described in Gene Bank, possition equivalent to the 83
of the gyrA gene of E. coli while the remaining presents a Val.
Conclusions: Despite its isolation previous to the introduction of
the quinolones in the clinical practice, the studied strains, presents
a constitutive resistance to quinolones, which may be related with
the presence of Ala in the position 91 and 85 of the QRDR of the
quinolone-targets (GyrA and ParC). To our knowledge this is the ﬁrst
report of a clinical isolate of B. bacilliformis presenting an amino acid
substitution in the QRDR of GyrA. These results dissapointed the current
clinical guidelines that recommended the use of ciproﬂoxacin to treat
bartonellosis in some countries of this area.
R2274 Molecular characterisation of penicillin non-susceptible
Streptococcus pneumoniae isolated in Turkey
O. Koseoglu Eser, K.P. Klugman, L. McGee and the Turkish
Pneumococcal Study Group
Objectives: The mechanism of penicillin resistance in pneumococci is
alteration in the structural genes of penicillin-binding proteins (PBPs).
In this study, the diversity of PBPs 2b, 2x, and 1a of Turkish
penicillin non-susceptible strains of Streptococcus pneumoniae (PNSP)
was investigated.
Methods: S. pneumoniae clinical isolates were collected at ﬁve centres
in different cities of Turkey from children and adults. Susceptibilities
of all isolates were determined by CLSI broth microdilution testing
of penicillin, ceftriaxone, levoﬂoxacin, erythromycin and clindamycin.
Serotypes were determined by sequential multiplex-PCR and quellung
reaction with speciﬁc antisera for S. pneumoniae. PNSP isolates were
examined for the PBP genes pbp2b, pbp2x, pbp1a by PCR and restriction
fragment lenght polymorphism (RFLP). All PCR-RFLP ﬁngerprints
were analysed and compared using Bionumerics software and assigned
to speciﬁc proﬁles.
Results: Of the 297 nonduplicated pneumococcal isolates, 128 (43.1%)
showed reduced susceptibility to penicillin (MICs 0.12g/L). Of these,
22 were invasive and 106 were non-invasive. Twenty ﬁve different
serotypes were recognised, while four strains were nontypeable. The
most frequent serotype was 14 (17.9%). Antimicrobial susceptibilities
of PNSP isolates are shown in Table 1. Intermediate resistance
(MIC 0.12−1g/L) to penicillin were found in 54 (42.2%) penicillin-
nonsusceptible isolates and high-level resistance (MIC 2 g/L) in 74
(57.8%). Thirty four (26.6%) of PNSP isolates showed a multi-drug
resistance pattern. PBP proﬁle clusters comprised 56 groups. The largest
group included 43 strains of seven different serotypes: 14, 9V, 6A, 23F,
19F, 13F, 22F; all strains had penicillin MICs 1g/L. Strains belonging
to this predominant proﬁle were found in all 5 centres. The second proﬁle
included eight serotype19A strains.
Conclusions: Penicillin nonsusceptibility among strains from Turkey
was relatively high with a rate of 43.1%. The major serotype associated
with resistance was serotype 14 which accounted for 17.9% of these
isolates. Analysis of PBP 2b, 2x and 1a proﬁles showed a relatively
heterogenous population with 56 different proﬁles determined. However,
one speciﬁc proﬁle associated with MICs of 1g/L was associated with
a variety of serotypes in all 5 centres.
Table 1. Antimicrobial susceptibilities of PNSP isolates
MIC50 MIC90 Range Susceptible, Intermediate, Resistant,
n (%) n (%) n (%)
Penicillin 2 >2 0.12−>2 0 54 (42.2) 74 (57.8)
Ceftriaxone 1 2 0.25−4 78 (60.9) 48 (37.5) 2 (1.6)
Levoﬂoxacin 1 2 0.5−>8 118 (92.2) 7 (5.5) 3 (2.3)
Erythromycin 0.25 >8 0.25−>8 70 (54.7) 2 (5.5) 56 (43.7)
Clindamycin 0.25 >8 0.25−>8 84 (65.6) 0 44 (34.4)
R2275 Detection of KPC-2 in a clinical isolate of Proteus mirabilis:
ﬁrst reported description of carbapenemase resistance in
this species caused by a KPC b-lactamase
R. Tibbetts, G. Morris, W. Dunne (St. Louis, US)
Background: Carbapenem resistance due to the blaKPC carbapenem
hydrolysing b-lactamase is a major healthcare concern in the U.S. Since
its discovery in 2001 blaKPC has been shown to be present in a variety
of Enterobacteriaceae including Enterobacter, Citrobacter, Salmonella,
and Serratia species as well as Pseudomonas aeruginosa. In August 2006
we instituted a prospective study to determine the prevalence of KPC-
producing organisms in our hospital. During this time we identiﬁed an
isolate of Proteus mirabilis that was resistant to ertapenem, meropenem,
and imipenem. PCR analysis using blaKPC-speciﬁc primers produced
an amplicon of the expected size. Herein we describe the ﬁrst reported
Proteus species possessing a plasmid with a functional blaKPC-2 gene.
Methods: blaKPC-speciﬁc polymerase chain reaction was performed
on total DNA and plasmid DNA. Plasmid isolated from P. mirabilis
was ampliﬁed and sequenced using KPC-speciﬁc primers and BigDye
Terminator sequence technology.
Results: blaKPC PCR assays were positive from both total and plasmid
DNA from a carbapenem resistant isolate of P. mirabilis recovered from
blood cultures from a single patient. Zone diameters for ertapenem,
impenem, and meropenem were 10, 6, and 6 respectively. The imipenem
MIC for the isolate was >16 ug/ml. Sequence analysis of PCR generated
DNA indicated 99.5% homology to previously the published KPC-2 gene
sequence.
Conclusions: These results suggest that blaKPC is transferable to
Proteus mirabilis. While this organism is not generally considered a
highly virulent pathogen, it does highlight that fact that blaKPC can
be harboured in normal and/or opportunistic bacteria, which could in
turn provide an opportunity for dissemination of this resistance factor to
other compatible organisms within the intestinal milieu. Further, this data
suggest that PCR analysis should be done on all carbapenem resistant
organisms to screen for the presence of the blaKPC gene.
Resistance surveillance
R2276 Easy accessible surveillance tool for clinical decision-making
of empirical antibiotic therapy
W. Heizmann, P. Heizmann (Berlin, Bad Griesbach, DE)
Objectives: In patients with severe infections like septicaemia, early and
appropriate empiric antibiotic therapy is of utmost importance, resulting
in decreased mortality of patients or shorter length of stay. However, the
always changing pattern of susceptibility of pathogens and geographic
differences in epidemiology makes it necessary to start empirical therapy
based on local data. Often microbiological laboratories produce only
once or twice a year statistical data with regard to epidemiology and
susceptibility. Normally, the clinician himself has no opportunity to
access the laboratory information system for statistical analyses.
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Methods: We developed a new surveillance tool to support analysis of
microbiological data by clinicians. It is based on a business programme
produced by Oracle and accessible via internet explorer.
Results: By means of this tool, the clinician is able extract information
including graphs from the past until the present day – Hospital as a
whole, department and single ward; group of pathogens or a single
pathogen; activity of an antibiotic against different pathogens or a single
pathogen; percentage of susceptibility; development of susceptibility
over different periods of time, e.g. years, quarter of a year, month;
detection of pathogens with predeﬁned resistance mechanisms like
MRSA, VRE or ESBL-producing bacteria; pre-deﬁned warnings, e.g.
MRSA> 20% or decrease of susceptibility >3% of a given combination
of antibiotic and pathogen over different periods of time; detection of
pathogens with a unique pattern of resistance within a hospital. The
number of inquiries is not limited and can be easily tailored to local
needs.
Conclusion: Regular analysis of microbiological data by means of this
easy to handle surveillance tool enables clinicians to optimize empirical
antibiotic therapy based on recent local data and also to detect emergence
of resistant strains in a very early phase.
R2277 Susceptibility of CTX-M producing Escherichia coli against
non-b-lactamase agents
A˚. O¨stholm Balkhed, M. Ta¨rnberg, H. Hanberger, A. Ha¨llgren,
H-J. Monstein, L.E. Nilsson (Linko¨ping, SE)
Objectives: To investigate the activity of different non-b-lactam agents
on CTX-M producing clinical isolates of Escherichia coli in the County
of O¨stergo¨tland, Sweden
Methods: From 2002 until August 2007 145 clinical isolates of
CTX-M producing E. coli were further analysed. Ninetyﬁve isolates
belonged to CTX-M group 1, 50 isolates to CTX-M group 9. Minimal
inhibitory concentrations (MICs) for nitrofurantoin, colistin, fosfomycin,
ciproﬂoxacin, tigecycline, trimethoprim, trimethoprim-sulfamethoxazole
(TMP-SMX) and gentamicin were determined with Etest (AB Biodisk).
The susceptibility was determined according to the breakpoints of the
Swedish Reference Group for Antibiotics. For fosfomycin there were
no available breakpoints and susceptibility was assessed according to
the wild-type distribution from EUCAST. MIC50 and MIC90 were
calculated. Genetic relatedness between isolates was not investigated.
Results: Susceptibility of E. coli belonging to CTX-M group 1 and 9
are shown in the table.
Agent MIC50 MIC90 Susceptibility (%)
group 1 group 9 group 1 group 9 group 1 group 9
Nitrofurantoin 16 8 64 32 68 80
Colistin 0.25 0.25 0.5 0.5 99 98
Fosfomycin 1 1 4 4 94 94
Ciproﬂoxacin 32 1 32 32 28 46
Tigecycline 0.25 0.25 0.5 0.5 99 100
Trimethoprim 32 32 32 32 31 26
TMP-SMX >128 >128 >128 >128 37 28
Gentamicin 2 1 64 64 51 76
Conclusions: The frequencies of susceptibile isolates were low for
ciproﬂoxacin, trimetoprim, TMP-SMX, gentamicin and nitrofurantoin
for isolates belonging to CTX-M group 1 and CTX-M group 9 However,
there was a tendency towards higher susceptibility to nitrofurantoin and
ciproﬂoxacin among isolates belonging to CTX-M group 9. Isolates
in both groups showed high susceptibility for fosfomycin, colistin and
tigecycline and these agents may offer therapeutically options
R2278 Multidrug-resistant bacteria in German intensive care
units, 2001–2007
E. Meyer, F. Schwab, P. Gastmeier (Freiburg, Berlin, DE)
Objectives: The proportions of meticillin-resistant S. aureus (MRSA),
vancomycin-resistant E. faecium and extended spectrum b-lactamase
(ESBL) producing enterobacteriaceae have increased worldwide in the
recent years. We analysed the resistance situation for these pathogens in
German ICUs.
Methods: From 2001 to 6/2007, 47 ICUs participating in SARI
(Surveillance of Antibiotic Use and Bacterial Resistance in Intensive
Care Units) were included in the analysis. Among other things, ICUs
collected prospective, unit-based data on patient days and resistance
proportions of MRSA, VRE faecium, 3rd generation cephalosporin-
resistant E. coli, K. pneumoniae and imipenem resistant P. aeruginosa.
Isolates were nonduplicate. Trends over time were tested using the
Cochran-Armitage trend test.
Results: MRSA resistance rates decreased from 26.3% in 2001 and 17%
in 2007 (p< 0.001). Imipenem resistant P. aeruginosa ﬂuctuated without
a clear trend between (24.2% in 2001 and in 27.6 2006, p = 0.381). The
same was true for 3rd generation cephalosporin resistant K. pneumoniae
(3.9% in 2001 and 8.2 in 2007, p = 0. 642). In contrast, 3rd generation
cephalosporin resistant E. coli increased continuously from 1.1% in 2001
to 10.1% in 2007 (p< 0. 001). Vancomycin resistant E. faecium showed
a sharp peak in resistance in 2005 of 5.6%, but decreased again to 2.7%
in 2007 (p< 0.109).
Conclusion: The continous increase of 3rd generation cephalosporin-
resistant E. coli (an indicator for ESBL production) is alarming and
requires attention and immediate action with respect to antibiotic policy
and infection control.
R2279 Susceptibility to tigecycline by Etest against
extended-spectrum b-lactamase-producing and AmpC-
hyperproducing isolates of Escherichia coli and Klebsiella
spp.
M.P. Roiz, I. De Benito, G. Peralta, R. Teira (Torrelavega, ES)
Objectives: Third generation cephalosporines resistance (TGCR)in
enterobacteria is increasing not only because of harbouring extended-
spectrum b-lactamases (ESBL) but the AmpC hyperproduction (AmpC).
123 ESBL enterobacteria isolates (EI) (108 Escherichia coli and 15
Klebsiella spp.), 23 AmpC EI (19 E. coli and 4 Klebsiella spp.) and 16
E. coli isolates without TGCR isolated from patients of our clinical area,
were investigated for in vitro activity of tigecycline.
Methods: Rutine identiﬁcation and determination of susceptibilities
of antimicrobial agents were tested by using MicroScan or Phoenix
systems. ESBL production was conﬁrmed according to CLSI guidelines.
Tigecycline E-Test was performed on freshly Mueller-Hinton agar and
according to manufacter instructions.
Results: According CLSI interpretative criteria, 3 AmpC EI, 3 ESBL EI
and 1 isolate without TGCR were intermediate. No resistant strains were
found. 95.6% of EI were susceptible to tigecycline. According EUCAST
interpretative criteria, 5 AmpC EI, 3 ESBL EI and 1 isolate without
TGCR were resistant and 1 isolate without TGCR was intermediate.
93.8% of EI were susceptible. Klebsiella spp. and AmpC EI showed
major MIC50 and MIC90 than E. coli and ESBL EI.
Conclusions: Even though there are no comparable number of isolates
between the different groups of EI tested, tigecycline seems to be more
active against E. coli and ESBL EI than against Klebsiella spp. and
AmpC EI. Nevertheless a good activity of tigecycline against EI was
found out. Comparing clinical results with tigecycline treatments in
knowing isolates producing infections would be interesting.
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R2280 Antimicrobial resistance of Spanish Pseudomonas
aeruginosa from blood according to the European
Antimicrobial Resistance Surveillance System (EARSS)
experience (2006–2007)
J. Oteo, O. Cuevas, J. Campos on behalf of the Spanish members
of The European Antimicrobial Resistance Surveillance System
Objectives: Antibiotic resistance in invasive Pseudomonas aeruginosa
(PAE) has been monitored in Europe since 2005 by the European
Antimicrobial Resistance Surveillance System (EARSS). The goal of
this study is to analyse the antimicrobial susceptibility data of invasive
PAE collected by 36 Spanish hospitals during 2006–2007 in comparison
with data from other European countries.
Methods: Each laboratory identiﬁed strains and tested their susceptibil-
ity using its own methods. To assess the comparability of susceptibility
test results, a quality assurance exercise was performed.
Results: We report data on 691 invasive PAE isolated from blood
from the same number of patients; 477 (69%) were males and
214 (31%) females. Twenty-seven patients were <15 years old,
307 between 15–65 years, and 357 >65 years. Resistance ﬁgures
were as follows: ciproﬂoxacin (CI), 23.7%; gentamicin (G), 14%;
tobramycin (T), 13.3%; imipenem (I), 13.3%; ceftazidime (CE), 8.5%;
piperacillin/tazobactam (P/T), 6.3%; and amikacin (A), 2.5%. Sixteen
isolates (2.3%) were simultaneously resistant to CI-G-I-CE-P/T, and 68
(9.8%) were resistant to three or more of these antibiotics. Resistance to
piperacillin/tazobactam, imipenem and ceftazidime was higher in ICUs
(12.8%, 22.2% and 14.9%, respectively) than in Medicine departments
(4.8%, 9.4% and 6.9%, respectively) (p< 0.002). Resistance rates in
isolates from children <15 years was lower than in >14 years for
all antibiotics (p< 0.05). No statisitical differences were observed in
the other age groups. In comparison with other European countries
participating in EARSS in 2006, resistance to carbepenems and
ﬂuorquinolones was lower in Spain than in Greece (46.6% and 45.5%,
respectively), Italy (21.3% and 36.1%), Portugal (20.7% and 20.7%),
Czech Republic (32.6% and 46.5%) and Turkey (32.7% and 30.1%),
but higher than in the United Kingdom (6.2% and 7.6%, respectively)
and The Netherlands (2.1% and 8.7%). Similar resistance ﬁgures than
in Spain were observed in Austria and France.
Conclusions: In contrast with other pathogens, mainly community-
acquired pathogens, antibiotic resistance in PAE in Spain is not amongst
the highest in Europe. However, emergence of co-resistance to multiple
antibiotics can generate important therapeutic problems.
R2281 Prevalence of antimicrobial resistance among uropathogens
causing acute uncomplicated cystitis in female outpatients
in South Korea: a multicentre study in 2006
Y.H. Cho for the Korean Association of Urogenital Tract Infection
and Inﬂammation
Objective: The Korean Association of Urogenital Tract Infection
and Inﬂammation (KAUTII) conducted a survey of the antimicrobial
susceptibility patterns of uropathogens responsible for female acute
uncomplicated cystitis in South Korea in 2006. KAUTII has already
reported similar data in 2002, which are compared with the results of
the present study. The present study is now the second report of an
ongoing programme that provides nationwide and regional references
needed to select empirical therapy.
Methods: This study was carried out with the participation of 22
hospitals in South Korea. A total of 301 isolates were obtained from
female outpatients with acute uncomplicated cystitis. The antimicro-
bial susceptibilities to ampicillin, ampicillin/sulbactam, gatiﬂoxacin,
ciproﬂoxacin, gentamicin, trimethoprim/sulfamethoxazole (TMP/SMX)
and tobramycin were determined by VITEK2 antimicrobial susceptibility
test systems. The antimicrobial susceptibilities to commonly prescribed
drugs were determined.
Results: The most prevalent causative organism was Escherichia coli
(71.1%), followed by enterococci (13.0%), coagulase-negative staphylo-
cocci (5.3%) and other species of Enterobacteriaceae (10.6%). Among
all Enterobacteriaceae isolates, 31.4% were susceptible to ampicillin,
52.3% to ampicillin/sulbactam, 97.6% to piperacillin/tazobactam, 78.9%
to ciproﬂoxacin, 80.3% to gatiﬂoxacin, 86.8% to cefazolin, 99.6%
to amikacin, 80.5% to gentamicin, 81.1% to tobramycin and 73.9%
to trimethoprim/sulphamethoxazole (TMP/SMX). The resistance rates
of E. coli to ciproﬂoxacin and gatiﬂoxacin were 23.4% and 21.8%,
respectively, and 12 (11.8%) of 102 strains were conﬁrmed of producing
extended-spectrum b-lactamase (ESBL). All the ESBL-producing strains
were also resistant to ﬂuoroquinolones. Enterobacteriaceae were highly
susceptible to piperacillin/tazobactam and amikacin (>97%). There was
a small increase in susceptibility to TMP/SMX (73.9%) compared with
the same study in 2002 (62.1%).
Susceptibility of urinary Enterobacteriaceae isolates from female outpatients with
acute uncomplicated cystitis to various antimicrobial agents
Antimicrobial agent Percentage of susceptible strains in 2006/2002
E. coli
(n = 214/291)
Other
Enterobacteriaceae
(n = 32/20)
Total
(n = 246/311)
Ampicillin 35.2/37.2 6.3/15.0 31.4/35.5
Ampicillin/Sulbactam 52.4/44.5 51.6/50.0 52.3/45.0
Piperacillin/Tazobactam 98.6/97.4 90.6/95.0 97.6/97.2
Ciproﬂoxacin 76.6/84.8 93.8/95.0 78.9/85.7
Gatiﬂoxacin 78.2/N.A. 93.8/N.A. 80.3/N.A.
Cefazolin 92.4/92.2 50.0/60.0 86.8/89.1
Amikacin 99.5/99.0 100/100 99.6/99.1
Gentamicin 77.6/81.7 100/80 80.5/81.5
Tobramycin 78.2/85.9 100/80 81.1/85.3
TMP/SMX 70.6/61.3 96.8/70 73.9/62.1
TMP/SMX, trimethoprim/sulphamethoxazole. N.A., not available.
Conclusions: Similar to 2002, the high prevalence of resistance
to ampicillin, ampicillin/sulbactam and TMP/SMX still exists. In
acute uncomplicated cystitis, ﬂuoroquinolones and cephalosporins show
adequate rates of susceptibility for empirical use. The increasing number
of ESBL-producing or ﬂuoroquinolones-resistant strains remains a
serious clinical problem in South Korea.
R2282 Ventilator-associated pneumonia in a tertiary hospital’s
polyvalent intensive care unit: a sixteen-month study
C. Kydona, P. Pappas, D. Avgousti, T. Giasnetsova, C. Tsiotras,
N. Gritsi-Gerogianni (Thessaloniki, GR)
Objectives: ICU is an area of elevated nosocomial infection rates. In our
polyvalent 10-bed Unit of a tertiary care hospital Ventilator-associated
pneumonia (VAP) is the second more frequent infection, complicating
a high percentage of mechanically ventilated patients. Our aim was to
study the incidence and outcome of VAP as well as the trends of the
infective ﬂora.
Methods: We studied all patients who were hospitalised above 72 hours
in our ICU during the last 16 months. Protected bronchial samples of
all patients with suspected VAP were taken and cultured and standard
diagnostic criteria were followed.
Results: 341 patients were hospitalised from 1st August 2006 until 1st
December 2007 in our ICU. 118 patients were excluded due to length
of stay (LOS) less than 72 hours. 223 patients were studied and 42 were
proved to suffer of VAP. Mean age was 55.09±18.57 years, male/female
ratio was 33/9, mean APACHE II score was 23.8±5.63, and average LOS
was 25.7±10.84 days. 44 episodes of VAP were recorded, two of them
being of double pathogen cause and 7 had concomitant bacteraemia.
The mean VAP onset day was 12.25±6.6 days. The most prevalent
pathogens were Gram-negative bacteria: Acinetobacter baumannii 19
(42.2%), Pseudomonas aeruginosa 18 (40%), Klebsiella pneumoniae 4
(8.8%), Stenotrophomonas maltophilia 2 (4.4%) and of Gram-positive
cocci only Staphylococcus aureus 2 (4.4%). The incidence of late VAP
due to MDR Gram-negative pathogens was 28 (63.6%) and 6 of them
(13.6%) were sensitive only to colimycin. The sensitivities are presented
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in the table. Positive outcome was found in 26 patients (61.9%) and was
reversely related to APACHE II score, LOS and MODS.
aminog carbap cephalo cipro pip/tazo
A. baumannii 31.5% 21% 5.2% 0 5.2%
P. aeruginosa 50% 27.7% 16.6% 44.4% 88.8%
K. pneumoniae 75% 50% 25% 25% 25%
Conclusion: Even though the percentage of MDR pathogens was
high, the survival rate was fairly good. Colimycin is still 100%
efﬁcient on MDR Gram-negative pathogens, given both intravenously
and aerosolised for the treatment of VAP, and remains our only constant
ally.
R2283 Antimicrobial resistance and co-resistance in Escherichia
coli isolates from blood cultures. Data from the Regional
Surveillance System of Emilia-Romagna, Italy
C. Gagliotti, C. Capatti, C. Cassani, M. Sarti, C. Venturelli, M.L. Moro
on behalf of the Emilia-Romagna Antibiotic Resistance Study Group
Objectives: To describe the trends of antimicrobial resistance and the
patterns of co-resistance of Escherichia coli isolates from blood cultures
in Emilia-Romagna region, Italy.
Methods: Data were collected through the regional system for
surveillance of antimicrobial resistance which was started in Emilia-
Romagna (a northern Italy region of about four million inhabitants)
since 2003. The number of laboratories participating to the network
increased from 11 in 2003 to 19 in 2006. Each laboratory was requested
to provide data on all bacterial cultures performed, according to a
speciﬁed electronic format; ﬁles were centrally transferred through
secured protocols. Standard codes were used.
Figure 1. Escherichia coli isolates from blood cultures: co-resistance to
ﬂuoroquinolones (F), aminoglycosides (A) and third-generation cephalo-
sporins (C), Emilia-Romagna region 2006.
Results: The prevalence of antimicrobial resistance of E. coli had a
rapid rise during the surveillance period (2003–2006). Resistance to
third generation cephalosporins of isolates from blood increased from
4.8% in 2003 to 14.3% in 2006, due to a fast spread of extended-
spectrum b-lactamases phenotypes. Similar trends of resistance were
observed for aminoglycosides (from 9.6% in 2003 to 14.3% in 2006)
and ﬂuoroquinolones (from 25.1% in 2003 to 30.9% in 2006). A high
prevalence of co-resistance was also observed among the considered
antibiotic classes (third generation cephalosporins, aminoglycosides and
ﬂuoroquinolones): most isolates resistant to one of these three classes
were resistant to at least one of the remaining two (Figure 1). High
prevalences of resistance and co-resistance were also observed for E. coli
cultured from urine and other sites.
Conclusion: The surveillance data from Emilia-Romagna show a high
prevalence of resistance for E. coli which is likely to further increase
due to the promoting effect of co-resistance toward third generation
cephalosporins, aminoglycosides and ﬂuoroquinolones. The burden of
resistance and the speed of its spread are impressive and raise concerns
for the future availability of an effective therapy for infections caused
by this organism. Therefore urgent control measures are needed to
counteract this phenomenon in Emilia-Romagna region.
R2284 Real-time PCR for the detection of qnrA gene in
Enterobacteriaceae: the incidence of plasmid-mediated
quinolone resistance in a London teaching hospital
C. Jenkins, S.M. Naqvi, E. Cunningham, T.D. McHugh, I. Balakrishnan
(London, UK)
Objectives: Mechanisms of resistance to quinolones are classically
chromosomally mediated. However, the plasmid encoded gene, qnrA,
encodes a protein that binds to the subunit of topoisomerase IV,
preventing quinolone binding and conferring resistance. The plasmid
encoded nature of the gene may facilitate spread in a hospital
environment. The aim of this study was to determin the prevalence of
strains harbouring the qnrA gene in our hospital.
Method: A previously described PCR for the detection of qnrA was
modiﬁed to a real-time PCR format and used retrospectively to screen
45 extended-spectrum-b-lactamase enterobacterial isolates collected at
the Royal Free Hospital between January 2005 and December 2007.
In addition, 59 isolates of quinolone resistant Enterobacteriaceae were
screened prospectively between October and December 2007.
Results: Of the isolates from the retrospective and prospective study,
4.4% and 1.7% carried the qnrA gene, respectively.
Conclusion: Enterobacteriaceae exhibiting quinolone resistance encoded
by the plasmid-medicated qnrA gene were isolated from patients in our
hospital but the incidence was low.
R2285 Genetic diversity of metallo-b-lactamases produced by
carbapenem-resistant Pseudomonas aeruginosa
N. Rizk, S. Zaki (Alexandria, EG)
Objectives: To investigate the prevalence of metallo-b-lactamases
(MBLs) among clinical isolates of carbapenem resistant (CR) Pseu-
domonas aeruginosa (P. aeruginosa), and to characterize their molecular
types.
Methods: A total of 134 non-repetitive clinical isolates of P. aerug-
inosa were collected and tested for carbapenem resistance by disk
diffusion method with imipenem and meropenem. Minimum inhibitory
concentrations (MICs) were determined by the microdilution technique
according to CLSI guidelines. CR isolates were screened for the presence
of MBLs by imipenem EDTA double disk synergy test. Isolates with
screen positive results were conﬁrmed by EDTA inhibition of imipenem
hydrolysis with their crude cell extracts, and by PCR using primers for
detection of bla IMP-1, bla IMP-2, bla VIM-1, bla VIM-2, bla SPM-1,
and intI1 genes.
Results: Of the total 134 P. aeruginosa clinical isolates included in this
study, 75(56%) isolates were CR, among them, MBL phenotype was
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detected in 30(40%) isolates by the double disk synergy test. EDTA
sensitive hydrolysis of imipenem by crude cell extracts conﬁrmed 14
(46.7%) isolates as MBL producers. PCR detected MBL genes among
15 (50%) isolates; 11(733%) isolates were positive for bla VIM-2, and
4(26.7%) isolates were positive for bla IMP-1. The integrase gene (intI1)
was detected in all of the 15 genotypically MBL producing isolates. No
isolate harbouring bla VIM-1, bla IMP-2, or bla SPM-1 was detected.
Conclusion: Continued screening for MBLs production among CR
P. aeruginosa isolates will be essential to control dissemination by this
important resistant mechanism, ensure optimal patient care, and the
timely introduction of appropriate infection control procedures. PCR
is an important step, since EDTA based screening tests can give false
positive results.
R2286 MYSTIC 2007: European results
P. Turner (Macclesﬁeld, UK)
Objectives: MYSTIC (Meropenem Yearly Susceptibility Test Informa-
tion Collection) is a longitudinal global surveillance study that examines
the activity of meropenem and other broad spectrum agents against
clinically signiﬁcant non-copy isolates. The data presented here cover
the European 2007 results.
Methods: Isolates were collected from centres in Belgium, Croatia,
Czech Republic, Finland, Germany, Poland, Spain, Sweden and the
UK and tested by CLSI reference methodology (agar dilution or broth
microdilution) and interpreted by associated criteria.
Results: See the table.
Organism n Percentage susceptibility*
MEM IPM CAZ CPM P+T CIP GM
S. aureus (MS) 391 100 100 34 98.8 97.4 88.5 92.9
CNS 131 89.3 91.6 48.1 84.2 89.3 70.2 84.6
Enterobacteriaceae 2008 99.4 98.1 84.3 94.6 83.3 82.6 84.9
K. pneumoniae 345 99.7 99.7 80.6 86.8 76.2 83.2 68.3
E. cloacae 276 100 98.9 72.5 97 81.5 93.5 88.6
P. aeruginosa 591 77 58.7 65.8 55.4 78.3 67.9 52.6
Acinetobacter spp. 129 73.6 80.6 65.8 55.4 78.3 67.9 52.6
*CLSI criteria.
MS: meticillin-susceptible; CNS: coagulase-negative staphylococci;
MEM: meropenem; IPM: imipenem; CAZ: ceftazidime; CPM: cefepime;
P+T: piperacillin + tazobactam; CIP: ciproﬂoxacin; GM: gentamicin.
Conclusions: Overall meropenem proved to have the broadest spectrum
of activity followed by imipenem. Carbapenems are less active
against Pseudomonas aeruginosa and Acinetobacter spp. than against
Enterobacteraiceaea. The importance of surveillance programmes such
as MYSTIC in tracking the occurrence of these types of strains is
emphasised.
R2287 Trends in susceptibility over last ﬁve years for European
isolates of Pseudomonas aeruginosa from the MYSTIC
programme
P. Turner (Macclesﬁeld, UK)
Objectives: The importance of longitudinal surveillance programmes
such as MYSTIC (Meropenem Yearly Susceptibility Test Information
Collection) is that they allow trends over a number of years to be
examined and the information provided can aid in rational choice
of antibiotics. The data presented here examines the percentage
susceptibility of European isolates of Pseudomonas aeruginosa over the
last ﬁve years.
Methods: Since 2003 nearly 5.500 European isolates of P. aeruginosa
have been examined as part of the MYSTIC Surveillance Programme.
The Minimum Inhibitory Concentrations (MICs) of a number of
anti-pseudomonal compounds: meropenem, imipenem, ceftazidime,
piperacillin+tazobactam, ciproﬂoxacin and gentamicin have been de-
termined by CLSI methodology and their percentage susceptibilities at
associated breakpoints determined yearly.
Results: See the table.
Year n Percentage susceptibility*
MEM IPM CAZ P+T CIP GM
2003 1195 78.1 70.2 74.5 78.8 66.2 71.2
2004 1112 73.4 66.9 73.1 77.8 66.4 63.2
2005 1118 75.5 66 72.4 78.9 67 63.2
2006 1052 77.4 66.8 74 84.2 66.4 67.1
2007 591 77 58.7 65.8 78.3 67.9 52.6
*CLS1 criteria.
MEM: meropenem; IPM: impenem; CAZ: ceftazidime;
P+T: piperacillin + tazobactam, CIP: ciproﬂoxacin, GM: gentamicin.
Conclusions: With the possible exceptions of imipenem and gentamicin
percent susceptibility for the compounds has been remarkably consistent
over the last ﬁve years. Piperacillin+tazobactam although appearing to
be the most effective compound has elevated results due to the very
high susceptibility breakpoint (<64mg/L) granted to it by CLSI for
P. aeruginosa.
R2288 Antimicrobial susceptibility of isolates from various body
sites in Europe: the T.E.S.T. Program
M. Hackel, R. Badal, S. Bouchillon, B. Johnson, J. Johnson, D. Hoban,
M. Dowzicky (Schaumburg, Collegeville, US)
Objectives: Bacterial resistance patterns vary over time and geography.
Surveillance studies help to identify those patterns to help guide therapy.
The Tigecycline Evaluation Surveillance Trial (TEST) is an ongoing
global surveillance study that serves to recognize current trends in
resistance. This report evaluates differences in susceptibilities of strains
from different body sites, collected in Europe 2004–2007.
Methods: 21,381 strains isolated from 8 body sites were collected and
identiﬁed from 2004–2007 at 79 hospitals in 22 countries in Europe.
MICs for each strain were determined per EUCAST guidelines at each
facility using broth microdilution. MIC50/90 was analysed to identify
any signiﬁcant differences in antibiograms from different sources.
Results: Tigecycline (TIG) MIC50 values for almost all organ-
ism/specimen pairings were +/− 2 log2 dilutions of each other, with no
single source giving a higher MIC50 than the others. The same was
seen for TIG MIC90 values, which were also almost always within 1−2
log2 dilutions of the MIC50, except for S. pneumoniae, whose TIG
MIC90 were 3−4 fold higher than the MIC50 for all specimen sources.
Comparator drugs also generally showed no variability in susceptibility
of isolates from various body sites. A notable exception was E. faecium
vs. vancomycin, for which the MIC90 of blood isolates was signiﬁcantly
higher than other sources.
Conclusions: Bacteria isolated from more than 8 different body sites had
generally similar antibiograms, with no isolates from any single source
showing signiﬁcantly different sensitivity patterns. TIG’s broad spectrum
of activity and consistently low MIC90/MIC50 ratios, including strains
resistant to other drugs, may make it an excellent therapeutic option
when treating infections often caused by strains refractory to treatment
with other agents.
R2289 In vitro activity of tigecycline against pathogens
isolated from lower respiratory infections – The Global
T.E.S.T. Program 2007
M. Hackel, R. Badal, S. Bouchillon, J. Johnson, D. Hoban, B. Johnson,
M. Dowzicky (Schaumburg, Collegeville, US)
Objectives: Tigecycline (TIG), a new glycylcycline, has been shown to
have potent broad spectrum activity against most commonly encountered
Resistance surveillance S681
species responsible for community and hospital acquired infections. The
Tigecycline Evaluation Surveillance Trial (TEST), a global longitudinal
surveillance study, determined the in vitro activity of TIG and 13
comparators against Gram-positive and Gram-negative species isolated
from lower respiratory infections.
Methods: 6,266 lower respiratory pathogens from 42 countries were
analysed in this survey. The isolates were identiﬁed to the species level
at the participating sites and conﬁrmed by the central laboratory. MICs
were determined by each site using supplied broth microdilution panels
and interpreted according to CLSI guidelines.
Results: TIG activity against pathogens isolated from lower respiratory
infections is shown in the table.
Organisms (n = 331) %Sus Tigecycline MIC (mg/ml)
MIC50 MIC90 Range
Acinetobacter spp. (n = 795) na 0.5 1 0.008−8
P. aeruginosa (n = 1,224) na 8 >16 0.008−>16
Enterobacter spp. (n = 879) 93.7 0.5 2 0.06−8
Enterococcus spp. (n = 82) 100 0.12 0.25 0.015−0.25
E. coli (n = 406) 100 0.12 0.25 0.03−2
Klebsiella spp. (n = 924) 94.9 0.5 2 0.03–16
H. inﬂuenzae (n = 951) na 0.12 0.25 0.12−0.25
S. aureus (n = 663) 99.8 0.12 0.25 0.03−1
MRSA (n = 293) 99.7 0.12 0.25 0.03−1
S. pneumoniae (n = 680) na 0.03 0.12 0.008−0.25
S. marcescens (n = 548) 96.5 1 2 0.12−>16
S. agalactiae (n = 54) 100 0.03 0.12 0.008−0.25
*na = breakpoints not available.
Conclusions: Tigecycline showed excellent inhibitory activity against
all pathogens from lower respiratory infections in this study, with the
exception of P. aeruginosa. Tigecycline demonstrated MIC90 values of
0.5mg/ml against Gram-positive pathogens (including resistant pheno-
types) and MIC50 values of 1mg/ml against the Enterobacteriaceae
and Acinetobacter spp., validating the potent inhibitory activity of TIG
against these pathogens.
R2290 In vitro activity of tigecycline and comparators against
vancomycin-resistant enterococci from western Europe
R. Badal, B. Johnson, S. Bouchillon, M. Hackel, J. Johnson, D. Hoban,
M. Dowzicky (Schaumburg, Collegeville, US)
Objectives: Tigecycline (TIG), a member of a new class of antimi-
crobials (glycylcyclines), has been shown to have potent expanded
broad spectrum activity against most commonly encountered species
responsible for community- and hospital-acquired infections. The
T.E.S.T. Program determined the in vitro activity of tigecycline compared
to amoxicillin-clavulanic acid, piperacillin-tazobactam, levoﬂoxacin,
ceftriaxone, linezolid (LZD), minocycline (MIN), vancomycin (VAN),
ampicillin (AM), penicillin (PEN), and imipenem against vancomycin-
resistant enterococci (VRE) collected from 94 hospitals in 22 Western
European countries from 2004 through 2007.
Methods: 76 VRE (15 Enterococcus faecalis, 61 E. faecium) clinical
isolates were identiﬁed to the species level at each participating site and
conﬁrmed by the central laboratory. Minimum Inhibitory Concentrations
(MICs) were determined by the local laboratory using supplied broth
microdilution panels and interpreted according to EUCAST guidelines
(tigecycline susceptible <0.25mg/L for enterococci).
Results: %S of all VRE to TIG, LZD, and MIN were 100, 100, and
71.7, respectively. For E. faecalis strains, the most active drugs were TIG
(100%), LZD (100%), PEN (93.4%) and AM (93.3%). For E. faecium,
the three most active drugs were TIG (100%), LZD (100%), and MIN
(78.7%).
Conclusions: TIG exhibited outstanding activity against VRE, inhibiting
100% of strains at 0.25mg/L with an MIC90 of 0.12mg/L, which
was 32-fold lower than the LZD MIC90 of 4ml/L. The exceptionally
broad spectrum of TIG, which includes many other multi-resistant Gram-
positive and -negative bacteria in addition to VRE, should make it a very
important addition to hospital formularies.
R2291 Antibiotic resistance of Salmonella enterica serovars in a
paediatric hospital in Greece
K. Papavasileiou, H. Papavasileiou, S. Chatzipanagiotou, M. Lampiri,
A. Vatopoulos, A. Voyatzi (Athens, GR)
Objective: was to investigate the frequency, the distribution of various
Salmonella serotypes and to determine their antimicrobial resistance
proﬁles in a Paediatric Hospital.
Material and Methods: During 2004–2007 a total of 644 Salmonella
enterica isolated from hospitalised children with gastroenteritis. The age
balanced from 1 month to 14 years. The identiﬁcation of Salmonella spp.
was performed by classical methods and susceptibility to antibiotics was
tested by a disk diffusion method. MICs were determined by automatic
system VITEK2 (bioMerieux – France). The serotypes were conﬁrmed
from the National Reference Centre for Salmonella.
Results: Out of 6762 stool specimen, the 1202 (17.8%) were found
positive for enteropathogens.644 (53.5%) Salmonella spp. and 473(39%)
Campylobacter were recovered.17 different serotypes were identiﬁed
being: S. enteritidis the most predominant (74.7%) followed by S.
Typhimurium (13.1%), S. Oranienburg (2.1%), S. Abony (1.5%) and
the remaining strains(8.6%) belonged to a wide variety of serovars.
All serotypes were susceptible to ﬂuoroquinolones. The majority
of S. enteritidis isolates were found susceptible to the following
antibiotics: streptomycin (S), spectinomycin (Sp), chloramphenicol (C).
Additional,increased resistance was observed to nalidixic acid 11%
(MIC50,90 4,32) and less to ampicillin (A) 9.8% (MIC50,90
2, 16), co-amoxiclav (AMC) 3.5% (MIC50,90 2, 4), cefotaxime
(CTX) 1% (MIC50,90 1) and trimethoprim-sulfamethoxazole (SXT)
2.6% (MIC50,90 1/19). In contrast high level resistant exhibited
serotype S. typhimurium to tetracycline (Te) 10% (MIC50,90 2, 8),
A 44% (MIC50,90 2,32), AMC 16% (MIC50,90 2, 16), CTX 4%
(MIC50,90 1), SXT 4% (MIC50,90 1/19), Sp 8.7%, S 13% and
C 8.7%.Multidrug resistance phenotype among S. typhimurium strains
probably related with the appearance and spread of the phage type
DT104, recently established in Greece.
Conclusions: All strains were susceptible to ﬂuoroquinolones. Re-
sistance to nalidixic acid presents an indicator for the detection of
low-level resistance to ciproﬂoxacin. The high incidence of resistance
to A in S. enteritidis recorded in past years, seems to reduce.
S. typhimurium phage type DT104 presented the multidrug resistance
phenotype(ACSSpSuTe). Presence of ESBLs was not observed. The
emergence of resistance to CTX should be followed by an efﬁcient
surveillance for antimicrobial drug sensitivity.
R2292 High co-trimoxazole resistance by bacteria associated with
oral lesions in a population of Ugandan HIV-infected and
AIDS patients
E. Agwu, J.C. Ihongbe, V. Pazos (Ishaka, UG; Ekpoma, NG)
Objective: Opportunistic infections continue to cause a signiﬁcant
amount of morbidity and mortality in sub-Sahara African patients
infected with HIV. This study was designed to assess the effect of
prolonged routine cotrimoxazole prophylaxis on bacteria isolated from
oral lesions in a population of HIV/AIDS patients in South Western
Uganda.
Methods: Exactly 605 swabs (469 from females and 136 from males),
were randomly collected from oral lesions of The AIDS Support
Organization (TASO) HIV/AIDS patients in 4 Districts (Masaka-
142, Rukungiri-152, Bushenyi with Mbarara-305) of Uganda. Sample
processing for isolation, identiﬁcation and antibiogram of bacteria was
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done aseptically using standard Microbiological techniques. Randomized
Block Design (RBD; alpha = 0.05) was used to compare both the
prevalence and resistance of each bacterium between districts and
bacteria within districts.
Results: Overall bacteria prevalence was highest in Mbarara/Bushenyi
(50.4%) followed by Rukungiri (20.8%) and Masaka (20.3%). Between
Districts, Streptococcus mutans (30.9%) from Mbarara/Bushenyi were
the most predominant bacteria followed by Proteus mirabilis (16.4%)
from Rukungiri. Within Districts, Streptococcus mutans (31.7%) from
Masaka were the most prevalent followed by: S. aureus (11.3%).
In Rukungiri, Streptococcus mutans (22.4%) was the most prevalent
followed by Proteus mirabilis (16.4%). In Mbarara/Bushenyi, S. mutans
(31.5%) was the most prevalent followed by: S. aureus (11.5%). Within
districts, all bacteria isolates from Rukungiri were resistant (100%) to
cotrimoxazole except Branhamella catarrhalis which showed (77.8%)
resistance. In Mbarara/Bushenyi, the most resistant strains (100%) were
S. aureus, B. catarrhalis and Non-haemolytic Streptococcus, followed by
Klebsiella pneumoniae (84.6%). Absolute bacterial resistance (100%)
in Masaka, were observed in 4 strains: B. cerius, S. aureus, E. coli
and B. subtilis. There was a signiﬁcant difference (p< 0.05) when
the prevalence of different bacteria strains in the oral mucosa were
compared within districts and between districts. There existed signiﬁcant
difference (p< 0.05) in the effect of the antibiotics when compared
between different bacteria and within each bacterium
Conclusion: Prolonged use of cotrimoxazole prophylaxis could be
associated with observed cotrimoxazole resistance by our bacteria
isolates and could explain observed rebound of oral lesions with bacteria
aetiology in the studied population.
R2293 Countrywide dissemination of CTX-M-3 type
extended-spectrum b-lactamase in Turkey
G. Terek, Z. Gu¨lay (Izmir, TR)
Objectives: To investigate the prevalance, of CTX-M type b-lactamases
and properties of the genetic elements responsible for the spread of these
among ESBL positive Enterobacteriaceae family which were isolated
from 7 different hospitals between November 2002-July 2003. Clonal
relationship between CTX-M producers was also evaluated.
Methods and Results: In this study blaCTX-M, blasSHV and blaTEM
presence was sought by PCR in 70 (E. coli (n = 32), K. pneumoniae
(n = 24), K. ornitholytica (n = 3), E. cloacae (n = 4), E. aerogenes
(n = 4), P. mirabilis (n = 2), S. sonnei (n = 1)) isolates which were
chosen randomly as 10 isolates per centre. blaCTX-M, blaTEM and
blaSHV production rates were 75.7%, 81.4%and 91.4%, respectively.
CTX-M prevalence varied between 50% (Uludag University School of
Medicine) to 100% (Hacettepe University School of Medicine) among
centres. Sequence analysis has shown that all of the CTX-M positive
isolates included in this study produced CTX-M-3, ERIC-PCR results
revealed no clonal relationship between the isolates from different centres
although clusters of up to 4 isolates were detected within individual
centres. Conjugation experiments revealed that plasmids with molecular
sizes of 46–85 kb were responsible from the transfer of blaCTX-M.
Conclusion: As a result, the widespread appearance of CTX-M-3 is
noteworthy in our country. According to ERIC-PCR results however
clonal dissemination of CTX-M b-lactamase producers between different
centres is not considered
R2294 Sensitivity proﬁle to some new antibiotics of most
frequently encountered bacterial species in infections in a
hospital in Romania – Comparison 2003 vs. 2006
D. Ciubotariu, C. Lunca, V. Frasin, I. Antonesi (Iasi, RO)
Objective: To evaluate the evolution of bacterial resistance to some
highly active, new antibiotics of the most frequently encountered
bacterial species in the Emergency University Hospital, Iasi, Romania,
in 2006 compared to 2003.
Methods: Retrospective evaluation of charts and records of hospital’s
Microbiology Laboratory (from January 1 to December 31, 2003 and
from January 1 to December 31, 2006). Bacterial sensitivity to antibiotics
was performed using disk diffusion method. For each antibiotic, results
were expressed as: sensitive, intermediate or resistant, according to CLSI
Guidelines. Comparison between resistance proﬁle in 2003 and 2006 was
performed using chi-squared test.
Results: In the investigated period, there were 1917 biological samples
from hospitalised patients sent for identiﬁcation and antibiogram.
The bacterial species was identiﬁed in 76.00% of cases (1457
samples). The three most frequently encountered identiﬁed species
were: Staphylococcus aureus (512 samples, 35.14% of identiﬁed
species, 26.71% of total samples), Acinetobacter baumannii (178
samples, 12.22% of identiﬁed species, 9.29% of total samples) and
Pseudomonas aeruginosa (162 samples, 11.12% of identiﬁed species,
8.45% of total samples). Comparative evaluation of resistance proﬁle for
Staphylococcus aureus revealed un-modiﬁed sensitivity to vancomycin
(0 in 2003 vs. 2.21% in 2006) and linezolid (2.49% in 2003 vs. 3.32% in
2006) and increasing sensitivity to teicoplanin (from 36.1% in 2003 to
49.08% in 2006, p< 0.01) and cefpirom (from 26.14% in 2003 to 33.95%
in 2006, p< 0.05). Percentage of meticillin-resistant strains increased
from 51.03% in 2003 to 70.18% in 2006 (p< 0.01). Acinetobacter
baumannii developed signiﬁcant resistance to imipenem (from 18.29% in
2003 to 31.76% in 2006, p< 0.01). In case of Pseudomonas aeruginosa,
we also noticed increasing resistance to imipenem (from 25% in 2003
to 33.78% in 2006, p< 0.05), while sensitivity to cefpirom remained
un-modiﬁed (45.45% in 2003 and 45.94% in 2006).
Conclusions: Staphylococcus aureus isolated strains keep satisfactory
sensitivity to vancomycine and linezolid (about 97%). Surprisingly,
Staphylococcus aureus sensitivity to teicoplanin and cefpirom increased.
Increasing resistance to imipenem of Acinetobacter baumannii and
Pseudomonas aeruginosa, as well as increasing percentage of MRSA
strains are to be considered. Rational use of carbapenems in infections
should be implemented.
R2295 European survey of antibacterial activity against
S. pneumoniae from 2006–2007: focus on ﬂuoroquinolones
D.J. Farrell, C. Couturier (London, UK; Paris, FR)
Objectives: To document the activity of a range of antibacterial agents,
including levoﬂoxacin, against strains of Streptococcus pneumoniae from
patients with community-acquired respiratory tract infections (RTIs).
Methods: Isolates were collected between January 2006 and April 2007
in 17 European countries (156 centres) from patients with community-
acquired RTIs either in the community or those hospitalised for less
than 48 hours. In vitro antibacterial activities and susceptibilities of
S. pneumoniae isolates were determined at a central laboratory using
Clinical and Laboratory Standards Institute methodology and interpretive
criteria.
Results: Overall, 10.3% (range: 0–33% across countries) of the 3026
S. pneumoniae isolates collected were resistant to penicillin, while
10.5% exhibited intermediate penicillin susceptibility. Rates of penicillin
resistance varied widely across Europe, being over 10% in 7 countries
(Eire, Finland, France, Hungary, Poland, Slovakia and Spain). Macrolide
(erythromycin) resistance was observed in 26.0% of isolates overall,
ranging from 3.8% in the Netherlands to 52.2% in Italy; 10/17 countries
had over 20% of resistance. The overall susceptibility of S. pneumoniae
isolates to the ﬂuoroquinolones levoﬂoxacin and moxiﬂoxacin was high
at 98.4% and 98.6%, respectively (range: 93.3–100% for both agents).
The ﬂuoroquinolones also demonstrated activity against isolates resistant
to other classes of antibacterials: of the 312 isolates resistant to penicillin,
97.4% and 97.8% remained susceptible to levoﬂoxacin and moxiﬂoxacin,
respectively, while the equivalent susceptibility rates against the 734
multidrug-resistant isolates (those resistant to 2 antibacterial classes)
were 95.4% and 95.6%.
Conclusions: This surveillance study demonstrates high levels of
resistance to macrolides and b-lactams among S. pneumoniae isolates
collected across Europe. In contrast, the ﬂuoroquinolones remain
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active against these isolates, including those resistant to several
different antibacterial agents. Overall, susceptibility of S. pneumoniae to
levoﬂoxacin and moxiﬂoxacin was high and comparable in all countries
studied.
R2296 Pan-resistance to commonly used antibiotics and nonsuscep-
tible to tigecycline Acinetobacter baumannii clinical isolates
A. Stylianakis, V. Papaioannou, E. Pantazis, D. Lykou, I. Merianos,
A. Koutsoukou (Athens, GR)
Objectives: To describe ﬁve panresistant to commonly used antibiotics
and intermediately susceptible or resistant to tigecycline Acinetobacter
baumannii clinical isolates.
Methods: We examined ﬁve A. baumannii isolates originated from
equal numbered patients treated in different wards of our hospital. Four
out of ﬁve patients were hospitalised in two different ICUs and the
ﬁfth in the neurosurgical ward. The sources of the examined isolates
were blood (n = 1), vein catheter (n = 1) and bronchoalveolar excretions
(n = 3). The identiﬁcation of the isolates and the susceptibility testing
were performed using the automated VITEK2 system (Biomerieux,
France). The resistance to colistin was conﬁrmed by E-test method (AB
Biodisk, Solna, Sweden) according to CLSI guidelines. The tigecycline
MIC levels were also determined using E-test strips in accordance
to the manufacturer’s recommendations. Isolates having MIC values
between 2 to <8mg/L were considered as intermediately susceptible to
tigecycline and MIC values 8mg/L as resistant to tigecycline according
to breakpoints recommended by the British Society of Antimicrobial
Chemotherapy [1].
Results: The examined ﬁve A. baumannii isolates were resistant to all
aminoglycosides, b-lactams, carbapenems, monobactames, quinolones
and colistin. The obtained tigecycline MIC values were 3mg/L (blood
and vein catheter samples, n = 2), 4mg/L (bronchoalveolar excretions
samples, n = 2) and 8mg/L (bronchoalveolar excretions sample, n = 1).
Conclusion: The nonsusceptible to tigecycline and panresistant to the
commonly used antibiotics A. baumannii isolates rapidly nullify the
whole of our therapeutic armamentarium leading to therapeutic failure.
It is very challenging to reach the knowledge of the tigecycline-
nonsusceptible mechanisms of this bacterium and to discover newer
antimicrobials to reduce the abilities of this dangerous pathogen.
Reference(s)
[1] R. Hope et al.: Determination of disc breakpoints and evaluation for
Etests for tigecycline susceptibility testing by the BSAC method.
Journal of Antimicrobial Chemotherapy (2007) 60, 770–774.
R2297 Biocide and antibiotic resistance in staphylococcal isolates
from household pets
F. Myers, M. Rich (Harrogate, Wetherby, UK)
Objectives: Biocides are synthetic compounds found in a wide range
of clinical, veterinary and domestic cleaning products. Their widespread
use is raising concerns regarding their impact on antibiotic resistance.
The aim of the study was to compare biocide/antibiotic resistance in
coagulase-positive staphylococci isolated from household pets and to
investigate the possibility of any linkage between biocide/antibiotic
resistance amongst the test strains.
Methods: A total of 136 strains of meticillin-resistant Staphylococcus
aureus (MRSA), 48 strains of meticllin-sensitive Staphylococcus aureus
(MSSA) and 96 strains of Staphylococcus intermedius were obtained
from household pets in a U.K. veterinary diagnostic laboratory.
Antibiotic susceptibility testing was performed on all isolates using
the VITEK® (1) automated instrument (bioMe´rieux, France). Strains
resistant to oxacilin, >2mg/L were conﬁrmed using the PBP2a latex kit
(Oxoid, Basingstoke) to detect the gene product mecA. All isolates were
screened for biocide resistance on Iso-sensitest (Oxoid, Basingstoke)
media containing one of the following biocides at pre-determined
concentration; benzalkonium chloride 4mg/mL, cetrimide 5.5mg/mL,
chlorhexidine 4mg/mL and triclosan 0.5mg/mL.
Results: A generally higher level of resistance to antibiotics was
seen amongst the MRSA isolates compared to the MSSA isolates.
Surprisingly resistance to biocides (especially triclosan) was found to
be more prevalent in MSSA than in MRSA. The chi-squared test was
used to compare differences in antimicrobial susceptibility amongst the
test strains. Statistical analysis using the kappa coefﬁcient was used
to determine whether a relationship exists between resistance to the
antibiotics and biocides tested. No signiﬁcant linkage was found between
antibiotic and biocide resistance.
Conclusion: This study provided no evidence to link biocide/antibiotic
resistance in coagulase-positive staphylococci isolated from household
pets.
R2298 Campylobacter infections in a central hospital, West-Tallinn,
Estonia in 2000–2005
I. Zolotuhhina, R. Voiko, K. Kirs (Tallinn, EE)
Objectives: Campylobacter species are the most common cause of
bacterial gastroenteritis in many developed countries. In the last years
there has been a considerable increase in the incidence of Campylobacter
infections diagnosed in West-Tallinn Central Hospital. The purpose of
the present study was to show the signiﬁcance of Campylobacter in the
aetiology of bacterial diarrhoea and to give some strain characteristics
of the isolated bacteria.
Methods: During the study period all patients admitted to the hospital
with the symptoms of gastroenteritis were routinely examined for
the presence of Campylobacter spp. in stools. The isolatoin and
identiﬁcation procedures included conventional bacteriological methods.
Campylobacter jejuni strains were differentiated on the basis of the
hippurate hydrolysis tested with sodium hippurate tablets (Rosco
Diagnostics). Susceptibility to erythromycin (ERY), ciproﬂoxacin (CIP)
and tetracyclin (TE) was determined by disc diffusion and Etest methods
perfomed on Mueller-Hinton agar with 5% sheep blood incubated at
42ºC for 24 hours in microaerobic atmosphere.
Results: During the period of 2000–2005 the aetiological role
of Campylobacter spp. as a cause of bacterial gastroenteritis was
increasingly growing from 14.7% in 2000 to 35.4% in 2005 of all
bacteriologically conﬁrmed cases. In 2003 and 2004 campylobacteriosis
was diagnosed more frequently than salmonellosis (33.5% versus 24%
in 2003 and 30.5% versus 16% in 2004). C. jejuni was isolated in 93%
to 100% of all cases in different years. Among the patients children
under 5 years old constitued 44% to 56%. Another big group was young
people from 20 to30 years old (10–16% of all cases). 276 strains were
tested for antimicrobial susceptibility. The results showed that most of
the isolates were susceptible to TE and ERY. Reduced susceptibility to
CIP increased from 3.1% in 2000 to 19.3% in 2005. Co-resistance to 2
drugs was also detected.
Conclusions: Campylobacter is one of the most important intestinal
pathogens specially among children of early age. Resistance to
commonly used antibiotics is increasing. ERY remains relatively effective
for the treatment of campylobacteriosis. The number of Campylobacter
strains with reduced susceptibility to quinolones is rapidly growing.
R2299 Tigecycline in vitro activity against vancomycin-resistant
enterococci in the U.S. analysed by CDC Regions
S. Bouchillon, B. Johnson, R. Badal, M. Hackel, J. Johnson, D. Hoban,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: The percentage rates of vancomycin-resistant Entero-
coccus spp. (VRE) vary by country and region. Tigecycline, a new
glycylcycline, has been shown to have potent activity against commonly
encountered species, including those with resistant phenotypes. The
purpose of this study was to determine regional variations, if any, and the
current activity of tigecycline (TIG) against VRE in the United States.
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Methods: 622 clinically relevant isolates of vancomycin-resistant
Enterococcus faecalis and vancomycin-resistant Enterococcus faecium
were collected from patients in 193 hospitals across the United States
from 2004 to 2007. MIC’s were determined by broth microdilution and
interpreted following CLSI guidelines. Regions are deﬁned by the CDC.
Results: Results are summarised in the table.
Region n Tigecycline MIC90
(mg/ml)
% Susceptibility
All Regions 622 0.12 100
East North Central 133 0.12 100
East South Central 34 0.12 100
Middle Atlantic 196 0.12 100
Mountain 16 0.06 100
New England 19 0.12 100
Paciﬁc 35 0.12 100
South Atlantic 115 0.12 100
West North Central 31 0.12 100
West South Central 43 0.6 100
Conclusions: Tigecycline demonstrated consistant potent activity against
VRE in the United States, regardless of region of isolation, with an
overall MIC90 of 0.12 mg/ml. The exceptionally broad spectrum of
tigecycline, which includes many other multi-resistant Gram-positive and
Gram-negative bacteria in addition to VRE, will make it a very attractive
addition to hospital formularies.
R2300 Susceptibility patterns of tigecycline and comparators from
clinical isolates in Spain and Portugal 2004–2007
M. Hackel, R. Badal, S. Bouchillon, B. Johnson, J. Johnson, D. Hoban,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: Development of bacterial resistance continues to cause
concern world wide, but the availability of newer agents offers clinicians
options for therapy. Tigecycline has a very broad spectrum of activity,
including strains resistant to other drugs. As part of the global
Tigecycline Evaluation Surveillance Trial, strains collected in Iberia from
2004 to 2007 were evaluated for susceptibility to several commonly used
antimicrobials.
Methods: 1710 strains were collected and identiﬁed at 9 sites in
Spain and Portugal. MICs were determined at each site using EUCAST
guidelines on microdilution panels.
Results: The tables summarise results.
Conclusions: Tigecycline’s in vitro activity was comparable to or greater
than commonly prescribed antibiotics against both Gram-negative and
Gram-positive pathogens, including resistant phenotypes. Tigecycline’s
MIC90 of 1mg/ml was the lowest of all comparator agents in this study.
Drug Enterobacteriaceae
(n = 736)
Acinetobacter spp.
(n = 116)
%Sus MIC90 %Sus MIC90
Tigecycline 97.8 1 na 1
Amikacin 98.8 4 49.1 >64
Cefepime 88.9 2 31 >32
Ceftazidime 0 16 25.9 >32
Imipenem 99.7 1 56.9 >16
Levoﬂoxacin 86.4 4 20.7 >8
Drug S. aureus (n = 216) Enterococcus spp. (n = 132)
%Sus MIC90 %Sus MIC90
Tigecycline 100 0.25 100 0.12
Levoﬂoxacin 78.7 8 62.1 >32
Linezolid 100 2 100 2
Minocycline 100 0.5 53 >8
Vancomycin 100 1 99.2 2
R2301 Effectiveness of an active intervention to improve
notiﬁcation in an antimicrobial resistance surveillance
system in a developing country
C. A´lvarez, J.S. Castillo, G. Buitrago, A.L. Leal, D.H. Henriquez,
J.A. Corte´s on behalf of GREBO
Background: Surveillance is the ﬁrst step for antimicrobial resistance
contention. Adherence to periodic notiﬁcation is an important problem
in surveillance systems, our work describe the impact of an active
intervention to improve this notiﬁcation in the Antimicrobial Resistance
Surveillance System (ARSS) in Bogota-Colombia.
Methods: Created in 2004, all institutions of high and intermediate
complexity with an institutional laboratory of microbiology in the
city were potential eligible. Training in software Whonet and quality
control of the laboratories was realised. Initially in 2005 we designed
a passive system of digital capture of information, across Internet.
Follow-up of notiﬁcation was done with especial indicators. In 2006
there we designed an active intervention composed by retraining in
Whonet, incorporation of variables of nosocomial infections, double
sending of information (laboratory and infections committee), calls and
mails, continuous assessment of the notiﬁcation and visits to institutions
problem. Change in notiﬁcation was evaluated with a Wilcoxon test.
Results: 52 institutions trained since 2004 initiated notiﬁcation in 2005,
proportion of gross notiﬁcation was 68.6% and timely notiﬁcation was
58.3%. In 2006 after the intervention, statistical difference in notiﬁcation
percentages (p< 0.002), were observed 96.1 and 95.1% respectively
(Figure 1). ARSS has generated trends in bacterial resistance for hospital
system in Bogota, alert system, technical advices and bulletins to
improve technical choices.
Conclusions: Our Active interventions to improve the notiﬁcation had
a signiﬁcant impact in the system. The ARSS has showed a more exact
panorama of the antimicrobial resistance in our city.
Figure 1
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R2302 Wide variation in rates of ESBL production among
Escherichia coli causing bacteraemia in the Asia-Paciﬁc
region: A SENTRY Program Report
J.M. Bell, J.D. Turnidge, R.N. Jones (Adelaide, AU; North Liberty, US)
Objective: Extended-spectrum b-lactamase (ESBL) producing E. coli
have been reported with increasing frequency in both hospital- and
community-acquired infections worldwide. We examined blood culture
isolates of E. coli from our APAC region to determine the prevelance of
ESBL and multidrug-resistant (MDR) strains.
Methods: Blood culture isolates were consecutively collected from 42
medical centres in nine countries in the APAC region. All isolates
were tested against a wide range of antimicrobial agents using CLSI
methods and broth microdilution panels (TREK Diagnostics). MDR
was deﬁned as resistant (R) to greater than three drug classes apart
from cephalosporins. ESBL phenotypes were deﬁned as those strains
demonstrating elevated MICs (>1mg/ml) to ceftazidime or ceftriaxone
or aztreonam (CLSI).
Results: A total of 1,621 isolates were received. E. coli was the
commonest bacteremic species overall and accounted for 26% of isolates
(range of 39.1% Taiwan to 7.5% Thailand). ESBL percentages ranged
from 0 to 75. In India and mainland China MDR was detected in the
great majority of strains, while in other countries, MDR was present
in approximately 50%. All strains were susceptible to carbapenems and
polymyxins.
Country (no. tested) Centres Ranka EBSL,
N (%)
MDR,
N (%)
Australia (60) 5 1 1 (1.7) 3 (5.0)
Hong Kong (12) 1 1 0 1 (8.3)
India (67) 10 2 50 (74.6) 43 (64.2)
Korea (39) 3 1 5 (12.8) 11 (28.2)
Mainland China (181) 10 1 109 (60.2) 116 (64.1)
Philippines (22) 1 1 3 (13.6) 6 (27.3)
Taiwan (36) 2 1 3 (8.3) 7 (19.4)
Thailand (3) 2 4 2 2
aRank of frequency of E. coli from blood cultures.
Conclusions: ESBL-producing E. coli are very prevalent among
bacteraemia isolates from India and mainland China, but still uncommon
in Australia. Many of these isolates were also R to multiple other drug
classes limiting therapeutic options.
R2303 Occurrence and resistance in pathogens from hospitalised
patients with pneumonia in the Asia-Paciﬁc region: a
SENTRY Program Report (2006)
J.M. Bell, J.D. Turnidge, R.N. Jones (Adelaide, AU; North Liberty, US)
Objective: As part of the SENTRY Antimicrobial Surveillance Program
we examined clinical isolates from the Asia-Paciﬁc region to determine
the occurrence and resistance (R) rates of pathogens from hospitalised
patients with pneumonia.
Methods: Up to 50 consecutive isolates were collected from each of
42 medical centres in nine countries in the Asia-Paciﬁc region centre
during 2006. All isolates were tested at a central monitoring laboratory
against a wide range of antimicrobial agents using CLSI methods and
broth microdilution panels (TREK Diagnostics). ESBL phenotypes were
deﬁned by elevated MICs (>1mg/ml) to ceftazidime or ceftriaxone or
aztreonam.
Results: A total of 1,642 isolates were collected. Gram-negative
pathogens (GN) were dominant in Indonesia (99%), Thailand (97%),
India (94%), Philippines (88%), Hong Kong (86%), mainland China
(84%), and Singapore (80%). Acinetobacter spp. was the most frequent
isolate in these countries, accounting for 63% and 75% of all isolates
in Singapore and Thailand, respectively. Only Korea (70%), Taiwan
(65%) and Australia (51%) had <70% GN. ESBL phenotypes were
present in 70, 50 and 20% of E. coli, Klebsiella spp. and P. mirabilis,
respectively. In Australia, S. pneumoniae and S. aureus accounted for
45% of strains. Carbapenem-resistant (CP-R) Acinetobacter spp. (class
D/B) was >60% in Hong Kong, Korea, Singapore, Taiwan and Thailand;
and also common in India (52%) and China (25%). CP-R Pseudomonas
spp. was also common with >60% of strains R from Taiwan, Korea,
Singapore resistant. One E. cloacae from India was imipenem-resistant.
No CP-R isolates were detected in Australia. All staphylococci were
susceptible to vancomycin, linezolid and quinupristin/dalfopristin. No
vancomycin-R enterococci were detected.
Conclusions: There are very high rates of R in pathogens causing
pneumonia in hospitalised patients in most countries in the Asia-Paciﬁc
region.
Molecular epidemiology of resistance genes,
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R2304 Molecular detection of ESBL-producing Enterobacteriacee
in northeastern Italy
M. Busetti, M. Comar, F. Fiermonte, C. Campello (Trieste, IT)
Objectives: The prevalence of extended spectrum b-lactamases (ESBL),
especially the CTX-M type, increased dramatically during the past 10
years. Moreover, a molecular epidemiology shift was observed in Europe
from TEM and SHV types to the predominant CTX-M enzyme. Among
ESBL producers, E. coli emerged as a cause of urinary tract infections
either in hospital or community settings.
Aim of this study was to assess by molecular methods the prevalence of
different enzymes among ESBL-producing Enterobacteriacee in Trieste,
North-Eastern Italy.
Methods: During 2007 we analysed 80 ESBL-producing bacteria (70
E. coli, 5 K. pneumoniae and 5 K. oxytoca) isolated from urinary tract
(n= 60), respiratory tract (n = 6), blood (n = 5) or various other sites
(n = 13). 57 strains were isolated from hospitalised patients and 23 from
outpatients.
E. coli was recovered in 65 cases (92.8%) from adult patients, 43
hospitalised and 22 outpatients, while the majority of Klebsiella spp.
(7 out of 9) were isolated in paediatric patients.
Identiﬁcation and screening for ESBL was performed with VITEK2
ID-GN and AST-N041cards. All isolates tested positive were conﬁrmed
by ESBL Etest strips with cefotaxime/ cefotaxime+clavulanate and
ceftazidime/ ceftazidime+clavulanate. The conﬁrmed isolates were
examined by PCR for the presence of ESBL-encoding genes blaTEM,
blaSHV and blaCTX-M, according to Mugnaioli et al (Antimicrob
Agents Chemother, 2006).
Results: Of the 70 ESBL-producing E. coli, 61 (87.1%) were positive for
blaCTX-M, alone (30, corresponding to 42.8%) or in combination with
blaTEM (31, 44.3%). Only 8 isolates showed other resistance genes (1
blaTEM alone, 1 blaSHV and 7 with associated blaTEM and blaSHV).
In K. pneumoniae, bla SHV was present in all 5 isolates, alone (n = 1)
or associated with blaTEM (n = 2) or blaTEM and CTX-M (n = 2). In
K. oxytoca, 3 strains carried blaSHV and 1 blaTEM, while bla CTX-M
was absent; only one strain resulted negative for all the ESBL tested.
n. TEM SHV CTX-M TEM+
SHV
TEM+
CTX-M
TEM+
SHV+
CTX-M
Negative
E. coli 70 1 1 30 7 31 0 0
K. pneumoniae 5 0 1 0 2 0 2 0
K. oxytoca 5 1 3 0 0 0 0 1
Total 80 2 5 30 9 31 2 1
(100%) (2.5%) (6.3%) (37.5%) (11.3%) (38.8%) (2.5%) (1.2%)
Conclusion: In our area, ESBL-producing Klebsiella spp. are rarely
detected, while E. coli is becoming the predominant ESBL-producing
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species, as reported in other Italian areas and other European
countries. Among ESBL-positive Enterobacteriacee, CTX-M type is
most frequently encountered, involving about 87% of E. coli strains.
Finally, ESBL resistance is not exclusively found in hospital settings,
but it is spreading even in the community, involving especially elderly
patients with urinary tract infection.
R2305 Evaluation of resistance mechanisms and epidemiology of
Acinetobacter isolates from intensive care units in a Turkish
university hospital
B. Altun, G. Hascelik, M. Akova (Ankara, TR)
Objectives: Multiresistant Acinetobacter spp. (MR-A) are responsible
for the increasing number of nosocomial infections. Local epidemiolgy
has outmost importance for determining therapeutic options in patients
infected with MR-A.
Methods: We examined one-hundred-ﬁfty Acinetobacter baumannii
strains isolated from blood cultures between 1997 and 2007 at the
Hacettepe University Medical School. All of the strains were isolated
from nosocomial infections. In vitro activity of netilmicin, amikacin,
ciproﬂoxacin, imipenem, piperacillin, cefoperazone/sulbactam, tetracy-
cline and colistine, were evaluated by the minimal inhibitor concentration
(MIC) technique using broth microdilution method according to CLSI
criteria. Presence of PER-1 and other b-lactamase proﬁles (IMP-1,
VIM-1, SPM and OXA-58) of the strains were determined using PCR.
DNA ﬁngerprinting by PFGE was used for epidemiological analysis of
the strains.
Results: Resistance rates are given in the Table. Sixty (40%) of 150
isolates were found positive for PER-1 gene. No isolates with IMP-1,
VIM-1 and SPM genes were determined. OXA-58 was detected in
75 (50.0%) of 150 isolates. Eight distinct patterns were detected with
genomic ﬁngerprinting by macrorestriction analysis with PFGE.
Table. In vitro susceptibility of Acinetobacter isolates
MIC50 MIC90 Range Susceptibility Results (n = 150)
Sensitive Intermediate Resistant
n % n % n %
Amikacin 128 256 0.50−>256 39 26.0 4 2.7 107 71.3
Netilmicine 2 8 <0.125–256 137 91.3 9 6.0 4 2.7
Ciproﬂoxacin 32 128 <0.125−>256 30 20.0 3 2.0 117 78.0
Imipenem 32 >256 <0.125−>256 46 30.7 18 12.0 86 57.3
Piperacillin >256 >256 1−>256 13 8.7 15 10.0 122 81.3
Cefoperazone/sulbactam 32 128 <0.125−>256 60 40.0 28 18.7 62 41.3
Tetracycline 8 256 <0.125−>256 63 42.0 42 28.0 45 30.0
Colistine 0.25 0.50 <0.125−1 150 100.0 – – – –
Conclusions: In a multiresistant population of Acinetobacter isolates,
PER-1 and OXA-58 were frequently detected. Along with the other
possible mechanisms, these two ESBL-type of enzymes seem to
contribute to multiresistance pattern of our Acinetobacter isolates.
R2306 Antimicrobial susceptibility and macrolide-resistance
mechanisms among clinical isolates of Streptococcus
pneumoniae in Bulgaria, 2006–2007
A. Alexandrova, B. Markova, I. Haydoushka, M. Sredkova, K. Bojkova,
U. Proevska, L. Setchanova (Soﬁa, Plovdiv, Pleven, Varna, BG)
In total, 186 clinical isolates of S. pneumoniae collected from four
University Hospitals in Bulgaria were analysed to determine their
susceptibility to 13 antimicrobials by the means of MIC testing and
their mechanisms of macrolide resistance. Of these pneumococci, 46.8%
were penicillin-nonsusceptible (28.5% penicillin-intermediate and 18.3%
penicillin resistant strains). Erythromycin resistance was found in 30.1%
of the isolates and 20.4% were clindamicin resistant. The susceptibilities
to other antimicrobial agents were: amoxicillin (95.7%), amoxicillin-
clavulanic acid (95.7%), cefuroxime sodium (73.1%), cefotaxime
(93%; all the rest 7% were intermediately resistant), chloramphenicol
(89.2%), tetracycline (67.2%), ciproﬂoxacin (93%), trimethoprim-
sulfamethoxazole (45.7%), rifampin (100%), and vancomycin (100%).
Among 55 erythromycin-resistant S. pneumoniae isolates, strains
harbouring erm(B) genes (n = 33; 60%) were found to be predominant
over strains with mef(A)/mef(E) genes (n = 17; 30.9%). Five isolates
(9.1%) carried both erm(B) and mef(A)/mef(E) genes. We observed
the prevalence of erythromycin ribosome methylase macrolide resistance
mechanism than macrolide efﬂux compared to isolates collected in 2001–
2005. Serotyping of S. pneumoniae isolates suggested that serotype (or
serogroup) 14, 6 and 19 were predominant (%) among erythromycin-
resistant strains. Among mef(A)/mef(E) positive isolates serotype 14
was predominant, among erm(B) positive isolates serogroups 6 and 19
were the most prevalent.
R2307 Detection of ambler class A, B, and D in multidrug-resistant
P. aeruginosa from central regions of Korea
S.H. Koo (Daejeon, KR)
Objectives: Outbreaks of multidrug-resistant P. aeruginosa give rise to
signiﬁcant therapeutic challenges in treating nosocomial infections. In
order to acquire data useful in preventing the extension of multidrug-
resistant P. aeruginosa, we identiﬁed genetic types and frequencies of
ESBL of Ambler class A and D, and carbapenemase of class B and D,
from a medical centre in central area of Korea.
Methods: A total of 37 selected strains of multidrug-resistant
P. aeruginosa isolated from March 2006 to May 2007 were analysed.
For the detection of multi-resistance, broth dilution methods were carried
out according to the CLSI guidelines. The strains showed resistance to
imipenem/meropenem, piperacillin, and ciproﬂoxacin. MBL-producing
strains were selected by the inhibitor-potentiated disc diffusion (IPD)
method. Genotype analysis of b-lactamase was carried out using
PCR and DNA sequencing. Clonality was tested using enterobacterial
repetitive intergenic consensus polymerase chain reaction (ERIC PCR)
in 19 OXA-10 producing strains.
Results: Twenty-nine of 37 isolates harboured blaOXA-10 (56.8%),
blaOXA-2 (18.9%), and blaOXA-1 (5.4%), respectively. IMP-1 produc-
ing strain was the only one case harbouring blaOXA-1. The strains
haboring ambler class A b-lactamase or class D carbapenemase were not
detected. One strain revealed a combination of IMP and blaOXA-1, while
the other had OXA-2 and OXA-10. The strains-producing Ambler class
D b-lactamase showed signiﬁcantly higher resistances in aminoglycoside,
compared to non-producers. The ERIC PCR pattern of the 19 OXA-10
producing strains indicated that the isolates were closely related in terms
of clonality.
Conclusion: OXA type b-lactamases of multidrug-resistant P. aerug-
inosa are widespread, but their extended-spectrum derivatives and car-
bapenemases are rare in central regions of Korea. The strains harbouring
OXA b-lactamase were deﬁned to have an effect on cross-resistances by
their signiﬁcantly higher resistance against aminoglycoside. To prevent
further spreading of the multidrug-resistant P. aeruginosa, consequent
monitoring and effective clinical policies are required.
R2308 Characterisation of extended-spectrum b-lactamases in
clinical Escherichia coli isolates in a Spanish hospital
S. Somalo, L. Vinue´, I. Olarte, E. Undabeitia, E. Ugalde, Y. Sa´enz,
M. Zarazaga, C. Torres (Logron˜o, ES)
Objective: To characterize the genes encoding ESBLs, their genetic envi-
ronments and the phylogenetic groups of broad-spectrum cephalosporin-
resistant clinical Escherichia coli isolates recovered in a Spanish hospital.
Methods: Seventy-seven broad-spectrum cephalosporin-resistant E. coli
isolates recovered in the Hospital San Pedro (Logron˜o, Spain) during
2004–2007, presented a positive ESBL-screening test and were included
in this study. Genes encoding CTX-M, SHV and TEM type b-lactamases
were analysed by speciﬁc PCR-RFLP and/or PCR-sequencing. The
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genetic environment of blaCTX-M genes were characterised by PCR-
mapping and the phylogenetic groups of ESBL-positive isolates were
determined by PCR (chuA, tspE4.C2, and yjaA genes).
Results: The origin of the 77 ESBL-positive isolates were: urine (77%),
blood (5%), wounds (5%), others (13%). The bla genes encoding the
following ESBLs were detected in our 77 E. coli (number of isolates):
blaCTX-M-14 (46), blaCTX-M-14 plus blaSHV-12 (3), blaCTX-M-67
(1), blaCTX-M-15 (2), blaCTX-M-9 (7), blaCTX-M-9 plus blaSHV-
12 (1), blaSHV-12 (10), and unknown mechanisms (7). Thirty-seven
of the 70 CTX-M and SHV-positive ESBL-isolates harboured a TEM
b-lactamase. The surrounding regions of blaCTX-M genes detected in
our isolates were as follows (number of isolates): ISEcp1-blaCTX-M-14-
IS903 (38), blaCTX-M-14-IS903 (4), ISEcp1-blaCTX-M-14 (1), ISCR1-
blaCTX-M-9-orf1005 (7), blaCTX-M-9-orf1005 (1), ISEcp1-blaCTX-
M-67-IS903 (1), and blaCTX-M-15-orf477 (2 isolates). Forty-eight per
cent of the ESBLs-positive isolates were classiﬁed into the A or B1
phylogenetic groups, and 52% into the B2 or D phylogenetic groups.
Conclusions: The ESBLs of the CTX-M-type are predominant in this
hospital (80%), mainly of the CTX-M-9 group (77%), associated to
SHV-12 (10%). Different genetic environments associated to ISEcp1 and
ISCR1 were detected among our blaCTX-M-positive isolates.
R2309 Staphylococcal cassette chromosome mec proﬁles of
Staphylococcus aureus isolated in 13 Korean hospitals
J.S. Kim, W.K. Song, H.S. Kim, J.S. Eom, K.M. Lee (Seoul, KR)
Background: There has been a nationwide increase in infections caused
by Staphylococcus aureus resistant to multiple antimicrobial agents in
Korea. The prevalence of MRSA in S. aureus in tertiary-care hospital is
nearly 70% since the mid-1990s. We assessed the staphylococcal cassette
chromosome mec (SCCmec) proﬁles and Panton-Valentine leukocidin
(PVL) on Korean nationwide collection of S. aureus strains from tertiary-
care hospitals in Korea.
Methods: We collected a total of 250 clinical isolates of S. aureus
from 13 clinical laboratories over the country during 2 months in
2007. Meticillin-resistant S. aureus (MRSA) isolates were conﬁrmed by
oxacillin susceptibility test and PCR detection of mecA gene. SCCmec
typing was performed by multiplex PCR. Panton-Valentine leukocidin
(PVL) gene was also detected by PCR.
Results: Among 250 isolates, 175 strains (70.0%) were MRSA. Of the
175 MRSA isolates, 0 (0%), 129 (73.7%), 31 (17.7%), and 15 (8.6%)
isolates belonged to SCCmec types I, II, III, and IV, respectively. The
most prevalent subtype was SCCmec type IIb (n = 109, 62.3%). SCCmec
type IVa strains known as community-associated MRSA in Korea were
10 (5.7%) isolates. None of the MRSA isolates were PVL-positive.
Conclusions: SCCmec type II strains are the most frequent SCCmec
type in Korea, followed by SCCmec types III and IV. SCCmec subtype
IIb strains were detected in 12 hospitals throughout the country and
have increased in Korea, compared to previous study (62.3% in 2007
vs. 33.7% in 2002). SCCmec type I strains or PVL-positive S. aureus
strains were not detected, though they are often isolated in Europe.
R2310 A new association of known genetic elements in a Tn916-
family transposon carrying tet(M), erm(B), and mef(E)
M. Del Grosso, G. Barbabella, R. Camilli, M. Fuzi, B. Libisch,
A. Pantosti (Rome, IT; Budapest, HU)
Objectives: In Streptococcus pneumoniae, macrolide resistance can
be conferred by two distinct genes, erm(B) and mef. Pneumococcal
isolates, carrying both erm(B) and mef, have been increasingly observed
in South Africa, in Asian countries, and in the United States. Dual-
gene isolates are rarely found in European countries, although one
such strain was described in Hungary. The genetic elements carrying
macrolide resistance genes in this Hungarian pneumococcal isolate were
characterised.
Methods: Antimicrobial susceptibility to penicillin, erythromycin,
clindamycin, and tetracycline were determined by Etest. PCR assays were
performed: to detect the presence of the resistant determinants mef(E),
erm(B), and tet(M), to deﬁne the genetic organisation of the elements
and a possible association among them, and to explore the chromosomal
location.
Results: In the multiresistant pneumococcal isolate from Hungary
belonging to serotype 19F, the resistance determinants mef(E), erm(B),
and tet(M) were identiﬁed. Analysis of the genetic elements carrying
the resistance genes performed by PCR mapping and by comparing the
amplicons obtained with those obtained with control strains, showed that
mef(E) was found included in the mega element, erm(B) in a Tn917-like
transposon, and tet(M) in a Tn916-like transposon. Since descriptions in
literature were reported where Tn2009 harboured mega in orf6 of Tn916,
and Tn3872 harboured Tn917 in orf9 of Tn916, PCRs targeting these
two ORFs were performed. The results obtained conﬁrmed the insertion
of mega and Tn917 in orf6 and orf9, respectively. The linkages among
the three elements, conﬁrmed by PCR, indicated the presence of a novel
composite transposon. The chromosomal location of this novel composite
transposon was identical to that previously found in other Tn916-family
transposons.
Conclusions: The multiresistant S. pneumoniae isolate from Hungary
harbours a novel Tn916-family transposon carrying mef(E), erm(B), and
tet(M). This transposon corresponds to a new modular combination of
three well-known genetic elements: mega, Tn917 and Tn916.
R2311 Panton-Valentine leukocidin positive, t008 spa-type
meticillin-resistant Staphylococcus aureus in a Romanian
western county hospital
I. Codita, M. Oprea, C. Szmal, E.C. Dragulescu, M. Trasca, D. Brehar
Cioﬂec, G. Chicin, R. Serban, A. Pistol (Bucharest, Timisoara, RO)
Objectives: To preliminary evaluate the possible hospital isolation
of the USA300 genotype community-associated meticillin resistant
Staphylococcus aureus strain in a Romanian Western county hospital.
Methods: Staphylococcus aureus strains were identiﬁed using con-
ventional, API and automate methods (VITEK2). Meticillin-resistance
was screened by the cefoxitin disc method and conﬁrmed by mecA
PCR. MecA gene was detected by a triplex PCR variant optimised in
our laboratory, detecting concomitantly the nuc gene coding for the
thermonuclease and the lukS/F genes coding for the Panton Valentine
leucocidin (PVL). PFGE was performed according to the HARMONY
protocol. Spa-typing was done by DNA sequencing analysis of the
protein A (spa) gene hypervariable region according to the SeqEUNet.org
recommended protocols.
Results: 91 S. aureus strains have been analysed at the National Noso-
comial Infections and Antimicrobial Resistance Laboratory, National
Institute of Research-Development for Microbiology and Immunology
“Cantacuzino”, Bucharest, including the SeqEUNet.org 2006/2007 6
months study and all ICU strains received during the January 2006–
June 2007 interval. Among these, 4 strains received from a Romanian
Western county hospital isolated in January/February 2007 harboured
the t008 spa-type, similar with the spa-type of the USA300 community
associated genotype, which has been recently discovered in Germany
(Witte et al. – JAC Advance Access published online on October 13,
2007). Two of the 4 strains were MRSA. These MRSA strains proved
lukS/F positive. The two strains were isolated from 2 patients, 3 months
and 14 years old, respectively, receiving healthcare in the ICU of the
Western county Romanian hospital. Both t008, PVL positive MRSA
strains harboured the same pulsotype. The Romanian strains pulsotype
looks very similar with the USA300 pulsotype (Johnson et al – Em. Inf.
Dis., 13, 8, 2007).
Conclusion: The t008 spa-type MRSA strains received from a Romanian
Western county hospital could be related with the USA300 genotype
strain based on the presence of lukS/F genes, spa type and PFGE proﬁle.
Further molecular studies, including SCCmec typing and searching for
the arginine catabolic mobile element (ACME) determinant will help us
to clearly establish the clonal relatedness of these 2 identical Romanian
strains with the USA300 genotype community associated strain.
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R2312 Characterisation of carbapenem-resistant Acinetobacter
baumannii carrying different OXA-type carbapenemases
from two hospital outbreaks in Berlin, Germany
P.G. Higgins, A. Kohlenberg, H. Seifert (Cologne, Berlin, DE)
Methods: Non-duplicate A. baumannii isolates were collected between
June, 2005 and November, 2006 from clinical specimens from patients
hospitalised on different wards in hospital 1 and between March
and June, 2007 from patients hospitalised in hospital 2, respectively.
Species identiﬁcation was conﬁrmed by gyrB multiplex PCR and
ARDRA. Antimicrobial susceptibility was determined by VITEK2
and agar dilution methods. Detection of IMP-, VIM- and OXA-type
carbapenemases was performed by PCR. Epidemiological typing of
isolates was performed by RAPD and PFGE.
Results: Forty-nine and fourteen A. baumannii isolates were collected
from hospitals 1 and 2, respectively. Data on the CR isolates is
summarised in the table. Molecular typing revealed that isolates from
hospital 1 had 6 PFGE patterns (A-D, G, H), of which pattern A was
the most prevalent. Patterns A1-A4 (5 isolates) were closely related
to pattern A. Isolates with patterns A2, A3, B and C were isolated
once each and were carbapenem-sensitive. Hospital 2 yielded two
PFGE patterns, I and J, of which I was the predominant strain. All
but the 4 isolates from hospital 1 mentioned above were resistant to
all penicillins, cephalosporins, ciproﬂoxacin, gentamicin, tobramycin,
amikacin, imipenem, and meropenem, and remained susceptible only to
colistin, i.e. isolates were pandrug-resistant. All A. baumannii isolates
carried the intrinsic OXA-51-like gene. With the exception of PFGE
type H, all CRAb isolates had either an OXA-23-like, OXA-58-like or
OXA-24-like gene. One isolate with PFGE pattern G carried an OXA-
58-like and an OXA-24-like gene. PFGE type H was negative for IMP-
or VIM-type metallo carbapenemases.
Conclusion: Carbapenem resistance was associated with the spread
of distinct clonal strains that carried an OXA-type carbapenemase.
In hospital 1 the predominant strain had closely-related carbapenem-
sensitive isolates. Resistance was associated with this strain acquiring
an OXA-23-like or OXA-58-like gene while one isolate has acquired
both of these genes. Molecular typing of all the CRAb isolates reveals
that there was no inter-hospital spread of CRAb, but rather it is the
dissemination in two different locations of strains that have acquired an
OXA-carbapenemase.
Hospital 1 Hospital 2
PFGE-pattern A A1 A4 D G H I J
No. of isolates 30 2 1 8 2 2 13 1
with OXA-23 30 2
with OXA-58 1 8 1 13
with OXA-24 2 1
Imipenem MIC (mg/ml) 16–64 32–64 32 16–32 256 8 16–32 64
R2313 Mechanism of resistance to antimicrobial agents in Shigella
strains isolated from stools among children under 5 years
of age in southern Mozambique
I. Mandomando, D. Jaintilal, L. Mensa, M. Pons, J. Ruiz, P. Alonso
(Maputo, MZ; Barcelona, ES)
Objective: To characterise the molecular mechanisms of antimicrobial
resistance of Shigella spp. strains isolated from stools among children
under 5 years of age in Southern Mozambique
Methods: Antimicrobial susceptibility testing: Shigella strains isolated
from children <5 years of age complaint with diarrhoea in Manhic¸a
District Hospital (MDH), Southern Mozambique were tested for
antimicrobial susceptibility to ampicillin (Amp), chloramphenicol (Chl),
cotrimoxazole (SXT), tetracycline (Tet), nalidixic acid (Nal), Ceftriaxone
(Cro) by disk diffusion method.
Detection of the mechanism of resistance: The presence of the
cmlA and ﬂoR genes associated to Chl resistance; tetA, tetB, and
tetG genes associated to Tet resistance; genes encoding b-lactamases
(OXA-1, OXA-2, TEM-like, SHV-like) associated to Amp resistance,
and dihydrofolate reductase genes were carried out by PCR and
electrophoresis in 2% agarose gel.
Results: The molecular mechanisms of antimicrobial agents resistance in
Shigella strains [Ampicillin (Amp), Tetracycline (Tet), Chloramphenicol
(Chl) and Trimetoprim-Sulfametoxazole (SXT)] were analysed. At total
111 isolates were analysed. The most frequently detected encoding
b-lactamases genes were oxa-like, from which oxa-1 (55 isolates) was
the most frequent followed by carb (7 isolates), while tem (4 isolates)
and oxa-2 (3 isolates) were recovered in low prevalence.
Resistance to Tet were mainly related to tetB (47 isolates), tetG (18
isolates), and tetA (9 isolates), genes. Nor ﬂoR neither cmlA genes were
found to be related to Chl resistance; however CAT is not researched yet.
Several genes encoding dihydrofolate-reductases (dfrA1, dfrA5, dfr14,
dfr7) were responsible for SXT resistance strains, being dfrA1-like (52
isolates), the most frequent followed drf14 (24 isolates) and dfr7 (3
isolates only).
Conclusions: Despite the fact that the isolates were recovered in
a speciﬁc geographic area, an high heterogeneity in the molecular
mechanisms of antimicrobial resistance has been detected.
R2314 Detection of clindamycin resistance in Staphylococcus
aureus: a comparison of agar diffusion tests, VITEK2 and
real-time PCR
K. McBride, E. McCulloch, C. Lucas, C. Williams, L. Williams,
E. Kilgour, A. Leanord (Glasgow, Airdrie, UK)
Objectives: The study of antibiotic resistance mechanisms in S.aureus
has never been more relevant with an exponential rise in public concern
over nosocomial MRSA infection. Community acquired MRSA is a
further problem, especially with the recognition that Panton-Valentine
Leucocidin is most commonly present in community MRSA and related
strains of MSSA.
Clindamycin is favoured for treatment of deep-seated S.aureus infection
due its excellent tissue penetration and ability to inhibit toxin production.
Unfortunately, while constitutively expressed resistance mechanisms are
evident using routine microbiological methods, inducible mechanisms
may evade detection by both the manual and automated sensitivity testing
techniques currently available.
This study compared detection of resistance to Clindamycin in S.aureus
using standard and molecular methodologies, with a view to assessing
the clinical impact inappropriate sensitivity testing.
Methods: Forty-seven Erythromycin resistant S.aureus strains were
collected randomly from patients attending a Scottish district general
hospital. D tests and E tests were performed using standard methodolo-
gies. DNA was extracted from strains using the EZ1 BioRobot (Qiagen)
and a tissue extraction kit (with a bacterial extraction protocol). DNA
ampliﬁcation and detection was achieved using an ABI Prism 7000
sequence detector and Sybr green universal detection dye (Applied
Biosystems). Duplicate samples were analysed using a real-time PCR
reaction designed to amplify a speciﬁc ermA, ermB, ermC and msrA
resistance gene target.
Results:
• Of 42 MSSA isolates, ermA, ermC and msrA genes were harboured
by 14, 24 and 4 isolates respectively
• 5/5 MRSA harboured the ermC gene
• VITEK2 failed to detect Clindamycin resistance in all MSSA and 2/5
MRSA tested
• E tests failed to detect Clindamycin in all MSSA and 4/5 MRSA
strains
• As predicted, D tests were negative in 4 strains which were PCR
positive for the msrA gene which does not confer clindamycin
resistance
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• The D test successfully detected Clindamycin resistance in all
strains PCR positive for erm genes associated with MLS (macrolide,
lincosamide, streptogramin B) resistance in S.aureus
Conclusion:
• VITEK2 and E test are inappropriate methods for detection of
Clindamycin resistance.
• The D test should be performed on all strains phenotypically resistant
to Erythromycin.
• The prevalence of erm genes in phenotypically Erythromycin sensitive
strains requires urgent investigation.
In vitro antibacterial susceptibility & drug
interaction studies
R2315 The antimicrobial susceptibility of 83 strains of S. aureus
against 14 antimicrobials from Belarus
K. Bowker, V. Gorbunov, L. Titov, A. MacGowan (Bristol, UK;
Minsk, BY)
Objectives: The aim of this study was to evaluate the antimicrobial
susceptibility of 17 MSSA and 66 MRSA clinical isolates from Minsk,
Belarus against 13 antimicrobials.
Materials and Methods: Bacterial isolates from the collection held in
Belarus were tested against the following agents; clindamycin (CLD),
gentamicin (GEN), amikacin (AMK), vancomycin (VAN), teicoplanin
(TEI), ciproﬂoxacin (CIP), fusidic acid (FUS), daptomycin (DAP),
rifampicin (RIF), linezolid (LIN), quinupristin/dalfopristin (Q/D),
erythromycin (ERY) and tetracycline (TET). MICs were performed using
CLSI agar dilution methodology using cation-adjusted Mueller Hinton
agar, supplemented with 50mg/L calcium for Daptomycin. The number
of strains resistant according to CLSI breakpoints were calculated.
Results: The range, MIC50 and MIC90 (mg/L) and percent resistant
for each drug are shown in the table below. Using CLSI breakpoints all
isolates were susceptible to VAN, TEI, DAP, LIN and Q/D, greater than
50% of MRSA strains were resistant to GEN, ERY and TET. MRSA
were more resistant than MSSA. Using MIC90 data rifampicin was the
most active agent against both MRSA and MSSA; ERY was the least
active agent.
MRSA (n = 66) MSSA (n = 17)
range MIC50 MIC90 % R range MIC50 MIC90 % R
Clindamycin 0.12–32 0.25 32 22 0.25−0.5 0.25 0.5 36
Gentamicin 0.25–128 64 128 81 0.25–128 0.5 16 42
Amikacin 2–128 4 16 11 2–32 4 4 6
Vancomycin 1−4 1 1 0 1 1 1 0
Teicoplanin 1−4 1 1 0 1−2 1 1 0
Ciproﬂoxacin 0.5–32 1 2 11 0.5–16 1 1 6
Fucidic acid 0.03−4 0.06 2 nd 0.03−1 0.06 1 nd
Daptomycin 0.12−1 0.5 1 0 0.12−0.5 0.5 0.5 0
Rifampicin 0.008–128 0.015 0.12 5 0.008−0.015 0.015 0.015 0
Linezolid 1−2 2 2 0 1−2 2 2 0
Quin/dalfo 0.25−0.5 0.5 0.5 0 0.25−0.5 0.5 0.5 0
Erythromycin 0.25–256 256 256 85 0.25–256 0.25 256 47
Tetracycline 0.5–128 1 128 55 0.5–64 1 64 42
Conclusion: As expected MRSA strains were generally more resistant
than MSSA however, aminoglycoside, macrolide/lincosamide and
tetracycline resistance was common. Glycopeptides and the newer agents
retained good activity against S.aureus from Belarus.
R2316 Urinary tract infection pathogens and their susceptibility
to antimicrobials at a university hospital, Setif, Algeria: a
7-year study (2000–2006)
F. Sahli, N. Radji, A. Touabti (Se´tif, DZ)
Objectives: To determine the most frequent pathogens causing urinary
tract infection isolated at the microbiology laboratory of the Setif
university hospital in Algeria during 7 years and we report their
susceptibility (S) rates to antimicrobials.
Methods: 3227 isolates were collected from urine specimens during
7 years (2006–2007). Strains were identiﬁed by standards methods. S
to antimicrobial agents was tested according to the CLSI guidelines as
well as the detection of the extended spectrum betalactamase phenotype
(ESBL).
Results: The most frequent pathogens were E. coli (59.4%), Kleb-
siella (12.9%), Proteus (8%), Pseudomonas aeruginosa (4.89%),
Enterococcus (3%) and Staphylococcus aureus (2.23%). For the
commonly isolated Enterobacteriaceae, antimicrobials S rates were:
cefotaxim (89.4%), imipenem (100%), ciproﬂoxacin (86.6%) and
trime´thoprim/sulfamethoxazole (sxt) (52.2%). ESBL phenotype rates
were 6.6% for E. coli, 8% for Proteus and 30% for Klebsiella. The S
rates for Pseudomonas aeruginosa were as follow: piperacillin (57.9%),
ceftazidime (64.9%), imipenem (94.8%), ciproﬂoxacin (69.7%) and
colistin (100%). Enterococcus was susceptible to ampicillin in 62.2%,
tetracycline in 20.6% and vancomycin in 100%. For Staphylococcus
aureus, oxacillin was active at 71.8%, oﬂoxacin 82.2%, sxt 85.5% and
vancomycin 100%.
Conclusion: Enterobacteriaceae and specially E. coli remained the most
frequent urinary tract infection pathogens. The most actives antimicro-
bials agents were imipenem and third generation cephalosporins (3GC)
although emerging BLSE phenotype had reduced the 3GC activity
particularly on Klebsiella isolates. Fluoroquinolones were still actives
but their S rates decrease progressively. Using adequate antimicrobial
therapy with broad spectrum agents will not solve the multidrugresistant
bacteria problem if strict measures aren’t applied to avoid such isolates
spread.
R2317 Pseudomonas aeruginosa infection and antimicrobial
susceptibility in hospital patients, Setif, Algeria
F. Sahli, N. Radji, A. Touabti (Se´tif, DZ)
Objectives: to report the antimicrobial susceptibility (S) rates of
Pseudomonas aeruginosa isolates from different specimens in Setif
hospital
Methods: 399 Pseudomonas aeruginosa strains were isolated between
January 2000 and September 2005 in the Setif hospital microbiology
laboratory. Strains were identiﬁed by standards methods. S to
antimicrobial agents was tested according to CLSI guidelines.
Results: most of our strains were isolated from respiratory sites (23%),
wounds (19%), urine (15%), blood (9%) and chirurgical wounds (9%).
Antimicrobial susceptibility rates were as follow: pireracillin (50%),
ceftazidime (74%), imipenem (95.6%), gentamicin (70%), amikacin
(91%), and ciproﬂoxacin (83.5%). Prior antibiotherapy was inadequate
in 67% including cefotaxim or ceftriaxone; this contributes to select the
most resistant strains and clinic deterioration. We note that susceptibility
rate to ceftazidime had increased from 50% in 2000 to 74% in 2004 and
2005. For imipenem, there was no resistance until 2004.
Conclusion: Most of third generation cephalosporins used commonly
haven’t any activity against Pseudomonas aeruginosa and once again,
almost third of our strains were resistant to ceftazidime. In critical ill
patients, antibiotherapy prior S tests results must include one or more
antimicrobials actives against Pseudomonas aeruginosa according to
local S data.
R2318 Drug susceptibility testing of Mycobacterium tuberculosis
strains by using two different methods
A.E. Aktas, H. Igan, A. Ayyildiz (Erzurum, TR)
Objective: The emergence of multi-drug-resistant tuberculosis points
out how important timely identiﬁcation of Mycobacterium tuberculosis
complex strains and their susceptibility testing may be to achieving
effective management of the disease and prevention of its spreading.
Currently, a number of susceptibility testing methods have been used
in many laboratories. In the present study we aimed to compare the
agar proportion method with the E-test method for susceptibility testing
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of Mycobacterium tuberculosis strains isolated from the patients in our
hospital.
Methods: A total of 45 isolates were tested for isoniazid, rifampin,
streptomycin and ethambutol susceptibility using an indirect-proportion
method and E-test method. The isolated strains were identiﬁed by
morphological, cultural and biochemical characteristics (microscopy,
time of growth, type of colonies, catalase, niacin-test). H37RV strain was
incuded in the test as reference strain. The E-test method was performed
on 7H11 agar with OADC, and the standard proportion method was
performed on Lowenstein-Jensen agar. E-test method gave correct results
from the eighth day, with stability of the zone of inhibition until the 21st
day.
Results: We found a good correlation between the two methods. The
correlations between the Etest and agar proportion methods were 98, 100,
100, and 100% for isoniazid, rifampin, ethambutol, and streptomycin,
respectively. The results are summarised in Table 1.
Table 1. Comparison of susceptible and resistant M. tuberculosis strains by the
E-test and agar proportion methods
Agent No. of isolates with indicated result by: % Agreement
Agar proportion method E-test method
Susceptible Resistant Susceptible Resistant
Isoniazid 40 5 41 4 98
Rifampin 43 2 43 2 100
Ethambutol 44 1 44 1 100
Streptomycin 43 2 43 2 100
Conclusion: Our results showed that there were no statistically
signiﬁcant differences in susceptibility testing results between E-test and
the proportion method. The results thus suggest that E-test method can
be routinely used instead of the proportion method because the average
times required for obtaining the ﬁnal result with E-test method are less
than the proportion method.
R2319 Detection of meticillin-resistant Staphylococci isolated from
nasal specimens using PCR
G. Sahba (Shahrekord, IR)
Background: The acquisition of mecA gene by Staphylococci is
contributed with resistance to methicilin. Nasal carriage among hospital
staff are believed to be a potential source of nosocomial infections. The
aim of this study is to determine the frequency of mecA gene in meticillin
resistant Staphylococci isolated from hospital staff nasal specimens in
Shahre kord city of Iran using PCR.
Methods: A total of 204 nasal swabs from hospital wards staff were
collected. Conventional microbiological methods were performed for
Staphylococcal isolation and identiﬁcation. Antibacterial susceptibility
pattern of the Staphylococcus isolates to oxacillin (meticillin) were tested
using agar screen method. The presence of mecA gene in meticillin
resistant Staphylococci were tested using duplex PCR.
Results: Staphylococcus aureus and coagulase negative Staphylococcus
isolates were cultured from 25.4% and 74% 0f nasal specimens
respectively. In antibacterial susceptibility testing, twenty-three(44%) of
Staphylococcus aureus and 70 (46%) of coagulase-negative staphylo-
coccal isolates were phenotypically resistant to methicilin. Using PCR,
mecA gene was detected in 52% of Staphylococcus aureus and 52.5%
of coagulase-negative staphylococcal isolates.
Conclusion: This study showed that staphylococcal nasal carriage
among hospital staff is a medical problem and the rate of mecA gene
in hospital strains of staphylococcus isolates is signiﬁcantly high. These
resistant isolates may have an important role in distribution of antibiotic
resistance in hospitals.
R2320 Comparison of coagulase-negative staphylococci isolated
from patients and healthy individuals
A. Zilevica, R. Treimane, R. Paberza, O. Nikitina (Riga, LV)
Introduction: More than forty species of the genus Staphylococcus
have been identiﬁed so far. Coagulase-positive S. aureus has been
frequently implicated in the aetiology of a series of infections. Over
the last decade, coagulase-negative staphylococci (CoNS) have been
recognised as aetiological agents of infectious processes. CoNS produce
different virulence factors, although the differentiation between virulent
and non-virulent strains is difﬁcult since the virulence factors of these
microorganisms are yet not well deﬁned.
Objectives: The aim of the study was to identify the species spectrum,
biochemical criteria and meticillin resistance of CoNS, isolated from
healthy individuals, in-patients of surgical hospitals and out-patients.
Materials and Methods: The study was carried out in two Riga
hospitals and a department for out-patients. The identiﬁcation of isolated
microorganisms from clinical samples was performed by the mini API
system, Crystal system, and susceptibility testing – by the mini API
system, the disk diffusion test, e-test.
Results: More than 400 strains of CoNS were investigated. The species
spectrum of CoNS, isolated from in-patients, was as follows: Staphy-
lococcus epidermidis 56.03%, Staphylococcus haemolyticus 14.18%,
Staphylococcus hominis 10.2%, Staphylococcus saprophyticus 5.0%
and others; from out-patients: S. epidermidis 48.73%, S. haemolyticus
36.97%, Staphylococcus sciuri 5.04%, Staphylococcus simulans 4.20%
and others; from healthy individuals: S. epidermidis 55%, Staphylococ-
cus capitis 16.6%, S. haemolyticus and Staphylococcus cohnii 6.6%,
Staphylococcus warneri and S. saprophyticus 5.0% and others.
The results of the tests of utilisation and degradation of speciﬁc
substrates revealed a signiﬁcant difference between nosocomial and
healthy strains in 2 tests – maltozide and methyl alpha, beta glucoside
utilisation.
Meticillin resistance in CoNS from in-patients and out-patients was
51.23% and 19.3%, respectively. Bacteraemia was caused only by
MRCoNS.
Conclusions: More virulent were S. haemolyticus, S. hominis, S. sciuri.
Meticillin-resistant strains occurred to be more invasive and were the
only causative agents of bacteraemia.
R2321 In vitro activities of tigecycline against Aeromonas, Vibrio,
and Salmonella species, Taiwan
Y-T. Huang, C-H. Liao, C-Y. Liu, P-R. Hsueh (Taipei, TW)
Background: Aeromonas, Vibrio, and Salmonella species are endemic
pathogens associated with a variety of clinical infections in Taiwan.
There are few reports regarding in vitro activities of tigecycline against
these pathogens.
Methods: A total of isolates of Aeromonas, Vibrio, and Salmonella
species were tested. These organisms were isolated from various clinical
specimens (blood, stool, and pus).
Bacteria (no. of isolates tested) MIC (mg/ml) No. (%)
Range MIC50 MIC90 S I R
A. hydrophila (n = 81) 0.06−2 0.25 0.5 81 (100) 0 (0) 0 (0)
A. caviae (n = 63) 0.12−4 0.25 0.5 62 (98) 1 (2) 0 (0)
A. sobria (n = 57) 0.12−1 0.25 0.5 57 (100) 0 (0) 0 (0)
S. choleraesuis (n = 63) 0.12−2 0.5 1 63 (100) 0 (0) 0 (0)
S. typhimurium (n = 63) 0.25−2 0.5 0.5 63 (100) 0 (0) 0 (0)
Other Salmonella spp. (n = 72)* 0.12−1 0.5 0.5 72 (100) 0 (0) 0 (0)
V. parahaemolyticus (n = 41) 0.06−0.12 0.06 0.12 41 (100) 0 (0) 0 (0)
Vibrio cholerae non O1 (n = 26) 0.03−0.12 0.06 0.06 26 (100) 0 (0) 0 (0)
V. vulniﬁcus (n = 15) 0.03−0.12 0.03 0.03 15 (100) 0 (0) 0 (0)
Other Vibrio species (n = 10) 0.03−0.12 0.06 0.12 10 (100) 0 (0) 0 (0)
*Including Salmonella serogroup O7 (n = 13), O8 (n = 14), and O9 (n = 45).
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MICs of tigecycline were determined by using the broth dilution method
(CLSI). The results were interpreted by the MIC criteria provided by U.S.
FDA tigecycline susceptibility breakpoints listed for Enterobacteriaceae
(S, 2mg/L; I, 4mg/L; R, 8mg/L)
Results: All 81 Aeromonas hydrophila, 57 A. sobria, 198 non-typhoid
salmonella, and 92 Vibrio isolates were susceptible to tigecycline. One
out of 63 A. caviae isolates revealed intermediate to tigecycline.
Conclusions: Nearly all isolates of Aeromonas, Vibrio, and Salmonella
species tested were susceptible to tigecycline. Further in vivo studies
should be conducted to conﬁrm the clinical efﬁcacy of tigecycline for
the treatment of infections due to these organisms.
R2322 Detection of ESBLs: comparisons of MicroScan, Etest and
double disc tests
P. Lanzafame, L. Pederzolli (Trento, IT)
Objectives: ESBLs are enzymes that mediate resistance to extended-
spectrum cephalosporins and monobactams except cephamycins and
carbapenems.ESBLs can be difﬁcult to detect because they have
different levels of activity against various cephalosporins. The ability
of MicroScan (MS) panels NBC 33 (DadeBehring, California,USA) to
detect ESBLs was compared with E-test ESBL strips and double disc
(DD) tests.
Methods: 27 E. coli, 14 P. mirabilis and 9 K. pneumoniae non-urinary
clinical isolates were tested. Microdilution susceptibility testing by MS
panel NBC33 was performed according to manufacturer’s instructions.
For DD test a plate is inoculated as for a routine susceptibility test, discs
containing cefotaxime and ceftazidime 30 ug are applied, at a distance of
25mm, either side of one with co-amoxiclav 20+10 ug. ESBL production
is inferred when the zone of either cephalosporin is expanded by the
clavulanate. Etest ESBL strips (AB Biodisk, Sweden) was perfomed
according the manufacturer’s instructions, ESBL production is inferred
if the MIC ratio for cephalosporin alone: cephalosporin + clavulanate
MIC is >8. b-Lactamases AmpC producing was conﬁrmed by DD
test using cefotaxime 30 ug and cloxacillin 10 ug. Controls included
K. pneumoniae ATCC 700603 as positive control and E. coli ATCC
25922 as negative control.
Results: In two strains of E. coli and two of K. pneumoniae producing
ESBLs and b-lactamases AmpC MS doesn’t detect the presence of
ESBLs that were relieved only by DD tests. Two strains of E. coli were
false positive with MS for the ESBLs producing, not conﬁrmed by DD
tests and Etest strips, in a strain of E. coli producing b-lactamases AmpC
MS asks a conﬁrmatory test to detect ESBL that wasn’t conﬁrmed by
DD tests and Etest. All the ESBLs in P. mirabilis were conﬁrmed.
Conclusion: 46 of the 50 strain(92%)were concordant with all methods.2
E. coli ESBL+ by DD were considered possible producers by MS and
an alternative method was suggested by Alert system, while Etest gave
out of range response. Two strains of K. pneumoniae ESBL+ with
MS, ESBL− with DD and out of range with Etest. Anyway, despite
this four discordances, there were no categorical differences in the
reported b-lactam and mono-bactam antimicrobics. The fact that the
simultaneously presence of ESBLs and other b-lactamases (AmpCs,
inhibitor-resistant TEMs, hyper-production of TEM and/or SHV) could
mask ESBL production, resulting in false-negative conﬁrmatory tests,
remains a unresolved problem with phenotypic methods.
R2323 Phenotypes of resistance to macrolide and related
antibiotics in Streptococcus agalactiae
V. Vuksanovic (Podgorica, ME)
Introduction: For Streptococcus agalactiae, as one of the most
important causes of neonatal infection and infections in pregnant women,
penicillin or its congeners is the treatment of choice. However, if
there is a penicillin allergy, erythromycin and clindamycin are the
major substitutes. Unfortunately, macrolide resistance among Gram-
positive cocci has been increasing worldwide. The resistance of group
B streptococci (GBS) is expressed as either a macrolide-restricted
(M) phenotype or inducible and constitutive macrolide-lincosamide-
streptogramin B (MLSB) cross-resistance phenotypes (iMLSB and
cMLSB).
Aim: in this study determinants of GBS isolates in Montenegro were
deﬁned for the ﬁrst time and compared with the reports of the other
country.
Materials and Methods: A total of 298 GBS isolates from vaginal
swabs, collected from March to May 2007, were investigated in
bacteriological department of Institute for Public Health, Montenegro.
Phenotype was determined with double disc test by placing a 2mg
clindamycin disc and 12mg erythromycin disc as a part of the normal
disc diffusion procedure and according to CLSI.
Results and Discussion: 247/298 (82.9%) of GBS were erythromycin
susceptible and 43/298 (14.4%) had resistance to erythromycin with
different phenotypes. M phenotype had 7/298 (2.3%) of strains and
36/298 (12.1%) had MLSB resistance: cMLSB 15 (5.0%) and iMLSB
21 (7.1%) of the strains. GBS had intermediate susceptibility in 2.7% of
cases. The macrolide resistance rate of 14.4% of our GBS isolates was
similar with report in Spain (14.7%) and lower than previous reports
of 18% in Canada, 16% in North Carolina, 29.7% in Taiwan, 22.4% in
Turkey.
Conclusion: As the macrolide resistance increase is evident in our
country too, this antibiotic should be in treatment under the rigorous
control.
R2324 The effect of testing parameter variations on the in vitro
activity of iclaprim
H. Laue, T. Valensise, P. Hadvary, S. Hawser (Reinach, CH)
Objectives: Iclaprim belongs to the diaminopyrimidine antibiotic class
and is a potent and selective inhibitor of microbial dihydrofolate
reductase (DHFR). It exhibits an expanded spectrum of activity and
is notably very potent against important Gram-positive pathogens,
including meticillin-resistant Staphylococcus aureus and Group A and
B streptococci. Intravenous iclaprim recently completed two pivotal
Phase III trials in complicated skin and skin structure infections and
a Phase II trial in Hospital- and Ventilator-Associated Pneumonia is
currently ongoing. The purpose of this study was to evaluate the effect of
varying the standard Clinical and Laboratory Standards Institute (CLSI)
microbroth dilution test conditions on the in vitro activity of iclaprim.
Methods: Minimal inhibitory concentrations (MICs) were determined
following reference CLSI conditions using four strains of Staphylococcus
aureus including ATCC 29213 and ATCC 25923, Enterococcus faecalis
ATCC 29212 and Escherichia coli ATCC 25922. The effect of varying
the inoculum concentration (5×104, 5×105, 5×106 CFU/mL), the
medium pH (pH 6.0, 7.0−7.2, 8.0), the calcium concentration (2.5,
25, 50mg/L), the incubation conditions (oxic and anoxic condition, 5%
CO2), medium supplementation (addition of 5% lysed horse blood) and
the presence of increasing concentrations of human serum (5%, 10%,
20%) was investigated.
Results: The calcium concentration, a higher medium pH, a lower
inoculum concentration, incubation in presence of 5% CO2, change
of medium supplementation or the addition of human serum had no
signiﬁcant impact on the activity of iclaprim. Minor changes in the MIC
values of iclaprim with maximal two dilutions differences were observed
by increasing the inoculum concentration, lowering the medium pH, or
incubation under anoxic conditions.
Conclusion: The activity of iclaprim was not signiﬁcantly affected by
variations in standard CLSI susceptibility testing methodology.
R2325 In vitro activity of daptomycin against vancomycin-resistant
Enterococci in patients with bacteraemia
A. Xanthaki, A. Tsiringa, V. Skandami-Epitropaki, X. Trelogianni,
V. Dimitriou, P. Fotiou, M. Toutouza (Athens, GR)
Objectives: The incidence of resistant Gram-positive bacteria in
nosocomial infections is increasing. Daptomycin is a newer antimicrobial
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agent active against Gram-positive pathogens including vancomycin-
resistant Enterococcus faecalis and Enterococcus faecium. The aim of
this study was to assess the in-vitro activity of Daptomycin by performing
susceptibility testing of a set of vancomycin-resistant Enterococci (VRE).
Methods: The collection included 32 VRE isolates (28 E. faecium
and 4 E. faecalis) isolated from patients with positive blood cultures
between 2005–2007 in our hospital. Identiﬁcation to species level
was determined with the use of VITEK-II system (BIOMERIEUX-
FRANCE). Phenotypically all isolates were of Van A type (vancomycin
MIC256mg/L, teicoplanin MIC16mg/L. They were also susceptible
to linezolid and expressed various susceptibility patterns to other
antibiotics. Daptomycin MICs were determined by E-test method (AB
Biodisk, Solna, Sweden). 4mg/L was used as a susceptible breakpoint
as approved by CLSI.
Results: Daptomycin showed very good activity, with all but one
enterococcal isolates being in the susceptible range. Daptomycin MICs
for vancomycin-resistant E. faecium: 39.3% (11/28) at 2mg/L, 35.7%
(10/28) at 3mg/L, 21.4% (6/28) at 4mg/L and 3.57% (1/28) at 8mg/L.
Daptomycin MICs for vancomycin-resistant E. faecalis: 25% (1/4) at
1mg/L, 25% (1/4) at 1.5mg/L, 25% (1/4) at 3mg/L and 25% (1/4) at
4mg/L.
Conclusion: Daptomycin was proved to be highly active against VRE
isolates from patients with bacteraemia and appears to be a very good
therapeutic option in treating serious infections.
R2326 In vitro activity of mecillinam in combination with
aminopenicillin/b-lactamase-inhibitor – Combinations
against ESBL-producing Enterobacteriaceae
K. Herbich, E. Zeitlberger, M. Stadler, O. Janata, F. Asboth, P. Apfalter
(Vienna, AT)
Objective: Due to raised MICs at high inocula it has been suggested
that the amidinopenicillin Mecillinam (MEC) is not stable to ESBLs
and should not be used in severe infections. The same is true for
amoxicillin/clavulanic acid (AMC) and piperacillin/tazobactam (PTZ),
since their activity largely depends on species, type of b-lactamase and
inoculum. MEC preferentially binds to PBP2 and amoxicillin as well
as piperacillin to PBP3. The aim of this study was to test (i) if MEC
combined with AMC or PTZ would result in synergistic in vitro activity,
and (ii) whether the effect would be stable in the presence of a high
inoculum.
Material and Methods: Forty-two consecutive ESBL-producers (thereof
E. coli, n = 36) isolated in 2007 from urine samples were studied. ESBL
production was detected by CLSI methods and an extended double disk
diffusion synergy test. Clonal relationship was investigated by means
of RAPD and ERIC-PCR. MICs and synergy testing [MEC/AMC;
MEC/PTZ] was done by Etest® and fractional inhibitory concentration
(FIC) indices were calculated (FIC = MICAB/MICA + MICBA/MICB).
In a preliminary study inocula were adjusted to comprise 104 CFU/ml
and 108 CFU/ml.
Results: Preliminary experiments: MICs for MEC were 1–64mg/L at
an inoculum of 104 CFU/mL, rising to 2–256mg/L at 108 CFU/mL.
For AMC, PTZ, and the combinations MEC/AMC and MEC/PTZ MICs
were not inoculum-dependent. Resistant colonies within the MEC ellipse
could be observed in some cases. If these colonies were retested, they
proved highly MEC resistant, what did not affect FIC indices. Synergy
testing was thus done with the higher inoculum. For MEC, AMC and
PTZ alone MICs50 were 1.5mg/L, 8mg/L, and 8mg/L. According to
CLSI, 76%, 57%, and 67% strains were susceptible. Synergy testing:
the MIC90A/B for MEC/AMC and MEC/PTZ was 1mg/L each, and
the MIC90B/A was 0.7mg/L and 0.3mg/L, respectively. A synergistic,
additive and indifferent effect for MEC/AMC [MEC/PTZ] was found for
66.6% [92.8%], 28.5% [2.3%], and 5% [5%] strains, respectively.
Polyclonality was shown for 34/42 E. coli (>80%) and 3/5 K. pneumo-
niae isolates.
Conclusion: MEC has a good, but inoculum dependent, in vitro activity
against ESBL-producing enterobacteriaceae. The susceptibility of AMC
and PTZ cannot reliably be predicted. When administered combined,
both combinations resulted in a signiﬁcant MIC reduction due to a highly
synergistic, inoculum independent effect.
R2327 Fosfomycine tromethamine as second agent for the
treatment of acute uncomplicated urinary tract infections
in all age groups in the Netherlands?
S. Nys, B. Knottnerus, G. ter Riet, G. Donker, S. Geerlings,
E. Stobberingh (Maastricht, Amsterdam, Utrecht, NL)
Background: Uncomplicated urinary tract infections (UTIs) are
common among female patients. According to the national guidelines
of the Dutch College (NHG) for General Practitioners (GPs) the drugs
of ﬁrst and second choice as therapy for UTIs are nitrofurantoin and
trimethoprim with resistance percentages of 2% and 23% respectively.
The third choice is fosfomycine tromethamine (FT) for which
unfortunately no current resistance data from the Netherlands are
available. The aim of this study was to determine these resistance
percentages.
Material and Methods: During a 2-year period urine samples were
collected from a representative sample of 21 general practices spread
over the Netherlands, the Sentinel Stations of the Netherlands Institute
for Health Services Research (NIVEL).
Escherichia coli isolated from female patients visiting their GP with
symptoms of an acute uncomplicated UTI were used. FT susceptibility
was determined with E-tests. An MIC for FT of 64mg/L or lower
was considered susceptible, MIC-values of 96mg/L or higher resistant.
E. coli ATCC25922 was used as a reference strain.
Results: In total, 1705 E. coli strains were tested of which 11 (0.64%)
were FT resistant. The MIC50 and MIC90 values in this population were
1 and 4mg/L respectively. Within the inhibition zone of 162 susceptible
E. coli strains, resistant mutant colonies were observed of which after
repetition of the susceptibility testing 68 were resistant. In total, 79
(5%) strains were FT resistant. There was no cross-resistance observed
between FT and other antimicrobial agents tested previously.
Discussion: The high in vitro susceptibility to fosfomycine tromethamine
in this population and the lack of cross-resistance between fosfomycine
tromethamine and other agents together with the extensive global
clinical experience support the choice of the NHG-guidelines to include
fosfomycine tromethamine as a second – instead of third – therapeutic
option in general practice for uncomplicated UTIs.
R2328 Comparative in vitro activity of ertapenem against
carbapenem-resistant Gram-negative bacteria isolated from
blood cultures
F. Lo´pez-Fabal, E. Culebras, J.J. Picazo (Madrid, ES)
Objective: Infections caused by multidrug resistant (MDR) organisms
are increasing. Carbapenems (imipenem and meropenem) are the
antibiotics commonly used to treat these agents but the emergence of
carbapenem resistance in those microorganisms represents a major public
health concern. The aim of this study is to evaluate the in vitro activity
of ertapenem and other 15 antibiotics against isolates recovered from
blood cultures. Presence of extended-espectrum b-lactamases (ESBL),
was also determined.
Method: 31 non-duplicate isolates were included in the study. All
isolates were collected between June 2006 and October 2007.
Minimum inhibitory concentrations (MICs) were determined using a
commercial broth microdilution method, in accordance with the CLSI
guideline M7-A6 (NCCLS, 2003).
Antimicrobials tested included, among others, cefotaxime, cefepime,
ciproﬂoxacin, aztreonam, amikacin, piperacillin-tazobactam and colistin
besides imipenem and meropenem.
E-test® (AB Biodisk, Solna, Sweden) methodology was used to study
ertapenem susceptibility. E-test® was also used to determine ESBL
production.
Results: All isolates were chosen because their imipenem resistance.
Only three isolates were susceptible to meropenem. Ertapenem MIC90
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was >32mg/L. Colistin showed the highest activity of all agents
tested followed by amikacin, piperacillin-tazobactam and cefepime with
resistance rates of 29%, 64.5% and 77.5% respectively.
None of the isolates produced ESBL.
Pseudomonas aeruginosa was the most common MDR Gram-negative
bacillus isolated from bacteraemia.
Conclusions:
1. Ertapenem and meropenem showed similar activity against the
carbepenem-resistant Gram-negative bacilli, analysed in this study
2. Ertapenem appears not to be a good option to treat carbapenem-
resistant Gram-negative isolates
3. Colistin demonstrated potent in vitro activity against MDR microor-
ganisms.
4. Carbapenem-resistant isolates were found to be resistant to all
b-lactam antibiotics tested.
R2329 Antimicrobial susceptibility of Escherichia coli isolated
from patients with uncomplicated urinary tract infections
in Asia and Middle East region
WT.M. Jansen, A.M. Verel, J. Verhoef, D. Milatovic (Utrecht, NL)
Objective: To test antimicrobial resistance patterns of Escherichia coli
collected prospectively in 9 different countries in Asia and Middle East
(Turkey, Saudi Arabia, Jordan, Korea, Indonesia, Philippines, Thailand,
Pakistan, and Taiwan) and the Netherlands from the urine of 15–50 year
old female patients with uncomplicated UTI.
Methods: Microtiter plates containing freeze dried dilutions of the
antibiotics have been prepared by Trek Diagnostics. Only one isolate
per patient was included. All isolates were re-identiﬁed in the University
Medical Center Utrecht and minimal inhibitory concentrations (MICs)
were determined by microdilution method according to CLSIguidelines.
E. coli ATCC 35218 and E. coli ATCC 25922 were used as control
strains for quality control.
Results: So far, we have analysed antimicrobial susceptibilities in
5 countries (Table 1) As compared to the Netherlands, substantial
resistance of E. coli was observed in the centres of countries in
Asia and Middle East. Third generation cephalosporins (ceﬁxime and
cefpodoxime) had superior in vitro activities as compared to the other
oral betalactams and the quinolones tested.
Table 1.
Antibiotic Korea (n = 73) Thailand (n = 48) Turkey (n = 78) Jordan (n = 75) Netherlands (n = 75)
%
S
M
IC
50
M
IC
90
%
S
M
IC
50
M
IC
90
%
S
M
IC
50
M
IC
90
%
S
M
IC
50
M
IC
90
%
S
M
IC
50
M
IC
90
Augmentin 37.0 8 16 14.6 8 32 39.7 8 16 34.7 8 16 65.3 4 16
Cefaclor 72.6 4 >32 45.8 16 >32 67.9 8 >32 60.0 8 >32 90.7 2 8
Cefurixime 46.6 8 >32 35.4 8 >32 51.3 4 >32 52.0 4 >32 77.3 4 8
Ceﬁxime 76.7 0.5 >32 52.1 1 >32 75.6 0.5 >32 73.3 0.5 >32 97.3 0.5 1
Cefpodoxime 80.8 0.5 >32 60.4 1 >32 85.9 0.5 >32 77.3 0.5 >32 97.3 0.25 0.5
Ciproﬂoxacin 64.4 0.25 >32 33.3 32 >32 62.8 0.12 >32 69.3 0.25 >32 96.0 0.03 0.03
Oﬂoxacin 64.4 0.5 32 35.4 32 >32 62.8 0.5 >32 69.3 0.5 32 96.0 0.06 0.12
Conclusions: Third generation cephalosporins were superior to
quinolones in their in vitro activity against E. coli isolated from
uncomplicated UTI in the countries of Asia and Middle East region.
Susceptibility of ciproﬂoxacin and oﬂoxacin, which have been long
primary agents for UTI, decreased against E. coli, possibly due to
overuse of these antibiotics. Results of the complete study will be
presented at the ECCMID.
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R2330 Effect of farnesol on planktonic versus bioﬁlm cells of
Staphylococcus epidermidis
F.I. Gomes, R. Oliveira, P. Teixeira (Braga, PT)
Objectives: Staphylococcus epidermidis is the most frequent cause
of nosocomial sepsis and catheter-related infections, in which bioﬁlm
formation is considered to be the main virulence mechanism. Quorum-
sensing system have been recognised as important regulators of virulence
in many bacteria. The goal of this study was investigate the effect of
farnesol, a quorum-sensing molecule, on planktonic and bioﬁlm cells
of four S. epidermidis strains and compare farnesol susceptibility of
planktonic with bioﬁlm cells.
Methods: Four strains of S. epidermidis were grown planktonically
and as bioﬁlms to determine the effect of farnesol. To bioﬁlm study,
farnesol was added before bioﬁlm formation and after 24 hours of bioﬁlm
formation. To study the effect of farnesol on planktonic cells, the utility
of a rapid colorimetric method that is based on the reduction of Alamar
Blue to measure cell viability was tested as well as standard bacterial
enumeration techniques. The growth inhibition effect of farnesol on
bioﬁlm cells of S. epidermidis was assessed using XTT assay that
measures cellular metabolic activity and Crystal Violet that measure
total biomass of bioﬁlm.
Results: It was observed that farnesol has inhibitory effect as on
planktonic cells as on bioﬁlm cells. Modest concentrations of farnesol
were sufﬁcient to exhibit an antibacterial effect on planktonic cells and
on bioﬁlm cells (before bioﬁlm formation). When farnesol was added
after 24 h of bioﬁlm formation, it was observed a small reduction of total
biomass and metabolic cellular activity with the increase of concentration
of farnesol.
Conclusion: The inhibitory effect of farnesol was more pronounced
on planktonic and bioﬁlm cells (before bioﬁlm formation) than when
farnesol was added after 24 h bioﬁlm formation. Bioﬁlm structure
impairs the action of farnesol. The results indicate a potential application
for farnesol as a novel therapeutic agent for the prevention of bioﬁlm-
related infections.
R2331 Enterocin C, a two-peptide bacteriocin produced by a
Enterococcus faecalis strain isolated from human colostrum
A. Maldonado, E. Jime´nez, M. Go´mez, B. Caballero, R. Jime´nez-Dı´az,
J.L. Ruı´z-Barba, J.M. Rodrı´guez (Madrid, Seville, ES)
Objectives: The aim of this study was the identiﬁcation and
characterisation of new antimicrobials compounds produced by bacterial
species isolated from colostrum obtained from healthy women.
Methods: Antimicrobial peptides EntC1 and EntC2 were puriﬁed
from Enterococcus faecalis C901 by cation-exchange, hydrophobic-
interaction and C2/C18 reverse-phase chromatography (RPC-FPLC).
The N-terminal amino acid sequences were determined by Edman
degradation. Molecular masses of the peptides were determined by
Matrix Assisted Laser Desorption/Ionisation-Time of Flight Mass
Spectrometry (MALDI-TOF). DNA sequencing of the genes encoding
EntC1 and EntC2 was carried using the plasmid pEntC as the template.
Detection of virulence determinants in E. faecalis C901 was carried out
by PCR.
Results: Enterococcus faecalis C901 showed inhibitory activity against
several bacterial species as Actinomyces neuii, Enterococcus faecalis,
E. faecium, Lactococcus lactis, Lactobacillus paracasei, Leuconostoc
mesenteroides, Propionibacterium acnes, Staphylococcus caprae, Strep-
tococcus anginosus and S. intermedius. This antimicrobial activity was
due to a bacteriocin, named enterocin C, which has been biochemically
and genetically characterised. Enterocin C consists of two different
peptides, EntC1 (39 aas, 4,284 Da) and EntC2 (35 aas, 3,899 Da), whose
complementary action is necessary for full enterocin C activity. The
genes encoding enterocins EntC1 (entC1) and EntC2 (entC2) as to the
putative immunity protein to these enterocins (EntCI) were localised in
a 9-kpb plasmid named pEntC. In addition, E. faecalis C901 presented
genes encoding several factors that are involved in the colonisation and
persistence of enterococci within a host.
Conclusion: Here we describe the puriﬁcation and genetic characterisa-
tion of enterocin C, a two-peptide bacteriocin produced by E. faecalis
C901 isolated from human colostrum. The presence of bacteriocin-
producing strains in such biological ﬂuid may constitute one of the
mechanisms explaining the protective effect of breastfeeding against
infectious diseases.
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Epidemiology of MRSA, VRE and other
Gram-positives
R2332 Bacteriological assessment of intravascular catheter-related
bloodstream infections versus colonisations
A. Radulescu, N. Hagau, A. Slavcovici, M. Flonta, A. Almas,
D. Studnicska, S. Cocu, M. Mlesnita, R. Gavrus (Cluj-Napoca, RO)
Background: Catheter-related bloodstream infections (CRBSI) due to
multidrug resistant bacteria represent a leading cause of nosocomial
infections.
Objectives: Bacteriological assessment of colonisation vs. CRBSI.
Methods: Prospective study upon all consecutive cases admitted in a
surgical intensive care unit, between May 2006 and June 2007. In all
cases either jugular or subclavian polyurethane or silver impregnated
short-term central venous catheters were placed. Bloodstream infection
was deﬁned as deﬁnite if a) the same pathogen grew in at least one blood
culture and from the distal segment of catheter or b) same pathogen
grew in at least one peripherally and centrally drawn blood culture, the
differential time to positivity of central vs. peripheral blood culture was
>120 minutes. Colonisation was deﬁned in the absence of criteria for
bloodstream or localised infection with bacterial growth from the catheter
(external culture and intraluminal lavage) measured through quantitative
and semi quantitative methods. Bacteriologic assessment was performed
using the automatic system BactT/Alert and resistance patterns were
determined with API 20E, Api 20NE and ATB automatic methods under
CLSI 2006 standards.
Results: There were 188 documented infections and colonisations related
to intravascular catheters. Average duration of in-place catheter was
9 days with similar gender, underlying diseases and type of catheter
distribution. The cumulative incidence of colonisation was almost equal
regardless of the catheter type (24/100 vs. 25/100 patients with in-place
catheter) but smaller rates of CRBSI were found if silver-impregnated
catheters were used (2.6/100 vs. 8/100 patients, NS). The most
commonly isolated organisms were Gram-positive cocci-159 strains-85%
(S. aureus-27.7%, coagulase negative staﬁlococci-28.7%, enterococci-
24%). Almost all staphylococci were meticillin resistant, highly resistant
to clindamicin and gentamycin but glycopeptide resistance was never
found. One third of enterococci were resistant to ampicillin and 89%
to gentamycin. All the 33 strains of Gram-negative rods (17.5%) were
multidrug resistant. Sixty eight percent of all strains were multidrug
resistant.
Conclusion: Staphylococcus spp. and enterococci are the most frequent
colonizers or pathogens related to intravascular catheters. The multidrug
resistant bacteria represent a therapeutic challenge. New technologies are
important tools in prevention of CRBSI.
R2333 Hospital infections caused by community-associated
meticillin-resistant Staphylococcus aureus strains
E. Protonotariou, D. Vitti, M. Tsalidou, A. Chatzidou, V. Pliatsika,
D. Soﬁanou (Thessaloniki, GR)
Objectives: Community-associated meticillin-resistant Staphylococcus
aureus (CA-MRSA) strains have been implicated in serious hospital
infections. CA-MRSA are unrelated to hospital-acquired MRSA (HA-
MRSA) because they carry the staphylococcal chromosomal cassette
mec type IV (SCCmec IV) and harbour genes encoding for Panton-
Valentine leukocidin (PVL) at higher frequency. The aim of our study
was to determine whether nosocomial MRSA infections were caused by
CA-MRSA strains.
Methods: During a 6-month period (April-October 2007) a total of
twelve non-duplicate isolates were collected from hospitalised patients
with nosocomial infections at Hippokration G. Hospital. Eight isolates
were recovered from skin and soft tissue infection, two from bronchial
aspirate and two from blood. Identiﬁcation and susceptibility testing
were performed using the VITEK2 automated system (bioMe´rieux,
France). Furthermore, coagulase production was tested with the tube
test. Meticillin resistance was assessed by disk diffusion method using
discs of oxacillin at 30ºC and cefoxitin at 35ºC. The presence of mecA
was conﬁrmed by PCR analysis using speciﬁc primers. In addition, the
identiﬁcation of SCCmec type IV and PVL genes by PCR permitted the
characterisation of isolates as CA-MRSA. Strains that were resistant
to erythromycin and susceptible to clindamycin were examined for
inducible resistance to clindamycin by disk diffusion test.
Results: All MRSA strains harboured the mecA gene. Six (50%) of
the 12 isolates were SCCmec type IV and were classiﬁed as CA-
MRSA. Genes coding for PVL were detected in three strains, two
CA-MRSA and one HA-MRSA. Susceptibility results to antimicrobial
agents are reported in the table. CA-MRSA strains showed greater
resistance to clindamycin, ciproﬂoxacin and erythromycin compared
to HA-MRSA however the number of strains tested was limited. All
isolates were susceptible to linezolid, vancomycin, teicoplanin and
trimethoprim-sulfamethoxazole. Two isolates exhibiting the phenotype
ErRCliS presented inducible resistance to clindamycin.
Table. Characteristics of meticillin-resistant Staphylococcus aureus isolates
Strain Source Ward Antibiotic susceptibilitya PCR
OXA CIP CLI E LZD TEC VAN TET SXT mecA SCCmec IV PVL
1 Wound Transplantation R S S S S S S R S + + +
2 Bronchial Int. medicinc R R R R S S S S S + + +
3 Wound Orthopaedics R R R R S S S S S + + −
4 Wound Orthopaedics R R R R S S S S S + + −
5 Wound Surgical R R S R S S S S S + + −
6 Blood ICUb R R R R S S S S S + + −
7 Wound Transplantation R S S S S S S R S + − +
8 Wound Surgical R R R R S S S S S + − −
9 Wound Surgical R R S R S S S S S + − −
10 Wound Neonatal R S S S S S S S S + − −
11 Bronchial Neurological R R S S S S S R S + − −
12 Blood Neonatal R S S S S S S S S + − −
aOXA, oxacillin; CIP, ciproﬂoxacin; CLI, clindamycin; E, erythromycin; LZD, linezolid; TEC, teicoplanin;
VAN, vancomycin; TET, tetracycline; SXT, trimethoprim–sulfamethoxazole.
bICU, intensive care unit.
Conclusions: Our results demonstrated that CA-MRSA has inﬁltrated
in healthcare settings, being often involved in serious infections. Our
study is preliminary and needs further investigation in order to improve
our knowledge about the molecular and epidemiological impact of CA-
MRSA in our hospital.
R2334 Impact of meticillin-resistance on the mortality in S. aureus
VAP: a systematic review
Z. Athanassa, I. Siempos, M. Falagas (Athens, GR)
Objective: To estimate the impact of meticillin-resistance on mortality
in ventilator-associated pneumonia (VAP) due to Staphylococcus aureus
(SA).
Methods: PubMed, Scopus and bibliographies of the eligible studies
were searched. We calculated pooled odds ratio (OR) and 95%
conﬁdence intervals (CI) by using the DerSimonian-Laird random effects
model.
Results: Eight articles were included. Crude in-hospital mortality was
higher in patients with VAP due to meticillin-resistant SA (MRSA) than
meticillin-sensitive SA (MSSA) (OR: 1.79, 95%CI 1.21−2.65). This
was also the case for the crude intensive care unit (ICU)-mortality
(OR: 2.49, 95%CI 1.54−4.06). However, 3 of the selected studies,
which adjusted for potential confounding factors, including adequacy of
empirical treatment and severity of illness, demonstrated no difference
in in-hospital mortality between patients with MRSA and MSSA VAP.
This was not the case for another eligible study that also adjusted, but
for confounders others than the above.
Conclusion: The limited available evidence seems to suggest that
meticillin-resistance is associated with death among persons acquiring
SA VAP. However, although supported by even more limited data,
adjustment of risk factors suggests that this association may be not
causal, but likely due to confounders, such as the adequacy of empirical
treatment and severity of illness.
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R2335 Investigation of vancomycin-resistant enterococci faecal
carriage in intensive care units of a Turkish teaching
hospital in a two-year period
N. Iris, H. Sayiner, F. Simsek, M. Arat, T. Yildirmak (Istanbul, TR)
Objective: Vancomycin resistant enterococi constitute a major problem
in nosocomial infections. The purpose of this study is to access the
prevalance, resistance patterns, antibiotic susceptibilities of enterococci
isolates and investigate the risk factors of carriage among the ICU
patients in our hospital.
Methods: During two year period; between April 2005 and April 2007;
rectal swab cultures were collected from patients in ICU. Samples were
collected from patients in ﬁrst 72 hours after hospitalisation and then
repeated every 7 days until patient’s discharge. Samples were cultured
in VRE agar bases which contain 6mg/ml vancomycin and 1mg/ml
meropenem. Identiﬁcation was performed by conventional methods and
Rapid ID 32 Strep (bioMerieux). Vancomycin resistance was detected by
E test and Van gene characterisation was performed by a multiplex PCR.
Antibiotic susceptibility patterns of strains for fosfomycin and linezolid
was detected by disk-diffusion methods according to CLSI criteria.
Results: In two year period 21 VRE were isolated from 112
patients (18.75%). VRE faecal carriage period range was 1–72 weeks.
Association between VRE colonisation and use of antimicrobials was
investigated. Faecal carriers were using two or more antibiotics. Mostly
used antibiotics were 3rd and 4th generation cefalosporins, vancomycin,
levoﬂoxacin and piperacillin-tazobactam. Fosfomycin and linezolid
susceptibilities were investigated. All of VRE isolates were susceptible
to linezolid and only one strain (4.5%) was resistant to fosfomycin. Van
gene characterisation was performed in 10 strains and all of them were
Van A type.
Conclusion: VRE colonisation must be monitored and risk factors
should be determined in ICU’s. Use of broad spectrum antibiotics is
an important risk factor for VRE colonisation. Invitro linezolid and
fosfomycin are effective on VRE strains.
R2336 The three-year presence of glycopeptide-resistant
Enterococcus faecalis in the hospital
G. Mlynarczyk, W. Grzybowska, A. Mlynarczyk, A. Mrowka, S. Tyski,
M. Luczak (Warsaw, PL)
Objectives: In the investigated hospital vancomycin resistant enterococci
(VRE) were not frequently isolated up to the 2003. However three strains
of vancomycin resistant (VR) Enterococcus faecalis were isolated in
1998 from patients of Intensive Care Unit (ICU) and they reappeared in
2003 in other ward. Between 2003 and 2006 years, 14 VR-E. faecalis
were isolated from different patients of transplantant wards. All strains
were recovered from urine. The aim of our work was to compare VR-
E. faecalis strains derived from different years and wards.
Methods: The PFGE method, which is reference among molecular
methods useful in epidemiological investigation was applied.
All 17 strains were defrosted, multiplied and their DNAs were examined
for the presence of vanA, van B, vanD or vanG genes by PCR. The
species status of each strain was conﬁrmed by demonstration of the
presence of the ddl gene speciﬁc for E. faecalis. PFGE was performed on
bacterial DNA digested with SmaI in agarose discs. Products of digestion
were separated using CHEF-DR II (Bio-Rad) and the obtained patterns
of bands were compared.
Results: It was shown that all examined strains were E. faecalis and all
harboured vanA gene. Comparison of obtained PFGE patterns revealed
that two strains isolated in 1998 from different patients of ICU were
identical, suggesting infection with the same strain. The third strain
differed. Among 14 strains of VR-E. faecalis isolated in 2003–2006,
seven displayed very similar patterns although they were isolated in
different years and from different patients (3 in 2003, 2 in 2004 and
2 in 2005). The patterns of these strains differed from patterns of
strains from 1998. All strains were obtained from patients of the two
closely collaborating wards where people after transplantations were
hospitalised. All eight strains were susceptible to ampicillin and highly
resistant to aminoglycosides (HLAR). The patterns of bands after PFGE
in the case of reminding seven strains were unrelated. Among strains
from 2006, no pattern similar to that obtained for seven strains from
2003 to 2006 was found.
Conclusions: The results indicated that in 1998 there was a small
outbreak in the ICU ward (2 patients infected or colonised with the
same VRE). The results suggested also that the single strain of VR-
E. faecium was present for three years in two closely related hospital
wards.
R2337 Corynebacterium striatum: a multidrug-resistant emerging
pathogen
B. Pini, G. Brigante, E. Aso-Taunta, A. Vardopoulou, F. Luzzaro,
A. Toniolo (Varese, IT)
Objectives: Corynebacterium striatum is a Gram-positive organism that
commonly colonizes the skin and mucous membranes. Over the last
few years, this organism has been increasingly recognised as a cause of
wound and low respiratory tract infections. The aim of the study was
to evaluate epidemiology and antimicrobial susceptibility of C. striatum
clinical isolates collected at our laboratory in 2006 and 2007.
Methods: Isolates of C. striatum obtained from routine specimens were
characterised at the Microbiology Laboratory of the Ospedale di Circolo
(Varese, Italy). Identiﬁcation was achieved using the BBL Crystal Gram-
Positive ID system (Becton Dickinson Diagnostic Systems, Sparks,
MD). Antimicrobial susceptibility was quantitatively evaluated by the
Etest method (AB Biodisk, Solna, Sweden). Results were interpreted
according to the M45-A document (Clinical and Laboratory Standards
Institute, 2006).
Results: Overall, 128 isolates were obtained during the two-year period,
most of them from skin and soft tissue specimens (76.5%), but also from
vascular catheter (8.6%), low respiratory tract (6.2%), and blood (3.1%).
Strains were frequently isolated from aged and/or compromised patients
admitted to different wards. The majority of isolates were characterised
by multi-drug resistance, including penicillin, gentamicin, erythromycin,
tetracyclines, expanded-spectrum cephalosporins, and ciproﬂoxacin.
Teicoplanin and vancomycin as well as newer antimicrobial agents
(linezolid, daptomycin, and quinupristin-dalfopristin) were consistently
active in vitro against C. striatum isolates.
Conclusion: C. striatum should be considered an emerging multidrug-
resistant nosocomial pathogen in aged/compromised patients and in long-
term hospitalised patients. Drugs recently introduced to treat skin and
soft tissue infections appear to represent an effective therapeutic option
in order to limit the use of glycopeptides.
R2338 The prevalence of vancomycin and gentamicin-resistant
enterococci isolated from human normal ﬂora in Iran
N. Noohi Babajan, M. Talebi, G. Ebrahimipour, M.R. Pourshaﬁe
(Tehran, IR)
Objective: Enterococci are natural inhabitants of the gastrointestinal
tract of humans and animals, but are also found in other anatomical sites
including the vagina and oral cavity, and in plants and insects. Multidrug
resistance is common among enterococci and presents a formidable
treatment problem. High-level gentamicin resistance (MIC 500mg/ml)
in enterococci is predominantly mediated by aac(6′)-Ie-aph(2′′)-Ia and
vancomycin resistance with vanA genes.
Methods: 172 faecal samples collected from healthy volunteers
were inoculated into BHI broth containing 6mg vancomycin and
32mg gentamicin. After enrichment the isolates were subcultured on
mEnterococcus agar containing 6mg and 32mg of vancomycin and
gentamicin respectively. The isolates were identiﬁed to the species
level by biochemical tests and identiﬁcation was conﬁrmed also by
PCR analysis. The MIC of isolates were performed by E test method.
Identiﬁcation of resistance genes were performed by PCR.
Results: Out of all isolates 15% gentamicin resistant enterococci (GRE)
strains and 0.6% vancomycin resistant enterococci (VRE) strain have
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been isolated. GRE isolates were highly resistant to gentamicin and the
MIC of the VRE isolate was 256mg. The only resistance genes were
detected for gentamicin and vancomycin resistant isolates were aac(6′)-
Ie-aph(2′′)-Ia and vanA respectively.
Conclusion: The rate of vancomycin resistance were low in healthy
population of our country. This indicative that the prevalence of
vancomycin resistance enterococci as a normal ﬂora is rare in the
communuity. In the contrary the gentamycin resistance isolates were
more prevalent in gut ﬂora
R2339 Staphylococcus aureus nasal carriage among diabetic and
non-diabetic volunteers
P. Sergouniotis, F. Sergouniotis, C. Karakoida, E. Koukou, E. Papoulia
(Amﬁssa, GR)
Introduction: S.aureus is one of the most important human pathogens.
It is a common cause of hospital and community-acquired infections
worldwide, the incidence of which has been rising with increasing
emergence of drug resistant strains.
Purpose: This study aims to estimate the extent of S.aureus carriage,
particularly MRSA, among diabetic and non-diabetic residents of Fokida,
a rural area in central Greece, by performing nasal swabs.
Methods: We conducted a cross-sectional study involving 82 adults.
Samples were collected from the anterior nares using sterile cotton wool
swabs. Nasal specimens were examined for the presence of S.aureus
by standard quantitive culture methods including the tube coagulase
test, the Microscan system and the Kirby-Bauer disk-diffusion test.
Epidemiological information concerning risk factors for nasal carriage
was also obtained. These included history of antibiotic usage in the
past month, previous hospitalisation, history of chronic illnesses and
residence in nursing home.
Results: A total of 82 individuals were examined. These comprised
40 diabetic (48.8%) and 42 non-diabetic (51.2%) persons with ages
ranging from 14 to 85 years (mean age 56.68±17.04 years). None of the
participants were ever hospitalised or had any other risk factor. Overall
nasal carriage of S.aureus in this study population was 31.7% (26/82).
From 82 nasal swabs collected, 4 MRSA isolates (4.88%) were identiﬁed,
2 of which were from diabetic persons. S.aureus positivity was noted in
12 of the 40 diabetic patients (30%) and 14 of the 42 healthy adults
(33.33%). Heavy colonised carriers were 12 persons (46.1%) and half
of them were diabetics.
Conclusions: Our study showed that there was no association between
S.aureus carrier state and diabetes mellitus. Among the diabetic subjects,
S.aureus colonisation was not associated with level of HBA1c and
glucose control.
The ﬁndings also revealed that nasal carrier rates among residents of
Fokida (31.7%) are higher as compared to those among the area’s hospital
personnel (20%), according to a previous study of ours. The prevalence
of MRSA in our study population was found to be 4.88%.
R2340 Prevalence and characterisation of caMRSA in West Austria
K. Grif (Innsbruck, AT)
Objectives: Community-acquired meticillin-resistant Staphylococcus
aureus (caMRSA) occur to play a signiﬁcant role in clinical and
outpatient care facilities.
The aim of the present study was to investigate the occurrence of
caMRSA at the University Hospital of Innsbruck, in outpatient care
facilities of small district hospitals and among patients of practitioners
in Tyrol (Austria).
720 MRSA were collected from the University Hospital of Innsbruck in
the period from January 2003 till November 2007. We used the CDC
guidelines (http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html) to frame
the “probable isolates of caMRSA”. 174 MRSA from the University
Hospital of Innsbruck were chosen for the study. Also 46 MRSA that
were collected from outpatients in the period from August 2006 till
November 2007were detected for caMRSA prevalence. All isolates were
identiﬁed by standard microbiological procedures.
Methods: These strains were investigated for the presence of the lukS-
lukF gene determinant of Panton-Valentine leucocidin (PVL). lukS-
lukF-positive strains were characterised by resistance proﬁle, SCCmec-
cassette, accessory gene regulator (agr) and molecular genetic method
(ribotyping). The patients’ records were screened for possible risk
factors.
Results: PVL-genes were detected in 23 MRSA: 13 at the University
Hospital (1.7%), 5 from outpatient care facilities of small district
hospitals (10.9%) and 5 among patients of practitioners in the Tyrol
(10.9%). The mean age was 37.5 years and median age 27 years. PVL-
genes were detected in 29% associated with cutaneous abscess and
wound strains and 9%– with pneumonia.
The majority of strains (19) carried SCCmec-cassette IV, 1 strain
SCCmec-cassette I, 1 strain SCCmec-cassette II, 2 strains SCCmec-
cassette III. The major agr-type was type-1 (n = 16), 4 strains harboured
agr-type 3, two strains – agr-types 3 and 4 each, and one could not
be determined. Ribotyping revealed 9 different patterns, ribotype 2 was
most prevalent.
Conclusions: The high prevalence of caMRSA in this study demon-
strates an important health concern in Tyrol. The characteristics of
the determined caMRSA-strains are comparable with the European
average. The prevalence was higher than the European average (0.03% to
1.5%), which was evaluated 2002. The determination of caMRSA in the
microbiological routine should be considered. In addition, practitioners
should be educated to pay attention to the threat of caMRSA.
R2341 Prevalence of Staphylococcus aureus in healthcare workers
in a general hospital in Komotini, Greece
T. Exiara, L. Papazoglou, A. Risggits, F. Paraskevopoulou, M. Filippidou,
E. Filippidou, D. Sismanis, S. Papanastasiou (Komotini, GR)
Objectives: The aim of present study was to determine the prevalence
of Staphylococcus aureus carriage in the noses and on the hands of
healthcare workers in our Internal Medicine Department and to detect
the antibiotic susceptibility of S. aureus.
Material and Methods: Samples were obtained from nasal mucous
(using swab) and hand skin (using imprints of each hand on blood
agar) of total 210 employers in our department, during a three-month
period. S.aureus isolates were identiﬁed by standard methods and typed
by pulsed-ﬁeld gel electrophoresis.
Results: 146(69.5%) females and 64(30.5%) males, with mean age
42±12.8 years, were included in the study. 156(74.3%) subjects were
medical and nurse staff and 54(25.7%) were administrative personnel.
Of total 630 samples, S. aureus isolated from 234(37.1%). 159 strains
isolated from 53 women and 75 from 25 men. The rate of S. aureus
in females and males were 36.3% and 39.1% respectively. There was
no found statistical difference between males and females. The rate of
S. aureus in medical stuff and administrative personnel were 45% and
19% respectively, p< 0.001. S. aureus isolated of 153 (65.4%) samples
from nasal mucus and 81 (34.6%) from hands. Nasal carriage had 34
women (23.3% of women) and 17 men (26.6% of men). Hand carriage
had 16 women (10.95% of all women) and 11 men (17.2% of all men).
Meticillin resistant S. aureus was found in 42(6.7%) samples. Most of the
S. aureus strains were susceptible to tested agents except erythromycin
and azithromycin. Vancomycin and teicoplanin were active against all
isolates even MRSA.
Conclusion: The prevalence of Staphylococcus aureus is quite high
among the healthcare workers in our department (nearly half of our staff)
but similar with colonisation rates reported in previously studies. The
usually hygienic methods such as hand disinfection after each patients
contact, masks use when is appropriate, must performed from all workers
in hospitals to protect patients from nosocomial infections. Alcohol
hand rub must be placed at every bedside in hospitals and promotional
materials must be used to remind health workers and visitors to use the
hand rub.
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R2342 Clonal analysis and toxin gene carriage of meticillin-
resistant Staphylococcus aureus isolated from three
hospitals in western Greece
E. Drougka, A. Foka, V. Chini, S. Levidiotou, K. Michalakopoulou,
S. Vamvakopoulou, I. Christodoulidi, E.D. Anastassiou, I. Spiliopoulou
(Patras, Ioannina, GR)
Objectives: Meticillin-resistant Staphylococcus aureus (MRSA) is
associated with an increasing number of both community and hospital-
associated infections (CA/ HA-MRSA). The aim of this study was to
identify clonal types correlated with the presence of genes encoding
TSST-1 (tst) and Panton-Valentine leukocidin (lukS and lukF, PVL)
among MRSA collected in three hospitals receiving patients from
Western Greece.
Methods: In total 692 S. aureus isolates were characterised by
conventional methods, followed by the determination of oxacillin MIC
by the Etest. PBP2a production was investigated by a Latex agglutination
test (bioMerieux). The presence of mecA, tst, lukSPV and lukFPV genes
(encoding PVL) and agr groups were deﬁned by PCRs. Clonal types were
identiﬁed by PFGE of chromosomal DNA SmaI digests and named by
their PFGE/agr types. CA-MRSA were isolated from patients without
any predisposing risk factors.
Results: A total of 315 MRSA (mecA-positive) were isolated from
different patients during one-year period, including 114 (36.2%) strains
from children. The great majority (228, 72.4%) was CA-MRSA while 87
strains (27.6%) were HA-MRSA, derived mainly from the department
of Orthopaedics. The PFGE analysis revealed 11 PFGE types (named
A, B, C, E, G, F, J, K, L, M and N) common among the hospitals.
Clonal and PCR analysis are shown at Table 1. Among the HA-MRSA
four new clones were identiﬁed (J/3, L/2, M/3 and N/1) which were
PVL and tst-negative. Among CA-MRSA clone C/3 carrying PVL genes
predominated.
Conclusions: In Greece we are encountering an increasing rate of
S. aureus infections, mainly due to the spread of CA-MRSA producing
PVL. The identiﬁcation of new clones in the participating hospitals
reinforces the aspect of the continuous MRSA evolution.
Table l. Clones and toxin genes among MRSA isolated during one-year period
Toxin HA-MRSA (87/100%) CA-MRSA (228/100%) Total
A/3 B/1 B/3 C/1 C/3 E/1 F/1 G/1 New
types
A/3 B/1 B/3 C/1 C/2 C/3 F/1 G/1 G/2 K/4
PVL(+) − − − − 39 − − − − 3 1 − 1 1 209 − − 1 − 255 (81%)
PVL(−)
tst(+) − 1 − − − − − − − − − − − − − − − − − 1 (0.3%)
tst(−) 3 30 3 2 − 3 1 1 4 3 2 1 3 − − 1 1 − 1 59 (18.7%)
Total 3 31 3 2 39 3 1 1 4 6 3 1 4 1 209 1 1 1 1 315
% 3.5 35.6 3.5 2.3 44.8 3.5 1.1 1.1 4.6 2.7 1.4 0.4 1.8 0.4 91.7 0.4 0.4 0.4 0.4 100%
R2343 Four-year survey of meticillin-resistant Staphylococcus
aureus producing Panton-Valentine leukocidin in northern
Greece
M. Panopoulou, E. Alepopoulou, A. Grapsa, A. Batarli, E. Petinaki,
S. Ktenidoy Kartali (Alexandroupolis, Larissa, GR)
Objectives: Meticillin-resistant Staphylococcus aureus is a major cause
of hospital and community-acquired infections, such as surgical wound,
skin and soft tissue infections and pneumonia.
The aim of this study was to deﬁne the prevalence and clonal distribution
of PVL-positive MRSA among patients with staphylococcal infections
in northern Greece.
Methods: Five hundred twenty eight Staphylococcus aureus isolates
were collected during the 4-year period between January 2004
and September 2007 at the University Hospital of Alexandroupolis,
Greece. Isolates were identiﬁed by conventional methods and the
automated system VITEK2 (BioMerieux, France). Susceptibility tests
were performed by the disk diffusion method and determination of MIC
by VITEK2. The presence of PVL gene was detected by PCR, while
the clonal relatedness was tested by PFGE.
Results: One hundred seventy three isolates(33%) were meticillin
resistant. Among them, seventy three (42%), were resistant to kanamycin,
tetracycline, intermediate susceptible to fusidic acid and carried the PVL
gene. PFGE analysis revealed that all these isolates belonged to the clone
C (ST 80), that predominates in Europe. The distribution of PVL positive
strains were 43%, 51%, 35%, 37% for the years 2004, 2005, 2006, 2007
respectively.
Conclusion: In Greece the majority of PVL-positive strains express
a common phenotype of antimicrobial agents(resistance to oxacillin,
kanamycin, tetracycline and fusidic acid). Thus, isolates recovered from
musculoskeletal infections with this phenotype must be examined for
the presence of PVL gene, in order to establish prevention measures.
R2344 Intrafamilial spread of Panton-Valentine-positive
Staphylococcus aureus: a Spanish case
I. Gutie´rrez-Gonza´lez, N. Batista-Dı´az, E. Pe´rez-Roth, M. Herna´ndez-de
la Torre, M. Dura´n-Trujillo, M. Delgado-Guerrero, S. Me´ndez-A´lvarez
(S/C de Tenerife, ES)
Background: Panton-Valentine leukocidin is a toxin associated with
severe cutaneous infections and highly necrotising pneumonia. This toxin
acts as virulence factor in some Staphylococcus aureus strains wich may
be transmissed by person-to-person contact.
Objectives: To describe a family outbreak of skin infections, including
furuncules, abscesses and cellulitis by Staphylococcus aureus Panton-
Valentine positive, during 24 months.
Methods: The family affected is composed by mother, father, six
children between the ages 6–17 years who lived at the same home. The
outbreak also affected a 75 years old woman who spent a lot of time with
the family, and the ﬁrst son girlfriend. Detailed information regarding
the history of infections of each patient and related diagnostic results
and treatment were collected from Family Physician, Dermatologist and
Paediatrician who treated the cases.
Samples were collected from infected skin areas affected and some of
the patients and their contacts were screened for nasal and pharyngeal
S.aureus.
All the S.aureus isolates were identiﬁed by conventional and molecular
methods.
PCR was made to detect genetic sequences encoding mecA gene,
PVL, enterotoxins, exfoliative toxins, alfa, beta, gamma and delta
hemolysins, LukE-LukD leukotoxin and different adhesins. Isolates were
typed by pulsed ﬁeld gel electrophoresis (PFGE) and later Multilocus
SequenceTyping (MLST) to ascribe the detected PVL-positive clone.
Antimicrobial susceptibility was studied with AST-P536 Vitek test.
Results: The cases were: furuncules, cellulitis and abscesses of diverse
location, doing a whole of sixteen episodes. Three needed surgical
incision and drainage, and seven episodes needed hospitalisation.
All clinic samples yielded Staphylococcus aureus PVL positive in pure
culture. All strains were only penicillin resistant (PRSA). Four nasal
swabs and ﬁve pharyngeal swabs were positive for PRSA (PVL+/PVL-
:4/5). None carryied meticillin resistant S.aureus. All clinical isolates
showed the same phenotypic and genotypic proﬁle.
All family received treatment with cloxacillin and topic mupirocin.
Conclusion: This is the ﬁrst case of intrafamilial spread of Staphylococ-
cus aureus Panton-Valentine positive described in Spain. It is of concern
the possible mupirocin resistance development after repeated treatment.
Finally, it could be of public health importance to control the spread of
infection, because the outbreak may involve non hospitalised persons.
R2345 Molecular characterisation of Staphylococcus aureus from
Dutch general practice patients
G.A. Donker, S. Nys, C. Driessen, R.H. Deurenberg, E.E. Stobberingh
(Utrecht, Maastricht, NL)
Objectives: Meticillin-resistant Staphylococcus aureus (MRSA) is an
increasing problem, both in the community (community-associated
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(CA)-MRSA) and in the hospital environment (hospital-associated
(HA)-MRSA). In order to investigate the prevalence, the antibiotic
susceptibility patterns and the population structure of S. aureus in the
community, nasals swabs from patients without infectious symptoms
visiting their general practitioner (GP) were taken and analysed.
Methods: GPs from 30 practices, situated all over The Netherlands,
send nasal swabs from their patients to the laboratory for isolating
and identiﬁcation of S. aureus. The antibiotic susceptibility pattern to
several classes of antimicrobial agents was determined according to CLSI
guidelines, and the genetic background of the isolates was determined
using spa typing and the algorithm based upon repeat pattern (BURP).
Results: From 617 out of 2,691 (23%) swabs, S. aureus was isolated. Of
the 617 isolates, 595 were available for further analyses. The prevalence
of resistance to penicillin, ciproﬂoxacin, macrolides, tetracyclin and
fusidic acid was 68%, 1%, 5%, 3% and 6%, respectively. All
isolates were sensitive to cefuroxime, clindamycin, imipenem, linozelid,
meropenem. moxiﬂoxacin, teicoplanin, trimethroprim/sulfamethoxazole
and vancomycin. No MRSA isolates were found.
Typing revealed 244 spa types (of which 48 were new types), and 173
were clustered into 23 spa-clonal complexes (spa-CCs) (490 isolates).
The remaining isolates could not be classiﬁed into spa-CCs. Up to 55%
of the isolates were associated with a genetic background common to
the endemic CA- or HA-MRSA clones, e.g. clonal complex (CC)1,
CC5. CC8, CC22, CC30, and CC45. The remaining isolates were
mainly associated with CC7, CC12, CC15, CC26, CC101 and CC121,
commonly observed among MSSA worldwide.
Conclusions:
1. The S. aureus prevalence among general practice patients was 23%.
2. No MRSA isolated were observed in the population.
3. The low resistance percentages suggest that the increased resistance
of S. aureus in hospitals is very likely not due to a reservoir outside
the hospital.
4. Over half of the MSSA isolates had a genetic background common
to endemic MRSA clones.
5. Several other MSSA lineages, not related to MRSA, were prevalent
among the general practice patients.
R2346 The population structure of Staphylococcus aureus isolates
of ICU patients in the Netherlands between 1996 and 2006
M.I.A. Rijnders, R.H. Deurenberg, M.L. Boumans,
M.A.A. Hoogkamp-Korstanje, E.E. Stobberingh (Maastricht, NL)
Objectives: In The Netherlands, the meticillin-resistant Staphylococcus
aureus (MRSA) prevalence is increasing. This increase could be due to a
genetic macro-evolution of the meticillin-susceptible S. aureus (MSSA)
isolates in The Netherlands. MRSA originated through the transfer
of the mobile resistant element staphylococcal cassette chromosome
mec (SCCmec) into MSSA. In order to investigate the changes in the
population structure of S. aureus and the macro-evolutions of MSSA in
The Netherlands, MSSA isolates from ICU patients were analysed.
Methods: S. aureus isolates (n = 856) from ICU patients were collected
in The Netherlands between 1996 and 2006. They were yearly collected
from January until July in two university hospitals and twelve general
hospitals. The minimal inhibitory concentration (MIC) of oxacillin was
determined by a micro-dilution method according to CLSI guidelines.
The genetic background of the isolates was determined with spa typing
and the algorithm based upon repeat pattern (BURP).
Results: Twenty-one isolates (2.5%) were resistant to oxacillin. Of the
287 spa types observed, 58 new spa types were identiﬁed and three new
spa repeats were found among the new spa types. Among the S. aureus
isolates, fourteen spa-clonal complexes were found. Ten isolates could
not be clustered, and were singletons. Three of the singletons were
classiﬁed as ST109. Seventy isolates were excluded from the analyses.
A genetic background common to MRSA clones, e.g. CC1, CC5, CC8,
CC22, CC30 and CC45 was observed among 46% of the isolates
(n = 393). The remaining isolates were associated with CC7, CC15,
CC25, CC26, CC51, CC97 and CC101.
Conclusions:
1. Half of the MSSA isolates (46%) had a genetic background common
to MRSA clones.
2. The prevalence of oxacillin resistance was higher in this study than the
prevalence found in The Netherlands. These isolates will be further
analysed using SCCmec typing.
3. Several clonal complexes not related to MRSA clones were prevalent
in the hospitals.
4. Further investigations to the changes over time and the virulence
factor Panton Valentine leukocidin (PVL) are necessary.
R2347 Molecular heterogeneity of meticillin-resistant
Staphylococcus aureus isolated in hospitals of Belarus
V. Slizen, L. Titov (Minsk, BY)
Objectives: The emerging spread of meticillin-resistant Staphylococcus
spp. poses a signiﬁcant threat to public health. A thorough understanding
of the molecular epidemiology and evolution of meticillin-resistance in
Staphylococcus spp. is required to control and prevent diseases due to
these organisms. The aim of the study was to examine the SCCmec types
and clonal composition of MRSA isolated in Belarus.
Methods: 212 clinical isolates of Staphylococcus spp. including 71
MRSA, obtained from different hospitals during multicentre resistance
monitoring in Belarus in 2006–2007 yy., were under study. It was
detected by M-PCRs the presence of genes controlling resistance to
meticillin and mupirocin (mec A, mup A), SCC mec types I−V, genes
for toxic shock syndrome toxin (tsst), exfoliative toxins A and B (etaA
and etaB), g-hemolysins (hlg g), leukocidin E (luk E), leukocidin Panton-
Valentine (pvl), genes for capsules of serotype 1, 5, 8 (cap1, cap5, cap8).
Results: Mec A positive isolates comprised 33% (71 isolates) of all
tested S. aureus. Two strains (0.9%) harboured the gene of resistance to
mupirocin. The majority of the tested MRSA possessed SCCmec type
III (69%, n = 49) with the prevalence of IIIa subtype (63%). SCCmec
types I, II, IV, V were detected less frequently in 10, 8, 8, 5% isolates
correspondingly. Most of the MRSA strains (85%) carried hlg g and luk
E – the genetic determinants of g-hemolysins, leukocidin E production.
1.1% of MRSA were positive for etaA gene controlling synthesis of
exfoliative toxins A. One of the virulence factors of S. aureus is
the capsular polysaccharide. Most MRSA produced capsules of either
serotype 5 (28%) or serotype 8 (65.5%). However, none of the studied
strains possessed the cap1 genes. Studied MRSA strains did not hold
the Panton-Valentine leukocidin and toxic shock syndrome toxin genes.
Conclusion: High isolation frequency of MRSA (33%) with the
prevalence of the SCCmec type III (69%) and capsule serotype 8 clone
was detected. The evolution and spread of this clone have to be monitored
closely to prevent the clone’s escape to non-hospital environment.
R2348 First detection of Chilean clone in clinical isolates
of meticillin-resistant Staphylococcus aureus in the
Colombian-Caribbean region
P. Espinal, M. Raciny, S. Gaitan, A. Mun˜oz on behalf of the Research
Group for Tropical Diseases and Bacterial Resistance
Objective: MRSA has become a leading cause of nosocomial infections
worldwide and it is beginning to prevail in the wider community as well.
The aim of this study was to perform the molecular characterisation
of MRSA clinical isolates from hospitals at the Colombian Caribbean
Region.
Methods: Twenty three isolates recovered between October/05 and
January/07 were identiﬁed by MicroScan® PC1A. Antimicrobial
susceptibility tests were performed according to CLSI: disk diffusion
with cefoxitin and oxacillin agar tests were used to conﬁrm the presence
of MRSA. PCR using speciﬁc primers was used to determine the mecA
gene, SCCmec type and the presence of PVL. Genetic relatedness was
assessed by PFGE, strain CHL93 (Chilean clone) was included for
comparisons.
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Results: The isolates were recovered primarily from ICU chieﬂy of skin
or soft tissue. Nineteen (83%) were oxacillin resistant by disk diffusion,
but only seven (30%) were positive by conﬁrmatory tests (CLSI). These
conﬁrmed isolates presented resistance to clindamycin, ciproﬂoxacin,
gentamycin and erythromycin; all were sensitive to vancomycin and
linezolid, also mecA gene and SCCmec type I were detected. Isolates
had no lukF-PV and lukS-PV genes. PFGE analysis of MRSA isolates
demostrated a clone with 4 identical isolates and 1 narrowly related in
the same institution, 3/5 were collected in ICU and 2 in Internal medicine
ward from different patients. The clone showed a pattern proﬁle equal
to Chilean clone, reported before in 2003, which is found circulating in
our region.
Conclusions: The presence of a multidrug resistance clone of HA-
MRSA (SCCmec type I), with similar proﬁle to the Chilean clone
suggests the clonal spread and is emerging as an important cause of
nosocomial infections in Colombian Caribbean hospitals.
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R2349 Molecular epidemiology of VIM-producing Klebsiella
pneumoniae in a Greek hospital
G. Totos, S. Vourli, P. Giakkoupi, E. Mournianakis, P. Salvaras,
A.C. Vatopoulos (Athens, GR)
Objectives: Carbapenem-resistant K. pneumoniae strains, mainly due
to metallo-b-lactamase (MBL) production, are widespread in Greek
hospitals. MBL-producing K. pneumoniae were sporadically isolated
in the Athens Navy Hospital since 2003. Following an outbreak that
occurred from May to June 2006, due to the spread of one MBL-
producing K. pneumoniae clone, all carbapenem-resistant K. pneumoniae
isolated in this hospital from 2003 to November 2007, were sent for
typing to the Microbiology Laboratory of the National School of Public
Health.
Methods: Twenty-three carbapenem-resistant isolates, from an equal
number of patients hospitalised in different wards, were studied.
Identiﬁcation and susceptibility testing were performed using the
VITEK2 system. All strains were tested for MBL production by the
imipenem-EDTA disk synergy test. MBL production was conﬁrmed by
detection of blaVIM and blaIMP genes with PCR. All isolates were
typed by PFGE and compared to the outbreak clone.
Results: All isolates were resistant to all major antibiotic classes and
gave positive imipenem-EDTA disk synergy test. Genes of the blaVIM
type were detected in all isolates. Typing revealed the spread of two
major genetic types, present in all wards during the study period, one of
them being identical to the outbreak clone.
Conclusions: Our study reveals the persistence of two VIM-poducing
clones in the Athens Navy Hospital over the study period. One of
these clones was responsible for the 2006 outbreak. Isolation rates of
carbapenem-resistant K. pneumoniae decreased signiﬁcantly after the
outbreak, due to implementation of strict infection control measures.
Surveillance, including typing, of carbapenem-resistant K. pneumoniae
is of major importance, in order to prevent further spread of these strains.
R2350 Epidemiology and clinical impact of cefotaxime resistant
E. coli, Klebsiella spp. and Enterobacter spp. causing
bloodstream infection, skin and soft tissue including
surgical site infection and closed space infection
D. Mathai, J. Vimal, H. Jose, S. Christopher, A. Kumar, A. Manoharan,
MK. Lalitha (Vellore, Chennai, IN)
Objective: Cefotaxime resistant (CTX-R) Gram-negative bacilli (GNB)
is endemic in Indian hospitals. The association with community and
nosocomial (NO) occurrence and treatment outcome of these infections
remains poorly characterised.
Methods: We analysed the prevalence and treatment outcome of 672
patients with GNB (E. coli (EC) n = 436, Klebsiella spp. (KS) n = 145,
Enterobacter spp. (ES) n = 91) seen during Jan-June 2005 (six months)
at our centre. Among them, 483 had soft tissue including surgical site
infection (SSTI), 137, bloodstream infection (BSI) and 97, closed space
infection (CSI) (peritoneal, pleural ﬂuid and meninges). Records were
missing for <1%. Acquisition of infection was clinically deﬁned as
community acquired (CA), when obtained as outpatient with no record
of hospitalisation upto 1 year and do not have any features of healthcare-
associated or NO (seen >72 hours after admissions). Antimicrobial
susceptibility was performed by Kirby Bauer disc diffusion method
against ﬁve antimicrobial classes. CTX-R was deﬁned as 27mm zone
diameter with a 30mgm CTX disc and multi-drug resistant (MDR) if
resistant >2 classes.
Results: Overall CTX-R infection rate was 56.8%; NO and CA rates
were 32.2% and 24.6% respectively. CTX-R among NO/CA isolates
were: EC 73/26%, KS 26/25% and ES 26/32%. CTX-R isolates
caused 110 post surgical SSTIs. Among CTX-R isolates, resistance to
ciproﬂoxacin was 85%, gentamicin 74%, pipercillin/tazobactum 70%
and amikacin (53%). Overall MDR rate was 27% and 18.6% in
CA-CTX-R isolates. All isolates were susceptible to imepenem and
meropenem.. Conﬁdence interval (CI) and Odds Ratio (OR) for clinical
outcome parameters such as delayed improvement, early failure and early
death were: 2.54 (1.44, 4.50); 0.49 (0.22, 1.07) and 2.86 (1.28, 6.37)
respectively, occurring signiﬁcantly more in SSTI and BSI caused by
CTX-R isolates. In the CA-CTX-R infections CI/OR for these cited
parameters were: 8.00(2.28, 28.05); 0.02 (0.06, 0.82) and 0.93 (0.9,
0.10) respectively Overall 36 (5.4%) patients died including 17 with
BSI. Eleven patients with MDR CTX-R infections died. Inappropriate
antimicrobial choice was observed in 36% of CTX-R infections with 25
deaths. All patients with CSI survived.
Conclusion: CTX-R GNB causing has emerged in the community, with
high NO prevalence and a three-fold increase in mortality. Carbapenem
resistance was not observed. As high rates of MDR exist clinicians need
to be aware that appropriate treatment choice could impact outcome and
post surgical. SSTIs are largely preventable via good infection control
practice.
R2351 Clinical analysis and mortality risk factors with proved
Acinetobacter baumannii bacteraemias
C. Bulut, M.A. Yetkin, C. Ataman Hatipoglu, F.S. Erdinc, G. Ertem,
E. Yildiz, E. Karakoc, A.P. Demiro¨z (Ankara, TR)
Objectives: Acinetobacter baumannii is an important nosocomial
pathogen because of high risk of mortality and increasing antibacterial
resistance. We aimed to evaluate the predisposing factors, epidemiology,
antibiograms and clinical features and mortality risk factors of
A. baumannii bacteraemias.
Methods: A retrospective analysis of 51episodes with A. baumannii
bacteraemia over two year period (2005–2006) at a tertiary hospital in
Ankara, Turkey was performed. Hospital acquired infections were diag-
nosed according to the CDC criterias. Conventional methods were used
for the identiﬁcation of Acinetobacter isolates. Disc diffusion method
was used antimicrobial susceptibility test of microorganisms. Multidrug
resistance (MDR) was deﬁned as resistance to all studied agents
(including piperacillin/tazobactam, cefepime, ceftazidime, aztreonam,
ciproﬂoxacin, gentamicin, tobramycin), but we allowed susceptibility to
amikacin, netilmicin, imipenem and meropenem.
Results: The mean age of the patients with A. baumannii was 60±14
years (range:1–91 year). Predisposing factors detected in patients
infected with A. baumannii were urinary catheter insertion (92%), central
venous catheter (53%) and mechanical ventilation (43%), consecutively.
The mean duration time between hospitalisation and occurrence of
infection were 13.9±10.1 days. Clinical pneumonia was detected on
25 of the patients due to A. baumannii. An overall mortality rate
was 61%. Mortality rate of the patients with clinical pneumonia was
63%. Among A. baumannii isolates 53% were detected as MDR. MDR
infection resulted in higher mortality rate than non-MDR cases (1.7
times) but this difference was not statistically signiﬁcant. Older age
(60 years), mechanical ventilation, central venous catheter, insertion
of urinary catheter, being a ICU patient, infection with a MDR isolates
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were analysed by univariate and multivariate test. Being an ICU patients
was found a risk factor for mortality on univariate analysis (p< 0.05).
However only infection with a MDR isolates was found as a risk factor
independently associated with mortality (p< 0.05).
Conclusion: These data suggest that, the infections due to MDR isolates
of A.baunannii may cause a high mortality rate especially in ICU
patients. Performing strict infection control measures might be critical
for the manegement of these infections.
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R2352 Tissue penetration and clinical efﬁcacy of gatiﬂoxacin,
a respiratory quinolone, in adult patients with
penicillin-intermediate Streptococcus pneumoniae and
penicillin-resistant Streptococcus pneumoniae sinusitis
R. Sugita, G. Sugita, K. Ikeda, Y. Suzuki (Chiba, Tokyo, Kanagawa, JP)
Objectives: The clinical efﬁcacy of Gatiﬂoxacin (GFLX), a respiratory
quinolone, in adult patients with acute bacterial sinusitis (ABS) was
examined. Tissue penetration to nasal discharge was also examined in
support of clinical efﬁcacy.
Methods: Subjects were ABS patients aged 18 years without
underlying disease or pregnancy. At ﬁrst visit, purulent or mucopurulent
nasal discharge in middle nasal meatus was collected for bacterial
cultivation. The clinical efﬁcacy was determined based on the volume
and viscosity of nasal discharge after oral administration of Gatiﬂoxacin
400mg/day b.i.d. Nasal discharge in middle nasal meatus two to seven
days after administering GFLX was collected with aspirating tube and
stored at −80ºC. The concentration of GFLX was analysed by gas
chromatograohy.
Results: Fourteen male and 37 female patients ranging aged 19 to 74
years were included, those in their thirties accounting for 45%. The
clinical efﬁcacy of GFLX was remarkably good in 11 patients, good
in 33 patients, somewhat good in two patients, and no response in ﬁve
patients. GFLX was effective in total 86.3% of patients. Six of 51 patients
had not responded to Telithromycin administered at ﬁrst visit, however,
GFLX administered at second visit was effective in all of them. In 32 of
34 patients (94.1%) with PISP and PRSP, GFLX was clinically effective
with remarkably good or good response. Tissue penetration of GFLX to
nasal discharge was examined in 9 patients. Nasal discharge sample was
collected 1.5 to 12 hours after administering GFLX. The Concentration
of GFLX in nasal discharge was 0.69−7.04 mu g/g. The antibacterial
activity of GFLX against S. pneumoniae was MIC90 0.06−0.5 mu g/mL,
against Hemophilus Inﬂuenzae was MIC900.06, and againstMoraxella
catarrhalis was MIC90 – 0.06−1mg/mL.
Conclusion: Efﬁcacy ratio of penicillin and cephem antibiotics against
PISP and PRSP is around 50–60%. GFLX showed high efﬁcacy ratio,
86.3%, with good antibacterial activity and high tissue penetration
maintained for long time. Our results suggest that GFLX is ﬁrst-line
antibacterial agent of ABS therapy.
R2353 Daptomycin monotherapy in the treatment of
vancomycin-resistant enterococcal bacteraemia
J.C. Gallagher, M.E. Perez, C.M. Rose, L. Abrardo, E. Marino,
M. Walker (Philadelphia, US)
Objectives: Daptomycin (DAP) is indicated for Staphylococcus aureus
bacteraemia, but has not been sufﬁciently studied in bacteraemia
caused by vancomycin-resistant enterococci (VRE), a difﬁcult-to-study
disease state common in the intensive care unit (ICU). The aim was
to retrospectively evaluate DAP monotherapy in patients with VRE
bacteraemia.
Methods: We performed a retrospective study of patients treated
for VRE bacteraemia between January 2004 and July 2007 by
reviewing medical records. Patients were included if they received DAP
monotherapy and had a blood culture positive for VRE at the time
DAP was started. Patients receiving concurrent antibiotics for VRE
bacteraemia and those with negative blood cultures prior to receiving
DAP were excluded. The primary endpoint was microbiological cure,
deﬁned as negative blood cultures for VRE at the end of therapy. Clinical
outcomes at the end of therapy were also evaluated with standardised
deﬁnitions and adverse events were assessed: cure or improvement were
considered positive, and worsening or death within 7 days of the end of
DAP therapy were considered negative. Descriptive statistics were used
and data are reported as median (range), except where noted.
Results: 31 patients were included. DAP was initiated 23 days (1–
281 days) into the hospital stay, for a duration of 13 days (1–42
days). 20/31 patients (64.5%) were in the ICU when presentation of
bacteraemia occurred, with an ICU stay of 35 days (2–298 days).
Prior to DAP therapy, bacteraemia was present for 3 days (0−7 days)
without effective therapy for VRE (i.e. no antibiotics active against VRE,
or linezolid failure occurred). Enterococcus faecium was cultured 28
times, E. faecalis was cultured 5 times, and E. rafﬁnosus was cultured
once; 3 patients had multiple species cultured. All isolates tested were
susceptible to DAP. The dose given was 6mg/kg (4.0−6.7mg/kg). Blood
cultures tested negative 2 days (0–24 days) after initiation of DAP
therapy. Microbiologic eradication was observed in 25 patients (80.6%)
and positive clinical outcomes were seen in 18 patients (58.1%). Mild
creatine phosphokinase (CPK) elevations were seen in only two patients
(CPK 243 U/L and 252 U/L; normal range 20–230 U/L) and both
spontaneously resolved while on DAP.
Conclusion: In this descriptive study, DAP monotherapy was effective
in clearing bacteraemia caused by VRE.
R2354 Prophylaxis of surgical site infections – Institutional Project
Phase II
E. Keuleyan, G. Kirov, M. Kondarev, R. Benchev, G. Markov,
I. Hlebarova, B. Moshev (Soﬁa, BG)
Objectives: Surgical site infections (SSI) are among the most frequent
and expensive Hospital acquired infections and are associated with
higher morbidity, disability and lethality. We report the second phase
(2003–2007) of an institutional project, aiming at reduction of SSI.
Methods: Prospective direct and indirect surveillance of SSI; devel-
opment of Guidelines for Hospital hygiene and Antibiotic prophylaxis
in Surgery; Audit of Antibiotic prescriptions; Calculation of Antibiotic
consumption in DDD/100 patient-day (pd); Microbiological methods:
according to the BSOPs, HPA, UK, 2005 (-wound, screen-, environment-
specimens) and to the CLSI, USA, 2005 (Disk diffusion Antimicrobial
susceptibility testing method).
Results: Guidelines for Hospital hygiene (standard and regarding the
care for patient: -before, -during and -after the operation) and Guidelines
for Antibiotic prophylaxis were actualised upon a consensus in 2003.
Three 3-month audits of antibiotic prescriptions were performed. The
ﬁrst one (2003) showed a usage of cephalosporins of higher generations
as a difference from the accepted rules, while in 2004/5- and 2006- audits
the choice of antibiotic and antibiotic dosage were correct. A relatively
high antibiotic consumption of 48.2–50.0 DDD/100 pd was calculated.
The cephalosporins of ﬁrst generation were the most commonly used
antibiotics (29.5–33.4 DDD/100 pd), followed by the group of imidazoles
(4.5−5.4 DDD/100 pd). Two unfavourable tendences took place: a
decrease in the usage of penicillines (from 5.3 to 2.1 DDD/100 bd) and
an increase of the cephalosporins of third generation (from 2.0 to 3.3
DDD/100 bd). The most frequent pathogens from the wounds of patients
were Staphylococcus aureus, followed by enterobacteriae and anaerobes.
Dynamic of Antimicrobial resistance showed a signiﬁcant increase in
2004 vs. 2003, when MRSA raised 4-fold (up to 20%) and carbapenem-
resistance in Pseudomonas aeruginosa – 2.5-fold (up to 35%), as a part
of a national-wide increase in resistance; the rate of ESBL-producing
Enterobacteriaceae was also high – 33%. Microbiological control tests
did not show signiﬁcant breaks in hospital hygiene.
Conclusion: The rate of SSI was decreased to <5% during the project,
due to the consensus-accepted guidelines by the personnel of the Clinic
for Surgery. However, further work would be necessary to decrease
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antibiotic use and to tailor the correct time and duration of antibiotic
prophylaxis.
R2355 Analysis on the transition of change in antimicrobical
use following preventive intervention in the perioperative
antimicrobial prophylaxis in a hospital
J.Y. Kim, Y.K. Yoon, D.W. Park, Y.M. Kim, M.J. Kim (Seoul, KR)
Objectives: To conﬁrm short-term effects of intervention in periopera-
tive antimicrobial prophylaxis using computed prescription system
Methods: This was a prospective, before-after comparative study of
the intervention conducted at an 860-bed university hospital in Korea,
from January 2007 through September 2007. Computed intervention
programme has been executed for the appropriate perioperative
prophylactic antimicrobial use from May 2007. Upon antimicrobial
prescription, computed intervention programme displayed pop-up pro-
viding recommended guidelines on the appropriate duration and type of
antimicrobials and required to check the reason for prescribing. A small
working group monitored the perioperative prophylactic antimicrobial
use by department, division and class every two weeks and gave feedback
to the departments and surgical doctors. The effect of intervention
programme was analysed in comparing antimicrobial use density (AUD)
in September 2007 with AUD in January 2007 (pre-intervention period)
and the average AUD of last year. The transition of change in the usage
of antimicrobials on overall and surgical purpose was analysed in detail,
by monthly doses and antimicrobial class.
Result: Average monthly AUD for surgical patients (surgical AUD,
715) was higher than overall AUD, 516 in 2006. After intervention
programme, surgical AUD dropped 23.0%, from 695 in January to 536
in September 2007. Likewise, overall AUD went down 8.8% from 503
to 459. Due to changes in doses by antimicrobial class, surgical AUD
for 3rd generation cephalosporin decreased 53.3%, from 187 of annual
average in 2006 to 87 in September 2007 and reduced 44.4%, from
157 in January to 87 in September 2007. For aminoglycoside class,
surgical AUD fell 44.2%, from 211 of annual average in 2006 to 118
in September 2007, and diminished 48.5%, from 229 in January to
118 in September 2007. This shows that antimicrobials in these two
classes have led the changes in overall antimicrobial use. Meanwhile,
2nd generation cephalosporin relatively increased 10.8% and 5.9% in
the same comparison as above.
Conclusion: Regarding the transition of change in antimicrobial use
before and after computed intervention programme, 3rd generation
cephalosporin and aminoglycoside classes use in surgical patients
were remarkably reduced, which attributed to the decrease in overall
antimicrobial use.
R2356 Antibiotic prescriptions at the central pharmacy of a
Hungarian town
E. Horvath, M. Matuz, R. Benko, E. Hajdu, G. Soos (Szeged, HU)
Background and Objectives: In Hungary, all antibiotics are prescription
only medicines. As during the dispensation process at pharmacies several
data are not electronically registered (e.g. patients’ age, dosage), retrieve
from prescription databases has limitations. Therefore, we aimed to
perform a study where a more sophisticated aspect of antibiotic use
could be determined.
Methods: The setting was the central pharmacy of a Hungarian town
with a population of 30,000. The manual review of all prescriptions
redeemed during six separated weeks in 2007 was performed. The
following data was copied out from antibiotic (Anatomical-Therapeutic-
Chemical class J01) prescriptions: the patient’s age, gender, the doctor’s
individual code, the product name, form, the indication and the
prescribed dosage.
Results: In total 26,638 prescriptions were reviewed, of which 1,032
(3.9%) were related to antibacterials. The antibacterial prescriptions were
originated from 176 different doctors. The age-distribution of patients
were the following: 0–14 years: 197 patients (19.1%), 15–65 years: 673
patients (65.2%), above 65 years: 162 patients (15.7%). Among children
we observed a male (55.0%), above 15 years of age, a female dominance
(65.0%). Parenteral therapy was indicated only in 6 cases (0.6%), oral
liquid products were also prescribed in minority (135 cases-13.1%). The
three most common diagnoses in children were tonsillitis, pharyngitis
and rhinopharyngitis. In 15% of cases antibacterials were prescribed for
otitis. In adults acute bronchitis was the most frequent diagnose, followed
by pharyngitis and tonsillitis. Infection of the urogenital tract was the
indication in 22% of cases. The top list of antibacterials were cefuroxime,
amoxiclav and chlarithromycin in children and amoxiclav, cefuroxime
and ciproﬂoxacin in adults. In adults, the prescribed antibacterial dosages
showed good accordance with the World Health Organisation’s (WHO)
deﬁned daily doses except amoxicillin, amoxiclav and cefuroxime, where
doctors prescribed higher doses.
Conclusion: The manual review of individual prescriptions enabled
us to perform an in-depth analysis. We have found that in several
cases antibacterials were indicated for infections where the need of
antibacterial treatment is questionable. We showed the lack of under
dosing, and highlighted the discrepancy between WHO deﬁned doses
and prescribed dose in case of amoxicillin, amoxiclav and cefuroxime.
R2357 Daptomycin for the treatment of Staphylococcus aureus
bacteraemia
K.C. Lamp, B.J. Donovan (Lexington, US)
Objective: To examine the outcomes of patients (pts) with Staphylococ-
cus aureus bacteraemia (SAB) treated with daptomycin; approved in US
2006 at 6mg/kg/qd.
Methods: Pts with a positive blood culture for S. aureus, and evaluable
for outcome (cure, improved, failure) were identiﬁed in a registry –
The Cubicin® Outcomes Registry and Experience (COREsm) 2005 and
2006 programme years. Outcome was assessed at the end of daptomycin
therapy using protocol-deﬁned criteria. Pts with blood cultures positive
for any other pathogen or for endocarditis were excluded. Success was
deﬁned as cure or improved.
Results: Of 238 pts with SAB meeting the selection criteria, 179
(75%) were evaluable; successful outcomes were reported in 157 pts
(88% overall; 89% meticillin-resistant S. aureus [MRSA] n = 119, 85%
meticillin-susceptible S. aureus [MSSA] or meticillin susceptibility
unreported, n = 60). 54% of pts were males and 35% were >65 years
of age. Comorbidities included diabetes (37%) and sepsis (20%). 26%
received daptomycin in an intensive care unit. 35% of pts had an
initial CrCl <30ml/min, 65% of these were receiving dialysis. The most
common concurrent infection types were skin and soft tissue (21%) and
osteomyelitis (11%). Other antibiotics were given prior to daptomycin
in 83% of pts, most commonly vancomycin (72%). The success rate of
daptomycin was 88%, irrespective of prior vancomycin exposure. The
most common reason for stopping prior antibiotic therapy was failure
(31%). Concomitant antibiotics (1 dose) were used in 57% of pts,
most frequently rifampin (26%) and vancomycin (25%). The receipt of
concomitant rifampin or vancomycin did not effect success (83% with
and 89% without rifampin or vancomycin, P = 0.3). The median ﬁnal
daptomycin dose and duration of therapy was 6mg/kg (60% received
6mg/kg) and 15 days (range, 1–84), respectively. Eight adverse events
in 8 (4%) pts were possibly related to daptomycin; three of these met the
regulatory criteria for seriousness. The mortality rate was 6%, n = 11, no
deaths were reported as being possibly related to daptomycin.
Conclusion: In this population, daptomycin was effective for SAB. No
apparent difference in success rates was seen between patients with
MRSA infections and those with MSSA infections. Previous treatment
with vancomycin did not inﬂuence the outcome of patients treated with
daptomycin, nor did concomitant use of the antibiotics rifampin or
vancomycin.
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R2358 Unlicensed and off-label antibiotic use in a paediatric city
hospital in Russia
S. Ratchina, A. Belokhvostova, L. Konovalova, L. Zharkova
(Smolensk, RU)
Objectives: To determine the proportion of unlicensed and off-label
antibiotic prescriptions in hospitalised paediatric patients.
Methods: All antibiotic prescriptions to children admitted to neonatol-
ogy unit and three medical units for toddlers, school-age children and
teenagers were prospectively recorded from 1st of January to 30th of June
2006. Categories of unlicensed use included: 1. unlicensed medicines
imported from foreign countries; 2. adult preparations that is not suitable
for children; 3. modiﬁcations to licensed drugs formulation; 4. use
of chemicals as drugs; 5. medicines prepared or modiﬁed by hospital
pharmacy. Prescriptions were considered off-label in the following cases:
1. use for indication not described in the licence; 2. use when product
is contraindicated; 3. administration outside the age range; 4. use of
wrong dose, frequency or alternative routs of administration. Package
inserts and National Drug Register edited in 2004 were used as reference
sources.
Results: Four hundred sixty nine patients aged from ﬁve days to 18 years
(55.3% female, median age 8.9 years) were included in the study. A total
of 469 antibiotic prescriptions were written for the patients. Antibiotics
were prescribed to 51% of children in neonatology unit, to 34%, 41% and
56% of toddlers, school-age children and teenagers, respectively. In 93%
of cases antibiotics were written by attending paediatrician, followed by
doctor on call (3.2%) and clinical pharmacologist (3.2%). There were
no cases of unlicensed antibiotic use recorded. The incidence of off-
label prescriptions was the highest in neonatology wards (49%) and
decreased with age (28%, 10% and 11% in toddlers, school-age children
and teenagers, respectively). Off-label use due to unproved indication
was registered in 38% of cases; it was related to dose and frequency
of administration, age limitations in 36% and 26% of prescriptions,
respectively.
Conclusion: The practice of off-label antibiotic use was quite common
in hospitalised children in Russia especially in neonatal wards. These
ﬁndings underline the importance of research on antibiotic use in
paediatric population as well as additional efforts to improve the quality
of their prescribing within the licence.
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R2359 Analysis of factors of virulence and LPSs from Vibrio
cholerae serotypes isolated from Slovak rivers
J. Vra´blova´, S. Bystricky´, M. Seman (Bratislava, SK)
Objectives: The analysis of genes of virulence and lipopolysaccharide
analysis of V. cholerae serotypes O1 and non-O1 was the purpose of our
work.
Methods and Results: Pathogenic potential of V. cholerae is represented
by several virulence factors – toxins. We analysed virulence factors in
O1 and non-O1 (O135, O34) serotypes of V. cholerae isolates using PCR
method. There were analysed 9 genes of virulence in our isolates: ompW,
ompU (genes determined porins), toxR (gene det. regulating factor) tcpA,
zot (gene det. zonula ocludens toxin), ace (gene det. accessory cholera
enterotoxin), hlyA/b (gene det. hemolysin), st (gene det. thermo-stable
toxin).
As all Gram-negative bacteria, their cell walls contain characteristic
lipopolysaccharide (LPS) structures – endotoxins. LPS is composed of
three parts: lipid A, polysaccharide core and O-speciﬁc oligosaccharide.
The O-oligosaccharide containing of mono- or oligosaccharide repeating
units with enormous structural variation determines the serological
speciﬁcity of the bacterium and also demonstrates vibriocidal activity.
We have used two serotypes of non-O1 V. cholerae: O135 and O34.
There were chosen 4 isolates of each serotype for cultivation, isolation
and analysis of LPS endotoxins. Proportion of saccharides, proteins
and nucleic acids in raw LPSs was determined by spectrophotometry.
Molecular weights of the elements (lipid A, polysaccharide core,
O-speciﬁc chain as an antigen) were determined by SDS-PAGE and
HPLC. Then, the dialysis and acid hydrolysis of samples of LPSs
were followed. The highly puriﬁed O-speciﬁc oligosaccharide chain
was obtained by the size exclusion chromatography. The highly puriﬁed
O-speciﬁc oligosaccharide chain (O-antigen) was analysed by NMR and
IR spectroscopy. Saccharide composition of O-antigen was determined
by gas chromatography.
Conclusion: Our results provide a conﬁrmation of diversity of analysed
serotypes on the basis of genotype variability and LPS variability, of a
degree of coincidence with determined serotypes and of informational
databasis about one important element of immunogen or antigen complex
of Vibrio cholerae. The detailed examination of LPS structures is
necessary for preparation of deﬁned glycoconjugates (O-antigen bound
to a protein vehicle) and could contribute to progress in creating a new
stable, safe and sufﬁciently immunogenic vaccine.
This work was supported by the Slovak Research and Development
Agency APVV No. 0032–06.
R2360 Genetic diversity of Vibrio pathogenicity island in Vibrio
cholerae isolates of clinical origin in Iran
H. Mohammadi Barzelighi, B. Bakhshi, A. Rastegar Lari, F. Masjedian,
M.R. Pourshaﬁe (Tehran, IR)
Objective: Two important virulence factors of Vibrio cholerae strains
includes cholera toxin and toxin coregulated pilus (TCP) encoded on
Vibrio Pathogenicity Island (VPI). This region which is 41.2 kb in size
encodes 29 proteins and including genes necessary for biogenesis of
TCP which plays an important role in the colonisation of bacterium in
the gut, bioﬁlm formation and CTX prophage attachment. The aim of
this study is to investigate the presence and diversity of the VPI in the
Vibrio cholerae isolates of clinical origin from Iran.
Methods: 20 Vibrio cholerae isolates investigated in this study using
biochemical and serological tests and subjected to analysis using Long-
PCR analysis of the central region of the VPI including the complete
TCP gene cluster. PCR products were subjected to Restriction Fragment
Length Polymorphism (RFLP) analysis using EcoRI, EcoRV, ClaI, BglI
and DdeI restriction enzymes. Left and right segments of VPI cluster
were also subjected to analysis using 6 pairs of primers which spans the
major gene clusters in these regions and also the integrase and joining
sites of the cluster.
Results: Serogrouping revealed that 25% of isolates belonged to the
O1 Ogawa, and 75% to the O1 Inaba serogroups. PCR analysis and
subsequent RFLP of PCR products showed that 85,100,100, 76,100,100
and 80% of isolates possesed LJ, aldA, tagA, toxT, acfB-C, int and
RJ regions, respectively. Long-PCR analysis and subsequent RFLP of
product revealed that 100 and 100% of isolates possesed tcpI-F, tcpQ-R
and tcpQ-F, tcpF-R, respectively, according to the standard strain ATCC
14035.
Conclusion: Results of this study emphasizes that, the integrity of TCP
gene cluster is necessary for toxin coregulated pilus production and
function and subsequent CTX prophage acquisition by V. cholerae and
showes the low diversity of the left and right segments of this cluster.
It seems that the ability of VPI for excision from the genome of the
V. cholerae and some point mutations in the binding region of the primers
stands for the absence of some of the fragments in a low percent of
isolates and our data are in consistent with the hypothesis that the VPI
can have a mosaic structure in some Vibrio cholerae strains and genotye
diversity is due to the circulation of virulence genes.
R2361 Sequence-based bacterial identiﬁcation from clinical
samples: one year experience
A.C. Mendes, M. Pereira, S. Fernandes, C. Valente, M.H. Ramos,
J.M. Cabeda (Porto, PT)
Introduction: Identiﬁcation of clinically relevant bacteria relies on
automated systems in clinical laboratories, assuming differences in
Molecular bacteriology S703
morphology, growth, metabolic and enzymatic activity. However, these
methods are generally less accurate than genotypic methods, particularly
when applied to poorly described, rarely isolated or phenotypically
aberrant species. Genotypic approaches can even lead to the recognition
of novel pathogens and non-cultured bacteria.
Objectives: The present study aimed at evaluating the use of MicroSeq
500 for the 16S rRNA sequence based identiﬁcation of bacteria
in isolates and primary clinical specimens with doubtful automatic
identiﬁcation results.
Methods: We analysed 6 isolates from an external quality control
programme and 27 clinical samples (isolates and primary samples)
by direct sequencing using MicroSeq 500 16S rDNA microbial
identiﬁcation system (Applied Biosystems).
Results: All QC samples showed the correct sequence based identiﬁca-
tion, and all clinical samples resulted in a clinically compatible bacterial
identiﬁcation. Of these, one isolate from a meningitis patient, showed
as Streptococcus suis by conventional methods. As the primary CSF
sample was still available it was analysed by an in house optimised 16S
rRNA based broad range real-time-PCR and showed a positive result.
We then applied MicroSeq 500 to the primary CSF sample, with the
results conﬁrming the automatic identiﬁcation.
We correctly identiﬁed the genus of three Brucella spp. strains
but could not reach species identiﬁcation. This was due to low
variability in the 500bp region sequenced that had been associated with
failure to discriminate the species in this genus. We were unable to
differentiate between Mycobacterium chelonae/M. abcessus, which is a
well documented limitation of this method.
Conclusion: The present results indicate that sequence based identi-
ﬁcation represents a useful method for bacterial identiﬁcation, whose
performance could be improved by the use of pyrosequencing, with
advantages both in turn-around-time (TAT) and the low TAT impact
of the use of other target regions.
R2362 Improving diagnosis of Bordetella pertussis to improve
patient management
E. McCulloch, C. Williams (Glasgow, UK)
Objectives: Bordetella pertussis is a serious potentially life threatening
infection particularly in unimmunised infants. There has also been
an increase in the number of people who, although fully vaccinated,
loose their immunity over time. Due to the fragile nature of the
organism and the prolonged time required to culture the organism
it is signiﬁcantly under reported. It was proposed that introducing
real-time PCR as a clinical service to detect Bordetella pertussis and
Bordetella parapertussis (a related less severe infection) would improve
the management of patients with this infection.
Methods: Pernasal swabs or naso-pharyngeal aspirates from patients
with a clinical suspicion of whooping cough were collected and cultured
immediately as per routine laboratory protocol. In our real-time PCR
assay, DNA is extracted using the EZ1 BioRobot (Qiagen) and a
tissue extraction kit, then ampliﬁed and detected using an ABI Prism
7000 sequence detector and Taqman probes (Applied Biosystems). Each
sample is performed in duplicate using a reaction which ampliﬁes a
speciﬁc B.pertussis or B.parapertussis gene target allowing detection
ampliﬁed DNA.
Results: In the ﬁrst year of introducing real-time PCR as a clinical
service the turn-around time of sample processing improved from 5−7
days using standard culture methods to 24 hrs with a maximum of 3 days
if a specimen was collected on a weekend. The sensitivity of the assay
was also improved with 4 cases from a total of 13 positive patients that
would not have been detected when culture was used alone. Clinicians
were also more likely to take specimens for pertussis testing due to the
improved service this resulted in cases of dual infection with RSV being
detected were a positive virology result alone may have resulted in no
further investigations.
Conclusion: The use of real-time PCR has allowed both a faster turn
around time in processing patient samples, increased sensitivity and more
appropriate isolation procedures for in-patients.
R2363 Antibiotic resistance of commensal Escherichia coli and
Lactobacillus isolates from the healthy gut microﬂora
M. Balayan, S. Mirzabekyan, L. Malkhasyan, A. Baghdasaryan,
K. Petrosyan, A. Pepoyan (Yerevan, AM)
The aim of our study was to investigate the antibiotic resistance of
commensal E. coli and Lactobacillus isolates in the gut of healthy
voluntaries during the period 2006–2007 years from Yerevan.
The resistance of 235 E. coli and 57 Lactobacillus isolates from
the faecal microﬂora of healthy voluntaries to the next antibiotics in
the following concentrations were tested: tetracycline (Tc) 15 mg/ml,
doxycycline (Dc) 15mg/ml, amoxicillin (Ac) 25 mg/ml, chloramphenicol
30mg/ml (Cm), streptomycin 50mg/ml (Sm). Statistical analysis was
performed using the CHITEST (null hypothesis).
Antibiotic resistance proﬁling has demonstrated that the E. coli strains
have a substantial level of resistance to commonly used antibiotics. In
2006 the proportion of resistant E. coli isolates was 18% to Dc, 12%
to Tc, 23% to Ac. The results for 2007 year showed that in healthy
volunteers the number of antibiotic resistant E. coli isolates increased
signiﬁcantly in comparison with 2006 year (36% to Dc, 32% to Tc,
25% to Ac). The resistance to tetracycline group antibiotics was almost
two fold greater in 2007. The sensitivity to Ac dropped insigniﬁcantly.
The proportion of multiresistant isolates (resistant to at least to two
antibiotic’s groups) remained same for the investigated period. The
increase was observed for single antibiotic resistant isolates (19.4% in
2006 and 23.4% in 2007 respectively).
Compared with the E. coli isolates the quantity of resistant Lactobacillus
isolates is low in the gut microﬂora of healthy persons and the quantity
of Lactobacillus isolates, having the same resistance to antibiotics as
E. coli isolates in individual is less.
Thus it could be concluded that there is an increasing trend in antibiotic
resistant commensal spreading in the gut of healthy subjects. This could
represent the risk factor for antibiotic resistance gene dissemination
by the commensal as it have been shown that the antibiotic resistance
factors (plasmids) may circulate in a broader environment and include
the bacteria of diverse origin and taxonomic position. In addition, E. coli
strains efﬁciently exchange genetic material with pathogens such as
genera Salmonella, Shigella, Yersinia, and Vibrio as well as pathogenic
E. coli.
R2364 CagA and other key genes in the cag pathogenicity island
of Helicobacter pylori isolated from dyspepsia patients
F. Jafari, L. Shokrzadeh, K. Baghai, H. Dabiri, M. Bolﬁon,
N. Sahebekhtiyari, H. Zojaji, R. Mashayekhi, MR. Zali (Tehran, IR)
Objective: Helicobacter pylori is a bacterium associated with upper
gastrointestinal diseases in humans. Several studies have tried to establish
an association between known virulence markers and clinical outcomes,
in many cases the results has been conﬂicting. Cytotoxcin associated
gene A (cagA), E (cagE) and certain vaculating cytotoxin (vacA)
genotypes are associated with peptic ulcer disease (PUD). The present
study compared the distribution of vacA allotypes and cag PAI status in
Iranian patients isolates.
Methods: From November 2006 to July 2007, two hundred and ten
patients referred to the Taleghani hospital for endoscopy.197 gastric
biopsy specimens of 169 none ulcer disease (NUD) and 28 peptic ulcer
disease (PUD) were distinguished qualify for next steps. The samples
were cultured by standard methods. PCR was performed for ure C
(glmM) gene to identify Helicobacter pylori strains. Isolation of cagE,
cagM, cagG, oipA and vacA allotypes were done by PCR.
Results: Among NUD and PUD, H. pylori was isolated in 148 of 169
(75.1%) and 21of 28 (75%) respectively. PCR ampliﬁcation detected
cag A gene in 103 (69.6%) of NUD patients and in 66.7% of PUD
patients. cagT, cagG, cagM, cagE and oipA genes were observed in
H. pylori isolates from NUD patients in 29.7%, 10%, 0.2%, 39.4% and
50% respectively. Also these genes were found in 23%, 9%, 33% and
42% of PUD patients respectively. Among analysis of vacA allotypes,
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s1 and m2 genotype were predominant types among H. pylori strains
(36.2%). CagM was observed in 4% of the H. pylori isolates in PUD
and was more than isolated strains in NUD(0.2%).
Conclusion: The data show that, infection by H. pylori is an important
cause of gastritis in Iranian patients. Also the results note that, there was
no association between cagA, cagG, cagM, cagE and oipA genes and
clinical outcomes. The result of this study showed none of the markers
are helpful in predicting the clinical presentation of a H. pylori infection,
however, for full conﬁrmation of our data and explanation of possible
factors of H. pylori to the pathogenesis of the diseases further data to
be collected and evaluated.
R2365 A molecular study on Enterococcus faecalis in primary and
secondary endodontic infections
S. O¨zbek, A. O¨zbek, E. O¨zbek (Erzurum, TR)
Objectives: This study were aimed to investigate the presence of
Enterococcus faecalis in primary and secondary endodontic infections
using real-time PCR (RT-PCR) and to determine the statistical
importance of the presence of E. faecalis in a Turkish population with
endodontic infections.
Methods: E. faecalis was investigated from 40 samples from patients
who were attended at the Endodontic Clinic of the Dental Faculty
of Ataturk University in Erzurum, Turkey. Samples were taken
from 40 root canals, 20 with acute periradicular abscesses (primary
endodontic infections) and 20 with failed endodontic treatments
(secondary endodontic infections). DNA was extracted from the
samples using a QIAamp® DNA mini-kit and analysed with RT-
PCR. 16S rRNA-directed species-speciﬁc primers were a forward 5′-3′
CCGAGTGCTTGCACTCAATTGG and a reverse 5′-3′ CTCTTATGC-
CATGCGGCATAAAC. Ubiquitous primers directed to 16S rRNA were
a forward 5′-3′ TTAAACTCAAAGGAATTGACGG and a reverse 5′-3′
CTCACGACACGAGCTGACGAC. As a positive control, we used an
E. faecalis strain from the bacterial stocks of our laboratory in the
Department of Microbiology and Clinical Microbiology. The bacterium
had been previously identiﬁed based on fatty acid proﬁles using the MIDI
Sherlock® Microbial Identiﬁcation System (MIS) (MIDI, Inc., Newark,
Delaware, USA). A proportion test and Fisher’s exact Chi-square test
were performed for statistical analyses using SPSS for Windows, 13.0.
Results: RT-PCR allowed for the detection of E. faecalis in 15 of
20 (75%) samples taken from patients in whom endodontic treatment
had failed, and in 5 of 20 (25%) samples of pus aspirated from acute
periradicular abscesses. E. faecalis was detected in 20 of total 40 patients,
which revealed statistically that it may exist in 62% of all endodontic
infections when the proportion test was applied (z = −1.645, alfa = 0.05).
Additionally, E. faecalis was found signiﬁcantly more often in patients
with secondary endodontic infections than in patients with primary
endodontic infections, based on Fisher’s exact Chi-square test (p = 0.004).
Conclusion: Our data suggest that E. faecalis is a frequently-found
bacterial agent in Turkish patients with endodontic infections, and is
more often associated with secondary endodontic infections than primary
endodontic infections.
R2366 Prevalance and molecular epidemiology of Staphylococcus
aureus isolates carrying Panton-Valentine leukocidin genes
during a ﬁve-year period (2003–2007) at a tertiary care
centre in Izmir, Turkey
B. Eryonar, Z. Gulay (Izmir, TR)
Objective: Panton-Valentine Leukocidin (PVL) is accepted as a marker
of disease severity in staphylococcal infections. In this study we have
determined the prevalance of PVL genes among S.aureus isolated from
clinical samples over a ﬁve year period.
Methods: 102 MRSA and 156 MSSA isolates which were obtained
from, blood, wound, urine and respiratory tract samples of hospitalised
patients were selected randomly from a collection of strains. PVL genes
were screened by a multiplex PCR protocol which detects pvl (luk S and
luk F) and nuc genes.
Results: PVL genes were detected in 0, 2 (4.3%), 4 (10.3%) and 2 (4.3%)
of MSSA isolates in 2003–2004, 2005, 2006 and 2007, respectively.
None of the MRSA isolates taken into the study contained pvl genes.
An increment in the prevalance of pvl-positive isolates was noted in
2006. PFGE analysis revealed a small cluster of clonally related isolates
in General Surgery patients with SSI.
Conclusion: PVL prevalance is low in MSSA and nil in MRSA strains
isolated in our hospital. This is probably due to the fact that none of the
MRSA isolates is community-acquired. PVL positive MSSA are distinct
from the predominant MRSA clone in our hospital as revealed by PFGE
analysis.
R2367 Vibrio cholerae among stool samples of patients with
diarrhoea and PCR detection of two housekeeping genes
hly and recA
A. Dashtbani, B. Bakhshi, M. Oskoui, M.R. Pourshaﬁe (Tehran, IR)
Objective: Vibrio cholerae is a noninvasive, Gram-negative bacterium
responsible for severe epidemics of cholera and endemic diarrhoea in
many parts of the world, especially developing countries. V. cholerae
strains may produce a variety of atypical biochemical reactions which
may pose some difﬁculties in rapid identiﬁcation and recovery of these
bacteria from patients. The objective of this study was to evaluate the
use of PCR ampliﬁcation of hly and recA housekeeping genes as a
screening tool for identiﬁcation of V. cholerae and comparison with PCR
ampliﬁcation of 16s-23s rRNA intergenic region and also with the time
consuming biochemical conventional methods.
Methods: Among several stool samples referred to our laboratory,
V. cholerae was recovered from 24 samples using conventional
biochemical methods for identiﬁcation of V. cholerae. The identity of
V. cholerae was conﬁrmed by PCR analysis of an intergenic region
between 16s-23s rRNA, speciﬁc for V. cholerae. Serogrouping of isolates
was performed by polyvalent and monospeciﬁc antisera according to
the guidelines of centre for disease control (CDC). Detection of two
housekeeping genes was investigated using primers which speciﬁcally
designed for these regions.
Results: Among 24 V. cholerae isolated, 21% identiﬁed as Ogawa and the
remaining 79% as Inaba serogroup. PCR analysis of the 2 housekeeping
genes (hly and recA) revealed the presence of these genes in 100% and
92% of isolates, respectively. V. cholerae ATCC 14035 was used as a
positive control in each assay.
Conclusions: The results of this study further conﬁrms the use of
ampliﬁcation of 16s-23s rRNA region for PCR detection of V. cholerae
strains from stool samples of patients with diarrhoea. Detection of the
hly housekeeping gene can also be used as a molecular marker for
identiﬁcation, although the use of recA which is also a housekeeping
gene is not recommended for identiﬁcation of V. cholerae isolates from
stool samples.
R2368 Detection of Neisseria meningitidis, Streptococcus
pneumoniae and Haemophilus inﬂuenzae in cerebrospinal
ﬂuid in children using PCR
H. Smaoui, M. Zouaghui, A. Saguer, A. Kechrid (Tunis, TN)
Bacterial meningitis is a medical emergency requiring early diagnosis.
Adequate treatment requires rapid detection of the bacteria in the
cerebrospinal ﬂuid (CSF). Traditional laboratory methods take up to
36 h or more and preadmission antibiotic treatment reduces the chance
of positive results.
Objective: in order to improve bacterial meningitis diagnosis in our
laboratory, we undertook a prospective study to evaluate the accuracy
of PCR of CSF for the detection of N. meningitidis, S. pneumoniae and
H. inﬂuenzae compared to conventional methods.
Methods: we include in this study 145 CSF specimens collected
between December 2005 and November 2007. Specimens were classiﬁed
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into ﬁve categories on the basis of laboratory ﬁndings. Category
1 (n = 31): culture was positive for N. meningitidis, S. Pneumoniae
or H. inﬂuenzae. Stains were identiﬁed using conventional methods,
serogroups of N. meningitidis were determined using anti-sera from
Sanoﬁ Diagnostics Pasteur, serotypes of H. inﬂuenzae were determined
using antisera from Difco. Category 2 (n = 12): culture was negative, but
direct smear and/or antigen detection for N. meningitidis, S. Pneumoniae
or H. inﬂuenzae were positive. Antigen detection was performed by
the latex agglutination kit Pastorex Meningitis (BIO-RAD). Category
3 (n = 44): CSF was abnormal with a high cell count but all other
investigations were negative. Category 4 (n = 3): culture was postive for
another bacterial species. Category 5 (n = 55): cases of viral meningitis.
All CSF samples were tested by PCR using three primers correspondig
to three genes: crgA for N. meningitidis, ply for S. pneumoniae and bexA
for H. inﬂuenzae.
Results: PCR were positive at N. meningitidis in 11 cases, at
S. pneumoniae in 18 cases and at H. inﬂuenzae in 6 cases. Among
category 1, 2 and 3, samples with PCR positive results were respectively
23, 7 and 5. PCR was negative in all samples classiﬁed in category 4 and
5. Among category 1, PCR was negative in 2 cases of N. meningitidis,
3 cases of S. pneumoniae and 3 cases of H. inﬂuenzae. Sensitivity and
speciﬁty were 73.2% and 95.2% respectively. The low rate of sensitivity
(failure of PCR in culture proven cases) could be due to the presence
of an inhibitory for PCR and/or to the small quantity of bacteria in the
CSF sample.
Conclusion: Our preliminary results suggest that use of PCR in
meningitis diagnosis is useful. To improve sensitivity, we must use a
method that separate bacteria from inhibitors.
R2369 16S rDNA PCR and sequencing: the only way for
identiﬁcation of Actinobaculum massiliae out of human
clinical samples
E. Leitner, G. Gorkiewicz, G. Feierl, A.J. Grisold, E. Marth (Graz, AT)
Objective: The identiﬁcation of Actinobaculum massiliae, a pathogen
which may affect the urogenital tract, is difﬁcult due to the absence
of suitable biochemical assays. We investigated A. massiliae isolates
identiﬁed by 16S rDNA sequencing on morphology, growth conditions
and variant commercial phenotypic methods.
Methods: A total of 17 A. massiliae isolates were identiﬁed by 16S
rDNA sequencing since 2005 in our routine diagnostic laboratory. 14
of the 17 isolates were recovered from the urogenital tract, one from
the abdominal wall, one from an abscess, and one from the auditory
canal. Growth conditions as well as colony morphology were studied on
blood agar with 5% sheep blood, schaedler agar with 5% sheep blood,
chocolate agar and in thioglycolat broth. All of the plates were incubated
aerobic, in a 5% CO2 atmosphere and under anaerobic conditions at
37ºC. In addition, Gram stains were performed and phenotypic analyses
were done with API 20Strep, API Coryne, API Rapid ID 32Strep and
API Rapid ID 32A (bioMe´rieux) systems.
Results: All of the 17 isolates (each fragment 1200bp) were
unambiguously identiﬁed by 16S rDNA sequencing. 14 isolates were
further investigated by re-culturing on the recommended agar plates in
different atmospheres. Characteristic cultures were observed on schaedler
agar as nonhaemolytic, greyish to white sometimes frayed colonies with
a rise in the middle of the colony. Gram stains showed coccoid straight
rods and were not distinct branched Gram-positive. With none of the
used phenotypic test methods reliable identiﬁcation could be achieved.
Conclusion: 16S rDNA sequencing is the only method for unambiguous
identiﬁcation of A. massiliae. This might be the cause of rare detection
rates for this organism. The typical colony morphology and the
appearance in Gram stain may be helpful for identiﬁcation; however,
establishing of a commercial system for reliable detection A. massiliae
is needed.
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R2370 Pulsed-ﬁeld gel electrophoresis and CTX-RFLP analysis of
Vibrio cholerae strains isolated from patients in Iran
B. Bakhshi, F. Navabakbar, A. Tavakoli, M.R. Pourshaﬁe (Tehran,
Isfahan, IR)
Objectives: The multiple copies of CTX prophage are tandemly arranged
in El Tor strains of V. cholerae but the number and arrangement of the
CTX elements and the repetitive sequences are known to vary in different
toxigenic strains and together with the Pulsed-ﬁeld gel electrophoresis
(PFGE) is a useful basis for study of diversity and characterisation of
isolates.
Methods: PFGE performed according to a standard protocol of Centers
for Disease Control (CDC) for V. cholerae. Composition and gene
arrangement of the CTX genetic element were compared in 36
Vibrio cholerae strains isolated in outbreaks from Iran. Southern blot
hybridisation using ctx and zot probes and Long-PCR ampliﬁcation of
the region between ig1-F and attB2-R which harbouring the entire CTX
prophage in the genome of the V. cholerae performed to analyse the
content and arrangement of the CTX genetic element, and the results
interpreted in combination with the PFGE patterns, for assessing the
clonality of isolates.
Results: Southern blot hybridisation with the speciﬁc probes revealed 3
proﬁles for each of the probes with the bands ranging from 4.2 to 8.3 kb
in size and showed the presence of 1(30%, proﬁle A), 2 (17%, proﬁle
B) and 3 (53%, proﬁle C) copy numbers among the isolates. The results
showed 3 Long-PCR ampliﬁcation patterns including products with 6.9,
5.6 and 2.6 kb in sizes. Restriction Fragment Length Polymorphism
(RFLP) analysis of patterns showed different CTX element content and
arrangements. Pulsed-ﬁeld gel electrophoresis (PFGE) was performed
and two pulsotypes were found among the isolates. Majority of isolates
(75%) with different CTX genomic arrangements and copy numbers
showed a single pulsotype.
Conclusion: The isolates belonging to pulsotype 2 showed different
CTX genomic arrangements, whereas the isolates with PFGE pulsotype
1 showed a single form of CTX arrangement. The results from this study
showed that the variations in the content, arrangement and copy number
of the CTX genetic element may occur in the same clonal isolates of
V. cholerae.
R2371 Typing of MRSA with chromID™ MRSA medium and
DiversiLab™ system
V. Collin, S. Mailler, N. Garcia, N. Fanjat, S. Chatellier (La Balme
Les Grottes, FR)
Objectives: MRSA isolates can be responsible for severe infections both
in hospitals and in the community. Molecular typing of these isolates
provides critical information for epidemiology investigations. The goal
of this study was to verify the compatibility of the chromID™ MRSA
as a culture medium for the rapid screening of MRSA isolates with the
DiversiLab™ system.
Methods: A total of 35 isolates recovered from 6 different body sites and
collected in 13 countries were included in this comparison study. Cultures
were performed on chromID™MRSA and Columbia Blood Agar media.
DNA was extracted from each culture using the UltraClean™ Microbial
DNA Isolation Kit. The DiversiLab Staphylococcus kit was used for rep-
PCR of non-coding intergenic repetitive elements in the genomic DNA.
The amplicons were then analysed using the DiversiLab system including
a microﬂuidics chip. Data analysis was performed with the web-based
DiversiLab software using the Pearson Correlation (PC) coefﬁcient. The
ﬁngerprints derived from bacterial cultures on Colombia blood agar were
compared to those obtained with ChromID MRSA medium.
Results: The 35 strains were distributed in 12 clusters containing from
1 to 14 isolates. The 2 culture media generated identical ﬁngerprints
for each given strain. No correlation between body site or geographical
origin was observed. As an example, the predominant cluster contained
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14 isolates collected in different countries including Chile, Argentina,
Spain and Switzerland.
Conclusion: The DiversiLab™ system has proven useful in strain-level
discrimination of MRSA strains. This study shows that chromogenic
medium chromID™ MRSA is compatible with the DiversiLab™ system
and could help to improve the total turnaround time for MRSA
ﬁngerprinting.
R2372 Clustering of antibiotic resistant and susceptible Iranian
Helicobacter pylori strains using RAPD-PCR proﬁling
M. Mohammadi, D. Doroud, S. Saberi Kashani, M. Douraghi,
N. Mohajerani, M. Esmaeili, M. Bababeik, A. Oghalaie, Y. Talebkhan
(Tehran, IR)
Objectives: Helicobacter pylori (Hp) infects the majority of the adult
population in developing countries including Iran and is associated with
gastrointestinal diseases such as gastritis, peptic ulcer disease (PUD) and
gastric cancer. Antibiotic resistance is a key factor in the failure of Hp
eradication therapy. Hence characterisation of susceptible and resistant
strains and identiﬁcation of their clonal population is critical. This study
conceived to provide information on the diversity of Metronidazole and
Clarithromycin resistant Hp strains in Iran.
Methods: The susceptibility testing of 50 Hp isolates were performed
and interpreted according to the guidelines from the Clinical and
Laboratory Standards. Two set of primers were designed to detect
point mutations in the 23S rRNA gene responsible for clarithromycin
resistance and RFLP was done to reveal point mutations via digestion of
PCR products with BsaI, MboII. Another set of primers were used for
detection of rdxA gene deletion responsible for metronidazole resistance.
All of the strains were typed by RAPD-PCR.
Results: Approximately 17.6% and 59.4% of strains were resistant to
clarithromycin and metronidazole respectively. One (3.3%) strain was
resistant to both antibiotics. RAPD-PCR revealed ampliﬁed fragment
sizes ranging from 2kb to 0.17kb. With 80% similarity 18 clonal
populations were identiﬁed based on RAPD proﬁling. Most (80%) of
the strains of cluster 5 were resistant to metronidazole whereas 78% of
the strains in cluster 6 were susceptible to both antibiotics.
Conclusion: These results indicate that clinical Helicobacter pylori
strains in terms of antibiotic resistance are highly diverse. It seems the
characteristics of the resistant and susceptible strains can be predicted
by clustering of strains using RAPD-PCR proﬁling.
R2373 Clonality of the blaVIM harbouring Klebsiella pneumoniae
clinical isolates in a tertiary hospital in Greece
C. Ferousi, A. Xanthaki, P. Giakkoupi, S. Vourli, M. Polemis,
A. Vatopoulos, M. Toutouza (Athens, GR)
Objectives: Hippokration General Hospital is among the ﬁrst to isolate
imipenem resistant Klebsiella pneumoniae due to the production of a
VIM type metalloenzyme in Greece in 2002. Since then and despite the
various infection control measures such strains are constantly isolated
in this hospital. The purpose of the study is to elucidate the molecular
epidemiological characteristics of the VIM producing K. pneumoniae
isolates recovered from patients in the hospital during the period 2003–
2006.
Methods: Eleven K. pneumoniae found imipenem resistant by the
VITEK-II method (Biomerieux-FRANCE), routinely used in the
hospitals laboratory, isolated during the study period, were selected.
Susceptibility testing was reconﬁrmed by the Disk Diffusion method
according to CLSI recommendations. Susceptibility to imipenem
was further evaluated by E-test. Production of extended spectrum
b-lactamases was determined by the double disk synergy test (DDST)
and metallo-b-lactamase production by the EDTA-synergy test. PCR was
used for detecting genes of the bla-VIM family. Isolates were genetically
compared by PFGE.
Results: At the disk diffusion method all 11 isolates displayed
susceptibility or intermediate resistance to imipenem with an MIC
ranging between 0.064 and 4mg/L in E-test. Ten isolates displayed a
positive EDTA-synergy test, and the presence of the blaVIM gene was
conﬁrmed by PCR. Five of these isolates demonstrated a positive DDST
test indicating a simultaneous presence of an ESBL in these strains.
PFGE allowed the isolation of 3 types of clones among the 10 isolates.
Clone A included 5 isolates, clone B: 4 and clone C: 1 isolates. Isolates of
both clones A and B were isolated during the entire period whereas clone
C was isolated in 2006. Further analysis of the MBL-determinant (bla-
VIM1) revealed the presence of integron 1 in all 3 clones. The cassette
region contained bla-VIM1, aacA7, dhfrI and aadA1 in all occasions.
Conclusions: Although a new blaVIM harbouring clone seem to have
been introduced quite recently, imipenem resistance in Klebsiella in this
hospital seem to be due to the persistence of two clones, a fact that
indicates the need of intensifying the infection control measures in this
hospital.
R2374 Rapid PCR-restriction fragment length polymorphism
method to differentiate among Campylobacter clinical
isolates
A. Gonza´lez, M.R. Crespo, M.A. Ferru´s, P. Ramos, A. Herna´ndez,
J. Herna´ndez, S. Botella (Valencia, ES)
Objectives: Thermophilic campylobacters, particularly Campylobacter
jejuni and Campylobacter coli, are the most isolated bacteria causing
diarrhoeal diseases in humans. Accurate routine Campylobacter speci-
ation is needed to attribute human illness to different Campylobacter
species and decide the most indicated antibiotic treatment. However,
identiﬁcation of these bacteria using phenotypic characters can be
difﬁcult; therefore the objective of this study was the development of
a rapid and easy to perform identiﬁcation system based on PCR-RFLP
analysis to distinguish C. jejuni from C. coli.
Methods: PCR-RFLP of 23S rRNA gene was performed on 44 clinical
isolates provided by La Ribera and Nou d’Octubre Hospital (Valencia,
Spain) and 2 reference strains, C. jejuni ssp. jejuni DSM 4688 and C. coli
DSM 4689 (German Collection of Microorganisms and Cell Cultures).
The isolates were cultured on blood agar and incubated at 37ºC under
microaerophilic conditions for 48 h. The strains were characterised by
morphology and Gram stain, and subsequently identiﬁed by PCR (Ferme´r
and Engvall, 1999).
For PCR-RFLP analysis, an internal region of the 23S rRNA gene of
about 2.6-Kbp was ampliﬁed according to Hurtado and Owen (1997).
Restriction endonucleases were selected by computer analysis using
REbsites (http://rebase.neb.com). PCR products (10 ml), showing a single
band of the expected size, were digested with 10 U of the restriction
enzyme HpaII (MBI Fermentas®) in a ﬁnal volume of 20 ml at 37ºC for
3 h. Restriction fragments were separated on 2.6% (wt/vol) agarose gel
electrophoresis in TAE buffer at 90V for 3 h and visualised after staining
with ethidium bromide. In order to assess reproducibility, all the strains
were analysed at least two times in different experiments.
Results: A 2.6-Kbp PCR product of the 23S rDNA was ampliﬁed in
all the strains. Digestion with restriction enzyme HpaII yielded speciﬁc
patterns for C. jejuni (625, 560, 455, 360 and 225 bp) and C. coli (670,
625, 560, 455 and 225 bp). These results were almost identical to the
predicted fragments based on the nucleotide sequence data. A total of
39 out of the 44 clinical isolates studied were identiﬁed as C. jejuni and
the remaining 5 as C. coli.
Conclusion: The RFLP method proposed is able to differentiate between
C. jejuni and C. coli in one work day using only a pair of primers and
a single enzyme; therefore it can be a simple, rapid and useful method
for routine identiﬁcation.
R2375 Pseudomonas aeruginosa strains DNA typing by
semi-automated repetitive-sequence-based PCR
A. Dole´ans-Jordheim, E. Bergeron, J. Croize´, H. Salord, B. Cournoyer,
J. Andre´, M.A. Mazoyer, F.N.R. Renaud, J. Freney (Lyon, Grenoble, FR)
Background: Pulsed-Field Gel Electrophoresis (PFGE), based on the
separation of long strands of DNA by length, is a highly discriminatory
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method. It is traditionally considered to be “the gold standard” for
gene mapping and epidemiological studies. However, it presents some
disadvantages since it takes several days to perform with specialised
equipment and often laborious techniques. A typing method, not time
consuming, is therefore needed to assess outbreaks in real time.
Objectives: the aim of this study was to evaluate the usefulness
and the performance of the semi-automated repetitive-sequence-based
polymerase chain reaction (rep-PCR) which examines non-coding highly
conserved repetitive sequences, interspersed throughout the bacterial
genome for typing Pseudomonas aeruginosa strains.
Method: the typing of 82 Pseudomonas aeruginosa strains by the
DiversiLab system® was realised on the basis of an 95% similarity
threshold, and results were compared with PFGE. Twenty-nine of these
strains were unlinked strains, 16 were issued from 5 epidemic cases, 7
from an epidemiological study, 5 from members of two families and 25
from water, aerosols and patient isolates of the same hospital.
Results: a good correlation was observed between the semi-automated
rep-PCR method and PFGE: the 29 strains were typed as different and
most of the other strains were linked in the same way as with the PFGE
method. However, two cases are discordant: one for which the source
of contamination was not the same with the two methods and one for
which results were not reproducible.
Conclusion: even if further studies must be performed to conﬁrm the
discriminatory power and the reproducibility of the rep-PCR method, this
simple and fast technique seems to be appropriate to type Pseudomonas
aeruginosa strains.
Molecular biology, including diagnostics –
others
R2376 Comparison of Seeplex VRE detection kit with chromID
VRE agar for the detection of vancomycin-resistant
enterococci in faecal specimen
S.Y. Lee, Y.J. Park, G.D. Lee, J.J. Park (Seoul, KR)
Objectives: As vancomycin-resistant enterococci (VRE) is increasing
as a nosocomial pathogen, rapid and accurate detection of VRE is
important. However, conventional culture methods take long time for
detection of VRE. Recently, Seeplex VRE Detection kit with internal
control (Seegene, Seoul, Korea) and chromID VRE agar (bioMe´rieux,
Marcy l’E´toile, France) were developed and we compared performance
of these two methods with conventional blood agar plate (BAP) based
culture after enrichment in Enterococcosel broth (EB).
Methods: For 10 days in September 2007, 180 rectal swab specimens
were received for detection of VRE and they were inoculated in 1
mL of EB containing 6mg/mL vancomycin. After 35.18 h incubation,
DNAs from 50 mL of bacterial pellets in black pigment-producing EB
were extracted and ampliﬁed for detection of van A and van B genes
by multiplex PCR using Seeplex VRE Detection kit. Ampliﬁed DNA
products were identiﬁed on 2% agarose gel electrophoresis. Blackened
EBs were also inoculated on chromID VRE agar containing 6 mg/mL
vancomycin and BAP containing 30 mg vancomycin and teicoplanin
discs. After 35.18 h incubation, VRE suspected colonies from each plate,
were submitted to identiﬁcation and antimicrobial susceptibility test.
Results: 131 out of 180 rectal swabs produced black pigments in EBs
and of them, 41 samples were positive for VRE by at least one method.
When these 41 samples were considered true positive for VRE, the
results were listed in Table 1.
Sensitivity of Seeplex VRE Detection kit, chromID VRE agar, and BAP
were 92.7% (38/41), 90.2% (37/41), and 75.6% (31/41), respectively. The
average time for reporting VRE positive specimen of them was 2 days,
3.4 days (range, 2−5), and 3.7 days (range, 2−6). Other bacterial species
seen as VRE-like colonies on chromID VRE agar were Gram-negative
bacilli, Gram-positive bacilli, Enterococcus gallinarum, Enterococcus
casseliﬂavus, Pediococcus pentosaceus, yeast, and unidentiﬁed colonies.
Conclusions: Seeplex VRE Detection kit revealed the highest sensitivity
and the shortest time for reporting VRE. chromID VRE agar revealed
good performance but had longer reporting time up to 5 days. Therefore,
Seeplex VRE Detection kit can be the best choice of methods for VRE
surveillance.
Table 1. Comparison results of Seeplex® VRE Detection kit with those
of chromID VRE® agar and BAP based culture
Method Number of results (131 swabs in total)
True
positive
False
positive
True
negative
False
negative
Seeplex® VRE Detection 38 0 90 3
chromID® VRE 37 18 72 4
BAP 31 38 52 10
Total 41 90
R2377 Usefulness of immunocytochemical p16ink4a expression in
routine screening of a tested female population
S. Mahmutovic-Vranic, A. Hardick, E. Beslagic, M. Slakovic,
M. Seremet, C. Gaydos (Sarajevo, BA; Baltimore, US)
Objectives: This study aimed to compare the detection of P16ink4a
protein staining and HPV DNA testing for human papillomavirus (HPV)
detection in cervical swab samples in population of Bosnian women.
Methods: P16ink4 biomarker (Ventana) was applied on 31 HPV DNA
cervical swab samples of 97 examined women which were detected
by high risk HPV Hybride Capture-2 (HC2), Digene and research
polymerase chain reaction (Roche, primer set PGMY 09/11). Age groups
were deﬁned as: 20–24 yr., 25–29 yr., 30–34 yr., 35–39 yr., 40–44 yr., 45–
49 yr., and >50 yr. old. Cervical swab samples and slides were collected
for December 2004 to January 2005 at Sarajevo clinics and shipped to
Johns Hopkins University.
Results: Positive cytoplasmic immunostaining by P16ink4a biomarker
showed prevalence 9.27 (9/31) of total HPV DNA positive (HC2 and
PCR). The overall prevalence for high risk HPV by HC2 was 22.68%
(22/97). Total of both high risk and low risk HPV prevalence by PCR
was 29.89% (29/97).
Conclusion: Despite a good correlation of the results of HC2 and
P16ink4a and PCR and P16ink4a, we cannot draw any ﬁrm conclusion
regarding the usefulness of this technique in routine screening.
R2378 A novel Gap-PCR for detection and differentiation of BK
and JC virus infections
M. Shenagari, M. Ravanshad, S. Hosseini, R. Ghanbari (Tehran, IR)
Introduction: BK virus is a causative agent of nephropathy in renal
transplant recipients and can cause premature graft failure, while JC virus
is aetiologic agent of multifocal progressive leukoencephalopathy (PML).
Despite similarities at the genetic level (more than 75% homology)
among JC virus and BK virus, differentiation of them regarding to
aetiologic differencies is intransitive.
Methods: In this study we utilised discrepancy in genetic level of BK
virus and JC virus for designing of a Gap-PCR that ﬁnally would create
two different fragments in length from concerned virus. Positive Control
sera and urines containing BK and JC viruses were used in this study.
Viral DNA extraction was performed by a commercial kit and then was
ampliﬁed by designed Gap-PCR. Product has been running on agarose
gel to detection of infection and coinfection of JC and BK viruses.
Results: The performance of this new assay for detection and
differentiation of BK and JC viruses was evaluated with 1 duplicated
urine and serum samples from 40 renal transplant reciepents who
underwent on renal transplantation at least 6 month previous assay. To
establish the sensitivity, a serial dilution of plasmid containing whole
BK virus genome was used. Finally this new assay found sensitive and
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simple for detection and differentiation of BK and JC viruses infection
and coinfection.
Conclusion: The acceptable sensitivity and very high simplicity of the
Gap-PCR, which allows the easily screening of transplant recipients and
HIV positive patients for recurrence of BK virus and JC virus, make this
new assay especially suitable for this purpose. While previous studies
usually have been used multiplex PCR and hybridisation methods for
differentiation of JC and BK we designed two primers that ampliﬁed and
differentiate simultaneous both viruses without need to other complicated
steps.
R2379 Use of GenoType® Enterococcus test to improve enterococci
detection correctness
I. Liduma, D. Rudzite, G. Skenders, R. Paberza (Stopinu Novads,
Riga, LV)
Objectives: Enterococci as cause for bacteraemia, wound infections,
endocarditis, urinary tract infections and infections of CNS are
associated with intra-hospital infections. In some cases infections are
caused by enterococci with multi drug resistance (MDR). Vancomycin
is important to treat MDR enterococci patients. Some enterococci species
exhibit natural resistance to vancomycin. Therefore it is highly important
to identify enterococci species correctly and to interpret results from drug
susceptibility testing. Our aim was to compare molecular biology method
for identiﬁcation of enterococci species with phenotypical detection
methods.
Methods: This study was performed on 40 enterococci cultures obtained
in 2 Latvian hospitals: clinical hospital “Gailezers” and State Agency
of TB and Lung Diseases. We used a DNA strip assay (GenoType®
Enterococcus; Hain Lifescience GmbH) designed for the simultaneous
detection of the most frequent enterococcal species, Enterococcus
faecium, E. faecalis, E. gallinarum, E. casseliﬂavus, and E. ﬂavescens,
and of the vancomycin resistance genotypes vanA, -B, -C1, and -C2/3.
The assay is based on the speciﬁc ampliﬁcation step followed by reverse
hybridisation on nitrocellulose strip. Mini Api® rapid ID 32 Strep
(bioMerieux) and BBL Crystal™ GP ID Kit (Becton Dickinson) were
used as phenotypical methods for culture identiﬁcation. Susceptibility to
vancomycin was tested by disc diffusion and E-test.
Results: Of the 40 tested enterococci species, 26 (16 E. faecalis, 10
E. faecium) were identiﬁed as same species with the phenotypical and
genotypical methods, 2 E. faecium identiﬁed by molecular method
and by BBL Crystal™ but as E. casseliﬂavus by Mini Api®, 1
E. faecium was identiﬁed by molecular method and by Mini Api®
but was identiﬁed as E. gallinarum by BBL Crystal™. 2 E. faecium
identiﬁed by molecular method but as E. gallinarum by Mini Api® and
as E. casseliﬂavus or E. casseliﬂavus/ E. gallinarum by BBL Crystal™.
Other species represented E. avium or E. rafﬁnosus. Phenotipicaly
identiﬁed E. casseliﬂavus/ E. gallinarum showed susceptibility to
vancomycin. 1 vancomycin resistant E. faecalis isolate was having vanA
by the GenoType® and was conformed by disc diffusion and E-test.
Conclusion: Our results shows that correctness of enterococci identiﬁ-
cation only by phenotypical testing methods can lead to wrong diagnosis
and genotypical methods should be used when drug susceptibility testing
mismatch with species identiﬁed.
R2380 Seroepidemilogical study of HTLV and its clinical impacts
in thalassaemia, haemophilia and haemodialysis patients
in Hormozgan
F. Abedi, A. Shkibzade, B. Khalvati, M. Yavarian (Shiraz, IR)
Background: Transmission of blood borne infections is common
among multitransfusion patients such as thalassaemia, Hemophilia and
haemodialysis patients. HTLV (Human T-Lymphotropic Virus) is one
of the Retroviruses which is transmitted by blood and its products. In
Iran HTLV is endemic only in Khorasan. This virus causes (HAM/TSP)
and (ATL). In this study we consider the seroepidemiological patterns of
HTLV infections in thalassaemia, Hemophilia and haemodialysis patients
in Hormozgan in South of Iran in order to assess the possibility of the
virus trasmision and its clinical impacts.
Methods: In this study, 210 patients, including 163 thalassaemias, 40
haemodialysis patients and 7 hemophilia (98 female, 112 male) with
the age range of 9 to 79 were analysed. Their plasma was tested for
detection of Ab against HTLV and patients were examined for its clinical
manifestations.
Results: Anti-bodies against HTLV were detected in 2.38% (5 patients)
which is higher than its prevalence in healthy individuals. All of positive
samples were belonging to Thalassaemia patients. Anti-body positive
patients were symptomatic clinically as well.
Conclusion: This study shows that multitransfusion patients were
infected probably via blood transfusion or haemodilyse and existence
of this virus is not limited only to the Khorasan.
R2381 Highly prevalent protistan intestinal parasites not detected
by use of the formol ethyl acetate concentration technique
is revealed by the routine use of PCR- and culture-based
detection
R. Stensvold, S. Soegaard, K. Moelbak, H.V. Nielsen (Copenhagen, DK)
Objectives: The detection of protistan intestinal parasites (PIP)
traditionally relies on examining faecal concentrates obtained by the
formol ethyl acetate concentration technique (FECT) including Ziehl-
Neelsen staining for (oo)cysts. However, this procedure does not
consistently allow for the detection of trophozoites. For some common
parasites, e.g. Dientamoeba fragilis and Blastocystis, regular cyst stages
either do not exist or are hardly recognisable in faecal concentrates.
Moreover, in case of increased gastrointestinal passage due to PIP, only
trophozoites may be shed in the stool, which is why the examination
of fresh, warm stools or stools ﬁxed in e.g. sodium acetate-acetic acid-
formalin (SAF) has been undertaken. However, these methodologies are
not routine practice or even possible in all diagnostic laboratories, which
is why other methods are wanted for. PCR technology has enabled
sensitive, high-throughput assays for detecting species-speciﬁc DNA
from parasites such as e.g. Entamoeba, Giardia, Cryptosporidium and
Dientamoeba extracted directly from unpreserved faeces. In-vitro culture
in Jones’ medium for 48 h has proven inexpensive and sensitive regarding
the detection of Blastocystis.
This study sought to examine the diagnostic relevance of integrating
supplementary analyses based on PCR and culture in routine diagnostic
parasitology.
Methods: In a period of two months 1000 fresh faecal samples were
randomly selected and examined by three methods: The FECT including
Ziehl-Neelsen staining, Blastocystis culture, and PCR for Entamoeba
histolytica, Entamoeba dispar, Giardia intestinalis, Cryptosporidium sp.,
and D. fragilis.
Results and Conclusions: The study is ongoing, and results will include
a comparison of FECT vs. PCR for the above mentioned protozoa and
Blastocystis culture. Results will include semiquantitative (FECT, PCR)
and qualitative scores (culture). Preliminary data show that the negative
predictive value of the FECT is <80%, which is mainly attributable
to the fact that this method is inapt for the detection of D. fragilis
and Blastocystis, which seems to be remarkably prevalent parasites in
Denmark. The study will reveal data essential for the discussion and
contemplation of the relevance of supplementing the FECT with PCR
for protozoa and Blastocystis culture.
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R2382 Application of the chromID ESBL medium in a routine
microbiological laboratory
K. Burdynowski, K. Golec (Opole, Rzeszow, PL)
Objectives: The chromID ESBL medium (bioMerieux) applicability
assessment in routine ESBL-positive strain detection in a hospital
laboratory.
Methods: 223 strains of G− bacilli, isolated from different clinical mate-
rials of hospital wards patients, were used: Enterobacteriaceae (n = 201),
Acinetobacter (13), Pseudomonas (7) and Stenotrophomonas (2). From
among the Enterobacteriaceae rods, 105 were ESBL+. The strains were
inoculated onto the assessed medium and onto a Columbia Agar with
blood. VITEK GNI+ cards were used for identiﬁcation, ESBL production
was determined using GNS 650 cards and veriﬁed using the double
disk test. All strains grown on the assessed medium underwent double
identiﬁcation and ESBL production determination.
Results: Identiﬁcation The growth of 138 out of the 223 strains
inoculated onto the chromID ESBL medium was observed. All of
the Enterobacter (n = 15), Klebsiella (n = 95) and Escherichia (n = 5)
colonies were pigmented as expected, all the non-fermenting rod colonies
were not pigmented. The growth of 2 Citrobacter freundii and of 1
Proteus mirabilis strains was colourless.
ESBL detection On the tested medium, out of the 105 ESBL+
Enterobacteriaceae, 103 strains developed colonies (98%). No growth
of 1 Klebsiella pneumoniae and 1 E. coli strains was attained, in spite
of the ESBL+ phenotype detection for both of them.
On the assessed medium, 119 (59.2%) Enterobacteriaceae strains
developed colonies, whereas there were 105 (52.2%) ESBL+ strains
in this group. It was found that 16 ESBL-negative Enterobacteriaceae
developed on the assessed medium. This was mainly concerning
Enterobacter cloacae, where 13 out of 17 strains developed, and only 1
of them was ESBL+.
Out of 22 non-fermenting rods (all of them being ESBL−), 19 developed
colourless colonies.
Conclusion: Obtained results show that the chromID ESBL medium
sensitivity makes it applicative in ESBL+ strain detection. However,
a growth of a certain number of ESBL-negative strains, as well as
identiﬁcation of cases of colourless Enterobacteriaceae growth, entails a
necessity to verify ESBL production using some other method, and to
identify the bacteria giving colourless growth.
Using the medium in question in most cases leads to shortening of the
examination time, as well as to cost-cutting, thanks to the limitation of
the amount of tests necessary only to the strains growing on the evaluated
medium.
R2383 Comparative evaluation of performance and convenience of
the RapID NH (OXOID™) with the API-NH (BioMe´rieux™)
S. Rey-Cao, R. Mohedano, S. Va´zquez, S. Quevedo, M. del-Alamo,
I. Wilhelmi-de Cal (Legane´s-Madrid, ES)
Objectives: Evaluate the RapID NH (OXOID™) for the identiﬁcation
of microorganisms of the family of Neisseriaceae and Haemophilus and
other related species in comparison with the API-NH (BioMe´rieux™)
for both performance and convenience in our laboratory daily routine.
Methods: This study compares 88 clinical stains that have been sampled
from January 10 to October 24 2007 (53 H. inﬂuenzae; 13 Moraxella
catarrhalis; 5 H. parainﬂuenzae, 13 N. gonorrhoeae, 2 N. meningitidis
and 2 Haemophilus spp.). All samples have been processed according
to manufacturer’s instructions provided with the kits. We analysed the
identiﬁcation results and used a scored grid (1 to 5) for evaluation of 10
parameters to assess the adaptability/versatility/practicality of each kit
in daily use. We also used 2 quality control strains Neisseria lactamica
NTCC 10617 and Haemophilus parainﬂuenzae ATCC 7901.
Results: Eighty six of the 88 strains studied and both quality control
strains coincided in the identiﬁcation to the species level for both
techniques. The mean score for the evaluation grid was 3.72 for the
RapID® NH and 2.95 for the API™ NH. The mean inoculation time
for one panel was 1 minute for RapID® NH and 2.25 minutes with
the de API™ NH. The data base of the RapID® NH also includes 8
additional genera in addition to the Neisseria spp., Haemophilus spp.
and Moraxella spp., widening its range and potential use.
Conclusions: The identiﬁcation results for Neisseria spp., Haemophilus
spp. and Moraxella spp. have been comparable for both techniques. As
to the overall convenience of use, the RapID® NH characteristics were
more adaptable to our laboratory conditions.
R2384 Prevention of false-positive reactions in whooping cough
ELISA
T. Dalby, M. Seier-Petersen, K.A. Krogfelt (Copenhagen, DK)
Objectives: Since 1991 is has been known that heat inactivation of serum
results in very high false-positive values when analysing for the presence
of antibodies to pertussis toxin (PT) by ELISA [Tada, Dev. Biol. Stand.
1991, 73: 175–184]. Since PT is widely agreed to be the antigen of
choice for whooping cough ELISA, prevention of false-positive reactions
is crucial when analysing sera with unknown treatment. No reports so
far have addressed this issue. Furthermore, heat could present a major
problem e.g. in tropic areas.
Methods: An indirect ELISA based on pertussis toxin for detection
of antibodies in human serum was optimised for the removal of false-
positive results occurring at analysis of heat treated sera. Heat treated
sera (56ºC, 30 minutes) with known low contents of PT-antibodies were
used, as well as non-treated sera from patients with conﬁrmed whooping
cough.
Results: When analysing heat treated sera with known low contents of
PT-antibodies in the non-optimised PT-ELISA, the resulting estimates
for PT-antibody contents were similar to, or even higher than, the values
obtained when analysing sera from patients with conﬁrmed whooping
cough. Dilution curves of the heat treated sera moreover produced
markedly different slopes than those obtained with non-treated sera, as
was also seen by Lopez in 1998 [Lopez, Diagn. Microbiol. Infect. Dis.
1998, 30: 21–24].
An ELISA-method based on Maxisorp microtiter plates (Nunc®,
Denmark), using 1% milk in blocking solution and 0.1% milk in sample
dilution, was seen to be a stable assay with elimination of the false-
positive results. PT-antibody values obtained with heat treated sera were
identical to values obtained with the corresponding non-treated sera.
Conclusion: False-positive results for PT-antibodies arising from heat-
inactivation of sera were eliminated by a blocking step with 1% milk.
Studies involving measurements of PT-antibodies in historic sera should
involve such a blocking step, since historic sera might have been
subjected to routinely heat inactivation. Moreover, in settings where sera
have been heat-inactivated for safety reasons, an accurate analysis of
PT-antibodies is now feasible.
R2385 Comparison of antifungal MICs for yeasts obtained using
EUCAST in a reference laboratory and Etest in ten
different hospital laboratories
E. Dannaoui, D. Raoux, A. Paugam, F. Botterel, M. Develoux,
C. Chochillon, J. Matheron, M. Cornet, A. Datry, C. Bouges-Michel,
C. Bonnal, F. Dromer, S. Bretagne (Paris, Creteil, Bobigny,
Kremlin-Bicetre, FR)
Objectives: The determination of MICs for yeasts in routine laboratories
often relies on Etest® because it is easy to perform and it has shown a
good correlation with reference techniques in liquid media. However, this
correlation was established in speciﬁc studies performed by reference
laboratories. We took the opportunity of the surveillance programme of
candidaemia set up in 2003 to compare the E-tests results performed
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on a routine basis in ten different hospitals and the EUCAST results,
obtained in a reference laboratory unaware of the hospital results.
Methods: A total of 722 isolates were included in the analysis (374
C. albicans, 118 C. glabrata, 72 C. parapsilosis, 58 C. tropicalis, and 100
other yeast species) and tested for amphotericin B (AMB), ﬂuconazole
(FCZ), itraconazole (ITZ), voriconazole (VRZ), ﬂucytosine (5FC), and
caspofungin (CAS). Etest® was not performed for each antifungal for
each isolate depending on the hospitals. Both on-scale and off-scale
values were included in the analysis. Low off-scale values were left
unchanged and high off-scale values were converted to the next higher
concentration. For comparison purpose, the Etest® MICs were raised to
the next corresponding EUCAST concentration. Agreement was deﬁned
as differences of no more than 2 dilutions between results obtained by
the two techniques. Categorical agreement were also calculated based
on breakpoints previously published (Cuenca-Estrella M. et al, Clin
Microbol Infect 2005, 11, 486–92).
Results: See the table.
n % agreement
+/1 dil +/2 dil
AMB 681 47.4 75.0
FCZ 694 54.2 71.8
ITZ 198 39.4 70.7
VRZ 612 72.9 86.4
5FC 332 82.5 90.4
CAS 249 36.5 73.9
The best correlation was observed with 5FC. The good correlation for
AMB could be explained by the narrow range of MICs. The correlation
for azoles ranged from 71% for ITZ to 86% for VRZ. The results by yeast
species did not show signiﬁcant differences excepted for susceptibility
of Cryptococcus neoformans to 5FC for which the correlation was
<40%. Categorical agreement ranged from 59.6% for ITZ to 91.0 for
5FC. Major and very major discrepancies occurred in less than 10 and
2%, respectively. Differences between hospitals were not statistically
signiﬁcant.
Conclusion: This study conﬁrms that results obtained with Etest®, even
if performed in non reference laboratories, show a good correlation with
results obtained by EUCAST reference method. Regular quality controls
should be implemented to maintain the performance of the Etest®.
R2386 Correlation of antibodies to antigens of Epstain-Barr virus
with systemic lupus
M. Seremet, M. Hukic, M. Sisirak, S. Mahmutovic-Vranic (Sarajevo, BA)
Objectives: We have examined a correlation of Epstein-Barr virus
(EBV) infection with Systemic lupus (SLE). We determined antibodies
on EBV speciﬁc antigens and heterophilic antibodies in SLE patients
and control group.
Methods: The SLE group consisted of 50 patients treated at the
Clinic for Rheumatism or at the Rheumatologic Counseling Ofﬁce of
the same Clinic. Mean age of the group was 48 years. The female-
male ratio was 47/3. The control group consisted of 21 patients with
degenerative arthritis and 29 clinicaly healthy individuals, all of the
similar age and gender structure as the SLE group. Each serum samle
was tested by Elisa for: Enzygnost anti-EBV/IgG, Enzygnost anti-
EBV/IgM, anti-VCA/IgG, anti-VCA/IgM, anti-EA-D/IgG, anti-EBNA-
1/igG and heterophilic antibodies.
Results: Anti-EBV/IgG antibodies were positive in 50 (100%) SLE
patients and 39 (78%) controls. SLE and control groups were negative for
EBV/IgM antibodies. Anti-VCA/IgG and anti-EBNA-1/IgG antibodies
were positive in 50 (100%) SLE patients and 39 (78%) controls. SLE
and control groups were negative for anti VCA/IgM antibodies. Anti-
EA-D/IgG antibodies were positive in 35 (70%) SLE patients and 8
(16%) controls. Heterophilic antibodies were positive only in two SLE
patients.
Conclusion: There was no signiﬁcant difference in frequency of anti-
EBV antibodies in two groups (p = 0.585). However, the percentage
of high antibodies concentrations in serum was signiﬁcantly higher in
SLE patients than in control group (p = 0.0001). The frequency of anti-
VCA and anti-EBNA-1 antibodies was similar in both groups, while the
frequency af anti-EA-D antibodies was signiﬁcantly higher in SLE.
EBV infection is closely related to SLE, whether as a triggers or as
precursors of EBV infection.
R2387 Validation of the Abbott Architect syphilis TP test against
the Dade Behring Enzygnost syphilis ELISA and the
Fujirebio Treponema pallidum particle agglutination test
C.A. Benne, A. Luchtenburg, J. Drenth, H. Feikens, B.C. Meijer
(Groningen, NL)
Objective: The performance of the recently introduced automated
Abbott Architect syphilis TP test (ARS) was compared with the Dade
Behring Enzygnost syphilis ELISA (DBS) and the Fujirebio Treponema
pallidum particle agglutination test (TPPA) as a screening test for
syphilis.
Methods: Speciﬁcities of the ARS, DBS and TPPA were assessed in
1227 prenatal and 775 diagnostic sera obtained in a low prevalence
setting for syphilis. To determine the sensitivities of the ARS, DBS and
TPPA, 227 sera were selected from patients previously diagnosed positive
and 5 sera from patients previously diagnosed negative for syphilis with
increasing TPPA titres (80). Sera with concordant test results were
considered as true negatives or true positives. Equivocal DBS results
were considered as negative. For discrepant sera a previous diagnosis
of syphilis and a syphilis line immunoassay (LIA) were used as the
reference.
Reproducibility of the ARS was assessed by calculation of intrarun and
interrun coefﬁcients of variation (CV) from 3 repeated determinations
of 5 negative (index <0.2), 5 low positive (1.0 < index < 5.0) and 5
positive sera (index >10.0).
Results: In 12/1938 (0.6%) truly negative sera discrepant results were
observed. Five sera were positive in DBS only, 6 samples were positive
in TPPA only and 1 serum was positive in TPPA and equivocal in DBS.
Three prenatal sera were positive in ARS only and indeterminate in
LIA and therefore classiﬁed as indeterminate. In 9/293 (3.0%) truly
positive sera discrepant results were observed. One serum was negative
in ARS only, 5 sera were equivocal in DBS only, 2 samples were negative
in DBS only and 1 serum was negative in TPPA and equivocal in
DBS. Speciﬁcities of ARS, DBS and TPPA were 100% (99.8% with
indeterminate sera included), 99.4% and 99.4%. Sensitivities of ARS,
DBS and TPPA were 99.7%, 97.3% and 99.7%. ARS intrarun and
interrun CV’s were 2.3% and 38.3% for negative sera, 3% and 5% for
low positive sera and 1.4% and 7.3% for positive sera.
Conclusions: The ARS showed excellent speciﬁcity and sensitivity as
compared to DBS and TPPA and was highly reproducible. Therefore
ARS can reliably used as a screening test for syphilis. Its fully automated
design makes ARS very suitable for large scale testing.
R2388 Efﬁcient automated puriﬁcation and accurate quantiﬁcation
of cytomegalovirus DNA
M. Boehm, A. Burmeister, M. Rudolph, M. Maehl, L. Zamudio-Maueira
(Hamburg, DE)
Objectives: An efﬁcient combination of preanalytical processing steps
and molecular diagnostic assays is required for reliable diagnosis
and accurate quantiﬁcation to monitor CMV infections and determine
antiviral therapy. The aim of this work was to evaluate the combination
of automated viral DNA extraction using a BioRobot® EZ1® workstation
and real-time PCR-based CE-marked artus® CMV PCR Kits for the
detection and quantiﬁcation of CMV from human plasma samples.
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Methods: Serial dilutions of human EDTA plasma spiked with CMV
were puriﬁed using the BioRobot EZ1 workstation in combination with
the EZ1 Virus Mini Kit v2.0. The extracted viral nucleic acids were
analysed using artus CMV PCR Kits on different platforms, using
LightCycler® 1.1/1.2/1.5, Rotor-Gene™ 3000, and ABI PRISM® 7000
SDS instruments. The limit of detection (LOD) was determined by probit
analysis. In addition, the linear range, robustness, and effect of interfering
substances (haemolysis, icterus, and lipaemia) were deﬁned.
Results: The LOD (p = 0.05) for the combination of the BioRobot EZ1
workstation with artus CMV PCR Kits was determined to be 67.2
copies/ml on the LightCycler1.1/1.2/1.5, 21.8 copies/ml on the Rotor-
Gene 3000, and 38.3 copies/ml on the ABI PRISM 7000. The linear
range for this combination has been determined to cover concentrations
from at least 3.16×102 – 1×107 copies/ml. The robustness of the
BioRobot EZ1 workstation in combination with artus CMV PCR Kits
was about 99%. No inhibition or lack of sensitivity was observed due
to the presence of interfering substances in plasma samples.
Conclusion: The combination of automated sample preparation using
the BioRobot EZ1 workstation and the EZ1 Virus Mini Kit v2.0 with
sensitive detection using artus CMV PCR Kits allows reliable diagnosis
and monitoring of CMV infections in routine diagnostic laboratories.
Trademarks: QIAGEN®, artus®, BioRobot®, EZ1® (QIAGEN Group);
LightCycler® (Roche Group); Rotor-Gene™ (Corbett Research); ABI
PRISM® (Applera Corporation or its subsidiaries).
Disclaimer: EASYartus CMV: The combination is currently for
Research Use Only. Not for use in diagnostic procedures. The CE-
marked combination for diagnostic use will be available in 2008. No
claim or representation is intended to provide information for the
diagnosis, prevention, or treatment of a disease.
R2389 An analysis of two sets of paired BACTEC aerobic/F
and anaerobic/F blood culture vials with or without an
agar-broth biphasic selective fungal culture vial for the
detection of fungaemia
C.Y. Low, A.L. Tan, B.H. Tan (Singapore, SG)
Objectives: It is important to know our own laboratory’s diagnostic
ability for detecting fungaemia which is a nosocomial infection with high
mortality. We evaluated the utility of a second set of paired BACTEC
Plus Aerobic/F and Anaerobic/F blood culture vials for the detection of
fungaemia and also analysed the beneﬁts of adding an in-house (modiﬁed
after the BACTEC Myco/F Lytic medium) agar-broth biphasic selective
fungal culture vial.
Methods: This is a retrospective study of patients admitted to the
Singapore General Hospital over a 27-month period, from April 2004
to June 2006, who had at least one positive blood culture for fungi
using the BACTEC vials or the in-house selective fungal culture vial.
Comparative analyses were made exclusively on blood culture sets in
these conﬁgurations: two sets of paired BACTEC vials (2−2), and two
sets of paired BACTEC vials with one in-house fungal culture vial
(2−2-1).
Results: There were 86 two sets of paired BACTEC (2−2) vials with at
least 1 set of either paired vials positive for fungi. 53.5% (46/86) had both
sets positive. This implied the addition of a second set of paired BACTEC
vials had increased the fungi recovery rate by 87.0%. There were 23
two sets of paired BACTEC vials with one in-house fungal culture vial
(2−2-1) that had at least 1 vial positive for fungi. 26.1% (6/23) had
positive cultures in both the BACTEC and selective fungal culture vials.
43.5% (10/23) had a positive culture only in BACTEC and 30.4% (7/23)
had a positive culture only in the selective fungal medium. There is poor
agreement (kappa, measure of agreement = −0.558) between the two
culture media for the diagnosis of fungaemia.
Conclusion: The use of a second set of paired BACTEC blood culture
vials increased the detection of fungaemia by 87%. In spite of this, the
addition of one vial of our in-house selective fungal culture medium
would detect 30% more fungaemia. Hence, this ﬁnding lends strong
support for the use of a selective fungal culture medium to complement
even two sets of paired BACTEC Aerobic and Anaerobic vials to enhance
the diagnosis of fungaemia.
R2390 Diagnostic signiﬁcance of procalcitonin in assesing septic
complications after major gynaecological surgery
N.G. Miksic, J.G. Rebersek, M. Pakiz, B. Gorisek (Maribor, SI)
We wished to establish the value of procalcitonin (PCT) in assessing
early postoperative sepsis in patients after major gynaecologic surgery.
After major surgery traditional inﬂammatory parameters (C-reactive
protein – CRP, white blood cell count – WBC, percentage of
granulocytes, erythrocite sedimentation rate) can be elevated on account
of tissue trauma caused by surgery.
Methods: The prospective study included 88 patients from the Uni-
versity Clinical Hospital Maribor, Clinical department of Gynecologic
Oncology, 47 of these after a minor gynaecologic operative procedure
acc. to Piver I, 35 after a major procedure acc. to Piver II and III with
no postoperative infectious complications, 6 patients with postoperative
sepsis. In all patients inﬂammatory parameters (PCT, CRP, ESR, WBC
and percentage of granulocyte) were determined on postoperative days
1–10.
Results: PCT levels under 0.5 ng/ml were noted throughout the 10
postoperative days in patients after minor Piver I operation and in 77%
of patients after major surgery (Piver II and III) while 17% of these had
transitional levels between 0.5 and 1ng/ml on the second day and 6%
had 1−2ng/ml on the second day after the procedure. After the procedure
all 6 patients with septic complications had levels well above 2ng/ml,
already on the second postoperative day(median 23ng/ml). The CRP
level was elevated in all study patients. The concentration corresponded
to the extent of tissue trauma during the procedure, low levels were
observed post Piver I, and higher post Piver II and III (median 45mg/dl
vs. 135mg/dl, P = 0.03). The maximum values of CRP in non-septic
group were reached on the second postoperative day, then CRP slowly
returnd to normal values in the folowing days. Septic patients had
signiﬁcantly higher CRP levels than those without septic complications,
although signiﬁcant difference between septic group and the group after
major surgery(Piver II, III) group was not observed before the forth
postoperative day. On the other hand, the signiﬁcant difference in PCT
level between septic patients and patients after major surgery without
septic complications was observed already on the second postoperative
day.
Conclusion: Procalcitonin proved a good diagnostic parameter for
early detection of bacterial sepsis in gynaecology, particularly when its
postoperative level exceeded 2 ng/ml, since procalcitonin is not reﬂecting
surgical trauma.
R2391 Bacterial pathogens isolated from patients with bloodstream
infection
M. Nica, T. Biolan, E. Mozes, A. Dascalu, D. Caliga, V. Melinte,
E. Ceausu, P. Calistru, A. Tudor, I. Apostol (Bucharest, RO)
Objectives: To determine the frequency of pathogens isolated from 1483
patients with Blood Stream Infections (BSI) and to investigate their
resistance patterns, between January 2005 and July 2007, in “Dr. V.
Babes” Hospital of Infectious and Tropical Diseases, Bucharest.
Methods: Blood cultures were performed using the BacT/ ALERT 120
automated system. ATB/ Expression and VITEK2 Compact automated
system (bioMerieux, France) was used for identiﬁcation and resistance
testing of pathogens, according to NCCLS 2005–CLSI 2007. Internal
quality control was provided by using S. aureus ATCC 25923,
S. pneumoniae ATCC 49619, E. coli ATCC 25922, P. aeruginosa ATCC
27853.
Results: A total of 3561 blood cultures were screened for aerobic
and anaerobic bacteria. Bacteraemia occurred in 176 cases (4.9%).
Out of 176 isolated strains, 107 were Gram-positive (60.8%) and
69 were Gram-negative (39.2%). Among Gram-positive, the most
prevalent was Coagulase-Negative Staphylococci 34.6%, followed
S712 18th ECCMID, Abstracts accepted for publication only
by Staphylococcus aureus 26.2%, Streptococcus pneumoniae 14.0%,
Enterococcus spp. 4.7%. The most frequent of streptococci were
Streptococcus pyogenes and Streptococcus bovis (3.7% each). Among
the Gram-negative Escherichia coli was 47.8%, Klebsiella pneumoniae
15.9%, Salmonella spp. 13.0%. In lower rates we found: other
Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa,
Neisseria meningitidis, Haemophilus inﬂuenzae and anaerobic bacteria.
All Gram-positive isolates were susceptible to glycopeptides. 20/ 37
of CoNS were MRSCN, 13/ 37 resistant to ﬂuoroquinolone, 12/ 37
to gentamicin. 9/28 of Staphylococcus aureus were MRSA, 4/28 were
resistant to aminoglycosides, 5/28 to ﬂuoroquinolones. In S. pneumoniae
isolates, 1/15 was reported with high level resistance to penicillin.
E. coli and K. pneumoniae strains produced ESBL in 12.1% and 45.4%
respectively. Most of A. baumannii and P. aeruginosa strains were
susceptible to carbapenems.
Conclusions: 1. CoNS (21.0%) were the leading cause of BSI, followed
by E. coli (18.7%), S. aureus (15.9%), S. pneumoniae (8.5%). 2.
All Gram-positive isolates were susceptible to glycopeptides. 3. 45.4%
K. pneumoniae was ESBL positive. 4. Carbapenems had a good activity
against Gram-negative bacilli.
R2392 Optimisation and evaluation of an immunomagnetic
separation method using a monoclonal anti-LPS antibody
for the detection of Legionella pneumophila serogroup 1 in
environmental water samples
S. Allegra, J. Rissoan, F. Berger, S. Riffard, P. Berthelot, B. Pozzetto,
F. Grattard (Saint-Etienne, FR)
Objectives: Rapid and sensitive techniques are urgently needed to detect
the presence of Legionella in environmental water samples. The main
objective of this study was to develop an immunomagnetic separation
(IMS) method aimed to improve the recovery by plate culture of
L. pneumophila serogroup 1 (Lp1) from environmental water samples
of different origins.
Methods: IMS was performed with Dynabeads (Dynal, France) coated
with different antibodies (Abs) including monoclonal Abs directed
towards the Lp1 LPS and the mip protein (Microbiodetection, France)
and a commercial polyclonal anti-LPS Ab (Dynal). The test was ﬁrst
evaluated on a panel of 38 epidemiologically unrelated strains of Lp1
from different origins. The performance of the test was evaluated for
each Ab by comparing the rate of bacteria recovered by combining IMS
and culture to that obtained after culture alone. The best antibody was
then applied to the detection by IMS of Lp1 cells in environmental
samples taken from hospital water circuits and air cooling towers.
Results: The anti-mip Ab was not found adequate to capture Lp1 cells
with regards to its low and late expression in the course of the bacterial
growth cycle. By contrast, the monoclonal and the polyclonal anti-LPS
Abs were both found able to capture most of the Lp1 isolates since 32 out
of 38 isolates were recognised by each Ab. However, the monoclonal Ab
was found more speciﬁc than the polyclonal one to detect Legionella in
samples contaminated with other bacterial species such as Pseudomonas
aeruginosa. This latter point was conﬁrmed when the method was
applied to environmental samples taken from hospital water circuits and
air cooling towers. In these samples, the method combining IMS and
culture led to the detection of higher amounts of Lp1 as compared to
culture alone.
Conclusion: The method that combines IMS using a monoclonal anti-
LPS Ab and culture was found promising to selectively capture Lp1 cells
from water samples highly contaminated by various micro-organisms,
leading to an improved sensitivity of the culture assay.
R2393 Evaluation of VITEK2 ID NH for identiﬁcation of
fastidious organisms in a paediatric hospital
A. Voyatzi, K. Kalimeratzi, G. Oikonomopoulos, H. Iliadou, F. Gavalaki
(Athens, GR)
Objectives: to investigate the accuracy and performance of a rapid and
automated commercial identiﬁcation system (VITEK2 ID NH card),
using a clinical set of fastidious organisms, especially Haemophilus and
Campylobacter which frequently encountered in paediatric community
acquired infections.
Methods: A total number of 129 strains and 2 quality control strains
(102 Haemophilus and 17 Campylobacter strains as well as 10 Neisseria
strains provided by National Meningitis Reference Laboratory) were used
for assessing the performance of VITEK2 ID NH Colorimetric Card
(bioMe´rieux, Marcy l’Etoile) in comparison with conventional methods
and biochemical API system.
All Haemophilus and Neisseriae isolates had been identiﬁed using API
NH and manual disc factors (xv, x, v), Campylobacter species using the
Api Campy and hippurate hydrolysis as gold standard compared with
VITEK2 ID NH card.
Results: A total of 118 (91.5%) isolates were correctly identiﬁed at
species level without additional tests while 8 (6.2%) were correctly
identiﬁed at the genus level with low discrimination between two species,
thus requiring supplemented testing. Three (3) isolates were identiﬁed
correctly at genus but were misidentiﬁed at species level. Only 3
isolates of H. inﬂuenzae were misidentiﬁed as H. parainﬂuenzae and
one C. jejuni strain as C. coli. No misidentiﬁcations were observed at
genus level for those fastidious species.
Final identiﬁcation results
Species Correct ID Correct with
suppl. testing
Mis ID
species
Mis ID
genus
no ID
H. inﬂuenzae (80) (71) 88.8% (6) 7.5% (3) 3.7% 0.0% 0.0%
H. parainﬂuenzae (22) (19) 86.4% (3) 13.6% 0.0% 0.0%
N. lactamica (5) (5) 100% 0.0% 0.0% 0.0% 0.0%
N. meningitidis (4) (4) 100% 0.0% 0.0% 0.0% 0.0%
M. catarrhalis (1) (1) 100% 0.0% 0.0% 0.0% 0.0%
C. jejuni (13) (12) 92.3% 0.0% (1) 7.7% 0.0% 0.0%
C. coli (4) (4) 100% 0.0% 0.0% 0.0% 0.0%
Total 91.5% 6.2% 2.3% 0.0% 0.0%
97.7% 2.3% 0.0% 0.0%
Conclusions: The VITEK2 ID NH set is an easily used, promising new
tool for the identiﬁcation of fastidious species, providing rapid results
within 6 hours, demonstrating a very good accuracy for various genus,
including Haemophilus, Neisseria and Campylobacter spp.
R2394 Evaluation of a Latex Agglutination test for the detection
of Helicobacter pylori in stool specimens
S. Blanco, A. Lacoma, M. Forne, C. Prat, M. Cuesta, I. Latorre,
N. Garcia, S. Roses, S. Viver, J. Dominguez (Badalona, Terrassa, ES)
Objectives:
1. To evaluate the usefulness of a new latex stool antigen assays:
PYLOGEN, (CerTest Biotec, Zaragoza, Spain) in the diagnostic of
Helicobacter pylori infection and to conﬁrm H. pylori eradication
after treatment.
2. To compare their accuracy with a Immunocromatographic antigen
assay: H. pylori Letitest (leti diagno´sticos) and with two ELISA
assays Premier Platinum HpSA (Meridian Diagnostics, Cincinnati,
OH), Ampliﬁed IDEIA Hp StAR (DakoCytomation, Cambridge, UK).
Methods: We evaluated stool samples from 38 patients diagnosed with
H. pylori infection and from 9 patients without infection. To conﬁrm
H. pylori eradication we evaluated 57 patients who received H. pylori
treatment. Eradication was conﬁrmed with 13C-urea breath test 6 weeks
later. The assays were performed according to the recommendations of
the manufacturer. Sensitivity, speciﬁcity, correlation and kappa values
with UBT were calculated.
Results: PYLOGEN test detected H. pylori antigen in 30/38 samples
from study group (78.9% sensitivity), H. pylori Letitest in 35/38 (92.1%),
Premier Platinum HpSA in 33/38 (86.8%) and Ampliﬁed IDEIA Hp
StAR 37/38 (97.3%). All tests were negative for samples from control
group patients (100% of speciﬁcity).
Diagnostic/laboratory methods (other than molecular) S713
In the 57 patients evaluated 6 weeks after eradication therapy, the
overall agreement between urea breath test and the antigen tests were:
PYLOGEN 89.4% (k 0.683), Letitest 80.7% (k 0.468), Ampliﬁed IDEIA
Hp StAR 94.7% (k0.348) and Premier Platinum HpSA EIA 73.7% (k
0.837).
Conclusions: PYLOGEN is latex agglutination assay, quickly and easy
to perform, with a good sensitivity to determine H. pylori infection and
a good speciﬁcity. Compared to the 13C UBT, PYLOGEN and Premier
Platinum HpSA EIA show a comparably good correlation to assess the
success of eradication therapy.
R2395 Rapid culture based detection of Streptococcus agalactiae
on vaginal/rectal swabs
M.L. Tritten, H.H. Siegrist, A. Jacquet, R. Lienhard (La
Chaux-de-Fonds, CH)
Objectives: To develop and test a rapid method based on direct
agglutination of a selective Todd-Hewitt broth to detect group B
streptococci (GBS) on routine vaginal and/or rectal swabs obtained for
perinatal screening.
Methods: A total of 447 swabs for the detection of GBS were cultivated
in Todd-Hewitt + antibiotics enrichment broth overnight at 35ºC. The
next day 2 drops (100ul) of the broth were extracted and a direct latex
agglutination (Streptex®, Remel Inc.) was performed for the detection of
Lanceﬁeld group A, B, C, D, F and G streptococci. On the same broth,
subcultures at 35ºC overnight were made on sheep blood agar (n = 447)
and chromogenic agar plates (STREPTO B ID® bioMe´rieux, n = 168) to
search for GBS. Agglutination was then used again to identify all types
of colonies.
Results: Overall, direct agglutination gave 81 broths (18.1%) positive
for a group B streptococcus. Subcultures conﬁrmed GBS in 80 (98.7%)
of the samples, only 1 colony type could not be identiﬁed on sheep
blood agar after 24 hours. Out of the 366 broths presenting none or
other streptococcal groups on direct agglutination, only 1 presented a
GBS after subculture on sheep blood and chromogenic agar.
Conclusion: Direct agglutination of the Todd-Hewitt + antibiotics
enrichment broth containing vaginal/rectal swabs offers a rapid (within
24 hours), sensitive and speciﬁc method for the detection of GBS
colonisation in perinatal screening. This cost-effective procedure can
easily be performed in any clinical microbiology laboratory.
R2396 Evaluation of the new VITEK-2 ANC identiﬁcation card
in a clinical laboratory
F. Mory, C. Alauzet, P. Riegel, C. Matuszewski, S. Chatellier,
A. Lozniewski (Nancy, Strasbourg, La Balme Les Grottes, FR)
Objectives: The purpose of this study was to evaluate the ability of the
new VITEK2 ANC card (bioMe´rieux, Marcy l’Etoile, France) to identify
anaerobic and coryneform bacteria in comparison to reference methods.
Methods: a total of 319 strains belonging to the 63 species of
anaerobic and coryneform bacteria listed in the ANC card database
were investigated. Strains included 263 anaerobic clinical strains isolated
in the laboratory of Bacteriology, University Hospital Centre, Nancy,
France and 56 coryneform clinical strains isolated in the laboratory
of Bacteriology, University Hospital Centre, Strasbourg, France. These
isolates were previously identiﬁed by conventional methods. The new
VITEK2 ANC cards were used according to the manufacturer’s
recommendations. The cards were ﬁlled with organism suspensions
prepared in 0.45% aqueous NaCl to turbidity equivalent to a McFarland
#3 standard. Inoculated cards were incubated in the VITEK2 for
approximately 6 h. Identiﬁcation results were generated by a computer-
assisted algorithm. In the case of conﬂicting results, 16S rRNA and rpoB
gene sequencing methods were used for genetic identiﬁcation.
Results: The new VITEK2 ANC card was able to identify 314 (98.4%)
strains to the genus level and 281 (88%) to the species level. Nine (2.8%)
strains were misidentiﬁed and two (0.6%) could not be identiﬁed.
Conclusion: The new VITEK2 ANC appears to be a useful and reliable
method for the rapid identiﬁcation of anaerobic and coryneform bacteria.
R2397 Klebsiella oxytoca as a causative agent of antibiotic-
associated haemorrhagic colitis
D. Orth, A. Naim, K. Grif, M. Dierich, R. Wu¨rzner (Innsbruck, AT)
Objectives: Klebsiella oxytoca has been isolated from stool samples
of patients with Clostridium difﬁcile-negative antibiotic-associated
haemorrhagic colitis. However, the pathogenic role of this organism has
not been fully elucidated yet.
The aim of our study was to investigate the presence of toxin producing
Klebsiella oxytoca in patients with antibiotic-associated haemorrhagic
colitis.
Methods: 2500 stools specimens from patients with the clinical
diagnosis antibiotic-associated haemorrhagic colitis and 85 stool
specimens of a healthy control group were examined in the period from
June to November 2007 in Tyrol (Austria).
The specimens were cultured on MacConkey agar and investigated
for the presence of K. oxytoca by standard microbial procedures.
The cytotoxic effect of K. oxytoca strains was tested on Hep-2
cells and Vero cells, the amount of cytotoxicity was determined by
Lactat-Dehydrogenase release. The Klebsiella strains were characterised
phenotypically by antibiotic susceptibility testing and were typed by
Pulsed-Field Gel-Electrophoresis. In addition, all stool samples were
investigated for Clostridium difﬁcile toxin by ELISA.
Results: 119 of 2500 stool specimens (4.8%) of patients with antibiotic-
associated haemorrhagic colitis yielded K. oxytoca. In the control group
only 2 of 85 specimens (2.4%) were positive for K. oxytoca. The
rate of cytotoxic strains among K. oxytoca was 46% in patients with
antibiotic-associated haemorrhagic colitis compared with none in the
healthy control group.
In addition we could demonstrate that Vero cells are superior to Hep-2
cells for investigating K. oxytoca strains for toxin production.
Eleven percent of the stool specimens were positive for Clostridium
difﬁcile toxin.
Conclusions: Our study demonstrates that beside Clostridium difﬁcile
cytotoxigenic K. oxytoca are a causative agent of antibiotic-associated
haemorrhagic colitis. Thus, cytotoxigenic K. oxytoca should be included
in routine microbiologic diagnostic of stool specimens. Furthermore
we recommend Vero cells for determination of the cytotoxic effect of
K. oxytoca strains.
R2398 Septum sonication of removed ports for diagnosis of related
bloodstream infections
M. Alonso, A. Martinez, A. Serrera, A. Ramos, J.I. Bilbao, M.J. Etulain,
J. Leiva, J.L. del Pozo (Pamplona, ES)
Objectives: Venous access ports are used in patients receiving long
parenteral treatments. Diagnostics speciﬁc for port-related infections
have not been enough developed. In these infections microorganisms
are typically present forming bioﬁlms. The aim of this study was to
analyse the role of septum vortexing-sonication technique to diagnose
port-related bloodstream infections (PRBI).
Methods: All the devices removed in our hospital during a 27-month
period (august 2005 to October 2007) were prospectively studied. We
compared the septum sonicate-ﬂuid culture with the port internal lumen
swabbing and the culture after sonication of the catheter tip. We
considered a conﬁrmed port infection when the same microorganism
was isolated from blood cultures and in any port culture [for coagulase-
negative staphylococci (CNS), cultures were considered positive if there
were at least 1000 cfu/ml in any of the sonication techniques, or 15
cfu for the chamber swabbing. For other microorganisms any count was
considered signiﬁcative].
Results: 240 ports were removed from 240 patients. Ports were removed
due to end of use in 187 (77.9%) cases, because of suspected PRBI
in 29 (12.1%), because of mechanical complications in 19 (7.9%)
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and because of local infectious complications in 5 (2.1%). Finally,
27 patients met criteria for PRBI. Most of these patients (92%) were
receiving antimicrobial therapy when port was removed. The most
common isolated microorganisms were: Gram-negative bacilli (30.4%),
CNS (21.7%), yeasts (21.7%) and Staphylococcus aureus (17.5%).
Sensitivity of septum sonication (78.6%) was better than that of chamber
swabbing (67.9%) (p> 0.05), and than that of catheter tip culture
(51.8%) (p< 0.05). The speciﬁcity of the septum sonicate-ﬂuid culture,
chamber swabbing culture, and catheter tip culture were 97.1%, 95.7%
and 93.7%, respectively. Positive and negative predictive values for the
septum sonicate-ﬂuid culture were 66.7% and 97.1%, respectively. The
ROC curve analysis showed that the best threshold for the septum
sonicate-ﬂuid culture was 110 cfu/ml (S:78%, E:93%) for any isolated
microorganism.
Conclusions: According to data from the present study, the septum
sonicate-ﬂuid culture was the most sensitive method for the microbi-
ologic diagnostic of PRBI. The high negative predictive value of this
technique permits to exclude port as origin of the bloodstream infection
if culture is negative.
R2399 Value of antibodies to the C. albicans enolase for the
diagnosis of invasive candidiasis in non-neutropenic
critically ill patients
C. Castro, E. Martin-Mazuelos, S. Ruiz-Santana, A. Carolina,
N. Carrasco, L. Perez, M. Marin, A. Ubeda on behalf of the Cava
Project Group
Objective: Non-neutropenic critically ill patients with Candida colonisa-
tion are at high risk for invasive candidiasis. We evaluated the usefulness
of serum antibodies against C. albicans recombinant enolase in the
diagnosis of invasive candidiasis in non-neutropenic critically ill patients
as well as in those with Candida score <3 and 3. In a previous study,
a Candida score 3 accurately selected patients who would beneﬁt from
early antifungal treatment [1].
Methods: 381 patients (547 sera) with risk factors for fungal infection
were recruited from an ongoing prospective observational multicentre
study (“CAVA Project”). Besides surveillance screening cultures and
other work-up studies, antibodies directed to C. albicans recombinant
enolase were determined on weekly serum samples by a commercially
Candida Enolase ELISA IgG kit (Lab. Vircell®, Granada, Spain) [2],
according to the manufacturer’s instructions. Study groups were proven
invasive candidiasis (n = 20), Candida colonisation with Candida score
3 (n = 132) or Candida score <3 (n = 147), absence of Candida
colonisation (n = 82).
Results: Candida antibodies were documented in 182 patients (47.8%)
(250 sera), which corresponded to 11/20 patients with invasive
candidiasis (24/55 sera), 60/132 with Candida score 3 (82/174 sera),
82/147 with Candida score <3 (112/222 sera), and 29/82 (32/96 sera)
without colonisation.
Positive antibody test Positive serial serum samples, no. (%)
One Two Three Four
Invasive candidiasis, n = 11 4 (36.3) 4 (36.3) 0 3 (27.3)
Candida colonisation
Candida score 3, n = 60 48 (80) 5 (8) 6 (10) 1 (2)
Candida score <3, n = 82 62 (75.6) 16 (19.5) 2 (2.5) 2 (2.5)
No Candida colonisation, n = 29 28 (96.5) 0 1 (3.5) 0
Conclusion: In serial serum samples, Candida enolase antibodies
showed a good correlation with suspicion of proven Candida infection.
This assay, however, should be used together with other techniques for
deﬁnite diagnosis of invasive candidiasis in non-neutropenic critically
patients.
Reference(s)
[1] Leon C et al. Crit Care Med 2006;34:730−7.
[2] Mendoza J. (Lab. Vircell®, Granada, Spain).
R2400 Evaluation and comparison of organism identiﬁcation
and antimicrobial susceptibility results using direct and
conventional testing methods for clinically signiﬁcant
positive blood culture isolates
P. Orr, I. Winning, N. Logan, A. Leanord (Lanarkshire, Glasgow, UK)
Objective: To compare the direct inoculation of positive blood
culture organisms into an automated system (VITEK2), compared
to conventional overnight incubation, organism identiﬁcation and
antimicrobial testing methods.
Methods: For a 3-month period, 61 clinical isolates at Monklands hos-
pital were analysed using direct inoculation into VITEK2 identiﬁcation
and antibiotic susceptibility cards.
Results: Of these isolates, 3 were unsuitable for VITEK2; of the
remaining isolates 98.3% provided the same identiﬁcation proﬁles
as the conventional testing method. The most frequent organisms
associated with septicaemia were E. coli (33%), meticillin sensitive
Staphylococcus aureus (15%), meticillin resistant Staphylococcus aureus
(12%), and Streptococcus pneumoniae (13%). Overall the Gram-
positive isolates (GP) demonstrated 100% correlation between both
direct and conventional testing, however Streptococcus pneumoniae
had a comparison rate of 50%. Gram-negative (GN) isolates other
than E. coli demonstrated 100% correlation, and E. coli isolates had
95% correlation between the testing methods. Analysis of the time
taken for completion of both organism identiﬁcation and antibiotic
susceptibility testing (AST) for the direct testing method showed the
time (hours) of identiﬁcation of isolates and sensitivity (respectively)
as 5.25±0.28/9.44±0.27 (mean±sem; n = 9) for Staphylococcus
aureus, 5.54±0.63/8.07±0.53 (n = 7) meticillin resistant Staphylococcus
aureus, 5.50±0.48/9.5±0.51 (n = 4) coagulase negative Staphylococci,
4.31±0.39/9.66±7.30 (n = 4) Streptococcus pneumoniae, 4.54±0.14/
6.53±0.22 (n =19) E. coli, 7.00±8.88/9.38±0.02 (n = 3) Non-fermenting
organisms and other Gram-negative organisms 4.34±0.35/7.78±0.76 (n
= 8). The time taken for organism identiﬁcation and sensitivity using the
conventional methods of overnight culture ranged between 22.16–24.88/
24.59–27.81±0.75. The overall MIC agreement between the testing
methods was 96.9% (p< 0.05), with minor error rate (mE) of 1.2, major
error rate (ME) of 1.4 and very major error rate (VME) of 0.2 for all
organisms tested.
Conclusion: The direct testing of positive blood cultures using the
automated Vitek system was 18 hrs quicker than conventional testing,
with high overall MIC agreement for sensitivity testing.
R2401 The diagnosis of central venous catheter-related
bloodstream infection by differential time-to-positive
culture is affected by the time between bed to Bactec
H. Hedlund, L. Nilsson, A. Ha¨llgren (Linko¨ping, SE)
Objectives: Differential time to positive (DTP) blood culture is a
simple method to differentiate non-catheter-related from catheter-related
bloodstream infection (CR-BSI). A DTP of >2 hours is indicative of a
CR-BSI. In most studies where DTP is measured, the blood cultures have
been transported immediately to the laboratory. In clinical practice the
transport time may exceed 12 h. The aim of this study was to examine
if storing of blood cultures in room temperature before incubation
inﬂuences the DTP.
Methods: Fresh human blood was added to BACTEC + Aerobic blood
culture bottles, which were weighed to assess the amount of added blood.
Overnight cultures of S. epidermidis ATCC, S. aureus ATCC 29213, P.
auruginosa ATCC 27853 and E. coli ATCC 25922 were prepared in BHI
broth. Tenfold serial dilution was performed in PBS. For each species
three bottles per dilution (n = 9) were inoculated with 0.2ml aliquots of
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each dilution (1:104–1:106). The initial inoculums of each bottle (cfu/ml
blood) were enumerated by viable count. Three bottles with different
inoculums were immediately placed in a detector (BACTEC 9420). The
remaining bottles were placed in room temperature for 12 h (n = 3) and
24 h (n = 3). Each analysis was repeated at least once.
Time to positive blood cultures (TTP) and cfu/ml blood of the initial
inoculums were plotted and a regression analysis was performed. DTP
between 100 and 1000 cfu/ml blood of the initial inoculums and the
ratio of initial inoculums to obtain a DTP= 2 h were calculated.
Results: See the table.
Species Time in room-
temperature
(h)
TTP at
100 cfu/ml blood
(initial inoculum)
(h)
TTP at 1000 cfu/ml blood
(initial inoculum) (h)
DTP between
100 and 1000
cfu/ml blood
(initial inoculum)
(h)
Difference in
initial inoculum
size to obtain
DTP= 2 h
S. aureus 0 11.54 9.50 2.04 9.5 times
12 7.15 5.59 1.56 19 times
24 3.90 2.80 1.10 66 times
S. epidermidis 0 15.74 13.62 2.12 8.7 times
12 13.21 11.16 2.05 9.4 times
24 11.33 9.52 1.81 13 times
P. aeruginosa 0 13.03 11.26 1.77 13 times
12 8.48 6.89 1.59 18 times
24 4.60 2.97 1.63 17 times
E. coli 0 8.91 7.91 1.00 99 times
12 5.08 3.88 1.20 46 times
24 1.89 1.34 0.55 799 times
Conclusions: The time in room temperature before incubation affects
the DTP. Blood cultures should be placed in the positive-culture detector
no later than after 12 h from sampling. DTP should be used with caution
when E. coli is the causing organism of septicaemia.
R2402 Respiratory swab sampling for bacteria: comparisons of
swab material, sampling site, and sample processing
P.A. Ta¨htinen, J. Jalava, P. Huovinen, A. Ruohola (Turku, FI)
Objectives: Nasopharyngeal (NP) or nasal sampling is needed in
investigating the aetiology of respiratory infections. We conducted a
comparative study taking six nasal/NP swab samples to contrast two
different sampling swabs, nasal with NP sampling, and the saline elution
of the swab with the direct culturing of the swab.
Methods: The samples were collected from 36 children aged 6 months
to 11 years. First, right nostril was sampled with a dacron swab which
was placed into 0.5ml of saline. After vortexing, 10 ml was streaked
on culture plates. This specimen was termed the nasal dacron sample
(N-dacron-NaCl). The second sample was taken from the right NP with
a dacron swab which was processed as described above (NP-dacron-
NaCl). The third sample was taken from the right NP with a dacron
swab, but the swap was directly streaked on culture plates (NP-dacron).
The three following samples were taken and processed in the same
order and principle from the left nostril with a cellulose swab. Those
specimens were termed N-cellulose-NaCl, NP-cellulose-NaCl, and NP-
cellulose. The primary outcome was the number of bacterial colonies on
blood agar plates.
Results: Comparisons of swab material, sampling site, and sample
processing by cumulative logistic regression resulted in the following
age-adjusted odds ratios. Saline elution vs. direct plating: NP-dacron-
NaCl vs. NP-dacron 4.9 (P = 0.001); NP-cellulose-NaCl vs. NP-cellulose
11.0 (P< 0.001). Cellulose vs. dacron swab: N-cellulose-NaCl vs.
N-dacron-NaCl 1.9 (P = 0.221); NP-cellulose-NaCl vs. NP-dacron-
NaCl 3.4 (P = 0.024); NP-cellulose vs. NP-dacron 1.5 (P = 0.365).
Nasopharynx vs. nostril: NP-dacron-NaCl vs. N-dacron-NaCl 0.6
(P = 0.308); NP-cellulose-NaCl vs. N-cellulose-NaCl 1.1 (P = 0.897).
Conclusion: Saline elution of the sample did not affect the viability
of bacteria. Actually, signiﬁcantly more colonies were obtained with
this procedure than with direct plating of the swap. Most importantly,
the saline elution provides sample material for several different
microbiological analyses. In conclusion, we suggest NP swab sampling
and swab elution into saline for the bacterial analyses of NP.
R2403 Immunological diagnosis of early Pseudomonas aeruginosa
lung infection in cystic ﬁbrosis patients
A. Bifﬁ, D. Costantini, C. Colombo, L. Zazzeron, G. Clarizia,
M.l. Garlaschi, L. Cariani (Milan, IT)
Objectives: Serological methods to monitor Pa colonisation in patients
with cystic ﬁbrosis (CF) are advocated but the diagnostic value of a
commercially available P. aeruginosa antibody test to detect early Pa
colonisation has not been evaluated.
Methods: Colonisation of 235 CF patients (120 male) aged 10.5 years
(range 1–30 years) was assessed by regular culture (every three months)
of sputum or oropharyngeal secretions during four consecutive years
(2003–2007). At the beginning of the study period all patients were
negative for Pa.
Commercially available ELISA tests were performed to detect IgG and
IgA against Pa lipopolysaccaride in sera once a year.
A subgroup of 46 patients (22 male) aged 10.5 years (range 2–24 years)
showed culture conversion during the follow-up period and serology data
of one year before (T-1) and one year after (T+1) the ﬁrst infection, were
compared.
Results: Serum antibody level (mean + SD) of immunoglobulin G (IgG)
and immunoglobulin A (IgA) are showed in the table. IgG level at (T+1)
was signiﬁcantly higher when compared to (T-1).
In 13 patients (28%) at (T-1) the IgG levels were above the cut-off (6
U.I./ml), whereas the IgA levels were above the cut-off (8 U.I./ml) in 12
patients (26%).
At (T+1), 25 patients (54%) were positive for IgG antipseudomonas and
10 patients (22%) were positive for IgA.
IgG (cut off: 6UI/ml) IgA (cut off: 8UI/ml)
(T − 1) (T + 1) (T − 1) (T + 1)
Mean±SD 4.18±3.49 9.69±7.03 3.89±8.55 11.69±22.7
p (T + 1 vs T − 1) 0.000025 0.1056
Conclusions: Serology resulted in a higher number of positive patients
than culture suggesting:
– higher diagnostic value of serology than culture,
– culture identiﬁcation failures (because of lower bacteria densities in
the airways in case of ﬁrst infection),
– antibodies are markers of previous infection occurred several months
or years before.
CF patients with positive serological tests and negative cultural tests
might be monitored closely.
R2404 Usefulness of enzyme immunoassay as a screening method
in syphilis serology
E. Dopico, J. Ros, E. Grenzner, T. Vinuesa (L’Hospitalet de
Llobregat, ES)
Objective: The aim of this study is to evaluate the usefulness of the
enzyme immunoassay (EIA) method bioelisa SYPHILIS 3.0 versus RPR
and TPHA tests, in laboratory diagnosis of syphilis.
Methods: EIA was performed in 87 serums obtained in October and
November 2007, selected by their positive result in RPR, TPHA or FTA-
Abs in order to know if EIA test was able to screen them as positive
samples. In our laboratory, FTA-Abs was performed only when RPR or
TPHA test was positive. We considered true positives results when RPR
and TPHA were positive, or RPR negative and TPHA and FTA-Abs
positive and false positive when RPR or TPHA were positive and FTA
negative.
EIA results were compared to a combination of RPR/TPHA/FTA-Abs
that allowed considering true or false positive results.
Results: EIA versus current syphilis serology tests shows a sensitivity
of 93.3% and a speciﬁcity of 97.6%.
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Syphilis serology
RPR/TPHA/FTA-Abs (2 or more tests positive)
EIA + − Total
+ 42 1 43
− 3 41 44
Total 45 42 87
Sensitivity: 93.3%; Speciﬁcity: 97.6%.
Conclusion: Although EIA may be a useful screening method
in laboratories that perform a large number of tests in which
automation becomes absolutely necessary, positive tests need to be
conﬁrmed by classical methods of nontreponemal and treponemal tests.
Nontreponemal test are still useful as a measure of syphilis activity and
in monitoring drug response.
R2405 Portuguese EQA results for serogical diagnosis of syphilis
and brucellosis
A.P. Faria, H. Correia, R. Matos, M.A. Gomes, S. Almeida, C. Brito,
M. Mendes, P. Melo (Lisbon, PT)
Objectives: Syphilis is a chronic infectious disease caused by
spirochaete of the genus Treponema. It is usually transmitted by
sexual contact or from mother to infant. Brucellosis is the most
widespread zoonosis transmitted from direct contact from animals. As
both diseases have a worldwide impact on human health it is necessary
to monitor laboratory results. In 1989, the Portuguese EQA provider,
Programa Nacional de Avaliac¸a˜o Externa da Qualidade (PNAEQ),
created the Bacterial serology programme witch included toxoplasmosis,
hydatidosis, rubella, syphilis, brucellosis and typhoid fever. Since 2002
the Bacterial Serology programme only includes syphilis and brucellosis.
The main objectives of this programme are evaluating participant’s
results and consequently improve clinical laboratory performance
nationally. In this work we evaluate PNAEQ’s participant results in
syphilis and brucellosis.
Methods: Results of three annual assays, consisting of syphilis (human
sera), a brucellosis sample (animal sera) and clinical information.
For syphilis diagnosis we evaluated the data for treponemal tests (FTA-
abs, TPHA, TPPA, EIA IgG, EIA IgM, EIA IgG and IgM, Imunoblot)
and non-treponemal tests (VDRL, RPR, USR). For brucellosis diagnosis
we evaluated the data for Wright and rose Bengal tests. The results
were statistically treated accordingly with the answers given by the
laboratories.
Results: Throughout the year 2006 there was reduction of 20% in
the number of answers sent to PNAEQ and in 2007 a more active
participation.
For negative syphilis samples there is accuracy above 84% and for
reactive samples the mean accuracy is 79%. In Brucellosis the percentage
of correct answers for non-reactive samples is higher than 90% but for
reactive samples the mean accuracy is 70%. The behaviour of different
reagents used by laboratories was also studied, that being heterogeneous
in the different assays and different bacterial load. The majority of the
results were compatible with the clinical information provided.
Conclusion: There was a more active laboratory participation in 2007.
Treponemal tests for diagnosing syphilis had a better performance, as
in rose Bengal test for brucellosis diagnose. A deeper study of reagent
behaviour should be performed in order to improve the diagnosis of both
syphilis and brucellosis.
R2406 Sympathetic skin response in patients with purulent
meningoencephalitis
B. Sibanc, G. Lesnicar, J. Blatnik, S. Cvitan (Celje, SI)
Objectives: Sympathetic skin response (SSR) is deﬁned as a minute
change of skin potential after electrical stimulation. This test measures
the change in voltage that originates from the surface of the skin and
is attributed to sudomotor activity. The involvement of the autonomic
nervous system has been demonstrated with this method in diseases
affecting the central nervous system; we presumed either to be affected
in meningoencephalitis. It was the aim of our study to investigate SSR
in patients with purulent meningoencephalitis.
Methods: SSR was performed bedside by Medelec/TECA Saphire II
machine in 40 healthy volunteers and before lumbar puncture in18
patients with purulent meningoencephalitis. At the time of testing 8
patients were unconscious. The surface disk electrodes were attached
to the skin: for palmar/plantar SSR the active surface electrodes were
placed on the middle of the palm/sole and the reference electrodes were
placed on the dorsum of the hand/foot. The ground electrode was situated
in the forearm.
A single square electrical impulse triggered on the volar side of the
wrist was used to evoke SSR. The intensity of electrical impulse was
100–250V, the duration was 100–200ms. Responses were ampliﬁed with
bandpass 0.01 and 3 kHz for an analysis time 10 s.
Results: SSR were recorded in all 40 healthy subjects, regardless of
age and on all measured sites. The typical SSR consisted of triphasic
potential, ussually with negative initial peak. On the contrary, there
were absolute absence of all SSR in 8 patients, who were unconscious
at the time of test. In 4 patients, there was absence of plantar SSR
with prolongation of palmar SSR latency. Also, there were signiﬁcant
prolongation of palmar and plantar SSR latency and decrease of SSR
amplitude in 6 conscious patients with purulent meningoencephalitis.
One month after discharge from hospital, all survived patients had
normal palmar and planter SSR again.
Conclusion: SSR is a simple and bedside technique, with which we can
predict severity of CNS infection. There is typical reversible absence of
SSR in comatose patients and prolonged SSR latency and lower SSR
amplitude in conscious patients with severe purulent meningitis.
R2407 Use of mass spectrometry to identify clinical Fusarium
isolates
C. Marinach-Patrice, A. Lethuillier, A. Marly, I. Urtizverea,
J-Y. Brossas, F. Gene, F. Symoens, A. Datry, J. Guarro, D. Mazier,
C. Hennequin (Paris, FR; Reus, ES; Brussels, BE)
Fusarium spp. have recently emerged as signiﬁcant human pathogens.
Species identiﬁcation of these fungi is important both for epidemiologic
purposes and for patient management, but conventional identiﬁcation
based on morphologic traits is hindered by major phenotypic polymor-
phism.
In this study, we subjected 62 isolates belonging to nine Fusarium species
to both molecular identiﬁcation (TEF1 gene sequencing) and MALDI-
TOF analysis. Following stringent standardisation, the latter method
appeared both reproducible and robust even when various inﬂuencing
factors such as growth medium, temperature and time of incubation were
evaluated. Spectrum comparison with a database of the most frequently
isolated species correctly identiﬁed 57 isolates. As expected, the four
members of species not represented in the database were not identiﬁed.
Mass spectrometry and molecular identiﬁcation agreed in 5 of the 6
cases in which morphological and molecular identiﬁcation disagreed.
In conclusion, the constructed database and the standardised protocol
were validated for identiﬁcation of the most common clinical Fusarium
isolates. Uncommon species must now be added to the database.
MALDI-TOF yielded results within one hour, at a cost similar to
that of the molecular method. MALDI-TOF may also prove useful for
identifying other clinically important moulds.
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R2408 Detection of extended-spectrum b-lactamases among
Enterobacteriaceae by use of VITEK2 and manual
detection procedure
E. Van Hemelrijck, J. Vandeven, K. Lagrou, J. Verhaegen (Leuven, BE)
Objectives: Rapid detection of extended-spectrum b-lactamase (ESBL)
producing Enterobacteriaceae is crucial in order to control spread and
institution of optimal antibiotic therapy. Purpose of this study was to
compare the performance of different routine methods.
Methods: Isolates for this study were selected on basis of a positive
ESBL-screen test and/or resistance to cefuroxime with the VITEK2
system (cards N 045 and N 046).
Over a period of 6 weeks (March-April 2007) 254 isolates were
consecutively recovered from 215 clinical specimens (urine 54.9%,
sputum 19%, other 25.1% and blood 1%). The following species were
included: E. coli (n = 96), E. aerogenes (n = 39), E. cloacae (n = 34),
K. oxytoca (n = 15), K. pneumoniae (n = 22) and M. morganii (n = 48).
On all 254 isolates the disk approximation method with cefotaxime
(30mg), ceftazidime (30mg), aztreonam (30mg) and amoxicillin-
clavulanic acid (20/10) disks was used as reference method. Only
91 isolates were identiﬁed as ESBL producer. Routine performance
of three different methods for ESBL detection was compared:
the VITEK2 system (Biome´rieux, Marcy l’Etoile, France), E-test
ESBL (AB BIODISK, Solna, Sweden; strips with ceftazidime and
cefepime/clavulanic acid) and chrom IDTM ESBL (Biome´rieux, Marcy
l’Etoile, France). All analyses were performed in accordance with the
guidelines of the manufacturer.
Results: The performance characteristics of the three methods are shown
in the table.
Isolate No. VITEK2 Chrom ID E-test
Sens. Spec. Sens. Spec. Sens. Spec.
E. cloacae 34 100 58.1 100 41.9 100 100
E. aerogenes 39 93.3 29.2 86.6 16.7 100 100
E. coli 96 100 86.3 73.3 90.2 100 92.2
K. oxytoca 15 100 50 91.7 33.3 84.6 100
K. pneumoniae 22 92.9 75 100 100 100 87.5
M. morganii 48 100 14.9 100 91.5 100 100
All isolates 254 97 50.1 83.5 69.9 98.9 96.3
The method with the highest sensitivity for the detection of ESBLs was
the E-test (98.9%) followed by the VITEK2 (97%), however speciﬁcity
was more variable, ranging from 50.1% (VITEK2) to 96.3% (E-test).
The performance differed widely between the species investigated.
Conclusion: Considering the rather low speciﬁcity of the ESBL
detection by VITEK2 we recommend the use of conﬁrmation for all
organisms reported positive for ESBL production by VITEK2.
R2409 Comparison of direct and standardised antimicrobial disc
susceptibility testing on positive blood cultures
J. Breugelmans, H. Jansens, M. Ieven (Edegem, BE)
Objectives: To investigate the accuracy of immediate antimicrobial
disk diffusion susceptibility testing on blood cultures (=direct test, DT)
compared to standardised testing on subcultured isolates (=reference test,
RT).
Methods: A total of 573 positive blood cultures were investigated. RT
was performed on subcultures according to the CLSI protocol, DT by
swabbing the positive blood culture directly on the Mueller-Hinton II
agar. Cultures consisting of mixed ﬂora or isolates detected only on
subculture and species with a prevalence of less then 10 isolates in
2 years were excluded from the study. Discrepancies in susceptibility
results were classiﬁed as, minor errors (m): resistant or susceptible in
DT and intermediate in RT or vice versa; major errors (M) resistant in
DT but susceptible in RT; and very major errors (VM) susceptible in
DT but resistant in RT.
Results: Species isolated were S. epidermidis (43%), S. hominis (11%),
S. aureus (7%), E. coli (14%), S. haemolyticus (6%), P. aeruginosa (4%),
S. capitis (3%), K. pneumoniae (3%), E. cloacae (3%), E. aerogenes
(3%) and S. warneri (2%).
Direct and reference susceptibility testing showed an overall concordance
of 91.9% (5.5% m, 2.2% M and 0.4% VM): 91.8% for Gram-positive
isolates (5.0% m, 2.7% M and 0.5% VM) and 92.0% for Gram-negative
isolates (6.8% m, 1.0% M and 0.2% VM).
When analysing all antibiotic/isolate combinations, very major errors
occured most frequent for oxacillin (1.2%), clindamycin (1.0%) and
mupirocin (1.2%) in DT for Gram-positives and for sulfamethoxazole
(1.5%) in DT for Gram-negatives. Based on the bacterial species there
was a signiﬁcantly (p< 0.05) higher percentage of very major errors for
S. aureus and E. aerogenes compared to the other common Gram-positive
and Gram-negative pathogens, respectively.
Clustering of very major errors with prevalences >4% for speciﬁc
antibiotic–isolate combinations was evident for aztreonam/amoxicillin-
clavulanate – E. aerogenes (6.7%/6.7%), piperacillin–tazobactam –
K. pneumoniae (5.3%) and oxacillin – S. aureus (4.9%).
Conclusion: There is a very good concordance between the results
of direct susceptibility testing and reference testing even without
standardisation of the turbidity of the inoculum in the DT. Therefore
results of direct testing can be reported. However, they still need to be
conﬁrmed by the reference test in order to possibly correct categorical
differences especially within the species S. aureus and E. aerogenes.
R2410 MICs of non-tuberculous mycobacteria using the TREK
Vizion™ system compared to manual readings
B. Brown-Elliott, K. Beierle, M. McGlasson, R. Wallace (Tyler, US)
Objectives: o compare MIC readings of nontuberculous mycobacteria
using the TREK Vizion System with visual readings.
Methods: Seventy-six isolates of nontuberculous mycobacteria (16
Mycobacterium abscessus, 6 M. chelonae, 10 M. fortuitum group, 2
M. immunogenum, 1 undescribed rapidly growing Mycobacterium sp., 1
M. mucogenicum, 24 M. avium complex, 3 M. marinum, 4 M. simiae, 5
M. kansasii, 2 M. parascrofulaceum, 1 M. lentiﬂavum, 1 M. arupense)
were tested using Sensititre® (TREK Diagnostic Systems) 96-well
MIC plates following the Clinical and Laboratory Institute (M24-A)
including guidelines for antimicrobials tested. After incubation according
to species, all plates were read visually using a Sensititre mirrored light
box. Subsequently, the same 96-well plates were read in a blinded fashion
using the Vizion System. The Vizion System projects a digital image of
the growth in each well onto a touch screen monitor with the plate’s
antimicrobial template overlaid on the image. Touching or clicking the
MIC well provided instant feedback of interpretations and the images
were stored for later review. The results were automatically recorded
and printed with interpretations. Comparisons were made between the
readings using current recommended CLSI antimicrobial susceptibility
criteria for interpretation of susceptible (S), intermediate (I) and
resistant (R) isolates. Those with susceptibility interpretive category
change between the two methods from S to R or R to S had major
errors. Minor errors were those with susceptibility interpretative category
change from S to I, I to S, I to R, or R to I.
Results: 96% of the MICs were the same interpretative category for
visual and Vizion readings. Only 4% of the MIC comparisons had minor
errors and there were no major errors.
Conclusion: The Vizion System demonstrated excellent correlation
to visual MIC reads of nontuberculous mycobacteria. Additionally,
the Vizion System allows more rapid MIC reads, thus streamlining
laboratory workﬂow, providing a teaching and training tool for new
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laboratorians and enhancing collaborations between laboratories using
the stored images. The Vizion System also provides a built-in
comprehensive epidemiology programme which allows inter and intra
laboratory comparison of MICs and generation of antibiograms.
R2411 Comparison of 4 commercial methods for antimicrobial
susceptibility testing of temocillin
H. Rodriguez-Villalobos, A. Cardentey-Reyes, C. Thiroux, C. Nonhoff,
M.J. Struelens (Brussels, BE)
Objectives: Susceptibility testing for temocillin is currently performed
by disk diffusion method (DD). E-test (AB Biodisk) and new VITEK2
(VT) cards (bioMe´rieux) have been recently marketed for temocillin
testing. Data concerning the accuracy of these commercial methods are
limited. The aim of this study was to compare the accuracy of the VT,
E-test and DD methods (paper disk from Beckton Dickinson and Neo-
Sensitabs from Rosco) for determining susceptibility of Escherichia coli
to temocillin.
Methods: We tested 153 E. coli clinical isolates, including ESBL-
producing strains (54%): 70 CTX-M (CTX-M-2, CTX-M-9, CTX-M-
15), 12 TEM (TEM-24, TEM-30, TEM-52), 6 SHV-12, 15 AmpC hyper-
producers (AmpC HP) and 53 strains with wild phenotype or other
resistance mechanisms. ESBL production was conﬁrmed by combined
disk method (Bio Rad), PCR and DNA sequencing. Strains were tested
in parallel by VT (AST-N045 and AST-N046 cards), DD, E-test and agar
dilution (AD) according to the CLSI guidelines as gold standard method.
Results: MICs obtained by E-test and VT were within 1 dilution of
those obtained by AD in >99% of isolates. No differences were observed
between AD, E-test and VT (p> 0.5). VT and E-test showed the lowest
number of discrepancies (TABLE).
Table. Summary of results. Results interpretation based on breakpoints from Fuchs (MIC 16mg/L)
Method Susceptible MIC50 MIC90 Errors (%)
(critical zone diameters) (%) (mg/L) (mg/L) Minor Major Very major Total
Neo-Sensitabs (15–17mm) 95 3 0 1 4
BD (16–18mm) 74 15 5 0 20
VITEK2 93 8 16 0 2 0 2
E-test 95 8 16 0 3 0 3
Agar Dilution 95 8 16 − − − −
VT provided results in a mean time of 7 hours (6–10 hours). Errors
were observed with isolates showing borderline temocillin MIC of 16 or
32mg/L. No discrepancies were observed for strains with MIC< 4mg/L.
Conclusion: E-test and the VITEK2 system showed good accuracy
for determination of MICs of temocillin in E. coli including ESBL
and AmpC HP strains. For disk diffusion Neo-Sensitabs showed better
discrimination between susceptible and resistant strains and lower
number of discrepancies than BD disks.
R2412 Evaluation of the Etest and broth dilution methods for
susceptibility testing of Brucella melitensis
H. Aliskan, F. Can, M. Demirbilek, S. Colakoglu, C. Yazici, H. Arslan
(Ankara, TR)
Objectives: In vitro susceptibility tests are not standardised for Brucella
species and they are not rountinely performed. The main objective of
the present study was to evaluate the degree of agreement of two in
vitro tests (E-test and the broth dilution method) with several antibiotics
including tigecycline againist Brucella melitensis (B. melitensis).
Material and Methods: 16 B. melitensis isolates were collected between
May 2003-October 2004 from blood cultures of adults patients with acute
brucellosis at Baskent University Adana Practice and Research Center.
Samples of blood were cultured using an automated culture system
(BACTEC 9050, Becton Dickinson, Maryland, USA). The antimicrobial
agents used in this study were: tigecycline (Wyeth Research, Pearl River,
NY, USA), rifampin, trimethoprim-sulfametoxazole, and levoﬂoxacin
(Sigma-Aldrich, USA).
E-test method: Bacterial inoculum was prepared 0.5 McFarland turbidity
standart by Mueller-Hinton broth (Oxoid). The bacterial suspension was
spread on Mueller-Hinton agar (Oxoid) plates supplemented with %5
sheep’s blood agar and E-test strips (AB Biodisk, Solna, Sweden) were
applied.
Broth dilution method:The MIC values of antibiotics were determined by
the broth dilution technique, according to Clinical Laboratory Standarts
Institue with brucella broth (Merck, Germany), using an inoculum of 104
colony-forming units (CFU). Brucella broth medium was used within 12
hours after preperation. Tigecycline solutions prepared fresh on the day
of testing. The plates incubated at 350C in ambient air, and the results
were read after 48 h.
Results: In our study, the rate of agreement obtained with levoﬂoxacin,
rifampin, co-trimoxazole, and tigecycline between the E-test and broth
dilution methods were 25%, 18.75% 0%, and 18.75%, respectively.
Statistically signiﬁcant difference was found between the methods for
MIC values of levoﬂoxacin, rifampin, co-trimoxazole, and tigecycline
(p< 0.01, p< 0.001, p< 0.001, p< 0.05) (Table)
Table: Median and standard deviation values for MICs of antibiotics
determined by E-test and broth dilution method
Median±standard deviation
Median (min–max)
n = 16
E-test method Broth dilution method
Levoﬂoxacin 0.093±0.045 0.157±0.067**
0.079 (0.050−0.190) 0.120 (0.060−0.250)
Rifampin 1.219±0.256*** 0.641±0.258
1.000 (1.000−1.500) 0.500 (0.250−1.000)
Co-trimoxazole 0.025±0.045 0.184±0.137***
0.014 (0.000−0.190) 0.120 (0.060−0.500)
Tigecycline 0.035±0.015 0.065±0.036*
0.032 (0.020−0.060) 0.060 (0.020−0.120)
*p< 0.05; **p< 0.01; ***p< 0.001.
Conclusion: The MIC values determined with E-test method were lower
than the values determined with the broth dilution method. This situation
should be considered when evaluating the results of E-test method for
B. melitensis.
R2413 Validation of inoculation of the VITEK2 AST cards from
SA-select agar for S. aureus
W. Laffut, J. Besbrugge, J. Frans (Lier, Bonheiden, BE)
Objectives: To validate direct susceptibility testing of Staphylococcus
aureus from the chromogenic SA-select agar (Bio-Rad) on the VITEK2
system (bioMe´rieux).
Methods: Two Belgian regional hospitals (Imelda Ziekenhuis, Bonhei-
den (IZ) and H. Hartziekenhuis, Lier (HH)) prospectively analysed a total
of 90 S. aureus strains, isolated from routine clinical samples (IZ n = 46
and HH n= 44). These strains were identiﬁed following local routine
procedure in each lab.
Inoculation of Vitek AST-P536 cards was done in duplo from SA-select
medium and from blood agar, as neutral medium and reference method,
also cleared by bioMe´rieux for direct inoculation of VITEK AST cards.
In each centre, the ATCC 29213 strain (MRSA) was also included. IZ
used VITEK2 and HH VITEK2 compact instruments.
The degree of concordance of MIC values as well as that of categorical
values (RIS) was assessed.
Results: A total of 90 samples and 2 ATCC strains (one on each site)
were analysed. 2 Very major and 6 minor errors were encountered. No
major errors were found. Most discordances were found in oxacilline
and norﬂoxacin MIC values. The very major errors were observed in
nitrofuratoin and fosfomycin testing, both presumably random errors.
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Results of the ATCC strain 29213 showed no categorical errors on both
sites.
Conclusion: The degree of discordance between direct susceptibility
testing from SA-select agar and blood agar is acceptable. Therefore,
SA-select agar can be used as a primary medium for inoculation of
VITEK2 AST cards.
Public health & community-acquired
infections
R2414 A case of pyogenic liver abscess caused by Pseudomonas
aeruginosa
M. Ulug, E. Gedik, S. Girgin, M.K. Celen, C. Ayaz (Diyarbakir, TR)
Introduction: Pyogenic liver abscess (PLA) is a condition with
signiﬁcant morbidity and mortality. Biliary tract pathology is the most
common cause of PLA. The clinical manifestations of PLA are not
spesiﬁc; they include fever, chills, abdominal pain, and vomiting. The
diagnosis of PLA was based on the clinical ﬁndings and evidence
from imaging studies, either abdominal ultrsonography or computed
tomography (CT). Treatment with intravenous antibiotics and the
application of catheter drainage or aspiration are the primary therapeutic
strategies. Pseudomonas aeruginosa has long been regarded as a
relatively rare pathogen of PLA, because of this reason we decided to
submitt a case of PLA caused by Pseudomonas aeruginosa.
Case: A 28-year-old man presented to our hospital with a two
week history of pain in the right upper abdomen, follewed by
fever, chills and vomiting. In his history, he was exposed to trafﬁc
accident and posttraumatic empyema was developed two months ago.
On his physical examination the temperature was 38.6ºC, pulse rate
96/min, respiratory rate 28/min and blood pressure was 110/60mmHg.
Laboratory investigations revealed total leucocyte count of 11800/mm3
(polymorphs 88%), C reactive protein was elevated up to 63mg/dl,
ESR was 87mm/h. He got a liver abscess at right hepatic lobe which
was conﬁrmed by abdominal ultrasound and CT diagnoses. Ultrasound-
guided percutaneus aspiration of liver abscess was done soon after
the coﬁrmation. The culture result of aspirate grew Pseudomonas
aeruginosa. The patient received a 4 week corse of adequate antibiotics
treatment (Imipenem 2 gr/day + Amicasin 1.5 gr/day) after the
aforementioned aspiration procedure. A series of ultrasound were
performed to follow the resolution of abscess during the treatment period.
Finally, the lesion resolved completely without leaving any complication.
Conclusion: It is well known that PLA can be cause by several
organisims. The most common pathogenic agents, which enter the liver
by vasculer routes, are Escherichia coli, Salmonella typhi, Proteus
vulgaris, streptococci and staphylococci, but anaerobs may also be
present. In conclusion, PLA often presented with non-spesiﬁc symptoms
and was commonly associated with diabetes mellitus and biliary
pathology. It could be effectively treated by intravenous antibiotics and
drainage under ultrasound or CT guidance.
R2415 Antibiotic resistance and virulence markers of human
Salmonella enterica serovar Kentucky isolates from Slovakia
J. Majta´n, T. Majta´n, A. Ofukana´, V. Majta´n (Bratislava, SK)
Objectives: Salmonella Kentucky is well recognised as a serovar isolated
from cattle, ﬁsh, poultry, and other animals as an uncommon human
pathogen associated with occasional salmonellosis. The occurrence of S.
Kentucky is rare in Slovakia. The aim of present study was to investigate
the antibiotic resistance, presence of class 1 integrons, as well as the
selected virulence markers (bacterial adherence, motility and production
of bioﬁlm) of 95 sporadic human isolates of this serovar during 2005–
2006.
Methods: Antimicrobial susceptibility tests were performed by disk-
diffusion method using 10 different antibiotic disks according to the
method of CLSI. The intergron content was investigated by PCR method
using a 5′-CS/3′-CS primer pair. Bacterial adherence to xylene was
determined according to the method of Rosenberg et al. (1980), and the
motility was performed in semisolid agar (Braga et al., 1994). Bioﬁlm-
forming abilities of isolates were assessed by absorbance at 570nm in
the tissue culture plates (Stepanovic et al., 2004).
Results: Among 95 investigated strains multidrug resistance (MDR)
was found in 88 (92.6%) strains. The most frequent (47.4%) MDR
phenotype was: ampicillin, ciproﬂoxacin, gentamicin, streptomycin,
sulﬁsoxazole, tetracyclin. Three strains were also resistant to extended-
spectrum cephalosporin – ceftriaxon. The presence of class 1 integron
with 1500 amplicon was detected in 46 MDR strains. One MDR isolate
contained integron with amplicon of 2000 bp. Bacterial adherence to
xylene (hydrophobicity) of the isolates under study was weak. Only
16.8% isolates were evaluated as positive. The motility was positive
in 47.4% strains. Based on bioﬁlm-forming the strains were classiﬁed
as non-adherent (12.6%), weakly adherent (63.2%), moderately adherent
(22.1%) and strongly adherent (2.1%).
Conclusion: Previously, S. Kentucky was considered as an unsuccessful
pathogen because it was rarely associated with human illness. The
increased occurrence in human isolates in Slovakia highlights the
pathogenicity and the dissemination of this serovar and it will be
important to monitor further its occurrence as well as its features.
This work was supported by Science and Technology Assistance Agency
under the contract No. APVV-21–052602.
R2416 Isolation of sulfate reducing bacteria from dental unit
waterlines
N. Dogruoz, E. Ilhan-sungur, D. Goksay, I. Tu¨retgen, A. Cotuk
(Istanbul, TR)
Objectives: Dental Unit Waterlines (DUWLs) include a high number
of long pipes with small diameter. Direct contact with municipal water,
stagnant water, average temperature in DUWLs support the formation
of microbial bioﬁlms. Thus dental units might be contaminated by high
levels of microorganisms. Aerobic, opportunist microorganisms such as
Legionella pneumophila and also anaerobic sulphate reducing bacteria
(SRB) may be present in bioﬁlm. SRB reduce sulfur compounds to
hydrogen sulﬁde (H2S) that is toxic and acidic product. H2S can cause
corrosion, which leads to industrial loss, on metallic surfaces such as
galvanised steel, stainless steel. In addition, H2S causes ulcerative colitis
in human and, SRB trigger liver abscess and septicaemia. There is not
any worldwide standard that have been devote to number of anaerobic
SRB in DUWLs.
Methods: The aim of the present study was to determine the SRB
distributions within different DUWLs. Water samples were taken from
air-water syringe, high-speed drill and water source in 41 DUWLs.
Most probable number technique and Posgate B medium were used for
isolation and count of SRB.
Results: SRB were not determined in 21 (51%) inlet water source
samples. However, SRB were recovered from all outlets of the DUWLs.
While the highest determinable number of SRB in air-water syringe was
103 cells/ml, the lowest detectable count was 5 cells/ml. Also maximum
concentration value of SRB in high-speed drill was established as106
cells/ml, minimum viable counts were 5 cells/ml.
Conclusion: We think that the presence of SRB in DUWLs may be
undesirable since they can cause corrosion on metalic apparatus used in
dentistry and also health problems in human gastrointestinal system.
R2417 A survey on 80 cases of botulism and its clinical
presentations as a public health emergency, Tehran, Iran
Z. Aminzadeh, P. Vahdani, J. Mirzaei (Tehran, IR)
Botulism is a toxin-induced paralytic illness characterised by cranial
nerve palsies and descending ﬂaccid paralysis. Botulinum toxin is
regarded as the most lethal substance known. The diagnosis in sporadic
cases and even in small outbreaks is frequently missed. The aim of
this study was to assess clinical presentations of recorded botulism as a
public health emergency from Loghman Hakim hospital.
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A descriptive study (Routine data base study) was conducted in
80 admitted botulism cases between 1996–2006 in Loghman Hakim
hospital. The diagnosis of botulism was based on epidemiological data
and on a clinical score of severity. The patients were classiﬁed into three
forms: mild, intermediate and severe. SPSS 12 soft ware was used for
stastistical analysis.
The patients included 40 (50%) male and 40 (50%) female aged 1–66
years (mean 30.66±15.2year). The suspected causative food was cheese
in 25 patients (31%), sea-food in 20 patients (25%). The mean incubation
period was 1.06±1.8 days (range 4 h–10 days) and the mean from the ﬁrst
symptom to arriving into hospital was 3.77±4 days (2 h–17 days) and the
mean from the ﬁrst symptom to starting antitoxin therapy 3.95±4.27 days
(2 h–17 days). The ﬁrst symptom was nausea and vomiting in 17 cases.
11 (14%) patients were classiﬁed as suffering from severe disease, 5 (6%)
from intermediate disease and 64(80%) from a mild form. Conﬁrmation
of the diagnosis was obtained in 47 patients (58.75%). The most common
toxin was A [22 cases (27.5%)], then E [15 cases (20%)]. All the patients
were treated with antitoxin. All patients recovered without sequelae. Six
patients had to be admitted to intensive care unit (ICU) and required
ventilatory assistance. Only one patient (1.3%) died.
The mainstays of therapy are meticulous intensive care (including
mechanical ventilation, when necessary) and promptly treatment with
antitoxin.
R2418 Laboratory diagnosis of Toxoplasma gondii infection in
population in northern Greece
A. Kansouzidou, A. Kaftantzi, E. Vamvaka, M. Koltsida,
D. Karambaxoglou (Thessaloniki, GR)
Objectives: Toxoplasmosis is usually an asymptomatic infection, but
acute illness acquired during pregnancy may lead to severe sequelae in
the foetus. The diagnosis of toxoplasmosis is usually established through
serological methods. The aim of the study was to present the results from
the serodiagnostic approach of toxoplasmosis in patients of different age,
along with the results of prenatal and during pregnancy control against
toxoplasmosis in women.
Methods: A total of 697 subjects (247 males, 450 females) from 2
months to 81 years old (486 patients, 130 women before pregnancy,
81 pregnant women in the ﬁrst trimester) were studied and 805 serum
samples were analysed. All serum samples were tested for Toxoplasma
speciﬁc IgM and IgG antibodies and in subjects positive for IgM
antibodies IgG-avidity was determined using Vidas System. Also, IgA
antibodies were determined in selected samples using an ELISA method.
Results: IgM and IgG antibodies were not found in 500 subjects out of
the 697 (range 71.7%). The overall seroprevalence of toxoplasmosis was
19.5% (96 patients, 23 women before pregnancy, 17 pregnant women).
Increased IgM and IgG antibodies and high IgG-avidity were found in
28 subjects, out of the above 136, suggestive of latent infection with
persistent of IgM antibodies. Results suggestive of a recent infection
(positive IgM and IgG antibodies, low IgG-avidity) were found in 52
subjects (45 patients, 2 women before pregnancy, 5 pregnant women),
range 7.5%. Also, increased IgM and IgG antibodies and equivocal
IgG-avidity were found in 9 subjects, so that they were not able to
distinguish recent from past infection. From the total 697 subjects
examined 273 were women of reproductive age (15–40 years old) and in
58 of these immunity against Toxoplasma was observed (range 21.2%).
Also, signiﬁcant increase of the IgA antibodies in patients with recent
infection was found, but these were negative in subjects with latent
infection
Conclusion: Diagnosis of toxoplasmosis based on clinical appearance
and serological tests is not always easy and deﬁnitive. The interpretation
of the serological results is some times very difﬁcult and all the available
serological tests in more than one serum samples must be performed.
Speciﬁcally, a detailed serological examination and correct interpretation
of the serological results must be combined for the estimation of the
clinical situation in pregnant women.
R2419 Fluoroquinolone resistance in Enterobacteriaceae strains
isolated from community-acquired urinary tract infections
V. Skandami-Epitropaki, A. Xanthaki, A. Tsiringa, P. Fotiou,
CHA. Kontou, M. Toutouza (Athens, GR)
Objectives: Community-acquired urinary tract infections (UTI) are
among the most common bacterial infections in Greece. After quinolones
became the ﬁrst choice for empirical therapy of UTIs, their subsequent
overuse resulted to increasing quinolone resistance among uropathogens.
Aim of this study is to investigate the frequency and antibiotic
susceptibility of quinolone resistant bacterial stains isolated from
patients with community-aquired bacteriuria and compare it with urinary
pathogens from hospitalised patients.
Methods: During a 3-years period (2005–2007) a total of 1703 bactrial
strains were isolated from urine samples submitted for culture in our
hospital laboratory from the community (632) and from hospitalised
patients (1071) with UTI. Cultures and bacterial identiﬁcation were
obtained by conventional methods. The sensitivity to antibiotics was
tested by Kirby-Bauer disk diffusion method according CLSI criteria.
Results: Of the 1703 bacterial strains studied (Escherichia coli 1372,
Klebsiella pneumoniae 197, Proteus mirabilis 134), 15.6% were found
to be quinolone resistant. Quinolone resistance for all Enterobacteriaceae
was 21.1% for hospitalised patients (HP) and 6.2% for community
patients (CP). Quinolone resistance for E. coli was 17.4% for HP and
5.05% for CP, for K. pneumoniae 38.1% for HP and 18.9% for CP and
for P. mirabilis 24.7% for HP, 9.7% for CP. Susceptibility percentage of
the 1703 quinolone resistant isolates to other antimicrobial agents was
for HP and CP respectively as following: For E. coli ampicillin (AM)
7.1–10.7%, amoxicillin-clavulanate (AMC) 49.3%-53.6%, piperacillin-
tazobactam (TZP) 75.4%-85.7%, cefuroxime (CXM) 61.3%-82.1%,
sulfamethoxazole-trimethoprim (SXT) 19%-17.9%, ceftazidime (CAZ)
71.1%-82.1%, cefepime (FEP) 73.2%-85.7%, gentamicin (GM) 76.6%-
71.4%. For K. pneumoniae AM 0%-0%, AMC 16.4%-14.3%, TZP
19.7%-28.6%, CXM 14.8%-42.9%, SXT 1.6%-0%, CAZ 18%-42.9%,
FEP 26.2%-42.9%, GM 65.6%-85.7%. For P. mirabilis AM 0%-0%,
AMC 13%-0%, TZP 91.3%-100%, CXM 8.7%-0%, SXT 0%-0%, CAZ
13%-0%, FEP 95.7%-100%, GM 30.4%-25%.
Conclusions: High resistance rates to ﬂuoroquinolones were observed in
uropathogen bacteria isolated not only from hospitalised patients but also
in bacteria associated with community-acquired urinary tract infections
in Greece. Strict antibiotic policy concerning UTI in community patients,
is needed.
R2420 Mechanisms of resistance to oxyimino-cephalosporins
in clinical Escherichia coli isolates recovered from
food-producing animals in France
H. Salord, V. Gue´rin-Fauble´e, F. Pizette, J. Flandrois, S. Tigaud
(Lyon, FR)
Objectives: To characterize the b-lactamase genes encoding resistance or
diminished susceptibility to ceftiofur (a third-generation cephalosporin)
and/or cefquinome (a large-spectrum cephalosporin) in 24 Escherichia
coli isolates recovered in France in 2005–06 from sick animals (21
calves, two piglets, one pig).
Methods: Antimicrobial susceptibility to 15 b-lactams and 13 other
antibiotics was determined with the disk diffusion method. A double-
disk synergy test was carried for detection of ESBL. The presence of
genes encoding TEM, SHV, OXA1/4, phylogenetic group 1, 2, 9 CTX-M
and six families of plasmid-mediated AmpC b-lactamases as well as the
existence of mutations in the chromosomal ampC gene were investigated
by PCR and sequencing in the 24 E. coli isolates studied.
Results: The following ESBLs and plasmidic AmpC-type cephalospori-
nases were detected (number of isolates): CTX-M (13 including 12 CTX-
M-1), TEM-52 (1), and CMY (2 including 1 CMY-2). Mutations in the
ampC gene were identiﬁed in 17 isolates at positions −88, −82, −73, −42,
−28, −18, −1, +20, +34, +58, +70, or +81. Mutations at positions −18
(GA) and −42 (CT), resulting in the formation of a strong promoter and
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overexpression of AmpC, were observed in ﬁve isolates. Furthermore,
OXA-1 was observed in four strains moderately susceptible or resistant
to cefepime. PFGE performed with XbaI endonuclease showed that
the 24 isolates tested belonged to 22 distinct genotypes; two pairs of
isolates, containing CTX-M-1, showed indistinguishable PFGE patterns,
indicating a potential clonal dissemination among animals from different
farms.
Conclusion: Our data underscore the diversity of genes encoding
resistance to oxyimino-cephalosporins in E. coli strains isolated from
calves and pigs. The emergence of CTX-M-1-producing isolates in food-
producing animals in France is of major concern to both public and
animal health.
R2421 Measles and mumps epidemic outbreaks in two geographic
areas of Catalonia, 2007
M.R. Sala Farre´, C. Arias Varela, A. Recasens Recasens (Terrassa, ES)
Objectives: In Catalonia, a two-dose MMR vaccination programme for
children, free of charge and on a voluntary basis, was launched in 1988.
Catalonia is free of indigenous measles since 1999. In 2007 was set
the goal of mumps elimination but just in 2007 occurred the most
important measles and mumps outbreaks on the last ten years. This
report summarizes the differences between measles and mumps cases
reported in two geographical areas of Catalonia (Valle`s Occidental and
Valle`s Oriental) with 1.207.464 inhabitants.
Methods: Mumps and measles suspected cases should be reported
promptly to the Epidemiological Surveillance Unit. Conﬁrmation of
cases requires PCR testing of urine for measles or oral ﬂuid for mumps,
or speciﬁc IgM serum antibody, or to be epidemiologically linked to a
laboratory conﬁrmed case. Epidemiological data and vaccination status
had been collected individually from all cases. Correct vaccination status
was deﬁned as two doses of MMR vaccine, the ﬁrst dose after 12 months
of age and the 2n dose at least one month later.
Results: Measles outbreak ﬁnished in June 2007 with 18 conﬁrmed
cases; all of them were not or incorrectly vaccinated; 10 were less than
4 years old; 6 were nosocomial transmitted, 3 on personal staff.
Until September 2007 were reported 83 mumps conﬁrmed cases,
predominantly teens; 73% were correctly vaccinated. Most mumps cases
coincided with summer vacation. Delay in diagnosis and failure to report
in a timely manner occurred in some cases. Despite control effort and
highly vaccinated population secondary cases on families and schools
were detected but not nosocomial transmission.
Conclusion: The most important differences on epidemiology of the
measles and mumps cases were mean age and vaccination status. The
majority of mumps cases were correctly vaccinated. Healthcare providers
should suspect measles or mumps, dignose by using laboratory testing
and report cases immeditly. Furthermore mumps should be suspected
independent of vaccination history. When indigenous measles or mumps
cases are eliminated the goal must be to interrupt the virus transmission
from imported cases.
R2422 Comparision of the result of sinus track culture and bone
culture in chronic osteomyelitis
C. Ayaz, M. Ulug, M.K. Celen, M.F. Geyik, S. Hosoglu (Diyarbakir, TR)
Purpose: The infection of bone that contains bone marrow called
osteomyelitis, which was caused by different microorganisms. In this
study, we aimed to determine the diagnostic value and accuracy of
cultures of material from a sinus track compared with those of cultures
of bone specimens have been controversial.
Material and Method: Prospective study conducted at Hospital
University of Dicle, a 1090-bed university based hospital located in
Diyarbakir, Turkey. Between May 2005 and September 2006 sinus track
cultures were compared with those of bone cultures from 43 patients
with chronic osteomyelitis.
Results: The patients’ mean age was 30.6±3.6 year, and 29 (67%) were
male and 14 (33%) were female. Their mean ESR, C reactive protein
(CRP) and WBC were found 82.7mm/hour ±4.4, 122.4mg/dl±11,
11099.3/mm3 ±640 respectively. The high level of CRP and ESR
were determined meaningful (p 0.005), but total leucocyte number
was not meaningful by statistically. Organisms isolated from bone
cultures were staphylococcus 72.5% (29/40), Escherichia coli 10%
(4/40), Pseudomonas aeruginosa 10% (4/40), Proteus mirabilis 7.5%
(3/40) respectively. Cultures of sinus track and bone specimens gave
identical results in 62.7% of patients, with slightly better concordance
in chronic osteomyelitis caused by staphylococcus 78% than by all other
bacterial species.
Conclusion: The value of bone culture in the therapy of osteomyelitis
must be emphasised; it is the only reliable means of determining
the responsible agent, and then basing antibiotic therapy on this. The
correlation between sinus track and bone cultures was 37.3%. That
means, the failure in the treatment at four patients in 10.
R2423 Risk factors and molecular typing of community-acquired
urinary tract infections with ESBL (+) Escherichia coli
S. O¨ztu¨rk, S. Birengel, A. Tekeli, I. Dolapci;, A. Azap, G. Karamercan
(Ankara, TR)
Objectives: ESBL-producing E. coli is a well known aetiologic agent
of nosocomial infections. The incidence of community-acquired ESBL-
producing E. coli infections is increasing. The aim of this study is, to
determine the risk factors for urinary tract infections (UTI) caused by
ESBL-producing E. coli and deﬁne the molecular types of ESBLs.
Methods: Thirty-three patients who have community acquired UTI with
ESBL-producing E. coli, between 1st May 2006 and 1st Jan 2007,
included in the study. Control group was consisted of 70 patients who
have UTI with non-ESBL producer E. coli. Data were collected by the
help of a standardised survey form. Strains which were detected as ESBL
producer by phenotypic tests, controlled by PCR.
Results: In univariate analysis, female gender (p = 0.01), previous hos-
pitalisation (p = 0.01), urinary system abnormalities (p< 0.01), antibiotic
consumption in the previous three months (p< 0.01), ciproﬂoxacin
use (p = 0.04), aminopenicillin use (p = 0.01), having diabetes mellitus
(p = 0.03) were found to be signiﬁcant as risk factors. Any kind of
antibiotic consumption in the previous three months (OR, 11.42; CI
95%, 1.97–66.20; p = 0.007) and female gender (OR, 0.81; CI 95%,
0.007−0.82; p = 0.034) were found to be signiﬁcant in logistic regression
analysis. ESBL enzymes detected were 85% CTX-M, and 61% TEM.
No SHV enzyme was detected.
Conclusion: Community acquired infections with ESBL-producing
E. coli worth of concern. Judicious use of antibiotics is essential in
the control of infections caused by resistant microorganisms. It may be
possible to stop the spread of such resistant organisms by appropriate
antibiotic consumption policies and infection control measures, both in
the community and hospital.
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R2424 A case of Steven-Johnson syndrome caused by combined
use of lamotrigine and ﬂuoksetin
M. Ulug, N. Can Ulug, M.F. Geyik, M.K. Celen, C. Ayaz (Diyarbakir, TR)
Introduction: Steven Johnson Syndrome (SJS) is a rare, life threatening
acute allergic presentation with target lesions and blebs of epidermis.
Aetiology frequently comprises the use of sulfonamides, nonsteroid
antiinﬂamatory drugs, antimalarial agents and anticonvulsant medication.
However, combine duse of these drugs have been caused an increase
in the blood levels of each other by competing with glucuronidation
metabolism and leads to severe skin reactions. This report presents a
SJS case caused by combined use of lamotrigine and ﬂuoksetin.
Case: A 41-year-old man applied to emergency clinic with skin eruption,
especially on the face and trunk, and lesions around the mouth. The
history of him revealed lamotrigine and ﬂuoksetin use for the last
three weeks for major depression. On his physical examination the
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temperature was 38.5ºC, pulse rate 100/min, respiratory rate 18/min and
blood pressure was 130/80mmHg. Dermatological examination revealed
severe bilateral conjunctivitis, erosion of the lips with hemarrogic crusts,
pale erythematous papules, bullae and erosion on the ears, gingivitis, and
severe erosions of the pharynx. Laboratory investigations revealed total
leucocyte count of 8000/mm3 (polymorphs 80%), C reactive protein
was elevated up to 143mg/dl, ESR was 78mm/h. Liver function tests
such as AST: 230 U/L and ALT: 224 U/L were elevated. There was no
bacterial growth in throat, urine, faecal and blood cultures. First of all
the drugs which were used, was stopped. Additional treatment involved
ﬂuid replacement, prednisolone (1mg/kg/day), antibiotic eye drop and
oinment, mupirosin oinment for skin, bicarbonate and clorhexidine
mouth wash for oral mucosal lesions, wet dressing for epidermal
surfaces. When his biochemical values and general condition improved,
and there were no new lesions, the steroid dosage was gradually reduced
and completely stopped. He was discharged following complete recovery
on the 15th day of treatment.
Conclusion: SJS, a rare mucocutaneous reaction, has an incidence of
one in two or three million per year. Despite many aetiological factors,
usually certain drugs rank the ﬁrst. The risk arises most frequently within
the ﬁrst 2−8 weeks of antiepileptic treatment. In conclusion, clinicians
should bear in mind the possibility that the drugs increase the blood
levels of each other, especially those which compete with glucuronidation
metabolism, may lead to severe skin reactions.
R2425 Laboratory diagnosis of Crimean-Congo haemorrhagic
fever in Iran in the year 2007
S. Chinikar, S. Ghiasi, M. Goya, M. Moradi, N. Afzali, M. Rahpeyma,
M. Zeinali, M. Bouloy (Tehran, IR; Paris, FR)
Objectives: Crimean-Congo Haemorrhagic Fever (CCHF) is a viral
zoonotic tick-born disease with a mortality rate up to 50% in humans.
The CCHF Virus (CCHFV) is from genus Nairovirus and family
Bunyaviridae. CCHFV is transmitted to humans by the bite of infected
tick and by direct contact with blood or tissues from infected humans
and livestock.
Methods: In the year 2007, sera were collected from Iranian CCHF
probable cases and sent to the National Reference Lab, Pasteur Institute
of Iran. These sera were analysed with Immunological (speciﬁc ELISA)
and molecular (RT-PCR) assays.
Results: Among 128 probable human cases, 53 were conﬁrmed cases.
Between conﬁrmed ones, 42 were IgM positive (37 among them were
also RT-PCR positive) and 11 cases were only RT-PCR positive. Just one
case led to death during the year 2007(up to 14 November), comparing
with the year 2001 in which 11 death between 66 conﬁrmed cases were
observed.
Conclusion: CCHF is in the most important viral haemorrhagic fevers
in Iran. In this year, 16 out of 30 provinces of Iran have been affected
by CCHF. Sistan-Balouchestan in the southeast of Iran, because of being
near the border of endemic countries (such as Pakistan, Afghanistan), has
the highest rate of CCHF. In this study, it was demonstrated that CCHF
was seen much more in the age range of 21–40 and is more common in
professions related to livestock such as butchers, slaughterers, farmers,
etc. Therefore, it seems, informing the groups of high risk professions
has been efﬁcient. Fortunately, with a precise surveillance and laboratory
detection, the mortality rate in the year 2007(till 14 November) is
decreased up to 2% in contrast to 17% in the year 2001.
R2426 Bacteraemia after transrectal ultrasound guided prostate
biopsy in the era of multidrug resistance: impact of a new
preventive protocol
J.P. Horcajada, M. Busto, S. Grau, M. Salvado´, R. Terradas, L. Sorlı´,
A. Gonza´lez, H. Knobel (Barcelona, ES)
Objectives: Although the incidence of bacteraemia after transrectal
ultrasound guided prostate biopsy (TRUSGPB) is low under antibiotic
prophylaxis (0.5%), emergence of resistant microorganisms is becoming
worrisome. We had to implement a new preventive protocol because a
high incidence of bacteraemia was observed under the old preventive
protocol (OLDPP). We assessed the incidence of bacteraemia and
characteristics of isolated microorganisms, before and after the setting
up of a new preventive protocol (NEWPP) in patients undergoing
TRUSGPB.
Methods: this study was performed at an University hospital in
Barcelona, Spain, in which a mean of 200 TRUSGPB are performed
annually. Description of preventive protocols, analysis of the incidence
of bacteraemia before and after setting up a NEWPP, and description
of isolated microorganisms and antibiotic resistance patterns were done.
During the 2nd period patients were prospectively followed after the
procedure.
Results: OLDPP (Jan 2006-Feb 2007): amoxicillin/clavulanate 500mg
tid the day before, the day of the procedure and one day after; NEWPP
(Mar 2007-Nov 2007): cefoxitin 2 g one hour before the procedure and
ciproﬂoxacin 750mg po bid the day before, the day of the procedure
and 3 days after the procedure; a dipstick urinalysis (i.e., leukocyte
esterase test and nitrite test) was performed before the procedure, and
patients with positive results were not biopsed. Incidence of bacteraemia
after TRUSGPB with OLDPP vs NEWPP: 9/204 (4.4%) vs 0/105 (0%),
(p = 0.022); Isolated microorganisms in blood cultures with OLDPP:
Escherichia coli 6 (66.6%), Klebsiella pneumoniae 2 (22.2%) and
Morganella morganii 1 (11.1%). Enterobacter cloacae was also isolated
in one case; ﬁve (55%) of the isolates were quinolone resistant and
4 (44.4%) produced extended spectrum betalactamases and were also
resistant (CMI> 16/8) or intermediate to amoxicillin-clavulanate (CMI
= 16/8). With the NEWPP 2 (1.9%) cases of low-grade fever without
bacteraemia were recorded. 29 (27%) cases were not biopsed because of
positive dipstick urinalysis.
Conclusions: Before TRUSGBP, excluding patients with positive
dipstick urinalysis is an advisable practice. Antibiotic prophylaxis should
take into account local resistance patterns. Cefoxitin could be used
as prophylaxis in centres with high prevalence of extended-spectrum
betalactamase enterobacteriaceae
R2427 Emergence of Enterobacteriaceae producing VIM-1
metallo-b-lactamases in a tertiary hospital in Spain: clinical
and epidemiological characteristics
J.P. Horcajada, C. Segura, L. Sorlı´, M. Salvado´, F. Alvarez-Lerma,
E. Miro´, F. Navarro, H. Knobel (Barcelona, ES)
Objectives: The emergence of carbapenemases in Enterobacteriaceae is
becoming a matter of concern. We report the clinical and epidemiological
data of patients infected or colonised with Enterobacteriaceae producing
VIM-1 metallo-b-lactamases (MBL).
Methods: Retrospective descriptive study of patients infected or/and
colonised with MBL producing Enterobacteriaceae in a 450-bed Hospital
from December 2006 to May 2007. Clinical and epidemiological data
were collected by means of charts and hospital data base review.
Identiﬁcation and susceptibility of isolates were done by MicroScan
system (Urine ComboS1 and NC36 panels). To conﬁrm carbapenem
resistance, imipenem and ertapenem disc diffusion, imipenem and
imipenem+EDTA E-test and the cloverleaf test were performed.
Results: During the study period 12 MBL-producing Enterobacteriaceae
were isolated. One of them was isolated from a ﬂexible endoscope in a
rutine control. Data from one patient could not be obtained. Finally,
10 patients were studied. Six had E. cloacae, 3 K. oxytoca and 1
K. pneumoniae. Six (60%) were women. Mean (SD) age was 73 (14)
years. Seven (70%) patients had chronic underlying conditions. Three
(30%) patients had bacteraemia, 3 (30%) skin and soft tissue infection,
2 (20%) IV catheter colonisation, 1 (10%) respiratory infection and
1 (10%) peritonitis. All episodes were nosocomial acquired with a
mean (SD) previous hospital stay of 27 (17) days (range 2–55). During
the previous month, 8 (80%) patients had indwelling urinary catheter,
6 (60%) IV catheter, 5 (50%) had previous surgery, and 4 (40%)
mechanical ventilation. Seven (70%) patients received antibiotics during
the previous 2 months. Four of them received >3 Gram-negative active
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drugs and 3 patients were treated with carbapenems. Empirical treatment
was inappropriate in 5 of 5 patients. However, none of them dead under
empirical treatment. Antibiogram guided treatment was amikacin in 3
cases (one monotherapy, one combined with cotrimoxazole and one
with colistin) and tygeciclin monotherapy in 2 cases, with good clinical
outcome in all of them. Crude mortality rate was 60% and related
mortality rate 1 (10%). Mean (SD) stay was 47 (28) days (range 17–
102).
Conclusions: Emergence of VIM-1 MBL-producing Enterobacteriaceae
in Spain is reported. Isolates are nosocomial acquired. Most of
the patients have chronic conditions, receive multiple antimicrobials
previously, and undergo invasive procedures during prolonged hospital
stay.
R2428 Epidemiological, clinical and laboratory ﬁndings in human
Leptospirosis
A. Topan, V. Zanc, M. Muntean, M. Cristea, M. Flonta
(Cluj-Napoca, RO)
Objectives: Leptospirosis is a worldwide zoonosis of protean mani-
festations. Frequently it is underdiagnosed because of the nonspeciﬁc
symptoms of the disease. The aim of our study is to describe
epidemiological, clinical and laboratory features of patients with
leptospirosis.
Methods: We retrospectively reviewed medical records of 63 patients
with leptospirosis admitted to our hospital during 2003–2006. The
diagnosis was based on the clinical manifestations of the disease and
was subsequently conﬁrmed serologically by ELISA method.
Results: We observed an increase of the number of cases from six cases
in 2003 to thirty-four cases in 2006. During this period most of the
cases were diagnosed in the second part of each year and the peak
incidence occurred in the months August and November. The majority
of the cases were from rural areas (68.25%) and patients were infected
during occupational activities. A male gender distribution was found and
the median age was 47 within the range 22–72 years.
The most frequent signs and symptoms were fever in 80.95% of the
cases, nausea and vomiting in 71.42% of the cases, headache and myalgia
in 63.45%, respectively 52.38% of the cases. The icteric form (total
BIL >3mg/dl) and the conjunctival suffusion were observed in 36.50%,
respectively 26.98% of the cases.
Laboratory ﬁndings showed transient thrombocytopenia (<100×103)
in 32 cases (50.79%), creatinine >2mg/dl in 19 cases (30.15%) and
elevated liver enzymes in 28 cases (44.44%). There had been nine severe
forms with the decrease of the prothrombin index. (IP) under 60%,
two cases have deceased. The pulmonary involvement was conﬁrmed
by chest X-ray examinations in 29 cases (46.03%)
Conclusions: The frequency of the leptospirosis was 5.33 times greater
in 2006 than in 2003. The possible explanation can be the greater
rainfall and/or the underdiagnosis of the diseases. The diseases affected
mainly men from rural areas. Clinical data showed the prevalence of
the anicteric form of the disease. The most frequent involvements were
hepatic, pulmonary and renal. Having knowledge of the epidemiological,
clinical and laboratory characteristics of the leptospirosis is important
for the diagnosis and right treatment.
R2429 Optimal diagnostic approach in a Q fever outbreak situation
K. Boden, C. Wagner-Wiening, M. Baier, T. Seidel, E. Straube (Jena,
Stuttgart, DE)
Background: Over the last years an increase of outbreak activity of
Q fever in Germany has been recognised. The diagnosis of acute Q
fever largely depends on serology as culture of the organism is an
extremely hazardous procedure. However, the delayed development of
speciﬁc antibodies often leads to late identiﬁcation of Q fever cases or
misinterpretation of disease.
Objectives: To tackle this challenge we compared different serological
tests in patients with acute Q fever and evaluated the polymerase
chain reaction (PCR) as an additional tool in symptomatic seronegative
patients.
Methods: During the large Q fever outbreak in Jena in 2005 with 321
reported cases we tested several consecutive serum samples from 41
hospitalised patients with signs of acute Coxiella burnetii infection. 22
patients met the criteria of an acute Q fever (febrile illness, elevated
C-reactive protein (CRP), chest X-ray changes, residency in the outbreak
area, initial positive serology or at least seroconversion during follow
up) and were included in the study. The initial serum of all 22 patients
was than tested with a commercially available complement-ﬁxation-test
(CFT), an enzyme-linked immunosorbent assay (ELISA) and in initially
seronegative cases with PCR (modiﬁed by Fenollar et al. 2003).
Results: The sera were collected between the ﬁrst and seventh day of
illness. In two cases (9.1%) the CFT of the initial serum sample revealed
a positive result. The ELISA, in contrast, had a sensitivity of 59.1% (13
cases). The introduction of PCR as an additional test in seronegative
cases increased sensitivity by using ELISA in combination with PCR up
to 77.3% (17 cases).
Conclusion: In outbreak situations the combination of an ELISA with
additional PCR in seronegative patients provides a useful diagnostic tool
for early recognition of Q fever cases. The still popular CFT should be
replaced by an ELISA system.
R2430 Management of bacteraemia due to carbapenem resistant
non-carbapenemase-producing Klebsiella pneumoniae
C. Tascini, C. Mugnaioli, S. Santi, G. Gemignani, A. Leonildi,
R. Segantini, M. Rossi, G. Rossolini, F. Menichetti (Pisa, Siena, IT)
Background: Carbapenem resistance in K. pneumoniae is still
uncommon, but may emerge due to several mechanisms. Here we
report on two cases of bacteraemia caused by multidrug-resistant (MDR)
K. pneumoniae producing an Extended-Spectrum Beta-Lactamase
(ESBL) and showing resistance or reduced susceptibility to carbapenems.
Methods: MICs and MBCs of carbapenems were determined as
recommended by the CLSI. Susceptibility to other agents was determined
by disk diffusion. Serum bacteriostatic (SBA) and bactericidal (SBC)
activity against the K. pneumoniae isolated from the same patient
were determined according to CLSI. Carbapenemase production was
assessed by spectrophotometric assay. Genes encoding ESBLs and outer
membrane K35, K36 and K35 proteins were investigated by PCR and
sequencing.
Results: Two patients admitted to the same surgical ward developed
a post-surgical bacteremic infection due to an MDR K. pneumoniae
which was susceptible to imipenem (MIC, 2mg/L – MBC, 8mg/L),
but intermediate to meropenem (MIC, 8mg/L – MBC, 16mg/L) and
resistant to ertapenem (MIC, 32mg/L). Concerning other agents, the
isolates were only susceptible to amikacin, tigecycline and polymyxin
B. Carbapenemase production was not detectable, while both isolates
produced an ESBL (CTX-M-15) plus two broad-spectrum b-lactamases
(TEM-1 and SHV-1) and were deﬁcient in OmpK36 due to insertional
inactivation of the gene. Before isolation of the MDR klebsiellae,
one patient received empiric therapy with ceftriaxone (5 days) and,
susbsequently, piperacillin/tazobactam (4 days), while the other patient
received meropenem (5 days). When the results of blood cultures were
available, one patient was treated with imipenem 1g tid plus amikacin
1g od, and the other with imipenem 1g tid plus tigecycline 50mg bid.
Both regimens were able to resolve fever and bacteraemia, in 36 and 24
hours respectively. At the steady state, peak and through SBA were 1:2
or higher in either case.
Conclusion: Infections due to noncarbapenemase-producing MDR
K. pneumoniae producing multiple b-lactamases associated with porin
loss retaining susceptibility to imipenem, were successfully treated with
imipenem in combination with either amikacin or tigecycline.
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R2431 A retrospective study of the isolates of Nocardia spp. from
1997 to 2006
C. Segura, A. Gonza´lez, M. Salvado´ (El Prat de Llobregat, ES)
Nocardia infections, although low incidence, have experienced an
increase in recent years. To ﬁnd the current state of Nocardia spp.
infection in our environment, we have analysed retrospectively the
isolates of these microorganisms in the last ten years (1997–2006) at
the Hospital del Mar and the Hospital de la Esperanza of Barcelona.
Methods: Clinical samples cultivation was carried out by conventional
methods using a-BCYE addition when ﬁlamentous Gram-positive bacilli
were seen in the microscopic examination.
Nocardia spp. isolates were identiﬁed by Gram characteristic, colony
morphology, growth at 45ºC, urease and nitrate tests and antibiotic
proﬁle susceptibility. The molecular identiﬁcation was carried out at
the National Microbiology Reference Center (Instituto Carlos III) by
restriction enzyme analysis after 16S RNA PCR. The susceptibility study
was performed by disk diffusion in Mueller agar supplemented with 5%
of blood, adjusting the inoculum to 0.5−1 of the McFarland scale. It also
conducted E-test in cases where the disk results were not clear.
Results: In the period under review 41 isolates of Nocardia were
isolated, 8 came from soft tissue and 33 from respiratory samples. The
patients, 34 men and 8 women, were aged between 33 and 90 years
(76.2% older than 60 years). The molecular identiﬁcation was carried
out in 16: 2 N. brasiliensis, 1 N. paucivorans, 1 N. farcinica, 1 N. carnea,
5 N. abscessus and 6 N. cyriacigeorgica. Of the 25 isolates that are
available only phenotypic identiﬁcation, 9 would correspond to the type
VI, 1 and 2 type II to type V and the remaining 13 were not reached
a deﬁnitive identiﬁcation. Trimetoprim-sulfametoxazol (T/S) was active
on 38 of 39 isolates tested.
Conclusions: The number of Nocardia spp. isolates has experienced
a slight increase over the past years. The patient characteristics
(immunosuppression, bronchial pneumonopathy chronic treatment with
corticosteroids) correspond to the data of most of the series published.
Trimetoprim-sulfametoxazol retain its antibacterial activity, 97.4%
susceptibility in our series.
R2432 Enterobacter cloacae in bone and joint infections: analysis
of 22 cases from a university referral centre in Greece
E. Giannitsioti, S. Athanasia, A. Papadopoulos, D. Plachouras,
A. Drakou, P. Panagopoulos, V. Sakka, S. Tsiodras, E. Koratzanis,
K. Kanellakopoulou, H. Giamarellou (Athens, GR)
Objectives: Enterobacter cloacae is a rare pathogen in bone and joint
(BJ) infections. Current study assessed epidemiological and clinical
features of 22 patients followed at a referral BJ infection centre in
Athens, Greece
Patients and Methods: All cases of bone and joint infections that
were clinically, radiologically, laboratory and microbiologically assessed,
were retrospectively analysed via an electronic data-base registry. From
a total of 574 records, 22 (4%) were microbiologically documented
(cultures from pus, intra-operative tissues, bone and foreign material
samples) as BJ infections caused by E. cloacae. Treatment success
was the clinical, radiological and microbiological resolution of the BJ
infection while failure referred to all cases that did not ﬁt this deﬁnition.
Demographics, surgical operations, antimicrobial treatment, outcome and
infection relapses were evaluated.
Results: E. cloacae was isolated from intra-operative bone tissues
(n = 5, 23%), pus (n = 15, 68%), synovial ﬂuid (n = 1, 5%) and blood
(n = 1, 5%). Mean age of patients was 51.5 years (range 17–76). Men
predominated (14/22, 63.6%), as well as comorbidities (i.e diabetes
mellitus, cardiovascular disease and rheumatoid arthritis) (13/22, 59%).
Almost half of the cases (45.5%) had a history of car accident related
to the infection. The time from the infection onset to treatment ranged
from 0–24 (mean 5) months. BJ infection was located to joints (n = 4),
long bones (n = 17) and lumbar spine (n = 1). Only 3/22 (13.6%) had a
medical device (osteosynthesis) while 13/22 (59%) underwent surgical
debridement. Ciproﬂoxacin was administered in 77% of cases at a high
dose (1500 to 2000mg/day) for a mean of 7.3 months (2–16). Treatment
success was assessed in 12/22 (54.5%) of cases. There were 2 relapses
of the infection during a mean follow-up of 11.2 months (SD+ 10.9).
Conclusions: Although rare, E. cloacae is a difﬁcult to treat pathogen
in BJ infections, possibly because these infections are often post-
traumatic and affect patients with comorbidities. Moreover, despite long
and adequate treatment as well as surgical debridement, patients with
E. cloacae BJ infections presented with an important rate of failures
and relapses of the infection. Good collaboration of orthopaedists and
ID specialists on the ﬁeld is mandatory in order to improve therapeutic
approach in these patients.
R2433 Neurolisteriosis. Review of 22 cases
B. Artigas, A. Granados, B. Font, M. Navarro, D. Fontanals, F. Segura
(Sabadell, ES)
Objectives: To analyse the epidemiologic and clinical features of central
nervous system (CNS) infection by Listeria monocytogenes (LM) in a
general hospital in the last 11 years and review of the literature.
Methods:We reviewed the medical and laboratory records of all patients
diagnosed of CNS infection by LM between January 1996 and September
2007. Inclusion criteria were: adults, with blood or cerebro-spinal ﬂuid
(CSF) positive cultures for LM and symptoms of SNC infection.
Results: 22 patients were recruited, men 52%, mean age 64 years (range
28–90). The number of cases has been increasing during these years.
10 patients (45.5%) were not immunocompromised. The most frequent
clinical form was meningoencephalitis with 14 patients (64%). The
clinical picture was different depending on clinical presentation. Blood
cultures were done in all patients and were positive in 86% of them.
CSF culture was done in 19 patients (86%), 53% of them were positive
for LM. In CSF, lymphocytes dominated in 58% of patients, 74% had
a protein level over 0.45 g/L and only 21% had glucose levels below
40mg/dL, but with a CSF/plasma ratio below 0.5 in 15 patients (79%).
Gram stain was done in 17 cases and was negative in all of them. A
computed tomography brain scan was performed in 91% of patients,
being altered in 30% of them. Magnetic resonance imaging scan of the
brain was obtained in 59%, showing abnormal images in 63% of cases.
Mean time between admission and diagnosis was 2.3 days (range 0−6).
Mean time between admission and treatment was 1.1 days (range 0−4). A
correct double antilisterial treatment was prescribed in 11 cases (50%).
Mean duration of treatment was 27.6 days (range 1–70). Any of the
patients with brain abscess needed surgical treatment. General mortality
was 36% (6 patients), 4 of them (18.2%) directly related to LM infection.
Surviving patients presented neurological sequelae in 4 cases (18.2%).
Mean survival was 10.8 days (range 1–38).
Conclusion: LM must be considered in CNS infection especially
in the elderly and immunosupressed patients. Its incidence in not
immunocompromised patients is increasing. Early diagnosis and
empirical treatment including an antilisterial drug are very important
for prognosis. Domination of lymphocytes in CSF differential cell count
and a CSF/plasma glucose ratio below 0.5 can suggest LM and it can be
advisable to include an antilisterial drug empirically. CSF Gram stain is
usefulness in many cases.
R2434 Listeria monocytogenes bacteraemia. Review of 19 cases
A. Granados, B. Font, M. Navarro, D. Fontanals, F. Segura
(Sabadell, ES)
Objectives: To analyse the epidemiologic and clinical features of
bacteraemia caused by Listeria monocytogenes (LM) in a general
hospital and review of the literature
Methods:We reviewed the medical and laboratory records of all patients
diagnosed of LM bacteraemia between January 1996 and September
2007. Inclusion criteria were: adults (older than 18 years old), with blood
positive cultures for LM without symptoms or signs of infection in other
regions.
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Results: 19 patients were recruited, 58% were men. Mean age 61 years
(range 27–94). 12 (63%) were older than 60 years of age. The incidence
has increased from 1 case in 1996 to a maximum of 5 cases in 2003.
Only 4 patients (21%) were not immunocompromised, but all of them
were older than 60 years. The most frequent immunocompromising
conditions were: pregnancy 3 cases, non-haematological malignancies
(4), haematological malignancies (3), immunosuppressive treatment (2),
and steroids treatment (4). The clinical picture was fever in 10 cases
(53%) and chills in 5 patients (27%). 75% of patients presented
symptoms for less than 2 days before hospital admission (mean 2 days,
range 0−7). Mean time between admission and diagnosis was 1.7 days
(range 1−3). The 3 cases associated to pregnancy manifested in the third
trimester with fever and abdominal pain. All of them lead to premature
birth, but only one newborn was infected.
Mean time between admission and treatment was 1.8 days (range
1−3). The majority of patients, 15 cases (79%) received an antilisterial
treatment (Ampicillin 13 patients, in 4 cases associated with gentamicin
and one case associated with cotrimoxazole, amoxicillin-clavulanic acid
2 patients). Ceftriaxone was the ﬁrst treatment in one patient. 3 patients
died before receiving any treatment. Mean duration of treatment was 18
days (range 1–31). Mortality rate was 42.1% (8 cases), 3 patients directly
attributed to LM infection. Mortality rate between patients receiving an
antilisterial treatment was 27%. Mean survival was 14 days (range 3–
30).
Conclusion: LM bacteraemia incidence is increasing, probably caused
by the increase in the number of patients with immunosuppressant
conditions and the increase in life expectancy. In the elderly or
immunocompromised patients with symptoms suggesting bacteraemia
without symptoms or signs of infection in other regions LM infection
must be suspected and an empirical treatment with an antilisterial drug
must be administered as soon as possible.
R2435 Listeriosis infection in Kazakhstan
T. Meka-Mechenko, L. Nekrassova, B. Atshabar, G. Kovaleva
(Almaty, KZ)
In Republic Kazakhstan it is widely distributed Listeriosis registered
among people, agricultural animals, rodents and also birds. Listeria
strains were isolated in various products, mainly an animal origin,
including in the food stuffs ready to the use.
Materials and Methods: The material from patients for the
period 1993–2003 is investigated. Properties 188 Listeria strains are
investigated. Sensitivity to 21 antibacterial preparation L. monocytogenes
strains of various origins is determined.
Results: For the period of 1993–2003 207 patients with laboratory
conﬁrmed Listeriosis diagnosis are revealed. Patients had various clinical
picture and accordingly various diagnoses. In 7% of cases at patients
contact to pets has come to light, connection of disease with foodstuff
in 27% is marked: 2 families Listeriosis are ﬁxed, in everyone were ill
simultaneously on 3 members of families. Two patients had professional
character of disease (women from poultry farm and men-farmer). Four
cases of bacteriological conﬁrmed Listeriosis of newborn are marked
also.
The age structure of Listeriosis patients was from 1 month till 65 years,
middle age has made 19 years. 30% from number of all patients have
fallen to a share of children in the age of from 1 month till 14 years;
61% – on age from 19 till 40 years, 10% – on age from 55 till 65 years.
At research of material from people the percent of isolation Listeria
from tests of pathological material was the following: from pharynx –
45%, from blood – 31%, from contents of initial skin affect – 14%, from
urine − 10%.
Irrespective of source of isolation all cultures are submitted as
L. monocytogenes I serovar. Cultures had typical cultural-morphological
and biochemical properties, only some distinctions in ability or speeds
of fermentation of separate sugars and spirits were marked.
Resistance to cephalosporins, sulfonamide, polymyxin, and lincomycin
and nitrofurans preparation was (common for all investigated Listeria
strains of various origins. The most active in relation to Listeria strains
were amoxicillin, ampicillin, gentamycin, streptomycin, tetracycline and
erythromycin.
Conclusions: Listeriosis infection has a wide distribution in Republic of
Kazakhstan among people of various ages. Listeriosis strains basically
have typical properties are submitted L. monocytogenes I serovars.
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R2436 Does the use of probiotics/synbiotics in patients undergoing
abdominal surgery prevent postoperative infections? A
systematic review of randomised controlled trials
E. Pitsouni, V. Alexiou, V. Saridakis, G. Peppas, M. Falagas (Athens, GR)
Objective: Advanced surgical techniques and improved perioperative
care have considerably lowered postoperative morbidity. However, in-
fection following abdominal operation remains a considerable morbidity
factor. Probiotics are food supplements containing, beneﬁcial to the host,
live bacteria. These bacteria inhibit the growth of pathogens and support
microbial balance of the intestine towards a healthier ﬂora. Prebiotics
are indigestible sugars that stimulate the growth or activity of certain
bacteria of the gastrointestinal ﬂora, to the beneﬁt of the host. We sought
to evaluate the current literature and identify the potential beneﬁt, if
any, of perioperative administration of probiotics/synbiotics to patients
undergoing abdominal surgery.
Methods: We searched PubMed, Scopus, Web of Science and Cochrane
library to identify randomised controlled trials (RCTs) that studied
the perioperative administration of probiotics/synbiotics in patients
undergoing abdominal surgery.
Results: Eight RCTs studying 753 patients were included in our study.
The incidence of postoperative infectious complications (intra abdominal
abscess, wound infection, bacteraemia, cholangitis, liver abscess) were
less frequent in patients receiving probiotics compared to the control
group. In addition, in 1 study delayed gastric emptying was less frequent
in the group receiving probiotics compared to the control group. Two
studies report that septic morbidity between the group of patients
receiving synbiotics and the control group did not differ signiﬁcantly.
Two studies report shorter length of hospital stay in the group of patients
receiving symbiotics; however, 5 other studies do not report any inter-
group difference regarding the length of hospitalisation.
Conclusion: The use of probiotics and/or synbiotics may have beneﬁcial
effect in the reduction of postoperative infections after abdominal
surgery. However, available data do not permit the derivation of safe
conclusions. RCTs focusing in speciﬁc abdominal surgery, using the
same synbiotic supplement and the same therapeutic route are warranted
to further evaluate this promising preventive option that may decrease
morbidity, length of antibiotic therapy, hospital stay, and pressure for
emergence of antimicrobial resistance.
R2437 Investigation of an outbreak of Stenotrophomonas
maltophilia bacteraemia in an haemato-oncology unit:
unexpected genetic diversity of isolates
I. Nahimana Tessemo, L. Senn, C. Bellini, D.S. Blanc, G. Zanetti
(Lausanne, CH)
Introduction: Stenotrophomonas maltophilia (Sm) is ubiquitous in
aqueous environment. Several nosocomial outbreaks have been reported,
of which only 2 in haemato-oncology (HO) units. Between 1998 and
2006, 36 Sm bacteraemia occurred in our hospital (median 3/year, range
0−7) of which 14 in the HO unit (median 1.5/year, range 0−3). During
a 5-week period (12.06–01.07), 3 new cases were diagnosed in the
HO unit. An investigation was conducted to search a possible cross-
transmission and a potential source.
Methods: Clinical and epidemiological data of the 3 patients with Sm
bacteraemia were recorded. Environmental sampling of their rooms and
of a fourth room of the same unit was done twice one month apart
(02.07–03.07). One liter of water and swabs were taken from showers
and faucets in each room (total 16 samples). For the 2nd sampling, swabs
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of sink siphons were also analysed. Isolates were identiﬁed to the species
level by VITEK® 2 (bioMe´rieux, France) GN card. All Sm isolates were
typed by pulsed-ﬁeld gel electrophoresis (PFGE) using XbaI enzyme.
Results: The 3 patients were profoundly neutropenic at the time of Sm
bacteraemia. All had received myeloablative chemotherapy. The 3 Sm
isolates had 3 distinct PFGE patterns. One patient presented a second
Sm bacteraemia 3 months later with a strain genetically identical to the
ﬁrst episode, suggesting a relapse. The ﬁrst environmental investigation
revealed that 3/16 samples yielded Sm. These 3 samples originated
from 2 rooms, of which only one had been occupied by a patient
with Sm bacteraemia. The second investigation revealed that the 4
siphons were contaminated with Sm. PFGE genotyping showed that each
environmental isolate was unique. Moreover, no environmental isolate
shared the same genotype with one of the clinical isolates. Of interest,
Sm isolates recovered in 02.07 and 03.07 were different. No intervention
was done, and so far (11.07) no new case occurred in the HO unit.
Conclusion: Molecular typing proved that there was no cross-
transmission of Sm among patients. Environmental isolates were all
different from clinical isolates, suggesting that the source of infection
was not the water supply. However, as the isolates recovered during the
ﬁrst and the second investigations were genetically different, one can
postulate that the environmental Sm ﬂora is changing rapidly.
R2438 Infections after cardiac surgery
C. Ezpeleta, J.A. Alava, E. Go´mez, C. Busto, I. Atutxa, J. Unzaga,
R. Cisterna (Bilbao, ES)
Objective: the aim of this study is to know the rates of NI (Nosocomial
Infection) in patients operated on open heart surgery: valve replacement
and by-pass grafting.
Patients and Methods: The 1871 patients operated on open-
heart surgery in the hospital of Basurto between January 2000
& September 2007 were included. Preoperative protocol regarding
infection control includes: shower with 4% chlorhexidine soap the night
before surgery and repeated the day of surgery. Shave just before
surgery. Antibiotic prophylaxis: Cefuroxime 1.5 gr. IV beginning 5
minutes before anaesthesia induction. A second intraoperative dose is
administered if the operation lasts for longer than 6 hours, large estimated
blood loss or ﬂuid administration, since January 2006. The infection
control team makes infection surveillance. All the patients undergoing
open-heart surgery are prospectively studied since the day they are
operated until the end of the episode. A computer based surveillance
system INOZ designed for incidence studies of NI is used during
admission and continued 1 year after discharge. CDC deﬁnitions of
nosocomial infection are used. All the nosocomial infections not only
surgical site infections (SSI) are recorded.
Results: Age and sex: 1270 (67.87%) men, mean age 66.4 years. Mean
preoperative stay in the hospital 5.2 days (SD: 8.5). NNIS (National
Nosocomial Infection Surveillance) score 0: 126 patients, score 1: 1200
patients, score 2: 527 patients and score 3: 18 patients. Nosocomial
infections: 374 patients acquired 535 NI, 91 of them were Surgical
Site Infections (SSI): 26 incisional superﬁcial, 28 deep incisional and
37 organ space. NNISS score 0: 1.6%, score 1: 3.7%, score 2: 6.6%
and score 3: 38.9%. Microorganisms: S. aureus 11, Coagulase-negative
Staphylococci (CNS) 32. P. aeruginosa 10, Enterococcus spp. 5. Urinary
tract infections (UTI): 136. E. coli (45), E. faecalis (26), P. aeruginosa
18 and C. albicans (16) were the most frequent aetiological agents.
Respiratory infections: 178 patients. Pneumonia: 37 cases. Bacteraemia:
46 cases: 8 catheter related (S. aureus 3), 21 secondary (P. aeruginosa 5,
E. coli 4) and 17 primary bacteraemias (Enterococcus spp. 5).
Conclusions: Cumulated incidence of SSI dropped from 5.86% to 2.70%
after the introduction of the second intraoperative dose of antibiotic
prophylaxis. Coagulase-negative Staphylococci are the most common
bacteria isolated from Surgical Site Infections following cardiac surgery
during the study period.
R2439 Impact of a new perioperative antibiotic prophylaxis
policy on the antimicrobial resistance: experience in a
comprehensive cancer centre
R. Passerini, R. Bifﬁ, D. Riggio, L. Moretti, M. Sandri (Milan, IT)
Objectives: The use of inappropriate or broad-spectrum antibiotics
in perioperative prophylaxis is a signiﬁcant cause of antimicrobial
resistance in hospital.
To reduce this problem, the adherence to shared guidelines represents
a key step. Aim of our study was to evaluate the effectiveness of
the compliance with newly introduced guidelines in decreasing the
antimicrobial resistance of hospital bacteria.
Methods: At the European Institute of Oncology, until 2002 each divi-
sion followed an internal perioperative antibiotic prophylaxis schedule.
In November 2002 new guidelines were published, establishing, for each
surgical procedure, the appropriate choice of antibiotic, the way, timing
and duration of administration, and the alternative drugs in case of
allergic patients. Meetings with the clinicians, to discuss and share the
new indications, training courses for all the medical and nursing staff
were organised, and periodical checks to verify the compliance with
these indications were performed. To evaluate the effect of this new
policy, we compared, in surgical patients, the antimicrobial resistances
of the isolated bacteria, both pathogen and colonising, before and after
the introduction of the guidelines.
Results: With regard to compliance with the new guidelines, the ratio
of totally correct prophylaxis increased from 39.7% to 54.8% (ratio of
correct active principle from 52.9% to 96.7%).
The antimicrobial sensitivity of isolated bacteria increased overall from
72% to 76% (Wilcoxon, p = 0.0019); in particular, a signiﬁcant increase
in the susceptibility to tested antibiotics occurred for Staphylococcus
aureus, Coagulase Negative staphylococci (CoNS) and Pseudomonas
species; on the contrary, for Enterobacteria there was an increase of
the resistance, and for the other Gram-negative and the Enterococci no
signiﬁcant variations were found (Tab. 1).
Table 1. Percentage of antibiotic susceptibility in 2002 and 2005 and signiﬁcance
of the variation
% Susceptibility
Entero-
bacteria
Other
Gram(−)
S. aureus CoNS Enterococci Pseudomonas
species
Total
2002 80 63 81 34.5 68.5 68 72
2005 78 66 85 37 65 74 76
p 0.0001 0.4900 <0.0001 0.0005 0.8501 0.0001 0.0019
Conclusions: The introduction of guidelines for perioperative prophy-
laxis and the compliance with their indications were fundamental to
regulate the appropriate use of antibiotics, but it is also necessary that
these guidelines are shared with all the staff. It is also essential to train all
healthcare staff about the right use of the drugs, with training activities,
organised by the Infections Control Committee in co-operation with
clinicians, microbiologists and pharmacologists, regarding the diagnosis
and treatment of infections and the need to contain and face the increase
of antibiotic resistance.
R2440 Imipenem resistance among Pseudomonas aeruginosa
isolates: risk factors and impact of resistance on clinical
outcomes in a Tunisian burn unit
L. Thabet, K. Bousselmi, A. Messadi (Tunisia, TN)
Pseudomonas aeruginosa is an important cause of nosocomial infections
particularly in burned patients. Imipenem is one of the most effective
drugs against P. aeruginosa, but imipenem resistance had occurred and
has increasingly been reported in P. aeruginosa.
This study was conducted to determine the risk factors for acquisition of
imipenem resistant P. aeruginosa(IRPA)and the impact of this resistance
on clinical outcomes at a Tunisian burn unit.
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Patients hospitalised in the burn unit from January 2005 to December
2006 were included in this study. The features of patients with IRPA
isolates were compared with those of patients with imipenem susceptible
P. aeruginosa isolates (ISPA). Demographic features, total burn surface
area (TBSA), burn depth, antimicrobial used 15 days before, presence of
IRPA in the unit at the same period and previous ISPA isolated from the
patient were included in the risk factors analysis. We compared length
of hospitalisation and mortality in the two groups of ISPA and IRPA.
P. aeruginosa was recovered from 64 patients in this period, 25 were
IRPA and 39 were ISPA.
There was no signiﬁcant difference between patients with ISPA and
patients with IRPA in terms of age, TBSA burn depth and length of
hospitalisation. The percentages of septic choc were 64% in IRPA group
compared with 47% in ISPA group. The mortality rate among patients
infected with IRPA was signiﬁcantly higher: 40% versus to 17.9% with
ISPA (relative risk= 2. 23, p = 0.05).
Previous ISPA isolate from the patient (OD=14. 8, p = 0.02) and hospital
admission in the previous year (OD=8.25, p = 0.002) were independent
risk factors for acquisition of IRPA.
However, the presence of IRPA in the unit at the same period and
antibiotic use before isolation were not signiﬁcantly associated with
IRPA in our study (P> 0.05).
The imipenem resistance among P. aeruginosa strains had a signiﬁcant
impact on mortality in our study. The presence of ISPA in a patient
before isolation of IRPA is a signiﬁcant risk for acquisition of IRPA;
P. aeruginosa has the ability to develop drug resistance during therapy.
Carapenem exposure led the microorganism to this resistance. Therefore,
the judicious use of these antibiotics might be an important strategy to
prevent the imipenem resistance.
R2441 Antimicrobial effects of Persica© mouth wash on
Helicobacter pylori growth
K. Hosseinian Khosroshahy (Tehran, IR)
Introduction: The resistance of different bacteria to the current
antibacterial agents, toxicity of the antibacterial agents and the cost of the
treatment has led to the development of new active molecules against
the bacteria. Since ancient times medicinal plants have been used for
the treatment of bacterial infections. In present study we investigated
antibacterial activity of a commercial compound of Persica© mouth wash
on growth of Helicobacter pylori.
Material and Methods: Persica© mouth wash integrated of Meswak,
Mint and Yarrow plants extracts and some tannin compound. Agar
dilution was done by brucella agar and incubated in anaerobic jar for 72
hour. Helicobacter pylori 124823 used as a standard bacteria. Results
compared for clinical and standard bacteria.
Results: Antibacterial activity of Persica© mouth wash against
Helicobacter pylori emerged on 1/20 dilution of stock. This dilution is
conventional dilution presented as common prescribing dilution. There
was not difference on effect of drug between standard and clinical
samples.
Discussion: One of the sources of Helicobacter pylori infection is
mouth and dental plaque. Deletion of this bacterium from mouth and
dental plaque can prohibit probable reinfection of bacteria in stomach. In
present study we found Persica© as an effective plant drug for inhibition
of Helicobacter pylori. Maybe further investigation reveal fact of this
inhibitory effect.
R2442 Colonisation of hospital water distribution system by
Legionella pneumophila
A. Tarpatzi, M. Pantelaki, E. Velonakis, H. Phytrou, S. Damianidou,
A. Doganis, H. Giamarellou, A. Vatopoulos, L. Zerva (Athens, GR)
Introduction: Legionnaires’ disease is an important cause of community
and hospital-acquired pneumonia. The latter occurs after colonisation of
hospital water distribution system. Several countries, including Greece,
now mandate routine environmental surveillance for Legionella in
hospitals, regardless of occurrence of cases. This study describes the
problems of Legionella colonisation encountered in a Greek hospital
after implementing water surveillance cultures and their resolution.
Material and Methods: During a 14-month period 100 water samples
from cooling towers, boilers, taps and showers were cultured for
Legionella by the methodology of ISO 11731 (1998). The corrective
measures that were undertaken and the cost of these activities were
recorded. For the detection of infection a rapid urine Legionella antigen
test (Binax, Inc.) was used.
Results: Out of 100 water samples, 32 were positive for Legionella
pneumophila serotype 1. Colonisation of hospital water ranged from
500 to 350,000 CFU/L and the highest values were obtained from
the water boilers. Preventive and control measures were successfully
undertaken: shutting down of the warm water sullpy, hyperchlorination,
installation of ﬁlters in high risk wards and ﬁnally replacement of the
water heating system followed by heat shock and a constant elevation of
the warm water temperature (>55ºC). There were 4 cases of pneumonia
caused by Legionella but all were community-acquired. Main problems
encountered were high total cost, high energy consumption, damages
of water pipelines, increased temperature of cold water and adverse
publicity.
Conclusions: This is the ﬁrst description of hospital water colonisation
with Legionella in Greece. The problem was solved promptly and
because of the high levels of surveillance, there were no cases of
nosocomial infection.
R2443 The role of media ﬁll in the evaluation of
radiopharmaceutical manufacturing process at the
European Institute of Oncology
E. Omodeo Sale`, V. Sirna, R. Passerini, M. Chinol, S. Papi, L. Martano
(Milan, IT)
Objective: Aim of this study is to evaluate the microbial contam-
ination in the ordinary labelling of process to produce a sterile
therapeutic radiopharmaceutical. The manufacturing and handling of
radiopharmaceuticals are potentially hazardous, for this reason the
radiopharmaceuticals are usually released before sterility testing, while it
is carried out after complete decay. In this case the continuous assessment
of the effectiveness of the aseptic procedures has main importance.
Methods: Radioactive drugs sterility is deﬁned by the absence of viable
and actively multiplying microorganisms when tested in the speciﬁed
culture media. In order to obtain a validation of aseptic technique we
carried out a labelling simulation by the Media Fill Test. Applying
this method, operators simulate every step of the process using culture
medium instead of actual radiopharmaceutical product. Triptic Soy Broth
(TSB) has been used as nutrient medium because supports the growth
of a wide spectrum of microorganisms.
We created a written procedure to follow in simulation of 90Y-DOTATOC
compounding. It speciﬁes all working conditions and requirements that
need to be insured to obtain a good evaluation about process sterility.
Media ﬁll test has been subdivided into 4 phases from the simulation
of reagents preparation to the dispensing operations until ward delivery.
All the operations involving radioactive material need to be performed
inside the hot cell, while all other steps (e.g. reagents preparation) can
be done under a laminar ﬂow hood. At the end of the procedure the
processed medium is incubated at 35ºC for 14 days. If the compounding
procedure is adequately performed there will be no microbial growth.
Results: Microbiological analysis carried out on all vials obtained at the
end of each step showed no microbial growth. This is the reason why it
is possible to consider the test satisﬁed.
Conclusion: Application of media-ﬁll test allowed both to validate
operative modality used for 90Y-DOTATOC handling and to attest the
ability of operators who worked it. Additionally a correct quality control
of the radiopharmaceutical iv preparations allows control and prevention
of clinic infections.
Results are shown in media ﬁll ﬁnal report attached to the batch-record.
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R2444 Colonisation with meticillin-resistant staphylococci and
multidrug-resistant Gram-negative bacilli in hospitalised
patients: prevalence and risk factors
U. Altoparlak, O. Guler, H. Igan, A. Kadanali, Z. Ozkurt (Erzurum, TR)
Background: To determine the frequency of and risk factors for
colonisation of hospitalised patients by meticillin-resistant Staphy-
lococcus aureus and coagulase-negative staphylococci (MRSA and
MRCNS), or multidrug resistant Gram-negative bacilli (MDR-GNB)
and multidrug resistant nonfermentative Gram-negative bacilli (MDR-
NFGNB) classiﬁed as if they were resistant to at least 3 different
antibiotic groups, a one-day prevalence survey was conducted.
Methods: A total of 440 patients (172 were hospitalised within 72 hours
after admission, 268 were for more than 72 hours) were screened, using
nasal and cutaneous swabs. For each patient, the following variables
were recorded: age, sex, length of hospital stay, hospitalisation before
admission, the presence of anti infective therapy and invasive procedures
or devices.
Results: The prevalence of MRSA, MRCNS, MDR-NFGNB and MDR-
GNB colonisation was 9.9%, 34.3%, 1.7% and 0.6% among patients
hospitalised within 72 h; 36.6%, 81.3%, 14.6% and 11.9% among
patients hospitalised for more than 72 h, respectively.
Conclusions: There was a signiﬁcant difference (p< 0.001) in coloni-
sation of these bacteria between patients hospitalised for more than
72 h and within 72 h. Prolonged length of hospital stay, hospitalisation
before admission, surgery and anti infective therapy with betalactams
and glycopeptides for MRSA, MRCNS strains; the presence of urinary
and central venous or arterial catheter and anti infective therapy with
betalactams and carbapenems for MDR-NFGNB and MDR-GNB were
found to be independent risk factors for colonisation. Identiﬁcation of the
risk factors for colonisation is the ﬁrst step in formulating an effective
strategy to prevent hospital infections.
R2445 Acinetobacter spp. in the maternity hospital: is there a
relation between neonatal and maternal isolates?
N. Al-Sweih (Kuwait, KW)
Introduction: Multi-resistant Acinetobacter spp. has become an
important cause of nosocomial infection worldwide. The purpose of
this study was to deﬁne and compare the species proﬁle and antibiotic
resistance pattern of both neonatal and maternal clinical isolates.
Materials and Methods: All clinical isolates of Acinetobacter spp.
isolated between January, 2001 and December, 2006 were analysed.
Results: A total of 343 Acinetobacter spp. were isolated, 138 (40.2%)
were neonatal isolates and majority 102 (74%) were blood isolates. While
184 (90%) of maternal isolates were genitourinary isolates, 85 (41%), 65
(31.7), and 33 (16.1%) were HVS, urine and episiotomy wound isolates
respectively. Acinetobacter baumannii was the commonest identiﬁed
special both in neonatal and maternal isolates form 64.7% (185) of
species while Acinetobacter calcoaceticus form 33.2% (95) of identiﬁed
species. 77.3%, 86.5%, 45% Acinetobacter baumannii were resistant to
ampicillin, cefuroxime and cefotaxime respectively and only one isolate
was resistant to imipenem and tazocin and no resistance detected to
amikacin and meropenem. The Acinetobacter calcoaceticus had the same
antibiotic proﬁle as Acinetobacter baumannii.
Conclusion: The species proﬁle and the antibiotic resistance pattern for
both neonatal and maternal isolates were comparable and may indicate
that the neonatal isolates mainly acquired in the hospital may be related
to maternal community strains. At the same time we did not elicit
the trend of multi-resistant Acinetobacter spp. that is reported in the
literature as main problematic nosocomial isolates during the last six
years.
R2446 Pseudomonas aeruginosa bacteraemia: 303 cases
C. Ezpeleta, J. Alava, J. Unzaga, V. Cabezas, C. Busto, E. Gomez,
I. Atutxa, R. Cisterna (Bilbao, ES)
Objective: P. aeruginosa bacteraemia (PAB) is a serious infection
associated with high mortality, being one of the most common
nosocomial pathogen. Underlying diseases, source of infection and
inappropriate antibiotic therapy are associated with mortality. The aim
of this study is to asses clinical epidemiology of PAB in our hospital.
Methods: Prospective study of all patients with PAB. Study period
Nov 1993-July 2007. Blood cultures are performed by means of
BACTEC 9240. The Infection Control team studies every patient with
positive blood cultures. Variables under surveillance are age, sex,
underlying illnesses, predisposing conditions, source of bacteraemia,
nosocomial/community acquired, antibiotic susceptibility, treatment and
outcome. A computer based surveillance system (SEPSIS-DATA) is
used.
Results: 303 cases, 203 males (67%). Age: 67.6% >60 years. Underlying
illnesses: Neoplasia 42.24%, Diabetes 16.17%, COPD 13.2%, HIV
7.59%. Hospital acquired 48.84%. Source of bacteraemia: Primary
27.0%, Urinary tract 20.13%, Respiratory 21.12%, abdominal 11.22%,
skin: 6.60%, Catheter related 5.94%, surgical site 2.64%. Predisposing
conditions: mechanical ventilation 9.9%, ICU 11.5%, surgery 13.5%,
urinary catheter 25.4%, antibiotic 48 h before bacteraemia: 40.59%,
intravascular catheter 49.17%, immunosuppressive therapy 26.73%,
neutropenia: 16.17%. Time to positivity of blood cultures 80.2%
less than 48 h. Polymicrobial bacteraemia: 20.8%. Treatment and
outcome: Inappropriate antibiotic therapy 20.1%. Crude mortality:
32.34%. Sensitivity to antibiotics: Amikacin 94.72%, Imipenem 90.76%,
Ceftazidime 88.45%, Gentamicin 87.46%, and Ciproﬂoxacin 78.88%.
Nosocomial bacteraemia: 148 cases, 63.5% males, 55.4% older
than 60y. Underlying illnesses: neoplasia 45%, VIH 7.4%. Source
of bacteraemia: primary 31.7%, urinary 18.9%, respiratory 18.24%,
catheter related 10.14%, surgical site 5.4%, abdominal 8.11%. Crude
mortality nosocomial acquired: 37%.
Conclusions: The incidence of Pseudomonas aeruginosa bacteraemia
in our hospital remained stable over last years. Neoplasia was the
most common underlying disease. The most active antibiotics are
Amikacin, Imipenem and Ceftazidime. The rate of multidrug-resistant
P. aeruginosa has increased in the last years. For these reasons, patients
with Pseudomonas bacteraemia might receive empirical antibiotics that
are inactive against Pseudomonas, especially before identiﬁcation and
antibiotic susceptibility results become available.
R2447 Risk factors for nosomial infections in an intensive care unit
J. Murcia-Paya´, E. Garcı´a-Va´zquez, M. Canteras, M.D. del Rey
Carrio´n, N. Alonso Ferna´ndez, M. Galindo Martı´nez, A. Dı´az-Pastor,
M.D. Rodrı´guez-Mulero, A. Melgarejo-Moreno, J. Go´mez-Go´mez,
J.M. Allegue (Cartagena, Murcia, ES)
Objectives: Knowledge on risk factors (RF) for the development of
nosocomial infection (NI) is crucial to establish preventive measures;
our aim is to assess RF for NI in an Intensive Care Unit (ICU) at a
second level hospital.
Patients and Methods: A prospective and observational study of NI
cases on the ICU during a 12 month period; epidemiological and clinical
variables as well as information about risk factors related to NI were
assessed (underlying conditions, severity at admission, rate of urgent
surgeries, invasive techniques, ICU length of stay, mechanical ventilation,
etc.). A logistic regression statistical analysis was done to identify RF
for different groups of NI.
Results: 806 patients were assess during the study period (33% women;
mean age 66.4±14.86 years). Mean ICU length of stay was 4.6±6.72
days. Mean APACHE II score was 11.41±8.25. Reasons for ICU
admission were: coronary disease 65%, other medical reasons 27%,
surgical patients 5% and traumatisms 2%; 40% of patients required
central intravenous line (CIL), 20% mechanical ventilation (MV), 48%
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urinary catheter, 18% surgery and 5% urgent surgery. In the statistical
logistic analysis RF associated to NI were: a) for nosocomial pneumonia,
APACHE II >15 (OR= 6.17; CI 95%, 1.39–27.33), MV duration >5
days (OR= 9.98; CI 95%, 1.81–55.04) and tracheotomy during more
than 2 days (OR= 14.73; CI 95%, 3.13–69.27); b) for urinary infection,
urinary catheter duration >3 days (OR= 4.03; CI 95%, 1.60–10.18)
and ICU admission >10 days (OR= 3.55; CI 95%, 1.41−8.91); c) for
catheter related bacteraemia, neutropenia (OR= 5.46; CI 95%, 1.33–
22.39) and CIL duration >6 days (OR= 35.89; CI 95%, 16.31–79) and
d) for surgical site infection, surgical re-intervention (OR= 42.61; CI
95%, 3.25–558.64), urgent surgical re-intervention (OR= 30.89; CI 95%,
4.31–221.39) and ICU admission >10 days (OR= 4.94; CI 95%, 1.19–
20.47).
Conclusions: Mean RF for NI were identiﬁed in our cohort and were
related to severity at admission, invasive techniques (urinary catheter,
CIL and MV) and ICU length of stay. Knowledge on these RF for NI
is crucial to establish preventive measures mainly in terms of the care
associated to invasive techniques.
Travel medicine, tropical & parasitic diseases
R2448 Epidemiological investigation of hydatidosis infections in
Iran
H. Tavakoli, N. Jonaidi Jafari, M. Izadi, M. Parsa (Tehran, IR)
Objectives: Hydatidosis is an important parasite infection, which has
a global spreading. This zoonose disease as an endemic one, in Iran,
has caused mortality and economic damages. Aim of this study is to
determine prevalence of hydatidosis infection in human and livestock
populations during recent ﬁve years (2002–2007) and to propose
guidelines for prevention and control of it.
Methods: In this analytical-descriptive study, rate of infection to hydatid
cyst in slaughtered livestock in 28 provinces of Iran (in term of detected
infected organs) and also prevalence of human hydatidosis in mentioned
provinces were evaluated and analysed epidemiologically in the ﬁve year
period.
Results: Average rate of infection to hydatid cyst in slaughtered livestock
was determined as 6.73%. 4,298,882 livers and lungs in 63,851,561
slaughtered animals were taken out from consumption cycle due to
hydatid cyst infection. Lung infection was 1.8 times more than liver
one. Among 28 studied provinces, Khorasan and Yazd with 18.71% and
2.4% ranked highest and lowest infection rates respectively. In addition,
economic damage caused by omitting infected organs in this ﬁve-year
period was estimated to be about 76 million dollars. Average prevalence
of human hydatidosis during years 2002 to 2007 was determined 0.61 (in
each 100,000 persons). Khorasan province with 615 cases out of 2083
ones (29.52%) and Hormozgan province without any cases took the ﬁrst
and the last positions respectively.
Conclusion: Health and economic signiﬁcance evaluations and epidemi-
ologic studies for each infection are the ﬁrst steps for prevention and
controlling and also a conﬁdent starting point for facing with infection.
Livestock hydatidosis has been endemic in Iran and have had an ever-
increasing rate during studied ﬁve-year period. As this infection is
zoonose disease, proposed suggestions could be useful.
R2449 Epidemic typhus with concomitant Staphylococcus hominis
bacteraemia in an immunocompetant patient after tourist
trip to India and Nepal: case report.
MM. Dabrowska, H. Miegoc, J. Jaroszewicz, B. Puzanowska, R. Flisiak
(Bialystok, PL)
Background: Epidemic typhus is an acute febrile illness, caused by
Rickettsia prowazekii and transmitted by louse Pediculus vestimenti, that
may present with a broad spectrum of clinical manifestations. Epidemic
typhus occurs in Central and South America, Africa, northern China, and
certain regions of the Himalayas. Staphylococcus hominis is a harmless
commensal on human skin. We present a case of Rickettsia prowazekii
infection with concomitant Staphylococcus hominis bacteraemia in an
immuncompetant patient who returned from tourist trip in India and
Nepal.
Case presentation: A 30-year-old female was admitted with 2-week
history of high-grade fever of 40C, general weakness, chilly sensation
and sweating. A week before hospitalisation she returned from 19-
day tourist trip in India and Nepal. At the beginning of fever she
took 8-day oral amoxicillin therapy, during which she observed one-
day maculopapular rash on the arms and legs. Before the trip patient
obtained vaccine prophylaxis against hepatitis A and B, typhoid fever,
poliomyelitis, tetanus and diphtheria. During trip, she took regularly
antimalarial chemoprophylaxis with atovaquon-proguanil which was
interrupted by herself in Nepal, so initially malaria was considered.
Clinical examination revealed mild splenomegaly. Laboratory analysis
yielded erythrocyte sedimentation rate of 48mm/h, microcytic anaemia
and moderately elevated C-reactive protein and aminotransferases level.
A chest X-ray showed diaphragm-pleural adhesions. An ultrasonography
discovered restrained left pleural effusion. Serologic blood tests for HIV,
EBV, Mycoplasma pneumoniae and Bordetella pertussis were negative.
Malaria was excluded and all bacterial as well as fungal cultures of urine
and stool were negative. Blood cultures yielded Staphylococcus hominis
and empiric antibiotic therapy with ciproﬂoxacine was introduced. This
treatment was conﬁrmed as appropriate by further sensitivity data and
continued for 10 days. The Weil-Felix agglutination test was positive
in titer 1:800, so diagnosis of epidemic typhus was established and
oral doxycycline therapy initiated. The patient was discharged from the
hospital in good general condition.
Conclusion: Rickettsia prowazekii infection should be considered in
Europeans with acute febrile illness, especially following travels to
endemic regions. Moreover, the other concomitant infections are also
possible.
R2450 Trichomonas vaginalis: a point prevalence study in a
high-risk population in Havana, Cuba
I. Justo Roll, S. Yee Seuret, S. Balcildes Acosta, J.W. Mouton,
C.H. Klaassen, J.F. Meis (Havana, CU; Nijmegen, NL)
Objectives: To estimate Trichomonas prevalence, risk factors and its
association with past and current sexual transmitted diseases (STD’s) in
an urban, high risk population, in Havana City, Cuba.
Methods: A random, point prevalence study in a population with a
high risk for STD’s in urban areas of Havana City, Cuba. 375 healthy
young adults, 294 females and 81 males, with an age range from 14
to 35 years old gave consent to participate and been tested for STD’s.
Participants older than 35 years, younger than 14 and without previous
sexual intercourse and those who were under current broad spectrum
antibiotics or in the last 4 weeks were excluded. A cervical smear in
women and an urethral smear in men was used for molecular detection
of Trichomonas using an established real-time PCR procedure.
Results: Prevalence of Trichomonas vaginalis was 5.7%. Among
the subjects positive for Trichomonas, females were mostly affected
(95.2%;20/21). There was no relation with age and Trichomonas was
equally found among all age groups. The current infection with Tri-
chomonas was related with past STD infection(OR:3.3;p = 0.037). Pre-
vious vaginitis complaints (OR:2.2;p = 0.119) and pelvic inﬂammatory
disease episodes (OR:1.8;p = 0.238) were not signiﬁcantly related. The
age of ﬁrst sexual intercourse was highly associated(OR:2.9;p = 0.012)
with the diagnosis of Trichomonas in the study group; similar as
with having two or more sexual partners in the last ﬁve years
(OR:2.9;p = 0.06). Trichomonas infection was a predictor for concurrent
Chlamydia and gonorrhoea infection (OR:1.8 and 17.5, respectively).
Conclusion: Infection with T. vaginalis was found to be common
in sexual active women, but age was not a signiﬁcant factor of
infection. Trichomonas was not associated with other gynaecological
co-morbidities but was a marker of STD co-infections. Because positive
samples were equally distributed among all age groups, strategies to
approach the problem may greatly differ from other STD’s.
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R2451 Macroscopic and light microscopic manifestations of the
cyst of Coenurus cerebralis in sheep brain
E. O¨zbek, A. O¨zbek, Y. Kalkan, T. Demirci (Erzurum, TR)
Objectives: Coenurosis is caused by the larval stage of Taenia multiceps.
The larvae, Coenurus cerebralis, form cysts in cerebrum, cerebellum and
spinal cord of sheep, goats, cattle, horses, and have been also reported
in humans. When the parasite settles in the central nervous system of
intermediate host, it develops as a cyst growing slowly and becoming
5−6 cm in 6−8 months. The presence of freely roaming dogs (fox, jackal)
on grazing land greatly contributes to the existence of the diseases.
Dogs fed with offal including sheep head maintain the C. cerebralis–
T. multiceps cycle. Severity of the disease may be attributed to the
magnitude of the cyst in the brain. Because of the pressure of cyst/cysts,
the circling, the commonest sign becomes. When the animal is forced to
rotate, it circles to the affected side. Head deviation, to lag behind the
ﬂock and visual impairment are the other common signs. This study aims
to call especially medical doctors attention to Coenurosis, a zoonotic
disease and to show morphological features of the C. cerebralis cyst.
Methods: One of the sheep dead due to complaints similar to those
mentioned above was used in the present study. When the animal
sent for a necropsy to the Veterinary Control and Research Centre in
Erzurum, Turkey was dissected, a cyst 3.5 cm in diameter in the brain was
inspected. The cyst and brain tissue were evaluated at the macroscopic
level. After whole cyst was removed from the brain, it was ﬁxed in 10%
formalin, and dehydrated in graded alcohol series, and embedded in
parafﬁn for light microscopic examination. Parafﬁn sections were stained
with Haematoxylin-Eosin (H-E).
Results: Hyperaemia and petechial haemorrhages were present on the
brain. Whitish specks (0.3−0.4mm in diameter) on the transparent cyst
wall were observed with naked eye, representing invaginated scolices. In
H-E stained slides, scolices from the germination membrane and their
rostellums with a double crown hooks were examined microscopically.
Conclusion: However the cases of man are rare, coenurosis has to
be kept mind. Preventive measures are very important for this mortal
zoonosis.
R2452 Prevalance rate of Cryptosporidium infection in haemodialy-
sis patient admitted to hospital, Mashhad, Iran, 2006–2007
H. Yazdanfar (Mashhad, IR)
Introduction: Cryptosporidium parvum, an intracellular protozoan
parasite, is a signiﬁcant cause of gastrointestinal disease worldwide.
Transmission can occur from an infected person, animal or faecally con-
taminated environment. The clinical manifestations of cryptosporidiosis
are dependent on the immunologic state of the host. Infection among
immunocompetent hosts results in diarrhoea that is typically self-limited.
In immunocompromised hosts, however, the infection may be protracted
and life-threatening with no reliable antimicrobial therapy.
Results: In this study we compared the prevalence rate of Cryptosporid-
ium infection in hemodialysis patients and control group (patients family
member and general population). Stool specimens of 50 adult outpatient
chronic hemodialysis patients and 100 healthy individuals were examined
for the presence of Cryptosporidium oocysts by using a modiﬁed acid-
fast staining method and formalin-ether sedimentation technic. 6 of
50 (12%) dialysis patients were infected with Cryptosporidium. This
was signiﬁcantly higher than 1 of 100 (1%) cases in the control group
respectively (p = 0.006).
The prevalence rate of Cryptosporidium infection did not correlate
with patients’ age, duration of dialysis, cause of renal failure, history
of kidney transplantation, history of diabetes mellitus, history of
diarrhoea or history of taking antibiotics during last mount. As
hemodialysis patients are candidates for renal transplantation, general
preventive measures against acquiring Cryptosporidium infection must
be considered and these patients must be screened for their carrier state
before transplantation. We also should prevent transmission to other
dialysis patients by isolation of the index case until successful treatment
is accomplished.
R2453 Serum copper, zinc, magnesium and selenium levels in
patients with snake bite
C. Ustun, I. Tegin, M.F. Geyik (Diyarbakir, Siirt, TR)
Objective: The aim of this study is to compare the serum Copper (Cu),
Zinc (Zn), Magnesium (Mg) and Selenium (Se) levels of patients with
snake bite and healthy individuals.
Material and Methods: In this study, 40 patients with snake bite,
and 90 healthy individuals in the control group were included. From
totally 130 individuals, 5ml of venous blood was taken after fasting 10
hours at night. Serum samples were decomposed by centrifugeting at
5200 turn for 10 minutes. Serum samples were diluted with deionised
water. Cu, Zn, Mg and Se levels were measured in all serum samples
by using Unicam 929 Atomic Absorption Spectrophotometer. All data
entry and analysis were performed using SPSS for Windows Version 10.0
programme.
Results: The average age of 40 patients with snake bite was 40.1±19
years, of whom 18 were males (45%), 22 were females (55%).
The average age of 90 healthy individuals was 29.3±8.8 years, of
whom 45 were males (50%), 45 were females (50%). Serum Cu,
Zn, Mg and Se levels of patients with snake bite was found to be
75.8±21mg/dl, 86.9±25mg/dl, 1200.6±562mg/dl and 96.2±44mg/dl
respectively. Serum Cu, Zn, Mg and Se levels of healthy individuals
were found to be 57.1±17mg/dl, 55.8±13mg/dl, 1430.9±292mg/dl
and 118.4±56mg/dl respectively. A statistically signiﬁcant (p = 0.0001)
increase at serum Cu and Zn levels and decrease in Mg and Se levels of
patient with snake bite were detected, when compared with the control
group.
Conclusion: Snake bite is associated with signiﬁcant increase at serum
Cu and Zn levels and decrease in Mg and Se levels of trace elements.
Further studies on the measurement of trace element may be useful to
understand the course of snake bite.
R2454 Bioﬁlm production and antimicrobial susceptibility of
enteroaggregative Escherichia coli causing traveller’s
diarrhoea
E. Mendez Arancibia, S. Ramon, A. Gonzalez, J. Ruiz, J. Gascon,
J. Vila (Barcelona, ES)
Objective: The main objective of this study was to investigate the bioﬁlm
production and antimicrobial susceptibility of 75 enteroaggregative
Escherichia coli clinical isolates causing traveller’s diarrhoea.
Methods: The study population included adults who referred a diarrhoea
episode related to a visit to a developing country and had EAEC
isolated after attending at Hospital Clinic, University of Barcelona,
from January 2005 to December 2006. Bacteria were isolated in
different selective media and identiﬁed by conventional biochemical
tests. All recovered E. coli were analysed by speciﬁc PCR to establish
the E. coli enteropathotype and the presence of the aggR gene, a
transcriptional factor which regulates the expression of some virulence
factor. The antimicrobial susceptibility was established by mean of
commercial antibiotic panels (Sensititre® TREK Diagnostic Systems
Limited), whereas the production of bioﬁlm was determined using a
microtitre plate assay.
Results: The Laboratory of Microbiology received 900 for investigation
of TD between January 2005 and December 2006. EAEC was isolated
from 79 of those samples which represents 8.8% (nº of patients
submitting samples). Consistent data were available for 75 patients who
were included in the analysis. Antimicrobial susceptibility tests were
available for 50 isolates. Of those, 40 (80%) were resistant to ampicillin;
20 (40%) to nalidixic acid; 11 (22%) to ciproﬂoxacin, 44 (88%) to
tetracycline; 41 (82%) to cotrimoxazol and 13 (26%) to chloramphenicol.
It is important to highlight that 10% of the EAEC isolates were resistant
to third generation cephalosporins, all of them carried the blaCTXM-15
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and were isolated from patients to India. Forty-nine (49%) out of 75
EAEC isolates produced bioﬁlm. When the presence of the AggR gene
(35, 46.7%) was determined in the bioﬁlm-forming EAEC group versus
non-bioﬁlm-forming EAEC group, was the most prevalent virulence
factor in the bioﬁlm-forming EAEC group (70% vs 9%, p = 0.01).
Conclusions: These results show that bioﬁlm may be considered as
an important virulence factor, strongly associated with the presence of
AggR among EAEC isolates causing diarrhoea in travellers and that
the EAEC causing traveller’s diarrhoea show a high level of resistance
to ampicillin, tetracycline, trimethoprim and nalidixic acid. It is the ﬁrst
time that the presence of the blaCTXM-15 is described in EAEC clinical
isolates.
R2455 Synthetic Plasmodium falciparum GPI: TLR recognition
and structural requirements
J.P. Cramer, F. Kamena, B. Lepenies, X. Liu, G.D. Burchard,
P.H. Seeberger, T. Jacobs (Hamburg, DE; Zurich, CH)
Plasmodium falciparum malaria is conﬁned to blood stage parasites.
Host immune response to parasite antigens is essential for parasite
clearance but also contributes to disease manifestation. Plasmodial
glycosylphosphatidylinositol (GPI) contributes to malaria pathology by
induction of excessive cytokine release via Toll-like receptor (TLR) 2.
Since GPI is a promising anti-disease vaccine candidate, identiﬁcation
of structural requirements for TLR-activation is relevant.
Applying synthetic P. falciparum GPI-glycan analogues we identi-
ﬁed GPI moieties required for immune activation. On RAW264.7
macrophages, GPI substructures lacking the diacylglycerol moiety were
still stimulatory. However, at least four mannose residues were required
for TNF-alpha induction. Integration of lipidated GPI into erythrocyte
membranes induced increased TNF-alpha and IL-12 compared to pure
compound.
We conclude that the glycan moiety is the immune-stimulatory moiety
while the acyl chains confer optimal presentation of the molecule on cell
surfaces.
R2456 Leishmaniasis in Libya: epidemiological survey in Sirt
F. Elkasah, M. Dow, A. Elahwel (Sirte, LY)
Objectives: The cutaneous leishmaniasis in Libya to be, sometimes at
least, a rural zoonotic infection. We conduct a pilot study covering a 4
months period (October 2006 to February 2007) in the Alhish Hospital,
Sirt in Libya.
Patients and Methods: The diagnosis of cutaneous leishmaniasis
based on a clinical presentation, or positive parasitic smear. Information
gathered for each patient, including age, sex, geographic location,
previous history of leishmaniasis, a stay in an endemic area, the month
of consultation, lesion location, and the number and size of lesions. We
also note treatment and outcome.
Results: During this 4 months period, information on 84 (78 adult and 6
children) patients with lesions of cutaneous leishmaniasis was collected.
Distribution according to age showed that leishmaniasis affected adult
in 92.8 percent of the cases. Among the 84 patients were 26 female
and 58 male. All of our patients lived in an endemic area. The patients
gave a history of cutaneous leishmaniasis in other family members in
3.5 percent of the cases. The face was the most commonly affected site
(89%). Clinical diagnosis conﬁrmed by the parasitologic smear. Giemsa
stain revealed amastigotes, which appear pale blue.
Discussion: Leishmaniasis is quite prevalent in Libya. The distribution is
both in endemic areas and sporadic throughout the country. Coetaneous
leishmaniasis (CL) cases were recorded during this period (4 months) in
Elhisha, Sirt, an endemic area of CL in Libya. The age distribution of
cases showed that the age group 17–30 years was most affected. Most
case was in Elhisha (54.42%) and Tawargha (32.14%) may because of
presence of reservoir and the lakes. New case in new area (Algadahia)
indicate the spread of the disease to East. Various therapeutic regimens
were discussed. Only patients with severe lesions (approximately 21%)
were given 3 to 4 weeks’ treatment with intravenous Pentostam, to which
all except 4 responded satisfactorily with minimal side effects.
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R2457 Antifungal susceptibility testing of yeast isolates
from nine hospitals in Bulgaria and their species
distribution – a two-year study
Z. Ivanova, A. Kouzmanov, T. Kantardjiev, L. Boyanova (Soﬁa, BG)
Objectives: The aim of this study for a second year is to evaluate the
species distribution and antifungal susceptibility pattern of yeast isolates
from nine medical centres in Bulgaria.
In the current study was determined the ﬂuconazole and voriconazole
susceptibility of yeast strains mainly from genus Candida with the use
of E-test and micro-dilution kit Micronaut-AM (Merlin). The strains
with high minimal inhibitory concentrations (MICs) for ﬂuconazole and
voriconazole were additionally conﬁrmed with the referent broth micro-
dilution method CLSI (formerly NCCLS) M27-A2.
Methods: A total of 424 clinical yeast isolates were collected in the
clinical routine of nine participating medical centres from January 2006
to November 2007. All yeast strains were isolated from diverse body
site, of immunocompetent and immunocompromised patients, including
HIV infected ones. Etest MICs were determined with Mueller-Hinton
agar containing 2% glucose and 0.5mg per l methylene blue dye and
were noted after 24 and 48 h of incubation at 35ºC.
Results: The most frequently isolated species was Candida albicans
(70%). Among the non-albicans species, C. glabrata (8.5%) was the
most prevalent, followed by C. parapsilosis (5.9%), C. tropicalis (3.5%),
C. krusei (2.8%), and other Candida non-albicans strains (9%). Low
susceptibility to ﬂuconazole was detected among C. albicans strains
(2.3%, MIC >256mg l−1), C. glabrata (28%, MIC 16–32mg l−1;
36%, MIC >64mg l−1), C. krusei (27%, MIC 32–64mg l−1; 73%,
MIC >256mg l−1). No resistance to ﬂuconazole and voriconazole was
detected in C. parapsilosis, C. tropicalis and C. lusitaniae strains.
Resistance to voriconazole was detected only in C. glabrata (12.8%,
MIC >32mg l−1) and C. albicans (2.3%, MIC >32mg l−1) strains.
Voriconazole showed good activity to most of the tested isolates with
MICs in the range of 0.008−0.5mg l−1.
Conclusion: This study conﬁrmed the high percentage of isolated
C. non-albicans strains and showed that species distribution of Candida
isolates is similar to that in other European countries. An important
concern is the low ﬂuconazole susceptibility detected in C. glabrata and
C. krusei and their high prevalence.
R2458 Antifungal activity of Thymus serpyllum essential oil against
Candida albicans and Candida non-albicans clinical isolates
M. Pavel, F. Alecu (Bucharest, RO)
The increase of fungal resistance to classical drugs, the treatment cost,
and the fact that most available antifungal drugs have only fungistatic
activity, justify the search for new strategies. Aromatic plants and their
essential oils constitute the object of numerous studies, because alcohols
and phenols, components of essential oils, have strong antifungal
properties.
Objectives: The aim of this study was to establish the antifungal effect
(fungistatic and fungicidal effect) of Thymus serpyllum essential oil.
Material and Method: We used aerial parts of Thymus serpyllum
provided from a commercial lot. The essential oil was isolated by water
distillation from dried plant material, using a Clevenger-type apparatus,
according to the procedure described in the European Pharmacopoeia.
The antifungal activity of the essential oil was evaluated against 7
Candida albicans isolates (5 isolates recovered from patient with clinical
signs of oral candidosis (I to V) and two oral isolates from healthy
carriers (VI-VII) and one Candida glabrata recovered from a patient
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with oral candidosis associated to denture and diabetes (VIII). Antifungal
activity. MICs, determined by the macrodilution broth method, and
minimal lethal concentrations (MLCs) were performed according to the
references of National Committee for Clinical Laboratory Standards for
yeasts and ﬁlamentous fungi. Serial dilutions in ethanol ranging from
0.25 to 64 microl ml-1 were tested for essential oil. Equivalent dilutions
for ethanol were tested separately.
Results and Discussion: Evaluation of MIC and MLC showed that the
oil was active against all tested isolates. MIC values ranged from 1 to
2ml ml−1 for essential oil and 109ml ml−1 in case of ethanol. MLC for
essential oil was 2ml ml−1 for isolates I-III and 4ml ml−1 for isolates IV-
VIII while MLC for ethanol was 109ml ml−1. T. serpyllum essential oil
exhibited signiﬁcant antifungal activity and it is reasonable to consider
that the activity of this oil can be related to the presence of thymol and
carvacrol.
Conclusion: T. serpyllum essential oil has proved its potential to be used
as a topical antifungal agent against fungi that are pathogenic to humans.
This essential oil showed an important activity against Candida albicans
and Candida glabrata.
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R2459 Fungal infections at a Coimbra burns unit: 2003–2007
M. Caetano, S. Ramos, J. Abreu, J. Casalta, S. Pinheiro, C. Diogo,
L. Cabral, C. Cruzeiro (Coimbra, PT)
Objectives: Analyse the fungal infections, as well as the results of
systemic antifungal therapy in Coimbra Burns Unit (Portugal), during
the study period.
Methods: The authors retrospectively reviewed data of the patients
who developed fungal infections, admitted to the Burns Unit, from
January 2003 to November 2007. Epidemiological, microbiological and
pharmacological parameters were collected. The data was analysed using
the statistical programme SPSS.
Results: During the study period, 856 patients were admitted to the
burn unit and 69 patients were enrolled in the study, however, only
41 had complete data for the statistical analysis. The characteristics of
the patients admitted were: 62.9% male, mean age of 57.28 (± 87.6)
years [11; 96] and mean total burned body surface area (TBSA) of
15.8 (± 18.06) % [1; 100], versus 56.1% male, mean age of 63.54 (±
21.3) years [16; 96] and mean burned TBSA of 28.39 (±16.1) % [5;
60], for the patients enrolled. The mean hospital stay in the Burns Unit
was 16.72 days, whereas, 46.34 days for the enrolled patients and the
mortality average was 15.2% and 36.6% (40.2%/year), respectively. Eight
per cent of the patients developed fungal infections. Candida infection
was the most common (82%), being Candida albicans the main isolated
specie (56%). The antifungal agent most prescribed was amphotericin
B liposomal preparation (44%). In the study population, no statistical
signiﬁcant difference was found when comparing the days of hospital
stay required by the patients that used different antifungal treatment.
The mean cost of hospitalisation in Coimbra Burns Unit was 3272 € for
the average patient versus 11,915 € for a patient with antifungal therapy.
Conclusions: In the study population, a higher mean age and also a
greater mean percentage of TBSA was present in those patients who
developed fungal infections. These patients also required more days in
the hospital and had a higher mortality rate. Microbiological data should
be used frequently to monitor the evolution of the most frequent fungal
infections and in order to choose an adequate antifungal drug since these
agents contribute to higher costs of treatment.
R2460 Epidemiology and outcome of candidaemia at an
acute-phase community hospital
T. Saito, Y. Aoki (Kyoto, Tokyo, JP)
Objectives: To clarify the frequency of candidaemia, isolated Candida
species, and prognosis at an acute-phase community hospital, we
retrospectively analysed the clinical and microbiological data concerning
the cases of Candida species detected from blood between June, 2003
and February 2006.
Patients and Methods: In cases that candida species were isolated, we
recorded age, sex, underlying disease, identiﬁcation and susceptibility
for isolated candida species, doses of antifungal agents, duration of the
therapy, presence or absence for ophthalmic examination, and outcome.
Microbiological examination was carried out by an examination
company. Species identiﬁcation was conﬁrmed with the VITEK YBC
system or API 20 C AUX or API 32ID. The susceptibility testing
was performed by the use of a commercially prepared colorimetric
microdilution panel (ASTY®).
Results: In 329 patients with bacteraemia and/or candidaemia, 15
patients (4.6%) were candidaemia. The mean age was 79.5 years. There
were 8 men and 7 women. The underlying diseases were malignancy
(n = 7), cerebral infarction (n = 3), chronic renal failure (n = 1) and others
(n = 4). The isolated organisms were C. albicans (n = 5) C. parapsilosis
(n = 5), C. tropicalis (n = 2), C. glabrata (n = 2) and non-identiﬁed
candida species (n = 1). In the 15 patients, a central venous catheter
(CVC) had been inserted which was removed before determination
of the species identiﬁcation. In 12 patients that culture examination
of CVC tip was carried out, the same Candida species in the blood
was detected in 4 patients (33.3%). Thirteen of the 15 patients with
candidaemia (86.7%) were not performed the ophthalmic examination
for candida endophthalmitis. The patients with candidaemia were treated
with a daily dose of 100mg to 400mg of ﬂuconazole (n = 10), and of
250mg of micafungin (n = 1). Two patients received no treatment. Two
patients died before the species identiﬁcation. Nine of the 15 patients
(60.0%) died within the 30 days following a positive blood culture.
The susceptibility of isolates to ﬂuconazole was sensitive (n = 11) and
susceptible dose/delibery-dependent (n = 4).
Conclusions: In community hospitals, it is important that physicians
are cognizant of the possible occurrence of candidaemia in the patients
with CVC. Furthermore, if candidaemia occurred, appropriate antifungal
therapy and the ophthalmic examination for candida endophthalmitis are
also important.
R2461 In vitro susceptibility of clinical isolates of Candida kefyr
A. Gomez-Lopez, D. Pan, J.L. Rodriguez-Tudela, M. Cuenca-Estrella
(Majadahonda, ES; Montevideo, UY)
Background: Several surveillance programmes in Europe and USA have
detected an increase in the prevalence of fungal infections caused by
Candida species other than Candida albicans. Among these species,
C. kefyr has been reported recently as an a possible emerging pathogen.
We have reviewed the antifungal susceptibility proﬁle of the collection
of clinical isolates of C. kefyr in order to give any insight on the
management of this pathogen.
Methods: A total of 34 isolates of C. kefyr received in our institution
between 1995 and 2007 was evaluated. The isolates were identiﬁed
by routine physiological tests. The MICs of amphotericin B (AMB),
ﬂucytosine (5-FC), ﬂuconazole (FLC), itraconazole (ITC), voriconazole
(VRC), ravuconazole (RVC), posaconazole (POS), caspofungin (CAS),
micafungin (MCF) and anidulanfungin (AND) were determined ac-
cording to the recommendations proposed by the European Committee
on Antifungal Susceptibility Testing for fermentative yeast (EUCAST-
deﬁnitive document).
Results: Of the 34 strains, a total of 26.5% was isolated from
blood cultures, 17.6 from vaginal exudates, 14.7% from oropharyngeal
exudates, and 29.4% from other sites. A high number of isolates
were received in the last four years (19/34, 55.8% since 2004). All
of the strains were considered sensitive to AMB (Geometric Mean,
GM, 0.22mg/L and MIC range: 0.06−1mg/L). Of note, three isolates
exhibited an AMB MIC=1mg/L. Only one isolate was resistant in vitro
to ﬂucytosine (MIC 32mg/L). All the azole compounds showed great
activity against C. kefyr isolates, with GM values of 0.25, 0.029, 0.015,
0.024 and 0.015 for FLC, ITC, VRC, RVC and POS respectively. In
addition, echinocandins demonstrated excellent activity against all of
the strains tested. (MIC values lower than 0.12mg/L)
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Conclusions: C. kefyr seems to be an emerging pathogen. Most of
isolates are susceptible in vitro to all antifungal agents currently licensed.
R2462 Complement evasion by Candida is dependent on glucose
concentration
I. Lesiak, G. Vogl, C. Lass-Flo¨rl, C. Speth, M.P. Dierich, R. Wu¨rzner
(Innsbruck, AT)
Objectives: Pathogenic fungi represent a major threat to immuno-
compromised hosts, leading to severe, and often lethal, systemic
opportunistic infections. Factor H (FH), a soluble plasma protein
consisting of 20 short consensus repeats (SCRs), is the main ﬂuid
phase inhibitor of the alternative pathway of complement. C4b-binding
protein (C4bp), having a polymeric structure composed of 6−8 identical
alpha-chains and a single beta-chain, is the main ﬂuid-phase inhibitor
of the classical and lectin pathways of complement. Both proteins can
be acquired onto the surface of various human pathogens conveying
resistance to complement destruction and thus contributing to their
pathogenic potential. We have recently shown that Candida albicans
evades complement by binding both FH and C4bp. Preliminary data
suggest that a glucose transporter molecule is involved in this binding.
The aim of this study was to assess whether complement evasion via
this mechanism is dependent on the glucose concentration present.
Methods: Immunoﬂuorescence, ﬂuorescence activated cell sorting and
speciﬁc constructs of the proteins investigated, as well as antibodies
directed against particular parts thereof have been used to identify and
characterise these virulence factors.
Results and Discussion: We now show that binding of factor H and
C4bp is strongly dependent on the glucose concentration present and
discuss important implications, e.g. for diabetics.
Conclusion: By acquiring complement regulators from the host, yeasts
are able to evade the destructive action of complement. This acquisition,
however is dependent on the glucose concentration present.
R2463 Evaluation of disc diffusion in susceptibility testing of
anidulafungin against Aspergillus isolates
A.I. Martos, T. Gonza´lez, A. Romero, A. Gonza´lez, C. Martı´n-Martı´n
de la Escalera, E. Lo´pez-Oviedo, E. Martı´n-Mazuelos (Seville, ES)
Objective: We studied the applicability of a disk diffusion (DD) method
for testing the susceptibility of anidulafungin against Aspergillus spp. in
comparing with the broth microdilution (MD) reference method (CLSI
M38-A).
Material and Methods: We tested the antifungal susceptibility of
65 Aspergillus strains (A. ﬂavus, A. terreus, A. fumigatus, A. niger,
A. glaucus) isolated from clinical samples. DD method was done using
anidulafungin disks prepared in house (according the M44-A document
of the CLSI). Two ﬁnal concentrations were assessed: 1 mg and 2mg/disk.
Blank paper disks were impregnated with 20 ml of each anidulafungin
suspension (concentrations 50mg/ml and 100mg/ml), containing 1%
DMSO and 0.1% P-80 (Jones et al. Diagn Microbiol Infect Dis, 2007).
The media tested for DD method was Mueller-Hinton agar (MH) (Difco).
The inoculated plates were incubated at 35ºC and read the inhibition
zones diameters at the point of marked decrease in fungal density (IZ-2)
at 24 and 48 h. The MD test was done according M38-A document of
CLSI for ﬁlamentous fungi. Stock inoculum suspensions were prepared
from 7-days-old cultures grown on potato dextrose agar and ajusted
spectrophotometrically with saline solution to ~80% transmittance. The
diluted inoculum sizes achieved a ﬁnal concentration of ~104 CFU/ml.
For the MD method we read the MEC (minimum effective concentration)
at 48 hours. A. fumigatus ATCC 204305, A. ﬂavus ATCC 204304,
C. parapsilosis 22019 and C. krusei 6258 were included in each
susceptibility test for quality control and assessment of reproducibility.
Results: The results are expressed in Table 1, as Aspergillus spp.
(number of isolates) anidulafungin GM (geometric mean) of MEC
(minimum effective concentration in mg/ml) for MD at 48 h; AM
(arithmetic media) of IZ-2 in mm on MH 24/48 hours.
Table 1.
MD DD 1mg DD 2mg
48 h 24 h 48 h 24 h 48 h
Range GM Range AM Range AM Range AM Range AM
A. fumigatus (28) 0.03 0.03 25–37 31.3 25–35 29.1 25–45 36.5 25–41 31.8
A. ﬂavus (18)a 0.03 0.03 22–36 30.8 22–30 27.8 22–37 32.3 22–35 29.1
A. terreus (17)b 0.03 0.03 23–32 29.9 23–32 27.9 24–36 31.5 24–35 29.9
A. niger (2) 0.03 25–28 25–28 26–32 26–32
A. glaucus (1) 0.03 30 28 35
Total (65) 0.03 0.03 22–37 30.3 22–35 28.4 22–45 33 22–41 30.4
aNo growth observed in 2 strains at 24 hours.
bNo growth observed in 3 strains at 24 hours.
Conclusions:
1. All the strains of Aspergillus spp. tested with anidulafungin got MECs
0.03mg/ml and IZs-2 22mm at 24 h with disk of 1mg on MH agar.
2. Disk of 2mg produced very large zones, so the optimal concentration
for anidulafungin is 1mg/disk.
3. DD could be an useful method for testing the susceptibility of
anidulafungin against Aspergillus spp. already at 24 h of incubation,
although additional studies are needed to know the real applicability.
R2464 DHPS genotypes in Pneumocystis jirovecii infected patients
from Spain
L. Rivero, C. de la Horra, M. Montes-Cano, S. Gutierrez-Rivero,
I. Martin, R. Morilla, V. Friaza, N. Respaldiza, G. Wissman,
F. Medrano, J. Varela, E. Calderon (Seville, ES)
Objectives: The absence of a reliable method to identify Pneumocystis
jirovecii resistance to sulfa or sulfone drugs, has led to develop molecular
techniques based on identiﬁcation of punctual mutations at codon 55
and 57 on the Dihidropteroate Synthase gene (DHPS). Several studies
suggest that these mutations are associated with the failure of prophylaxis
and with the worsening of the Pneumocystis pneumonia (PCP) prognosis.
The aim was to establish the frequency of DHPS mutations in Spanish
patients infected by P. jirovecii.
Patients and Methods: The study includes 95 subjects were DHPS
gene was typed. Among patients included, 35 of them suffered of
Pneumocystis pneumonia (PCP) and 60 were colonised subjects without
evidences of immunosuppression.
P. jirovecii was identiﬁed by nested PCR at mtLSUrRNA gene.
DHPS polymorphisms were identiﬁed by Restriction-Fragment-Length-
Polymorphism; digestion with Acc I and Hae III identify mutations at
positions 55 and 57 respectively.
Results: The analysis provides a 22.1% rate of DHPS-gene mutations
in our population, with the presence of all possible polymorphisms
described. All polymorphism were found in a similary rate in both
groups. The presence of mutations was(20% in colonised vs 25.7% in
PCP patients.
The statistical analysis does not show differences due to age, sex;
exposures to steroid treatment, or smoking habit when patients infected
by P. jirovecii with or without mutations were compared.
Conclusions: This study shows the presence of DHPS mutations in our
area, not only conﬁned to patients who have followed chemoprophylaxis.
Project ﬁnanced by FIS 04/217
R2465 Smoking inﬂuence in Pneumocystis jirovecii colonisation
from patients with chronic obstructive pulmonary disease
V. Friaza, C. de la Horra, N. Respaldiza, R. Morilla, I. Martin,
S. Gutierrez-Rivero, R. Garcia-Contreras, L. Rivero, F. Medrano,
J. Varela, E. Calderon, M. Montes-Cano (Seville, ES)
Objectives: Chronic obstructive pulmonary disease (COPD) is char-
acterised by a continuous airﬂow limitation due to chronic bronchial
inﬂammation. Currently, it has been described the colonisation by
Pneumocystis jirovecii in patients with COPD, as well as reservoir and
source of transmission. Several studies carried out in HIV infection
patients have shown that smoking is a risk factor for developing
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Pneumocystis pneumonia (PCP). On the other hand, in a mouse model
of infection pneumonia has been found that nicotine reduces the rate of
infection/colonisation by this microorganism. This fact can be explained
because nicotine reduces s-adenosil-Methionine (AdoMet) levels, which
is a key nutrient in the metabolism of Pneumocystis. However, the
role that smoking can play in Pneumocystis colonisation remains
unknown. To assess the relationship between smoking and Pneumocystis
colonisation in patients with COPD.
Patients and Methods: From a previously study to determinate the
prevalence of Pneumocystis colonisation in patients with chronic lung
diseases, we selected those diagnosed with COPD based on GOLD guide
and from the smoking habit information was available. Sputum samples
from 238 patients were study. The presence of P Jirovecii colonisation
was detected by speciﬁc nested-PCR based on mitochondrial region
(mtLSUrRNA).
Results: A 15.5% of patients (37/238) were colonised by P. jirovecii
being 75.6% (180/238) active smokers. From the smokers patients,
18.8% (34/180) were colonised by Pneumocystis compared with 3 out
of 58 non-smokers (5.1%); p = 0.02. To evaluate the role of other factors
favouring colonisation multivariate analysis was performed including
sex, age, smoking habit, steroids consumption, levels of lymphocytes,
presence of emphysema and FEV1%. From all these variables only
active smoking habit was an independent risk factor for pneumocystis
colonisation in patients with COPD (OR 3.6, 95%CI: 1.07–12.6).
Conclusion: Smoking habit produces a ciliary dysfunction being a risk
factor for Pneumocystis jirovecii colonisation in patients with COPD.
This study was supported by the Consejeria de Salud de Andalucı´a.
Project nº 169/2006.
R2466 Prevalence and causative agents of tinea capitis among
primary school students in Erzincan, Turkey
A. Ayyildiz, G. Hocaoglu, A.E. Aktas, M. Atasoy (Erzurum, TR)
Objective: Tinea capitis is a worldwide-spread infection of the scalp
and hair caused by dermatophytes. Children between 3 and 9 years
old are at highest risk and outbreaks have been noted in schools and
day care centres. A variety of clinical presentations is recognised as
being either inﬂammatory or non-inﬂammatory and is usually associated
with patchy alopecia. Since the clinical appearances can be subtle,
mycological examinations should be done to ensure accurate diagnosis.
In the present study we aimed to determine the prevalence and the agents
of tinea capitis among the primary school students in Erzincan, Turkey.
Method: A screening study was performed in 94 schools, covering a
total of 19173 children with 9827 boys and 9346 girls, aged 6–14 years.
Of the students 13855 were going to the schools in the city centre, and
the others (5318 student) in the rural area.
All children were clinically examined and selected on the basis of
symptoms indicative of tinea capitis infection. From both clinically
evident and suspected cases skin scraping and hair samples were taken
for microscopy and culture in order to conﬁrm the diagnosis.
Samples were cultured onto Sabouraud Dextrose agar, incubated at 30ºC
for up to 30 days and checked for fungal growth every week. At the same
time, direct examination with KOH-DMSO was made to detect fungal
structures. Grown isolates were identiﬁed using conventional methods.
Results: According to the clinical examination, 34 students were pre-
diagnosed as tinea capitis, but only the 14 of them (9 boys and 5 girls)
were conﬁrmed by microscopy. In 11 of the cases, the clinical form
was tinea capitis superﬁcialis, and in the remaining 3 it was Kerion
celsi. Most of the tinea capitis cases were from rural regions (11 out
of 14). Causative agents were isolated in only 7 of the 14 samples of
which microscopy were positive. The isolated 7 strains were identiﬁed
as follows: Two were M. canis (28.5%), 2 were M. audouineii (28.5%),
2 were T. tonsurans (28.5%) and 1 was T. violaceum (14.5%).
Conclusion: In the study tinea capitis prevalence among the primary
school students in Erzincan province was found as 0.073%. This result
was generally in accordance with the previous studies made in the same
region. But T. tonsurans was the ﬁrst isolate in Eastern Anatolian while it
was not reported as a causative agent in the previous studies. In contrary
to the previous studies T. scho¨nleinii could not be isolated in the present
study.
R2467 Protothecal endocarditis in a dialysis dependent patient
P. Wright, J. Coia, S. Morris, J. Rathod (Glasgow, UK)
Background: Protothecosis is an uncommon infection in humans caused
by achlorophyllic algae of the genus Prototheca. The majority of
infections caused by these ubiquitous organisms involve the skin and
subcutaneous tissue, and rarely cause systemic disease. Here we report
a case of protothecal endocarditis in a patient dependent on dialysis via
a native arteriovenous ﬁstula.
Case report: A 56 year old female haemodialysis patient presented with
fever, rigors and a rising C-reactive protein. Her extensive past medical
history included chronic renal failure secondary to polycystic kidney
disease, Crohn’s disease with short bowel syndrome and subsequent total
parenteral nutrition via Hickman line, recurrent Hickman line sepsis,
polycystic liver disease and portal hypertension for which a TIPSS
procedure was carried out and long-standing leukopenia of unknown
cause. She had echocardiographic evidence of aortic valve vegetations.
Prototheca wickerhamii was isolated from multiple blood cultures via the
BacT/Alert continuous-monitoring system and identiﬁed to species level
by the Rapid ID™Yeast Plus System (Remel). Susceptibility and synergy
testing was carried out by the Mycology Reference Laboratory, Bristol.
She responded well to the administration of liposomal amphotericin
3mg/kg/day and oral doxycycline 200mg/day reﬂected by a drop in
C-reactive protein from 100 to 15. Surgical valve replacement was
considered unnecessary. No obvious source of infection was found.
Conclusion: Systemic protothecal infection is uncommon with only one
other case of protothecal endocarditis reported in the literature. This case
highlights several risk factors for infection and provokes some interesting
questions regarding appropriate management. We report a good clinical
response to treatment with intravenous liposomal amphotericin and oral
doxycycline.
R2468 Isolation from blood cultures and susceptibility testing of
Candida sp. strains during three years in a tertiary hospital
in Greece
M. Orfanidou, G. Ganteris, M. Karanika, K. Ziva, D. Petropoulou,
H. Malamou-Lada (Athens, GR)
Objectives: To study the isolation from blood cultures and the
susceptibility of Candida sp strains to antifungal drugs in a tertiary
Hospital in Greece, during a three year period (1/1/2004–31/12/2006).
Methods: During the study period blood cultures from 15723 patients
were sent to the laboratory. The vials of the blood cultures were incubated
in BACTEC 9240 (BD) and BacT/ALERT 3D (bioMerieux) automated
systems. Positive vials were subcultured on conventional media. The
strains were identiﬁed by VITEK2 (bioMerieux) automated system.
Susceptibility testing was performed on RPMI agar (E&O) by E-test
(AB Biodisk).
Results: During three years’ period, blood cultures from 2605 patients
were found to be positive (2605/15723, 16.57%). Candida sp strains
were isolated in 71/2605 (2.7%) of these patients. The origin of
the strains was from Internal Medicine Department 32/71 (45.1%),
Surgical Department 24/71 (33.8) and Intensive Care Unit (ICU) 15/71
(21.1%). Candida albicans was the predominant strain (29/71, 40.8%),
followed by C. parapsilosis (15/71, 21.1%), C. glabrata (13/71, 18.3%),
C. tropicalis (7/71, 9.8%), two strains of C. famata, two strains of
C. lusitaniae and C. krusei, C. dubliniensis and Candida sp one strain
each. Susceptibility was tested in 50 strains. The resistance rate of the
isolated strains was: itraconazole 29%, ﬂuconazole 22%, voriconazole
7%, ﬂuocytosine 6%, while there was no resistance to caspofungin and
amphotericin B.
Conclusions:
1. The rate of candidaemia in our hospital is approximately 3% of the
patients with positive blood cultures.
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2. C. albicans represented 40% while non-albicans Candida composed
60% of the total.
3. There was a high resistance rate to itraconazole and ﬂuconazole,
but also resistance of lower rate was observed to voriconazole
and ﬂuocytosine, while there was no resistance to caspofungin and
amphotericin B.
4. In cases of candidaemia antifungal therapy according to the
susceptibility test of the isolated strains is warranted.
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R2469 HIV-related morbidity in the HAART era
M.A. Escobar, A.A. Garcia-Egido, S.P. Romero, J.A. Bernal,
J.L. Puerto, C. Asencio, J.L. Andrey, J. Gonzalez-Outon, F. Gomez
(El Puerto Santa Maria, ES)
AIDS related hospital admissions and morbidity have decreased after the
introduction of HAART.
Objective: To assess the changes in hospital admissions and morbidity
with the improvement of HARRT.
Methods: We studied the hospital admissions and morbidity over three
different periods pre-HAART (January 1992 to December 1994), early-
HAART (January 1995 to December 1998) and post-HAART (January
1999 to October 2006), in HIV infected patients followed at our centre.
Results are expressed for periods pre-HAART, early HAART, and post-
HAART respectively. Mean (SD) CD4/mL were: 16±5, 37±11 and
118±33 (p< 0.0001). Undetectable plasma viral load (%) were: 0, 16
and 43 (p< 0.0001). Patients with a prior diagnosis of AIDS were:
91%, 68% and 36% (p< 0.001). The rate (%) of women/heterosexuals
was: 6/2, 11/5 and 21/11 (p< 0.01) and, that of IVDA (%) was:
96, 88 and 75 (p = 0.03). Hospital admissions due to AIDS-deﬁning
illnesses decreased (p< 0.001) with a signiﬁcant increase in the rate
of respiratory tract infections (p< 0.005), digestive tract (p< 0.01) and
liver diseases (p< 0.001). The proportion of AIDS-deﬁning illnesses
decreased after HAART (p< 0.01), whereas the rate of liver diseases
increased (p< 0.001).
Conclusions: The HAART era has been associated with a progressive
decrease in hospital admissions due to AIDS-deﬁning conditions, and
a steady enhancement of the spectrum of admissions by non-AIDS-
deﬁning conditions has increased.
R2470 CCR and HERV polymorphism in HIV-1 infection: Polish
population analysis
K. Zwolinska, E. Piasecki, K. Rybka, B. Knysz, J. Gasiorowski,
A. Gladysz (Wroclaw, PL)
Objectives: Polymorphism in many loci affects susceptibility to HIV-1
infection. The allelic forms of chemokine receptor CCR5 and CCR2
genes are known to be of importance. However, the exact signiﬁcance
of a particular allele in different populations and groups of patients
is not always established. Some of human endogenous retrovirus
(HERV) sequences have structural and/or functional similarity with HIV
sequences. Because of that there is possibility of positive or negative
effect on course of HIV-1 infection. Some of HERVs (HERV-K113
and HERV-K115) encode protein within the env gene, termed Rec. This
protein is a functional counterpart to the Rev protein of HIV.
In our investigation we determined frequency of CCR5-delta32, CCR2–
64I alleles and HERV-K113 and HERV-K115 sequences in the HIV-1-
positive patients in Lower Silesia Region of Poland in comparison to
exposed uninfected people (EU) and healthy, unexposed people from
control group from that region.
Methods: The genotype was determined by PCR method. In the case
of CCR2 two pairs of primers and PCR-RFLP method was used. The
genotype was determined by PCR method with three reaction for HERV-
K113 and four for HERV-K115.
Results: Frequency of CCR5-delta32 and CCR2–64I alleles in Polish
population was found to be 11.9% and 12.8%, respectively (healthy, non-
infected, non-exposed to HIV individuals). In HIV-1-infected patients
frequency of CCR5-delta32 allele was reduced (7.9%). On the contrary,
higher CCR5-delta32 allele frequency was found in the group of
exposed, uninfected individuals (16.7%). Comparable frequency of
CCR5-delta32 allele was found in homosexual and drug using HIV
patients (9.6% and 9.2%, respectively). In the case of heterosexually-
transmitted infection the frequency was lower (4.4%). Frequency of
CCR2–64I allele was found to be 12.5%. Frequencies of CCR2–64I,
HERV-K113 and HERV-K115 in Polish population were found to be
12.5%, 13.6% and 8.4% respectively. In the case of these alleles no
signiﬁcant differences between control, exposed uninfected and HIV-1-
infected groups were detected.
Conclusion: According to the obtained results individuals who had
CCR5-delta32 allele were signiﬁcantly susceptible to HIV-1 infection,
especially in the case of heterosexual transmission. Presence of CCR2–
64I allele didn’t protect against HIV-1 infection. Neither CCR5-delta32
and CCR2–64I nor HERV-K113 and HERV-K115 had inﬂuence on
progression of HIV-1 infection.
R2471 Detection of active polyomaviruses JC and BK in
HIV-1-infected patients
K. Zwolinska, E. Piasecki, K. Rybka, M. Pazgan-Simon, B. Knysz,
J. Gasiorowski, A. Gladysz (Wroclaw, PL)
Objectives: Up to 90% of human population is infected with two human
polyomaviruses JC (JCV) and BK (BKV). After primary infection,
which occurs during childhood, both viruses persist in renal tissues
and B lymphocytes. Reactivation of these viruses may be connected
with immunodeﬁciency or immunosuppressive therapy. JCV is the
causative agent of the progressive multifocal leukoencephalopathy in
AIDS patients as well as in other immunocompromised hosts. BKV is
associated with haemorrhagic cystitis in immunocompromised patients.
The aim of the study was to evaluate frequency of active JCV and
BKV infections and association between these infections and lymphocyte
CD4+ count among HIV-1 positive patients.
Methods: Polyomavirus were detected in plasma, urine and cere-
brospinal ﬂuid with PCR-RFLP method. Viral DNA from samples was
extracted and puriﬁed on Qiagen column according to the manufacturer’s
protocols. The primers pair ampliﬁed a 176-bp sequence from BKV
genome and a 173-bp sequence from JCV genome. Digestion of the
PCR products with the BamH1 prior to electrophoresis was used to
discriminate between BKV and JCV sequences.
Results: Three groups of patients were studied. The ﬁrst group was
comprised of 53 HIV-1 positive patients with CD4+ cell count less than
200/mcl. In the second group 21 patients with CD4+ cell count 200–
500/mcl were included. The third group was comprised of 22 patients
with CD4+ cell count >500/mcl. JCV was detected in urine of 8 patients
in the ﬁrst (15%), 3 patients in the second (14.3%) and 5 patients in the
third group (22.7%). BKV was detected in urine of 9 patients in the
ﬁrst (17%), 1 in the second (4.7%) and 1 in the third group (4.5%).
Beside it, two patients in the ﬁrst group had detectable polyomaviruses
in plasma: in one case JCV (1.9%), and in the second BKV (1.9%).
The viruses were not detected in cerebrospinal ﬂuids of 10 patients with
neurological symptoms. There was no statistically signiﬁcant differences
between activated JCV and BKV presence in tested groups. On the other
hand, no polyomaviruses were found in the control group (20 healthy,
not HIV-infected individuals).
Conclusion: According to the obtained results no correlation between
the active infections of JCV and BKV and the level of CD4+ cells was
found.
R2472 HIV infection presenting in older children: experience from
Cambodia
D. Horvathova, A. Kalavska, V. Sladeckova, E. Kalavsky, L. Seng
Duong (Trnava, Bratislava, Phnom Penh, SK)
Objectives: Because HIV infection is poorly described in older children,
we investigated social and clinical features in HIV-infected children aged
8–18 years from the cohort of 87 HIV-infected Cambodian children.
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Methods: All children and their guardians have consented to participate
in the study, have the basic examination including height, weight,
social status, clinical examination and laboratory tests (blood tests, liver
enzymes, basic biochemistry, CD4 count, TB check). HIV test was
always conﬁrmed at the National Institute of Public Health (referral
laboratory in Phnom Penh) before the beginning of the treatment.
Results: Of 87 children treated for more than 3 years, 42 were in the
age between 8–17 years (average 10.6 years). 11 of these children (26%)
are outdoor patients and 31 (74%) are indoor patients living in House of
Family and House of Smile – orphanages for HIV positive children in
Phnom Penh. Males are 23 (55%) of the children, 31 (74%) of children
are complete orphans and 11 (26%) are semi-orphans. None of the
children has both parents alive. All the living parents are HIV positive
and all of the death parents died of HIV infection.
CD4 count before the treatment was in the range from 2 cells/ml to 875
cells/ml with average 158 cells/ml. At the beginning of the treatment
40 children (95%) had respiratory infections and 27 (64%) of them had
recurrent respiratory infections after beginning of the treatment. Chronic
skin infection was present in 36 (86%) of children. TB of lungs was
diagnosed and treated in 17 (40%) cases, 1 child had TB of bowels.
Oropharyngeal candidiasis was present in 11 (26%) cases. 1 child is
now treated for lymphoma.
Treatment was started with ﬁrst line ART available in Cambodia.
28 (67%) of children are treating with combination of Stavudine +
Lamivudine + Nevirapine. Those contraindicated to Nevirapine therapy
are receiving Efavirenz. Length of the treatment varies from 1 to 40
months (average 25.6 months). CD4 count in treated children varies
from 54 to 1699 cells/ml with average of 781 cells/ml which is 5 times
more than on the beginning of the treatment.
Conclusion: All the children in our project who received HAART
did extremely well and medical doctors as well as social workers are
successful in their effort to help HIV-infected children in Cambodia.
R2473 Analysis of clinical variables for determining the caries
risk in patients with HIV/AIDS
G. Cadastro, E. Giovani, J. Cavasin-Filho, S. Egashira, R. Antonaccio,
P. Armonia, R. Andia-Merlin (Sa˜o Paulo, BR)
Aim: The aim of the present study was to evaluate the caries risk in
patients HIV+ by analysis of the following clinical variables: MDF index,
stimulated salivary ﬂow, buffer capacity, and presence of dental plaque.
Methods: Forty HIV-soropositive patients (20 men, 20 women) and 40
HIV-soronegative patients (20 men, 20 women) with a mean age of 58
years (range, 50–70 years) from the Special Patient Care Center, Paulista
University, Brazil, were evaluated. After clinical examination, the MDF
index and the presence of dental plaque were recorded. In addition, the
stimulated salivary ﬂow and the buffer capacity were measure by using
a Dental Buff (Inodon, Brazil) system.
Results: In the HIV+ patients, 70% had low salivary ﬂow (<1ml/min),
22% intermediate (1−1.5ml/min) and 8% regular (1.6−2.3ml/min). In
the control group, 25% had low salivary ﬂow, 27.5% intermediate, and
47.5% regular. On the other hand, 35% of HIV+ patients had a low buffer
capacity (pH< 4.5), 37.5% intermediate buffer capacity (pH 4.5−5.5),
and 27.5% regular buffer capacity (pH> 5.5). In the control group,
22.5% had low buffer capacity, 5% intermediate, and 72.5% regular. In
relation to MDF index, it was 22.12 in the HIV+ patients and 23.4 in the
control group. The dental plaque index was 69.96% in the HIV+ patients
and 67.05% in the control group. There was no signiﬁcant difference
when both groups were compared in relation to MDF and dental plaque
indexes.
Conclusions: Salivary ﬂow was low in the HIV+ patients. The pH of
these patients was critical when compared to that of HIV− patients. In
summary, the low salivary ﬂow associated to low buffer capacity and to
high plaque index renders to the HIV+ patients a high caries risk.
R2474 Kinetics of HIV-speciﬁc CD8+ T-cells in HIV-infected
adults: one-year follow-up
Z. Bartovska, O. Beran, H. Rozsypal, G. Reinvartova, M. Holub
(Prague, CZ)
Objectives: HIV-speciﬁc CD8+ T cells play a signiﬁcant role in
immunopathogenesis of HIV infection. Further knowledge of their role
could be applied in vaccination strategies and immunotherapy of HIV
infection. The aim of this study was to analyse the frequency of HIV-
speciﬁc CD8+ T cells in HIV+ patients during one year follow-up and
assess the effect of antiretroviral therapy (ART) on the frequency of these
cells.
Methods: In this prospective study, a total of 58 HIV+ patients were
enrolled based on their HLA-A2 haplotype. This group included 33
patients on ART (group A), 13 previously non-treated patients in which
ART was introduced after study enrollment (group B) and 12 patients
without therapy (group C). The following parameters were analysed at
baseline and after 12 months: CD4+ and CD8+ T cell count, HIV-1
viral load and the percentage of HIV-speciﬁc CD8+ T cells. HIV-speciﬁc
CD8+ T cells were detected using staining with HLA*0201/gag tetramers
and ﬂow cytometry analysis.
Results: The table presents percentage of patients with detectable levels
of HIV-speciﬁc CD8+ T cells and median viral load. The comparison of
the median frequency of gag-speciﬁc CD8+ T cells showed no difference
between all groups both at baseline (0.05%, 0.06% and 0.135% in A,
B and C, respectively) and after 12 months (0.05%, 0.12% and 0.185%,
respectively). Moreover, no signiﬁcant changes were observed in the
frequencies of gag-speciﬁc CD8+ T cells over the study period in any
group. Finally, lack of correlation was found between the frequency of
HIV-speciﬁc CD8+ T cells and CD4+ count as well as viral load.
Group No. (%) of patients with detectable
gag-speciﬁc CD8+ T cells
HIV-1 viral load
(copies/ml)*
Baseline 12 months Baseline 12 months
A (n = 33) 11 (33.3%) 13 (39.4%) 50 50
B (n = 13) 7 (53.8%) 8 (61.5%) 60400 50
C (n = 12) 8 (66.7%) 7 (58.3%) 9800 5135
*Median.
Conclusion: The results demonstrated that the higher percentage of
non-treated HIV+ patients has detectable gag-speciﬁc CD8+ T cells in
comparison to ART-treated patients. Also, the frequency of gag-speciﬁc
CD8+ T cells is not signiﬁcantly inﬂuenced by ART despite of its effect
on the decrease of viral load.
Acknowledgement: The study was supported by the grants GAUK Nr.
18/06 and GACR Nr. 310/05/H533.
R2475 Prevalence of and risk factors for anaemia on the medical
wards of a central hospital, Blantyre, Malawi
M. van Veelen, A. Huisman, J.L. Nouwen, E.E. Zijlstra (Rotterdam,
NL; Blantyre, MW)
Introduction: To study the prevalence and determinants of anaemia and
to test if anaemia was a risk factor for morbidity and mortality in patients
admitted to the medical wards of the Queen Elizabeth Central Hospital,
Blantyre, Malawi.
Methods: All patients admitted to the medical wards between April
and July 2007 were included. Patients’ presenting clinical features,
dietary intake, mid upper arm circumference (MUAC), full blood count
(FBC), HIV status and HAART use, duration of hospitalisation and
ﬁnal diagnosis on discharge or death were registered. Proportions were
compared using chi-squared tests, continuous data were analysed using
Mann-Whitney’s test. Multivariate logistic regression analyses were
employed to look for independent risk factors for anaemia, duration
of hospitalisation and mortality.
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Results: 907 patients were included; in 676 complete FBC were available
and included in the study. Median Hb in males was 11.0 g/dL (2.0–19.5)
and 9.7 g/dL (2.5–18.4)) in females. According to the WHO criteria
490 patients were anaemic (72.5%). 348 patients were HIV positive
(78.7%). Median Hb in HIV negatives positives was 12.5 g/dL (2.0–
19.5) versus 9.2 (2.5–18.4) in HIV positives (p< 0.001). Within the
group of HIV positive patients on HAART, median Hb and MCV was
signiﬁcantly higher in those on HAART for 6 months or more (Hb 11.3
[6.1–15.3]; MCV105.0 [61.0–131.0]) as compared to those on HAART
for less than 6 six months (Hb 9.0 [2.9–18.4; MCV 94.0 [66.0–121.0];
p = 0.002 and p = 0.001 respectively). Median MUAC and dietary score
were signiﬁcantly lower in the anaemic group(213.0 [143.0–340.0] and
6.0 [4.0–11.0]) compared to the group with no anaemia (241.0 [135.0–
529.0] and 6.0 [4.0–11.0]; p< 0.001). The discharge diagnoses TB (OR
3.1 95%CI [1.9−4.9) and sepsis (OR 2.3 95%CI [1.5−3.8]) were also
associated with anaemia. Duration of hospitalisation was signiﬁcantly
longer in anaemic patients (7.0 [1–36] vs 5 [1–37] days in non anaemics;
p = 0.003). Anaemic patients had a signiﬁcant increased risk for in-
hospital mortality (OR 2.3 [1.6−3.5]).
Conclusion: Anaemia as well as HIV are very prevalent in patients
admitted to the medical wards of the QECH. In this cohort, HIV,
malnutrition, TB and sepsis are all associated with anaemia. Anemic
patients have an increased duration of hospitalisation and mortality when
compared to non-anemic patients. Both HIV and TB are in essence
treatable diseases and treatment with HAART was shown to ‘protect’
from anaemia.
R2476 Detection of human papillomavirus in HIV-positive
Venezuelan patients
M. Avila, M. Correnti, M.E. Cavazza, O. Reyes, R. Alfonso
(Caracas, VE)
Objective: The aim of this work was to evaluate the association between
the HIV infection and the genotypes of HPV in genital and anal lesions.
Methods: Patients: Thirty eight patients with a diagnosis of HIV
infection (thirty seven men and one woman) were rolled after informed
consent and complete physical examination.
Nineteen biopsies of the genital area and eighteen anal swaps were
obtained for HPV test. The ampliﬁcation of 450 Pb fragment of HPV
DNA included in the open reading frame of L1 region was performed
using the degenerate primers MY09 and MY11. To determine specimen
adequacy, the GH20/ PC04 human beta-Globins target was co ampliﬁed
with HPV sequences. A known positive specimen and a negative
specimen were included in each assay as controls. The typing of HPV
was determinated by MPCR Ampliﬁcation (Maxim Biotech, Inc.) that
simultaneously detects the HPV types 6, 11, 16, 18 and 33. The MPCR
DNA products were separate eletrophoretically on a 2% agarose gel
containing ethidium bromide. The CD4 count and viral load were
evaluated in 18 patients of the study group.
Results: HPV infection was detected in 35 HIV infected patients
(95%). The 19 biopsies of genital area were histological diagnosed
as condylomata acuminate. The location of these lesions was observed
with more frequency in the perianal area (57.89%), followed of penis
(36.84%) and vulva (5.27%). The HPV was detected in all specimens of
condylomata acuminate, the type 11 was observed with more frequency
(63.16%), followed by the type 6 (21.05%), three cases (15.17%) was
none typiﬁed and neither case was observed co-infection with types of
high risk oncogenic. In contrast, HPV 16 genotype was found in 16/18
of the anal swaps samples.
We did not ﬁnd any correlation between CD4 cell count, HIV RNA viral
load and the presence of speciﬁc HPV genotype.
Conclusion: In this study the results show a clear association of the low
oncogenic risk types 6 and 11 and the development of the genital warts.
Our data showed that in our population of HIV infected men, there is
a high prevalence of HPV 16 genotype in anal samples. A screening
programme to detect anal squamous intraepithelial lesions in high-risk
individuals may be of value to prevent anal cancer.
Grants: FONACIT G-2005000408.
R2477 Increased expression of Werner and Bloom helicases in pe-
ripheral blood mononuclear cells of HIV-1 infected patients
A. Amendola, L. Bordi, G. D’Ofﬁzi, C. Vlassi, E. Lalle, R. Nardacci,
M. Capobianchi (Rome, IT)
Objectives: WRN and BLM helicases are two crucial proteins involved
in DNA metabolic pathways, such as cell repair, replication, and
ricombination. We previously described increased levels of WRN and
BLM gene expression in PBMC from HIV-infected persons (Bordi L,
et al., Human Immunology 68, 2007). The role of WRN as cofactor
for HIV-1 transcriprtion and replication has been also demonstrated by
Sharma A, et al. (J Biol Chem 16, 2007). Aim of the study is to analyse
the steady-state level of Werner (WRN) and Bloom (BLM) mRNA and
protein helicases in PBMC and CD4 and CD8 positive T subsets obtained
from a larger number of HIV-1 infected patients and HIV-seronegative
healthy donors.
Methods: The mRNA expression level of WRN and BLM genes and wrn
and blm proteins were investigated in ex-vivo PBMC obtained from 70
HIV-1-infected patients and 27 HIV-seronegative healthy donors (HD).
WRN and BLM mRNAs were measured by real-time PCR; wrn and blm
proteins were analysed by immunocitochemistry, both in total PBMC
and in different subsets of PBMC (CD4-positive and CD8-positive T
lymphocytes, CD14-positive and residual cells) isolated by magnetic
beads.
Results: In total PBMC from HIV-1 infected individuals, 3.2-fold higher
mean level of WRN mRNA (mean +SEM: 1.004 +0.07) has been
detected in comparison to HD (0.315 +0.020) and this difference was
signiﬁcant (p< 0.0001). BLM mRNA mean levels were slightly higher
than in controls (0.165 +0.0162 versus 0.419 +0.052, respectively), but
the difference was equally signiﬁcant (p = 0.018). WRN increase (but not
BLM) resulted to correlate positively with CD4 and CD8 T cell absolute
numbers. CD4 and CD8 T cells were the main subsets containing higher
levels of WRN mRNA in HIV-infected patients (in comparison to HD),
while no differences were observed within subsets from HD and HIV-
infected persons for BLM. Analysis of wrn and blm proteins in different
subsets are still in progress.
Conclusion: The increase in helicases expression observed in T
cells from HIV-infected persons could be a mechanism aimed to
prevent hyper-recombination, transformation and premature senescence
in replication-competent cells, and therefore, it may be explained as a
modiﬁcation induced by the virus ﬁnalised to assure the host genomic
integrity and an efﬁcient viral replication.
R2478 Bone mineral density in HIV infection
J.L. Puerto, C. Asencio, J.L. Andrey, M.A. Escobar, J.A. Bernal,
S.P. Romero, A.A. Garcia-Egido, Y.A. Abu, F.J. Fernandez, F. Gomez
(El Puerto Santa Maria, ES)
Background: Anti-HIV therapy is associated with an increased
prevalence of osteopenia and osteoporosis. Nevertheless, the relationship
between the duration of anti-HIV therapy and bone mineral density
(BMD) is not established.
Objective: To determine the relationship, if any, between the duration
of anti-HIV therapy and bone mineral density.
Methods: Prospective study of BMD in 108 HIV-infected patients,
compared with 239 HIV-uninfected controls, from January 2002 to
December 2006 at a teaching hospital (median follow-up of 3.86 years).
Results: A total of 108 HIV-infected patients were studied, 76 men
(age: 38±11 years, CD4: 351±119/mL) and 32 women (age: 44±16
years, CD4: 368±127/mL), of them 57 initiated HIV therapy in the pre-
HAART era (52.8%), 36 (33.3%) and 15 were naive (13.9%). None of
the patients received treatment for osteoporosis. Osteoporotic fractures
were not observed during follow-up. 66 patients (61%) had osteopenia,
and 14 had osteoporosis (13%), with an OR of 5.9 and 3.2, respectively
compared to controls. HIV treated patients had a 2.9-fold increased odds
of a reduced BMD compared to naive HIV patients. HIV patients treated
with PIs had a 4.3-fold increased odds of a reduced BMD compared to
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patients who did not receive PI treatment, and a 6.8-fold increased odds
of a reduced BMD compared to naive HIV patients. Factors associated
with a reduced BMD in multivariant analysis were treatment with PIs
[RR (95%CI), 2.27 (1.88−2.39), p = 0.03), and time on HIV therapy [RR
for <2 years on HIV therapy: 2.33 (1.93−2.68), RR for 2−4 years on
HIV therapy: 5.17 (4.52−6.38), and RR for 4 years on HIV therapy: 8.74
(7.06–10.12), p< 0.001 in all cases). Sex, body mass index, CD4 levels
or, viral load were not related with the BMD.
Conclusions: HIV infected patients have an increased prevalence of
osteopenia (6-fold), that, is associated with the time on anti-viral
treatment, and with PIs’ therapy.
R2479 An epidemiological and clinical survey of 298 HIV-positive
patients in 3 centres, Tehran, Iran
M. Talebi Taher, M. Eshaghi, M. Barati (Tehran, IR)
Objectives: The total number of registered HIV-infected cases was
13,702 by mid-September 2006 in Iran, and the most frequent route of
transmission was injection drug use. There are more new HIV infections
every year, so we have to know more about the epidemiology of HIV in
Iran.
Methods: In this retrospective descriptive cross-sectional study, the
subjects were the HIV positive patients who had been visited in two
teaching hospitals (Rasoul-e-Akram and Bu-Ali)and Tehran West Clinic
from March 2000 to March 2005. Demographic data, risk factors and
clinical symptoms were determined in 298 HIV positive patients.
Results: The mean age of the patients was 33.2 years(±8.45).
269 cases(90.3%) were male and 29 cases(9.7%) were female.231
cases(77.5%) all of whom were IDUs with a history of shared drug
injection, had a history of staying in prison. Injection drug use and
unsafe sexual contacts were the possible major routes of transmission
of HIV infection. The most common clinical diseases were Thrush and
pulmonary tuberculosis. HBsAg and HCV RNA were detected in 7% and
29.5% of the patients respectively. There were 38(12.8%) PPD-positive
patients. VDRL and FTA-abs in 2 cases were positive. The mean CD4+
count (±SD) was 500.31/mm3 (± 382.87).
Conclusion: Our ﬁndings suggest that drug injection inside prison
carries a particular risk factor for HIV infection and we need HIV-
related programmes to strengthen HIV surveillance and introduce harm
reduction programmes to IDUs. Such programmes should be integrated
with a condom promotion programme to support the well-being of young
Iranian population.
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R2480 Hepatitis C virus infection in patients from the haemodial-
ysis clinic of a medical university, Plovdiv, Bulgaria
M. Atanasova, V. Kardjeva, M. Kicheva, M. Draganov, T. Stoyanov,
T. Kostadinova, N. Mateva, E. Kapon, M. Murdjeva (Plovdiv, BG)
Objectives: It has been reported, that patients with end-stage renal
disease on dialysis therapy form a high risk group for hepatitis C virus
(HCV) infection. Risk factors such as number of blood transfusions and
frequent exposure to parenteral interventions have been pointed. The
aim of our study was to determine the prevalence of HCV infection in a
caseload of Bulgarian patients on permanent hemodialysis and to assess
risk factors for HCV in this group.
Methods: All subjects were tested for HCV antibodies by ELISA
method, as well as for HCV-RNA by real-time PCR. Liver function
tests (ALT) were performed by routine methods and epidemiological
data (age, sex, ethnic group, duration on hemodialysis, number of blood
transfusions) were collected.
Results: A total of 85 patients (mean age 52.6 years; male/female:
48/37), visiting three times weekly Hemodialysis clinic of Medical
University in Plovdiv were enrolled. HCV antibodies were found in
41(48.2%) and viraemia – in 29 (34.1%) subjects, thus the overall
prevalence of HCV (HCV antibody and/or HCV-RNA positivity) was
51.8% (44 patients). HCV viraemia was detectable in 63.4% of the anti-
HCV-positive patients and in 6.8% of the anti-HCV-negative patients.
Hence 3.5% of the whole study group were HCV infected, but could
not be diagnosed by routine HCV antibody testing. Duration of dialysis
and number of received blood transfusions were established as main risk
factors for acquiring HCV infection.
Conclusion: HCV prevalence is high in hemodialysed patients and
nosocomial spread of hepatitis C virus is suggested. These data indicate:
(i) the need for strict adherence to infection control measures in dialysis
units and (ii) the importance of screening by both PCR and serological
methods at stated intervals to reveal all HCV infected patients.
R2481 Implication of basal core promoter/precore mutants upon
genotype and clinical outcome in the hepatitis B virus
B. Puche, J.C. Palomares, M.C. Nogales, B. Figueruela, C.V. Almeida,
E. Martin-Mazuelos (Seville, ES)
Background and Aim: Hepatitis caused by HBV is a major health
problem worldwide, with more than 350 million people affected.
Understanding the implication of HBV’s virologic characteristics is
important in the management of the disease. Our aim was to study
genotype prevalence and to determine basal core promoter/precore
(BCP/PC) mutations in a cohort of 61 Andalusian patients with different
clinical features.
Materials and Methods: 61 samples with viral load >1,500 IU/ml
from 61 patients (73.8% men, 26.2% women) were studied. 88.5%
were HBeAg− and 11.5% were HBeAg+. 59% patients were diagnosed
of chronic hepatitis B (CHB), 31.1% of liver chirrosis (LC) and
9.8% were inactive carriers (IC). Viral load was measured by real-
time PCR using the COBAS Ampliprep/Taqman technology (Roche
Diagnostics). Genotypes were determined sequencing the surface gene
using the Trugene HBV genotyping kit (Siemens). BCP/PC mutations
were determined by semi-nested PCR ampliﬁcation (using primers
RMD26−Ci1 in the ﬁrst round and RMD26–PC1 in the second
round) and sequencing of the core gene using the 7-Deaza-dGTP-
Cy5/Cy5.5 Dye Primer Sequencing Kit (Siemens). Statistical analysis
were performed with SPSS version 14.0.
Results: 60.7% were genotype D, 34.4% genotype A, 3.3% genotype F,
1.6% genotype B and 1.6% genotype F. Only patients with CHB, LC
and genotypes D and A were included in this study. BCP and/or PC
mutations were detected in 83.4% of CHB patients, 95% of LC patients,
92% of genotype D and 81% of genotype A patients. The most abundant
BCP/PC mutations are shown in Table 1.
Table 1
CHB LC Gen.D Gen.A
BCP
T1753C 41.7% 52.6% 59.5% 19%
A1762T–G1764A 55.6% 73.7% 59.5% 42.8%
G1764A 8.3% 10.5% 2.7% 19%
C1766T 5.6% 21.1% 5.4% 19%
T1768A 2.8% 31.6% 10.8% 14.3%
PC
C1857T–G1897A 2.8% – – 4.8%
G1896A 61.1% 57.9% 78.4% 28.6%
In the statistical analysis, we compared these mutations with genotypes
and clinical status. Statistical signiﬁcance (p 0.005) was observed
between T1753C, G1896A and genotype D and between T1768A and
patients with LC.
Conclusions: 1 – HBV genotype D is the most prevalent in Andalusia,
followed by genotype A. 2 − Double mutation A1762T–G1764A were
the most frequent changes in the BCP region and G1896A in the PC
region. 3 − Due to the predominance of genotype D in our population
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and its association with mutations T1753C and G1896A, high prevalence
of these are expected in those areas where genotype distribution is
similar to ours. 4 − Although we could associate mutation T1768A and
chirrotic status, more studies are necessary to conﬁrm our data and
to establish a clear relationship between this and other mutations with
clinical outcome.
R2482 Changes in serum lipid proﬁle during and after pegylated
IFN and ribavirin therapy in chronic hepatitis C
M. Zangi, E. Akbarian, S. Alavian, A. Ghojavand, P. Safavi naeini,
M. Yavari (Tehran, IR)
Objectives: chronic Hepatitis C is one of the most signiﬁcant health
problems worldwide. At present, the most effective therapy available
for the treatment of HCV infection is the combination of pegylated
IFN (pegIFN) and ribavirin and using such therapy is associated with a
wide range of systemic side effects and complications such as metabolic
changes. In fact, its use has been associated with a change in serum
triglyceride and cholesterol levels.
Therefore, we designed this study to investigate changes in serum lipid
concentrations during and after therapy with pegylated interferon in
combination with ribavirin in these patients.
Methods: 71 patients with active chronic hepatitis C were enrolled in
this study and received Pegylated interferon at a dose of 180 mg in
combination with ribavirin at a dose of 1000–1200mg, daily for 48
weeks. Blood samples were collected before, during (3 months after the
start of), at the completion of and after (6 months after the completion
of) IFN therapy.
Results: 65 male (91.5%) and 6 female (8.5%) with the mean age of
37.9 years were evaluated. mean serum triglyceride levels rose from
105mg/dL to 129mg/dL at the third month and 134mg/dL at the
completion of therapy (p< 0.0001). Afterward, mean serum triglyceride
levels decreased to 130mg/dL six months after stopping therapy.
Serum cholesterol levels had no signiﬁcant changes during the same
time period; however, decreased levels during the therapy were noted
and returning levels to baseline were seen 6 months after stopping
therapy. Thus, levels decreased from 154mg/dL to 147mg/dL at the
third month and 145mg/dL at the completion of therapy; subsequently,
levels returned to baseline by 6 months after stopping therapy (mean
156mg/dL).
Conclusion: We clariﬁed that Serum triglyceride levels increases
consistently in patients with chronic hepatitis C during therapy and
returns to normal after it, while serum cholesterol level follows the
opposite trend.
R2483 Hepatitis E in Cuba: the case report of an infected
pregnant woman
M. Montalvo Villalba, L. Rodriguez Lay, V. Chandra, M. Bello
Corredor, A. Gutierrez Moreno, S. Sariego Frometa, M. Sanchez Wong,
S. Jameel (Havana City, CU; New Delhi, IN)
The HEV is transmitted primarily through the faecal–oral route in
contaminated drinking water. It has been classiﬁed in the genus
Hepevirus of the family Hepeviridae. Although there is only one serotype
four major genotypes of HEV have so far been reported. Infection
leads to high mortality rates among pregnant woman in their third
trimester of pregnancy (20–25%). We report here the case of a 22
year-old Cuban pregnant woman with a gestational period of 35 weeks,
admitted in 2005. She reported four days history of febrile episodes,
asthenia, epigastric pain, nauseas, and vomiting. Her urine was dark-
yellow and her faeces white. The patient had no previous jaundice,
no international travel and no eats exotic food. Physical examination
reveled icteric sclera, abdominal examination revealed an enlarged uterus
according to gestational age and a fetal heart rate of 140 beats/min;
the liver and spleen were not palpable. The results of biochemical
indicators in blood showed 47.9mmol/L creatinine, 358.1mmol/L uric
acid, 143.2 IU/L ASAT, 58.4 IU/L ALAT and 50 mmol/L of direct
bilirubin. Coagulogram revealed a blood clotting time of 8 min, platelet
counts 218×109 cells/L and retraction of the blood clot. The clinical
signs improved and enzymatic tests returned to normal levels 4 weeks
after onset of symptoms. The hepatitis A virus IgM, HBsAg, HBc IgM
and anti-HCV were all negative. Anti-HEV IgM was found to be positive,
total anti-HEV showed increasing levels in several determinations, which
was a strong evidence of acute HEV infection. Viral genomes were
detected in stool samples using primers speciﬁc for the open reading
frame1, described by Zhai. PCR ampliﬁcation of an RNA dependent
RNA polymerase was used as a consensus genomic region for HEV
genotyping. A phylogenetic tree (Fig. 1) was constructed for this
sequence and the four major genotypes were deﬁned. The Cuban strain
CUB2–2005 clustered within the Asian genotype I and was closely
related to Indian HEV strains. It shared 98% nucleotide homology with
Yam-67 isolated in Yamuna Nagar.. This molecular characterisation of
an indigenous HEV strain from the Americas showed for the ﬁrst time
the presence of HEV genotype I in this region. It is noteworthy that HEV
shows a global presence and the genotype distribution, while dominant
in a given geographic area, is not limited to it. The case reported in this
letter had a satisfactory clinical course of her pregnancy and successfully
delivered at 39 weeks.
Phylogenetic tree constructed on the basis of 307 nucleotides (RdRp)
from ORF1 region using the Neighbour Joining method. Bootstrap values
for 1000 replicates that were above 70% are shown in the internal nodes.
The major branches represent HEV genotypes.
R2484 Recombination analyses in intrapatient populations of
hepatitis C virus
V. Sentandreu, N. Jimenez, M. Torres-Puente, M.A. Bracho,
M.J. Gosalbes, E. Ortega, A. Moya, F. Gonzalez (Valencia, ES)
Objectives: Hepatitis C virus (HCV) is a major cause of liver disease
worldwide and a potential cause of substantial morbidity and mortality in
the future. HCV is characterised by a high level of genetic heterogeneity.
Although homologous recombination has been demonstrated in many
members of the family Flaviviridae, to which HCV belongs, there are
only a few studies reporting recombination on natural populations of
HCV, suggesting that these events are rare in vivo. Furthermore, these
few studies have focused on recombination between different HCV
genotypes/subtypes but there are no reports on the extent of intra-
genotype or intra-subtype recombination between viral strains infecting
the same patient. Given the important implications of recombination
for RNA virus evolution, our aim in this study has been to assess the
existence and eventually the frequency of intragenic recombination on
HCV.
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Methods: We retrospectively have analysed two regions of the HCV
genome (NS5a and E1-E2) in samples from two different groups:
(i) patients infected only with HCV (either treated with interferon plus
ribavirin or treatment naive), and (ii) HCV-HIV co-infected patients (with
and without treatment against HIV). The complete data set comprised
17712 sequences from 136 serum samples derived from 111 patients.
Recombination analyses were performed using 6 different methods
implemented in the programme RDP3.
Results: Recombination events were considered when detected by at
least 3 of the 6 methods used and were identiﬁed in 10.7% of the
ampliﬁed samples, distributed throughout all the groups described and
the two genomic regions studied. The resulting recombination events
were further veriﬁed by detailed phylogenetic analyses.
Conclusions: Recombination must be considered as a potentially
relevant mechanism generating genetic variation in HCV and with
important implications for the treatment of this infection.
R2485 Case report: chronic hepatitis B infection susceptible to
adefovir despite the rtI233V mutation
M.R. Capobianchi, F. Vairo, M. Solmone, D. Vincenti, F. Iacomi,
A. Mariano, F. Zoulim, G. Antonucci (Rome, IT; Lyon, FR)
The mutation I233V in HBV polimerase has been associated with
primary resistance to adefovir dipivoxil treatment (ADV). We report a
chronic hepatitis B which responded to ADV although bearing I233V.
Italian man born in 1930, affected by HBeAg-negative chronic hepatitis
B; HDV-HCV-HIV negative. He had a bronchial adenocarcinoma
resection in 2001 and is on chronic treatment with interleukin-2 for the
ﬁrst week of each odd month since then. Hepatitis B was unsuccessfully
treated with interferon in 1998. Treatment with lamivudine 100mg qd,
started in November 1999, initially suppressed viraemia but a viral
breakthrough occurred at 3 years of therapy and lamivudine was stopped.
In May 2003: HBVDNA was 20,680,000 IU/ml (TaqMan Roche); ALT
122 IU/L; the pol gene sequencing and clonal analysis showed that all
clones analysed had both I233V and S159T mutations, Y141H and
V142G were present in 6/11 clones, M204V in 6/11 clones (3 in
association with L180M). ADV 10mg qd was started in June 2003.
At one year of treatment: HBVDNA was 971,000 IU/ml; ALT 50
IU/L; sequencing and clonal analysis were unchanged compared to
baseline, except that M204V was detected only in 1/11 clones. ADV
was stopped in September 2004 (15 months of therapy). In November
2004: ALT increased to 111 IU/L; HBV DNA decreased to 127,000
IU/ml; genotypic analysis showed that I233V, S159T, Y141H, V142G
and M204V were present in almost all clones. ADV was restarted in
February 2005 and it is ongoing. At the time of ADV restart ALT had
spontaneously declined to 40 UI/L, and HBV DNA to 700 IU/ml; I233V,
S159T, Y141H and V142G were present in almost all clones, M204V
was not detected. During this second course of ADV ALT are always
normal; HBVDNA is always <12 IU/ml; HBsAg is still positive.
HBVDNA had a 1.3 Log decline of at one year of ADV despite I233V
mutation. HBVDNA further decreased when ADV was stopped and it
is persistently undetectable during the 2nd course of ADV. It seems
that the patient shifted from a highly replicative to an inactive carrier
status. Other mutations detected (S159T, Y141H, V142G) might play a
role in reducing viral ﬁtness and possibly restore ADV antiviral activity.
Complementarily, interleukin-2 regularly taken by the patient might have
enhanced ADV activity and played a role in this unexpected “change of
status”.
The real impact of I233V mutation on ADV anti-HBV activity needs to
be better deﬁned, especially when in combination with other mutations.
R2486 First complete genome of a hepatitis C virus genotype 1g
isolate
M. Bracho, V. Saludes, E. Martro´, A. Bargallo´, F. Gonza´lez-Candelas,
V. Ausina (Paterna, Badalona, ES)
Objectives: In our study, we present the ﬁrst complete genome sequence
of an HCV subtype 1g isolate. Hepatitis C virus isolates have been
classiﬁed into six main genotypes and a variable number of subtypes
within each genotype, mainly based on phylogenetic analysis. Although
the most reliable analyses of genetic relationships among genotypes and
subtypes are performed using complete genome sequences (or at least the
full coding region), up to now only 31 out of 80 conﬁrmed or proposed
subtypes have at least one complete genome available.
Methods: Virus genome was isolated from a serum belonging to a
Spanish woman that received a blood transfusion in 1996. Serum was
obtained before pegylated interferon plus ribavirin treatment to which
the patient didn’t respond. Complete HCV-1g genome was obtained
by direct sequencing of ten overlapping RT-PCR fragments. ClustalW
implemented in MEGA was used to obtain a multiple alignment. All
phylogenetic trees were constructed by maximum likelihood in PHYML
with the nucleotide substitution model that best ﬁt the data for which
we used the procedure implemented in Modeltest. The robustness of the
tree topology was assessed by bootstrap analysis with 1000 replicates
implemented in PHYML.
Results: The nucleotide sequence of the HCV-1g genome (9490 nt)
includes the complete coding region and partial sequences from both
5′UTR and 3′UTR. Phylogenetic and genetic distance analyses reveal
that HCV-1g is the most divergent subtype among the HCV-1 conﬁrmed
subtypes. HCV-1g genome does not arise as a recombinant form of
previous known genotypes or subtypes.
Conclusion: In light of this, we propose to change from provisional to
conﬁrmed the current status of its subtype-speciﬁc designation.
R2487 Different response to anti-HCV treatment may be related
to immunological gene expression proﬁle in chronically
HCV-infected patients
A. Almeida, J. Caetano, P. Santos, A. Martinho, A. Paiva, C. Valente,
B. Pais, C. Luxo (Coimbra, Lisbon, PT)
Objectives: Hepatitis C virus (HCV) is estimated to infect approximately
170 million people worldwide, being the leading cause of chronic liver
diseases in many countries. Without an effective vaccine for HCV, our
weapons in the ﬁght against HCV infection are limited to antiviral
treatments. Combination therapy with pegylated interferon alpha (peg
INF-alpha) and ribavirin is currently the standard treatment for patients
with chronic hepatitis C however, this treatment is still limited by a
high non-response rate. The mechanism by which peg INF-alpha and
ribavirin therapy induces resolution of chronic HCV infection is not fully
understood. As immunological mechanisms behind response differences
still not completely known, we approached to immunological gene
expression proﬁle of chronically HCV-infected patients. Gene expression
was accessed in eight chronically HCV-infected patients (four responder
and four non-responder patients) during peg IFN-alpha and ribavirin
treatment.
Methods: Peripheral blood mononuclear cells were collected before
treatment, and one month after starting therapy. RNA isolated
from PBMC, was reverse transcribed and gene expression relative
quantiﬁcation was performed by real-time PCR, responders vs non-
responders patients.
Results: Our results show differences in various genes expression levels
between responders and non-responders patients in pre-treatment and one
month after starting therapy. In pre-treatment we observed Increments
(1−2 logs) on IL-12p40, IL-2, IL-5, IL-8, FAS, FASL, HLADRB1,
GZMB, MADH3 and a lower expression of IL6, IL-17, IL-18, CD4 in
responders vs non-responders patients. One month after starting therapy
we observed a higher expression of IL-3, IL-6, IL-18, CD4, C3, CCR4,
cox-2, HLA-DRB1, IKB2, MADH3 and a lower expression of IL-10,
IL-12p35, IP-10, ITAC, MCP-1, MIP-1a in responders vs non-responders
patients.
Conclusions: These results point out that response to therapy may
be related to differences in expression of genes involved in effectors
mechanisms of viral elimination, suggesting potential markers for future
approaches. Further prospective large studies are needed to conﬁrm these
observations.
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R2488 Genetic variability of hepatitis B virus "a" determinant in
Iranian isolates
S.R. Mohebbi, N. Zali, S. Amini-Bavil-Olyaee, F. Derakhshan,
M. Chiani, M. Rostaminejad, F. Sabahi, M.R. Zali (Tehran, IR)
Objectives: Hepatitis B virus (HBV) persistently infects more than 350
million people worldwide and can induce a spectrum of acute and
chronic liver diseases. Because HBV is a DNA virus with a reverse
transcription step, it is subject to a high mutation rate. HBsAg is the
primary diagnostic marker for HBV infection. The "a" determinant
of HBsAg is a highly conformational, immunodominant antigenic
determinant and is common to all subtypes. There is very limited
knowledge about the genetic variability of HBV strains circulating in
the population of Iranian HBV infected patients. The aim of this study
was to determine HBV subtypes and to analyse mutations in HBV "a"
determinant among chronically infected patients from different regions
of Iran.
Methods: 249 sera from HBV infected patients living in different regions
of Iran were collected between January 2004 and July 2007. Serological
markers of HBV infection were determined by available commercially
ELISA kits. A 402 bp fragment of the HBV S gene including the "a"
determinant was ampliﬁed, sequenced and then subjected for genetic
variability analysis. Subtypes were also predicted from the sequence
encoding the HBsAg by identifying the amino acids encoded at speciﬁc
positions.
Results: The majority of Iranian isolates were ayw2 (239/249, 94.4%).
Five isolates were ayw3 (2%), Seven isolates were ayw1 (2.8%) and One
was detected as ayw4 (0.4%). Interestingly, one isolate was unknown
subtype because it had atypical substitution at subtype specifying
residues (127S). Various point mutations in the sequence of HBsAg
have been found among Iranian HBV isolates. The most common escape
mutant amongst Iranian patients was S143L (5.2%) and P120S (1.6%),
T118A (0.8%), S136Y (0.8%) and T118K (0.8%) ranked next. Other
mutations were also found with minor prevalence (0.4%) as P120T,
T123N, T126S, A128V, G130N, P142L, D144E, G145R and P153Q.
Conclusion: Amino acid substitutions within the "a" determinant can
lead to conformational changes. Some of these changes may cause
important medical and public health issues such as vaccine escape,
failure of hepatitis B immune globulin treatment in liver transplant
patients, and failure of commercially available immunoassays to detect
infected individuals. Our results showed high prevalence of HBsAg
mutants in HBV infected Iranian patients and these mutants may play a
role in HBV evolution against mass vaccination.
R2489 Do HBV-DNA levels affect liver histology in patients with
chronic hepatitis B?
M.A. Yetkin, C. Bulut, S. Kinikli, H. Ustu¨n, M. Yu¨cel, E. Karakoc,
N. Tulek, A.P. Demiro¨z (Ankara, Samsun, TR)
Objectives: In hepatitis B patient hepatitis B virus DNA (HBV-DNA)
in serum is correlated with the progression of the liver disease. In this
study we aimed to determine the relationship between hepatitis B virus
(HBV-DNA) levels and clinical and histological ﬁndings in patients with
chronic hepatitis B.
Metods: A total number of 216 patients with chronic hepatitis B (CHB)
(112 inactive carriers, 44 HBeAg positive CHB and 72 HBeAg negative
CHB patients) who were admitted to our clinic between 1999 to 2005
were included into the study. CHB was diagnosed on patients who were
HBsAg positive for more than six months and had HBV DNA levels
greater than 105 copy/mL and whose alanin transferase (ALT) levels
were elevated persistently or intermittently. Inactive HbsAg carrier state
was accepted as presence of HBsAg for more than six months, having
HBV DNA level less than 104 copy/mL and persistently normal ALT
levels. Serum HBV-DNA levels and the other parameters relevant to liver
function were determined in all patient. Liver biopsy was performed on
116 patients with CHB patients.
Result: The HBeAg positive CHB patients were signiﬁcantly younger
than the HBeAg negative group and inactive carriers (p = 0.000). The
mean HBV-DNA levels were 2×103copy/ml, 3×108 copy/ml and 9×108
copy/ml in inactive carriers, HBeAg negative CHB patients and HBeAg
positive CHB patients respectively. HBeAg positive CHB group had
signiﬁcantly higher HBV DNA levels than HbeAg negative CHB
patients and inactive carriers (p = 0.003). The HBeAg negative group had
more severe inﬂammation and ﬁbrosis scores compared to the HBeAg
positive groups (p = 0.037 and p = 0.001). There was not any correlation
between HBV-DNA levels and necro-inﬂammation and ﬁbrosis scores
of neither HBeAg negative CHB patients or HBeAg positive CHB
patiens. Alanine aminotransferase and aspartate aminotransferase levels
correlated positively with HBV-DNA levels in HBeAg negative CHB
patients. Similar correlation was not observed in HBeAg positive CHB
patients.
Conclusion: Although HBV DNA levels were higher in CHB patients
when compared with inactive carrieres, no correlation between serum
HBV DNA level and ﬁbrosis of liver was detected in CHB patients.
R2490 Efﬁcacy of vaccination against hepatitis B in HIV-infected
patients in northern Greece
M. Pape, K. Mandraveli, P. Kollaras, E.I. Kazakos, P. Nikolaidis,
S. Alexiou-Daniel (Thessaloniki, GR)
Objective: Several studies have shown that HIV-positive patients
with HBV co-infection have higher HBV replication, lower rates
of seroconversion to anti-Hbe and anti-Hbs, and show accelerated
progression towards cirrhosis. Since HIV and hepatitis B share
epidemiological risks, it is essential to prevent hepatitis B by vaccination.
The aim of this study was to evaluate the antibody response rates to HBV
by immunisation in HIV-infected patients as compared to HIV-uninfected
healthcare professionals and to identify differences in responsiveness
correlating to CD4 counts in the HIV-infected group.
Methods: 158 HIV-infected patients and 480 HIV-uninfected healthcare
professionals, tested negative for hepatitis B surface antigen (HBsAg)
and antibody to HBsAg (anti-HBs) received vaccination with hepatitis
B vaccine (Engerix). All subjects received three standard doses of the
vaccine at 0−1-6 months. Upon completion of vaccination anti-HBs
levels were examined by ELISA (AXSYM, Abbott) and a positive
response was deﬁned as an anti-HBs titer of 10 IU/L. CD4 cells
measurements were done by ﬂow cytometry. Patients and healthy
individuals were divided into two groups according to the magnitude
of response to vaccination.
Results: Protective antibody titres were evident in 37% (n = 58) of
patients with a mean CD4 cell count of 749.36 (±-259.1)/mm3.
Interestingly, in 13.8% (8/58) of those subjects, CD4 cells did not exceed
500/mm3.
The remaining 63% (n = 100) showed inadequate seroconversion titres.
Mean CD4 cell count among HIV-infected non-responders was 621.1
(±306.43)/mm3, while 50% of those patients had a CD4 count of
>500/mm3. Statistical analysis using Student’s t test, revealed that overall
differences in CD4 counts between responders and non-responders are
signiﬁcant (p = 0.0126). Protective antibody titres were found in 88.2%
of healthy controls.
Conclusion: Efﬁcacy of current HBV vaccination schedule is low among
HIV-infected patients. Despite signiﬁcant differences observed in CD4
counts in relation to antibody response, the former cannot be used as the
sole marker of immune system activation. Failure to generate an antibody
reaction maybe due to other factors as inferred by the high percentage
(11.8%) of non-responders in the control group. Alternative strategies
such as higher hepatitis B vaccine doses, prolongation of the vaccination
schedule, or both, as prescribed for many patients with non-HIV-related
immune deﬁciencies, may be considered.
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R2491 An outbreak of hepatitis A in northeastern Greece
T. Exiara, L. Papazoglou, A. Risggits, F. Paraskevopoulou, M. Filippidou,
E. Filippidou, D. Sismanis, S. Papanastasiou (Komotini, GR)
Objectives: Hepatitis A virus (HAV) is one of the most important causes
of focally transmitted acute infectious hepatitis worldwide. In Greece,
beside the sporadic HAV infections, outbreaks also occur, particularly
in our area, the northeast part of the country. The aim of this study was
to present the epidemiological, clinical and laboratory features of acute
hepatitis A outbreak among adults in our area.
Material and Methods: An outbreak of acute hepatitis A occurred
in our area during October and November 2007. 176 cases of acute
hepatitis A reported to local Public Health Authorities in our city
and 67(38.1%) cases concerned adult patients above 15 years of age.
64 patients hospitalised in our internal medicine department with the
diagnosis of acute hepatitis A and we registered the demographical,
clinical and laboratory ﬁndings and outcome. Acute hepatitis A cases
were conﬁrmed if patients had a positive IgM anti-HAV serology.
Results: Of a total 64 patient (37 were females and 27 males)
56(87.5%) patients were between 17–25 years of age. All the patients
were inner inhabitants and living at the same area of the city. The
most of them belonged to families with low socioeconomic level.
Epidemiological investigation revealed drinking water as a common-
source of the outbreak. Regarding clinical features main prodromal
symptoms included weakness, fatigue, nausea, vomiting and anorexia.
Fever was present in 51(79.7%) cases, artralgia and myalgia in 31(48.4%)
and epigastric pain in 28(43.7%) cases. Hepatomegaly was present in
all cases, splenomegaly in 26(40.6%) and lymphadenitis in 11(17.2%)
cases. Jaundice was present in 61(95.3%) cases. Mean serum bilirubin
level was 5mg/dl, ranging from 1.6 to 14mg/dl. The mean serum AST
and ALT levels were 1100 and 1650 UI, respectively. The mean length
of hospitalisation was 7±2.4 days. No death was registered.
Conclusion: The pattern of this common-source water-associated
outbreak indicates that some regions of Greece, such as our area, are
still considered of moderate endemicity of HAV infection. Methodical
sanitary controls of water supply and vaccination of patients belonging
to high risk groups are the keys to prevent outbreaks of HAV infections.
Virology (non-HIV/non-hepatitis)
R2492 Determination of inhibitory effects of buthionine
sulfoximine on apoptosis induced by measles virus
K. Haratian (Tehran, IR)
Background: Measles virus is a highly contagious agent which causes
a major health problem in developing countries. We studied the effect of
buthionine sulfoximine (BSO) on the replication of an AIK-HDC strain
of measles virus (MV) and its induced apoptosis in Vero cell lines.
Methods: In this study, toxicity of BSO on Vero cells was investigated
ﬁrst, resulted in determination of sub-lethal or non-toxic concentration
zone of BSO for cells. Next, antiviral effect of BSO at various time limits
was evaluated and virus titer was determined at each stage either as
50% tissue culture infective dose (TCID)50 or by plaque assay method.
Using speciﬁc antimeasles IgG, antiviral effect of BSO on measles virus
replication cycle was evaluated through indirect immunoﬂuorescence
assay, meanwhile presence of viral RNA was investigated by RT-PCR
and gel electrophoresis.
Results: According to the experiments, BSO, at concentration of 50mM,
markedly inhibited the cytopathic effect (CPE) induced by measles virus.
BSO also signiﬁcantly inhibited apoptosis induced by measles virus.
BSO either inﬂuences replication of measles virus genome, or may
inhibit virion formation.
Conclusion: These results suggest that the inhibition by BSO of CPE
and apoptosis induced by measles virus may be associated with the effect
of BSO on viral RNA genome. Therefore, it is suggested that measles
virus infections can induce apoptosis through the activation of a common
pathway that can be inhibited by BSO.
R2493 Human herpesvirus 6 infections in patients with allogeneic
haemopoietic stem cell transplantation in a medical
university in Warsaw 2004–2006
T. Dzieciatkowski, M. Przybylski, A. Tomaszewska, T. Torosian,
M. Mucha, M. Luczak (Warsaw, PL)
Objectives: Human herpesvirus 6 (HHV-6) has been recognised as a
potential signiﬁcant pathogen in haemopoietic stem cell transplant re-
cipients. Different clinical manifestations have been described including
fever, skin rash, bone marrow suppression and encephalitis.
We want to measure prevalence of the HHV-6 DNA in group
of allogeneic haemopoietic stem cells recipients hospitalised in
Haematology, Oncology and Internal Medicine Clinics of Medical
University in Warsaw.
Methods: A retrospective review of group of 26 adult recipients of
allogeneic HSCT was made. Serum samples taken before transplant were
examined for presence of speciﬁc anti-HHV-6 antibodies in IgM and
IgG classes. After transplantation quantitative real-time PCR was used
to determine viral load in 294 plasma samples in range 0–180 days.
Results: HHV-6 DNA was detected in plasma samples in eight (30%)
of the 26 recipients between day 18 and day 41 of transplantation.
All of them developed fever of unknown origin, and 50% had GvHD
features. Three individuals from this group died during detectable
HHV-6 viraemia. Additional two recipients showed a single positive
PCR result in later period. Thus, infection with HHV-6 was conﬁrmed
in 10 (38%) of the 26 graft recipients.
Conclusions: There is a high frequency of detectable HHV-6 viral load
in SCT recipients in Poland. Further investigation to monitor HHV-6
reactivation in graft recipients will be important to improve the outcome
for these patients.
R2494 Serodiagnosis of human cytomegalovirus infection by
completely automated chemiluminescent immunoassays:
Architect CMV IgG and IgM
C. Galli for the Italian Study Group for the Serology of Congenital
Infections
Objectives: To evaluate the performances and suitability of new
automated assays for the detection of IgM and IgG antibodies directed
against human Cytomegalovirus (CMV).
Methods: The Architect CMV IgG and IgM assays are two fully
automated chemiluminescent immunoassays that employ a viral lysate
(IgG assay) or a combination of viral lysate and recombinant antigens
(p52 and pp150, IgM assay) on the solid phase (paramagnetic particles)
and, respectively, an anti-human IgG or IgM conjugate. The two
assays were evaluated both on unselected and on repository sera in
12 Microbiology labs from 7 Italian regions, in comparison with other
commercial tests. Samples were obtained from pregnant women (PW),
from volunteer blood donors (BD), and from hospital in- and outpatients
(HP).
Results: A total of 6,009 samples (3,590 from BD, 942 from PW,
1,477 from HP) have been analysed so far. Among BD the general
seroprevalence (Architect) for IgG was 79.6% and for IgM 1.6%, with
signiﬁcantly lower rates (38.5%) for IgG and higher (2.7%) for IgM in
the single Centre that tested only new donors and formerly seronegative
regular donors. Seropositivity rates for IgG and IgM among PW and
HP were 63.5% and 6.0% vs. 73.4% and 9.6%, respectively. Cumulative
positivity rates for IgG increased with age, from <50% in subjects aged
less than 20 years to >90% in subjects 60 years. The Architect CMV
IgG assay showed different concordance rates with the other tests, lower
in comparison with Diasorin Liaison and higher with Abbott AxSYM.
For the Architect CMV IgM assay the concordance with other methods
was generally <90%, due to the high number of discordant reactives.
Most IgM positive samples by any assay showed a high IgG avidity
index. The distribution of negative results showed a good separation
from the assays cutoff; for IgG (U/mL), the mean was 1.12+0.78 U/mL,
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the median 0.79, the 99th percentile 4.65; for IgM (Index) the mean was
0.34+0.19 S/CO, the median 0.30, the 99th percentile 0.92.
Conclusion: CMV IgG seroprevalence increases signiﬁcantly by age,
positivity rates for CMV IgM range between <2% to 10% in different
populations. The Architect CMV IgG assay seems more sensitive than
other automated methods; the Architect CMV IgM is more speciﬁc than
AxSYM and quite similar to other methods, though most IgM-positive
specimens are characterised by a high IgG avidity, as expected according
to literature. The Architect CMV assays are suitable for routine.
R2495 Prevalence of parvovirus B19 infections among patients
with sickle cell anaemia and thalassaemia in Saudi Arabia
A.J. Alzahrani, O.E. Obeid (Dammam, SA)
Objectives: The present study was aimed at serological assessment of
parvovirus B19 infection among sickle cell anaemia and thalassaemia
patients in Al-Khobar and Dammam, Saudi Arabia.
Methods: the methods used are clinical assessment, serological
measurement of parvovirus B19 antibodies using ELISA, viral DNA
using PCR and an interview-based questionnaire.
Results: the age of the patients included in the study (N=138) ranged
from 6 months to 61 years (mean 28 years). 40 samples (28.4%)
have detectable levels of Parvovirus B19 IgG. 6 samples (4.3%) have
detectable levels of Parvovirus B19 IgM antibodies. All IgM-positive
samples had detectable B19 parvovirus DNA by PCR. Samples of
sickle cell disease patients (N=138) were analysed for antibodies against
Parvovirus B19 using the novel western blot assay (recomblot assay). 46
samples (33.3%) have detectable levels of Parvovirus B19 antibodies by
recomblot assay.
Conclusion: establishing the extend of parvovirus B19 infection in
sickle cell anaemia and thalassaemia patients will help in proper
management of aplastic crisis in such patients and will also be useful
for epidemiological purposes.
Mycobacterial infections (including
diagnosis)
R2496 Features of tuberculous lymphadenitis – Experience of a
single tertiary centre in Greece
X. Yiakoumis, G.A. Pangalis, A. Andreopoulos, P. Diamantopoulos,
S. Bouros, M. Siakantaris, S. Sachanas, T.P. Vassilakopoulos
(Athens, GR)
Objectives: Tuberculous lymphadenitis (TBL) is considered the most
prevalent form of extrapulmonary tuberculosis. Incidence and clinical
features of various forms of tuberculosis have changed during the last 40
years, mainly due to introduction of new drugs, admixture of populations
and increased number of immunosupressed individuals.
We conducted a retrospective study to determine the clinical and
laboratory features of TBL in an adult population evaluated for peripheral
lymphadenopathy in a tertiary centre in Greece, where published data
on tuberculosis are sparse.
Patients and Methods: Among 516 adult patients, who presented with
peripheral lymphadenopathy between 1990 and 1995, 27 (5.2%) were
diagnosed with TBL, following an excisional biopsy. TBL was the 3rd
leading benign cause of lymphadenopathy in this population, following
infectious mononucleosis and toxoplasmosis. Patients were evaluated by
physical examination, complete blood counts, erythrocyte sedimentation
rate (ESR), chest X-rays and PPD skin test.
Results: All patients were native Greeks with median age of 47 years
(18–70); 70% were females. All presented with cervical/supraclavicular
lymphadenopathy. A single patient was diagnosed by axillary lymph
node biopsy, but small axillary and inguinal lymph nodes were found in
42% and 4% of patients respectively. Notably preauricular, postauricular
and suboccipital nodes were not palpable in any case. Only 19% had
concomitant fever, 15% weight loss and 7% sweats. The median size
of the nodes was 2.5cm2 (0.5–25.0) and none had ﬁstulas, while hard
texture was present in 46% and tenderness in only 8% of the patients.
Splenomegaly was noted in 4% and hepatomegaly in 15% of the patients.
All patients had positive PPD test. Hemoglobin and platelet count were
within normal limits, while, lymphocytopenia was observed in 29% of
the patients. Median ESR was 34mm (range 4–85). Chest X-rays did
not reveal abnormal ﬁndings in any case. All patients were successfully
treated with isoniazide and rifampicin for 9 months and ethambutol for
3 months.
Conclusion: TBL is a major cause of lymphadenopathy in adult
patients in Greece. It should be considered especially in patients >40
years old with clinically signiﬁcant, non-tender, cervical/supraclavicular
lymphadenopathy and positive PPD. The expansion of immigrant
population in Greece during the last decade should prompt for a further
increase in the level of suspicion for this curable disease.
R2497 Genotype MTBDRplus for detection of rifampin and
isoniacid resistance in clinical specimens of M. tuberculosis
M. Causse, P. Ruiz, J. Gutierrez, M. Casal (Cordoba, ES)
Objective: The present study sought to evaluate the use of the
new Genotype MTBDRplus assay (Hain Lifescience GmbH, Nehren,
Germany) directly from positive clinical specimens, comparing the
results with those obtained by conventional phenotypic resistance studies.
Methods: 59 bacilloscopy-positive sputum samples from patients with
suspected tuberculosis were subjected to the new Genotype MTBDRplus
assay. This technique is based on DNA-strip technology, consisting
of a multiplex PCR in combination with reverse hybridisation using
nitrocellulose strips for detecting mutations related with Rifampin (RIF)
and Isoniacid (INH) resistance comparing the result with those obtained
phenotypically in Bactec MGIT 960.
Result: Of the 59 M. tuberculosis strains tested, 9 were phenotypically
sensitive to INH and RMP, and displayed no resistance-linked mutations.
Among the 50 sputum specimens showing some form of phenotypic
resistance, 13 displayed RMP resistance, 14 INH resistance and 23 Multi-
drug resistance (MDR). All of the phenotypically RIF resistances were
detected by the test and only two of the INH resistant strains could not
be detected. Sensitivity for RIF resistance is 100% in our study and
94.5% for INH.
Conclusions: The new Genotype MTBDRplus assay is a valid technique
for detecting resistance to RMP and INH, providing within 6−8 hours a
result that enables a more effective orientation of patient treatment.
Since the detection of resistance-related mutations did not cover 100%
of possible cases of resistance, use of this new assay does not obviate
the need for conventional phenotypic resistance testing.
R2498 Risk factors for indeterminate results of a
tuberculosis-speciﬁc gamma interferon release assay in
immunocompromised patients
B. Lange, M. Vavra, W.V. Kern, D. Wagner (Freiburg, DE)
Introduction: Tuberculosis (TB)-speciﬁc interferon-g release assays
(TIGRA) have been introduced as an alternative to the tuberculin skin
test (TST) for the diagnosis of latent TB in the last few years. These tests
use stimulation of T-cells with phythemagglutinin as positive control,
which – in contrast to TST – allows identiﬁcation of false negatives.
Since little data exist on reliability of these tests in immunocompromised
(IC) patients, we prospectively used the QuantiFERON-TB Gold in tube
(QFT-IT, Cellestis) in IC patients to determine the rate of and identify
risk factors for indeterminate results (IR).
Methods: Of 420 patients 240 (57%) were male and 180 (43%) female.
234 (56%) had either kidney or liver transplants, 50 (12%) were HIV
positive, 77 (18%) had autoimmune diseases, 44 (10%) had primary
immunodeﬁciencies and 15 (3.6%) were stem-cell transplant patients. 88
healthy students and healthcare workers served as control group. Data
collection included demographic data, medical history, medication, and
laboratory values. For statistical analysis the Chi square based measure
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Cramer V was used to determine relationships of categorical variables
and tested for signiﬁcance in SPSS.
Results: 1% of healthy control subjects (1/88) had IR, signiﬁcantly
less than IC patients (11.4%, p< 0.05). IR rates were higher in female
(30/180, 16.7%) than in male patients (18/240, 7.5%; p< 0.001). IR
rates varied signiﬁcantly dependant on disease groups: patients with
autoimmune diseases had a signiﬁcantly higher percentage of IR than
organ-transplant patients (20.7% vs 7.6%; p< 0.05). The highest rate of
IR was found in patients with stem cell transplants (8/15; 53%). IR rates
in patients with immunosuppressive therapy (11%) were similar to those
observed in patients with primary immunodeﬁciencies or HIV-infection
(13%).
Conclusion: Although IR rates are higher in IC patients than in healthy
subjects, QFT-IT still produces reliable results in more than 88% of
this patient group. The study shows a signiﬁcant gender difference
of IR results using QFT-IT in IC patients that has not been reported
previously and needs conﬁrmation in future studies. Patients with
organ transplantation had signiﬁcantly lower rates of IR than patients
with autoimmune diseases. Use of QFT-IT prior to immunosuppressive
therapy seems to be especially important in stem-cell transplant patients.
If conﬁrmed the need for gender- and disease-speciﬁc cut-off values has
to be evaluated.
R2499 Low body mass index is associated with tuberculosis
infection in patients starting continous ambulatory
peritoneal dialysis
H.S. Lee, S.J. Jeong, H. Choi, B.S. Jin, S.H. Choi, S.H. Han, M.S. Kim,
C.O. Kim, J.Y. Choi, Y.G. Song, K.W. Choe, M.W. Kang, J.M. Kim
(Seoul, KR)
Background; Due to lack of the cell-mediated immune response that is
responsible for killing intracellular organisms in uremic individuals, there
is an 8 to 25-fold increased risk of tuberculosis in patients on dialysis due
to renal failure, compared to the general population. Because tuberculosis
is well managed if detected early, it is important not only to make an
early diagnosis based on clinical suspicion, but to suspect tuberculosis
of patients who are highly susceptible to the disease. This study was
undertaken to investigate the epidemiology and risk factors associated
with tuberculosis infection in patients starting continous ambulatory
peritoneal dialysis.
Method; A retrospective review of 203 patients who initiated peritoneal
dialysis from January 2000 to December 2005 at Severance Hospital due
to chronic renal failure was performed. Diagnosis of tuberculosis was
made based on the following; 1) if AFB was positive on sputum, body
ﬂuid smear, tissue stain, cultures or 2) caseous necrosis was present on
a tissue sample or 3) if x-ray ﬁndings strongly suggested tuberculosis
lesions and lesions improved after anti-tuberculous medication. To
determine risk factors for tuberculosis, we analysed gender, age, diabetes,
serum albumin level, hemoglobulin level, body mass index(BMI),
presence of heart failure, medication and etc. All the data including
biochemical, weight and height were collected within a month of dialysis
commencement.
Results; Among 203 patients enrolled, 18 patients were diagnosed with
tuberculosis infection during the study period. The incidence was 28 per
1000 patient years. Upon univariate analysis, risk factors that seemed
to be statistically signiﬁcant for tuberculosis infection were reduced
BMI, use of diuretics and the use of angiotensin receptor blockers.
No other factors including diabetes mellitus, statin use, age, albumin,
cholesterol level showed relevance. Logistic regression analysis revealed
that low BMI (P< 0.001) was the signiﬁcant predictor associated with
the development of tuberculosis.
Conclusion; Our study revealed that low BMI at the start of dialysis is
associated with tuberculosis. Since tuberculosis in chronic renal disease
patients have potential progressive nature and dangerous outcome, we
suggest that a more close observation made be needed for patients who
have low BMI, initiating peritoneal dialysis.
R2500 Drug resistance of Mycobacterium tuberculosis in Adana,
Turkey
F. Kibar, A. Turac Bicer, A. Yaman (Adana, TR)
Objectives: Drug resistance of Mycobacterium tuberculosis has been
widely reported in the world. We performed this study in order to
evaluate the drug resistance to M. tuberculosis strains collected between
2001–2006, in Adana city, Turkey.
Methods: Isolation and antibiotic susceptibility tests were carried out
using Mycobacterial Growth Indicator Tube (MGIT) system (Becton
Dickinson). From 2001 January to 2006 December, a total of 910
strains of M. tuberculosis were analysed. Out of 910 strains isolated,
640 (70.3%) were from sputum, 45 (5%) from urine, 59 (6.4%) from
bronchoalveolar lavage, 25 (2.8%) from abscesses, 37 (4.1%) from
cerebrospinal ﬂuid, 19 (2.1%) from gastric aspirate, 5 (0.5%) from
peritoneal, 31 (3.4%) from pleural liquids, and 49 (5.4%) from others.
Results: The rate of the resistant M. tuberculosis strains were: 8.5%
(78) to INH (Isoniazid), 0.9% (7) to RIF (Rifampin), 3.4% (31) to
ETB (Ethambutol), 3.4% (31) to SM (Streptomycin), 3.5% (32) to
INH+RIF, 1.2% (11) to INH+ETB, 1.3% (12) to INH+SM, 0.2% (2)
to RIF+ETB, 0.1% (1) to ETB+SM, 3.9% (35) to INH+RIF+ETB, 1.1%
(10) to INH+RIF+SM, 0.4% (4) to INH+ETB+SM and 1.2% (11) to
INH+RIF+ETB+SM. The rate of the strains susceptible to all four drugs
were 70.9% (645)
Table 1. Annual distribution (%) of drug resistant strains.
Years 2001 2002 2003 2004 2005 2006 2001–2006
Number 185 186 207 95 120 117 910
INH 13 8.7 6.8 7.4 5 9.5 8.5
RIF 1.6 0.5 – 1.7 0.8 0.9
ETB 2.1 2.1 7.7 5.9 3.4
SM 3.8 1.5 3.1 7.5 7.7 3.4
INH+RIF 1.1 3.2 3.3 8.5 2.5 5.1 3.5
INH+ETB 4.9 0.5 1.7 0.8 1.2
INH+SM 1.1 0.5 1.5 3.1 0.9 1.3
RIF+ETB 0.6 0.5 – 0.2
ETB+SM 0.6 – 0.1
INH+RIF+ETB 2.7 7.6 4.9 5.3 0.8 3.9
INH+RIF+SM 2.1 1.5 2.1 0.9 1.1
INH+ETB+SM 0.6 0.5 0.9 0.4
INH+RIF+ETB+SM 1.6 0.5 0.9 2.1 1.7 0.8 1.2
Susceptible to 4 drugs 69.1 71 70.5 68.4 74 72. 70.9
MDR (INH+RIF) 7.5 11.3 10.6 18 4.2 7.6 9.7
Conclusion: Tuberculosis is still an important public health problem in
our district, particularly because of drug resistance. That is why, effective
treatment and control programmes are necessary.
R2501 Genotyping of Mycobacterium tuberculosis MDR and XDR
strains in Lima, Peru
C. Tello, N. Borja, R.G. Gavila´n, J. Ruiz, L.J. del Valle, M. Vargas,
P. Ramirez, R. Garcia de la Guarda (Lima, PE; Barcelona, ES)
Objective: To characterise the genotypes of Mycobacterium tuberculosis
both multidrugresistant (MDR), expensive drug resistant (XDR) and
susceptible to drugs strains.
Methods: Forty-nine patients with TB were included in the study.
The genotypes of the M. tuberculosis isolates were established by
PCR using the primer Mtb2 (5′-CGG-CGG-CAA-CGG-CGG-CA-3′) in
combination with primers sited at inverted repeats ﬂanking IS6110.
Mycobacterial infections (including diagnosis) S745
The susceptibility to isoniazid, rifampicin, streptomycin, ethambutol,
kanamycin, para-amin-salicylic acid, tioacetazon and pyrazinamide was
studied.
Results: The 36.7% of the patients presents isolates susceptible to all the
drugs tested. The 12.9%, 9.7%, 9.7%, 48.4% and 19.4% were resistant
for one, two, three drugs, MDR and XDR, respectively. The resistance
levels to isoniazid, streptomycin and rifampicin were the most relevant,
ranged between between 47% and 49%.
The 16% of the patients were VIH+, three out of them presents MDR
strains, while no XDR isolate was isolated from these patients.
When considered the patients with MDR strains the 80% reported
previous TB.
Upon PCR-based genotyping analysis of 49 M. tuberculosis strains,
the presence of 42 different ﬁngerprints and 10 different clusters were
established, the number of bands for each ﬁngerprint ranged from 7 to
1 band(s). The MDR isolates were non-included in a speciﬁc cluster
Conclusions: An High number of MDR isolates were detected.
Additionally, the recovered isolates presents a low level of clonality,
showing a great variety of genotypes and a low level of clustering, this
phenomena affects specially the MDR isolates.
R2502 Is there a place for the military in contributing to a global
programme managing the MDR-TB challenge and beyond?
E. Dhondt, T. Peeters, G. Laire (Brussels, BE)
Background: In accordance with a reorganisation, the Central Military
Hospital of the Belgian Defence is looking for new opportunities in
cooperation with the civilian health services. Recently a partnership
has started with a tertiary care university teaching hospital belonging
to a hospital association specialised among others in the treatment of
infectious diseases and accredited as a federal SARS reference hospital.
The increasing mean annual incidence of MDR-TB in Belgium
(0.1/100,000 inhabitants; 10 new cases annually) and the complex,
prolonged and costly management of infected patients (on an average
14 country-wide) urge for a dedicated infrastructure and particular
environmental control technologies.
Objective: To study the architectural feasibility of an MDR-TB isolation
unit within the existing building of the military hospital.
Methods: A multidisciplinary design team was launched, consisting of
critical care and infectious disease specialists, infection control experts
and the Defence Operating Engineering staff.
Taking into account the hospital space programming and functional
planning and according to the Hospital Law and the CDC guidelines
for preventing the transmission of Mycobacterium tuberculosis in
healthcare settings (2005), design recommendations and state-of-the-
art requirements for an infectious airborne diseases isolation unit were
identiﬁed. The most suited spatial implantation was subsequently picked
out.
Results: Based on the modiﬁcation of a pre-existing abandoned medium
care burn centre, an optimum airborne disease isolation unit design is
described. (Figure)
Emphasis is laid on the lay-out of 16 single-patient negative-pressure
airborne infection isolation rooms, local exhaust and general ventilation,
air cleaning (HEPA ﬁltration), prolonged and socially warranted housing
and recreational facilities as well as intensive care, surgery and
laboratory capacities.
Conclusion: A dedicated MDR-TB isolation unit is justiﬁed.
The Belgian Defence can participate in a global national programme
to treat MDR-TB by lending appropriate space and high technical
infrastructure to achieve best practice environmental control.
The location in the country’s capital permits future centralisation and
nation-wide standardisation of protracted MDR-TB chemotherapy and
diagnostic drug susceptibility testing.
This project entirely ﬁts in the national contingency planning for the
management of emerging airborne infectious diseases like SARS or avian
ﬂu.
R2503 Usefulness of MTBDRplus assay for rapid genotypic
detection of Mycobacterium tuberculosis resistant to
isoniazid and rifampicin directly in clinical specimens
A. Lacoma, N. Garcı´a, C. Prat, S. Blanco, L. Haba, L. Fuenzalida,
J. Maldonado, J. Ruiz Manzano, J. Domı´nguez (Badalona,
Barcelona, ES)
Objectives: To evaluate the usefulness of MTBDRplus assay for
detecting resistance of Mycobacterium tuberculosis against isoniazid
(INH) and rifampicin (RIF) in smear-negative and smear-positive clinical
specimens.
Methods: Sixty-ﬁve clinical samples (53 sputa, 3 bronchoalveolar
lavages, 5 bronchial aspirates, 3 pleural effusions and 1 lymph node)
were recovered from 28 patients. All the samples were processed by
conventional mycobacterial procedures and after strain isolation on solid
culture, the antibiotic susceptibility was assessed by BACTEC460TB.
According to the Ziehl-Neelsen staining 39 samples were smear-negative
(19 INHs/RIFs, 4 INHr/RIFs and 3 INHr/RIFr) and 26 were smear-
positive (12 INHs/RIFs, 1 INHr/RIFs and 26 INHr/RIFr). The assay,
which consisted of DNA isolation, multiplex PCR with biotinylated
primers and reverse hybridisation on nitrocellulose strips, was carried out
following the manufacturer instructions. MTBDRplus combines control,
wild type and mutation probes, which allow the detection of the most
common resistance mediating mutations in rpoB, katG and inhA.
Results: Valid test results were obtained for 51 samples (78.4%). The
14 invalid results corresponded to Ziehl-Neelsen negative samples.
The concordance between MTBDRplus susceptibility pattern and
BACTEC460TB result for the samples with valid result was 98%
(50/51) for RIF and 96.2% (49/51) for INH. In relation to RIF,
the discordant sample was resistant according to the MTBDRplus,
because of the absence of one of the wild-type bands, but susceptible
according to BACTEC460TB. The two discordant samples for INH,
belonging to the same patient, were RIFr/INHr according to BACTEC
but the MTBDRplus INH pattern was susceptible. We detected 30 rpoB
mutations for the 29 RIF resistant samples that consisted of: 17 D526Y
(56.7%), 9 D516V (30%) and 4 S531L (13.3%). Mutations in katG and
inhA for the 30 INH resistant samples were: katG S315T in 11 cases
(39.3%) and both katG S315T and inhA-15 C-T in 17 cases (60.7%).
Conclusions: MTBDRplus assay is an easy to perform test that allows
the rapid detection of RIF and INH resistant M. tuberculosis directly
from clinical sample with a high sensitivity, being appropriated for the
use in the routine work ﬂow.
R2504 Genotypic detection of rifampicin resistance in
Mycobacterium tuberculosis: analysis of mutations
from high- and low-incidence areas using denaturing
high-performance liquid chromatography
J. Evans, A. Parveen, E.G. Smith, X. Li, E. Chan, R. Chan, P. Hawkey
(Birmingham, UK; Hong Kong, CN)
Objectives: With the emergence of MDR- and XDR-TB, there is a need
for a rapid method of detecting rifampicin resistance in M. tuberculosis
that can be applied to all isolates in a geographic area. Denaturing
high performance liquid chromatography (dHPLC) is a rapid screening
method that can analyse PCR amplicons up to 700 bp in length. The
aim of this study was to evaluate dHPLC analysis of the rpoB gene in
M. tuberculosis using a extensive collection of 16 distinct mutations in
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10 different codons from Hong Kong and the UK and a collection of 84
consecutive clinical isolates.
Methods: DNA from 52 rifampicin resistant M. tuberculosis isolates
from the UK and Hong Kong identiﬁed from 1996–2005 was extracted
using a sonication and heating method from positive liquid cultures
incubated at 37C. Each mutation was deﬁned by DNA sequence analysis
using capillary electrophoresis. In order to evaluate clinical utility,
84 consecutive clinical isolates identiﬁed as M. tuberculosis by the
Hain LifeScience GenoType MTBC assay were analysed by dHPLC.
Phenotypic drug sensitivity testing was undertaken using the BD MGIT
liquid culture system. A 400 bp product was ampliﬁed from each
DNA extract, hybridised with a known sensitive control (H37Rv), and
analysed on a WAVE system at 67.0C. Mutations were detected if two or
more peaks were detected on a chromatogram with one peak indicating
no mutation was detected. Sensitivity, speciﬁcity, PPV and NPV were
calculated.
Results: 45/52 (88.2%) rifampicin resistant isolates with deﬁned
DNA mutations were detected by dHPLC at 67.0 ºC. 83/84 (98.8%)
consecutive DNA extracts were ampliﬁed with the ampliﬁcation
failure bring phenotypically rifampicin sensitive. Two isolates were
phenotypically rifampicin resistant and dHPLC detected a mutation in
the rpoB amplicon for both these isolates (S531L and S531W). dHPLC
detected a mutation in 1/82 phenotypically rifampicin sensitive isolates
(M482T, a non-cluster I/II mutation). In a combined analysis of all
isolates, detection of mutations in the rpoB gene by dHPLC analysis
exhibited sensitivity of 88.7%, speciﬁcity of 98.8%, PPV of 97.9%, and
NPV of 93.0%.
Conclusion: This study of dHPLC analysis of an expanded collection
of mutations from high and low areas of incidence and clinical strains
in an area of low incidence shows that dHPLC analysis is sensitive and
speciﬁc and could be implemented in a routine clinical service alongside
routine MIRU-VNTR DNA ﬁngerprinting on a WAVE system.
R2505 Diagnosis of tuberculosis infection in HIV-infected patients:
an interferon-gamma assay versus tuberculin skin test
S. Casas, M. Saumoy, P. Robres, R. Moure, A. Andreu, F. Alcaide,
D. Podzamczer, M. Santı´n (L’Hospitalet del Llobregat, ES)
Objectives: To compare the tuberculin skin test (TST) with a whole-
blood interferon-gamma (IFN-g) assay in the diagnosis of tuberculosis
infection (TBI) in HIV-infected patients.
Methods: Cross-sectional study of X HIV-infected patients evaluated
at the HIV Unit of a third-level teaching hospital, between February
and October 2007. Diagnosis of TBI was based on TB exposure, chest
X-ray, two-step TST and IFN-g assay (QuantiFERON® TB Gold-in Tube,
QFT). According to the manufacturer’s instruction, QFT was considered
as positive when the TB antigen minus negative control IFN-g production
0.35 UI/mL; an indeterminate result was deﬁned as either a positive
control IFN-g response of 0.5 UI/mL or a negative control IFN-g level
of >8 UI/mL. A positive TST was deﬁned as a 5mm induration.
Agreement between TST and QFT was assessed by the Cohen kappa
(k) index.
Results: 39 patients were assessed for TBI, 69% men, with a mean age of
36 years. 49% were foreign-born. 54% had some TB risk factor and 39%
were BCG vaccinated. 5% had a previous story of TBI. Mean CD4+ cell
count was 376 (±279), 11 (28%) patients with CD4+ <200 cells/mL,
and mean HIV-RNA was 118,569 copies/mL. 2 (5%) patients had a
positive TST compared with 5 (13%) with QFT (p = 0.02). 3 patients
had discordant results, all of them positive QFT/negative TST. 1/11 (6%)
patients with CD4+ <200 showed a positive QFT but no one had positive
TST. In the positive QFT group, some TB risk factor was presented in
60% (3/5) of cases but in no one in the positive TST group.)There were
no indeterminate results due to low production of IFN-g in positive
control tube. Overall agreement between the 2 tests was 92% (33/36,
k=0.53, CI 95% 0.24−0.82).
Conclusions: These results suggest that QFT has higher sensitivity than
TST for the diagnosis of TBI in HIV infected adults, particularly among
those more immunosuppressed. TST and QFT agreement was moderate.
There were not any indeterminate results due to low production of IFN-g
even among patients with CD4+ <200.
Infection in the immunocompromised host &
transplant recipients
R2506 Diagnostic yield of blood cultures from antibiotic-naive
and antibiotically treated febrile neutropenic patients
with acute leukaemias and patients after high dose
therapy and autologous blood stem cell transplantation –
a single centre experience
M. Hummel, C. Warga, D. Buchheidt (Mannheim, DE)
Objectives: Infections are common complications during neutropenia
after intensive cytoreductive therapy and a major cause of morbidity
and mortality. Especially when drawn under empiric antibiotic therapy,
the diagnostic signiﬁcance of blood cultures concerning the detection of
pathogens, the identiﬁcation of pathogen shifts and resistance patterns
in these patients is unclear.
Methods: To assess the yield of blood cultures, the spectrum of
pathogenic organisms and the inﬂuence of blood culture results on
the therapeutic management of febrile neutropenia, we retrospectively
evaluated the results from 2520 blood culture samples obtained from
consecutive febrile neutropenic patients with acute leukaemias (n = 90)
and patients treated with high dose therapy schedules and autologous
haematopoietic stem cell transplantation for other haematologic malig-
nancies (n = 36) in our department.
Results: 2217 (88%) out of 2520 blood cultures remained sterile, 71
(2.8%) blood cultures yielded contaminating germs. In 232 (9.2%) of all
blood cultures bacterial and/or fungal pathogens were detected, among
them in 219 (94.4%) bacteria, differentiated as 78.5% Gram-positive
und 21.5% Gram-negative bacteria. Fungi were found in 13 (5.6%) out
of the positive blood cultures. Mainly coagulase negative staphylococci
(n = 104/232), Escherichia coli (n = 2/232) and yeasts (n = 13/232) were
detected. Pathogens were found in 14.3% out of the positive blood
cultures drawn at the beginning of fever, the yield of repetitive blood
cultures under empiric antibiotic treatment was 7.03%. The diagnostic
yield in patients after PBSCT was distinctly lower than in patients
with acute leukaemias. Yeast fungaemias occured later in the course
of neutropenic episodes. The empiric antibiotic treatment was modiﬁed
according to blood culture ﬁndings in 116/232 (50%) of positive blood
cultures.
Conclusion: The diagnostic yield of repetitive blood culture sampling in
risk patients populations with neutropenia and fever is signiﬁcant, both
in antibiotic-naive patients and in patients receiving antibiotic treatment,
and provides important information for clinical decision making. The
epidemiologic data obtained from blood cultures are helpful for selecting
empiric antibiotic treatment regimens. A prospective multicentre trial
is warranted to deﬁne beneﬁts for patients and hospital economics of
repetitive blood cultures under empiric antibiotic treatment in leukemic
patients.
R2507 Registration of frequency of isolated Candida strains in im-
munocompromised and cancer patients and determination
of their tolerance in the usual antimycotic treatment
S. Patiakas, I. Dovlatidis, X. Xaralampous, P. Akritopoulos,
K. Akritopoulou, S. Sereti, D. Oplopiadis, K. Pandelidou
(Thessaloniki, GR)
Objective: To investigate the frequency, the fungus type and their
sensitivity towards the antimycotic treatment in patients with cancer or
immunocompromised patients, because of their high risk in developing
fungal infections.
Methods: We studied 182 patients in total (103 men and 79 women),
mean age of 66.3 years who showed signs of fungal infection. From these
patients 135 suffered of cancer (with histological conﬁrmation of primary
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or secondary neoplasia) and 47 patients suffered of immunosuppression.
We isolated 49 Candida (C) strains, which came out of 25 sputum
samples, 12 from stool cultures, 11 out of urine cultures, and one out
of trauma culture. As for the identiﬁcation we used the API 20C system
and for the determination of sensitivity in antibiotics we used E-test and
other classical methods.
Results: We found 25 cases (51%) of C. albicans, 9 cases (18.4%)
of C. parapsilosis, 8 cases (16.3%) of C. tropicalis, and 7 cases
(14.3%) of C. lusitaniae. All these strains were sensitive in Caspofungine
and Amfotericine B, while we found that 32.7% (16/49) tolerance in
Fluconazole, 24.5% (12/49) in Voriconazole. Nearly 50% of the non-
albicans strains, presented equal tolerance in both antifungal drugs.
Conclusions: (1) C. albicans was the most common isolated strain.
(2) Out of the non-albicans strains that we isolated, the most frequent
was C. parapsilosis, then C. tropicalis and then C. lusitaniae. (3) All
the isolated strains where sensitive in Amfotericine B and Caspofungine.
(4) There was a high level of tolerance in Triazole (mostly by the non-
albicans strains).
R2508 Oral infection with Prototheca zopﬁi (ﬁrst human isolates
in the Balkans)
L. Suvajdzic, Z. Svircev, L. Dzambas (Novi Sad, RS)
Objective: The genus Prototheca belongs to the family Chlorellaceae.
It is an unicellular achlorophyllous alga that is frequently isolated from
a variety of environmental sources. These colourless microalgae have
been identiﬁed to be the only known plant causative agent of human and
animal infections.
Prototheca wickerhamii and Prototheca zopﬁi have been associated with
human disease. Cases of disseminated disease involved the blood, the
peritoneum, the GI tract, the liver, and the meninges. Patients, who
are severely immuno-compromised, can develop disseminated disease,
which is often fatal. This yeast-like organism resembles the green alga
Chlorella, and reproduces asexually by internal septation and cleavage
to form sporangia containing sporangiospores.
This study illustrates the ﬁnding obtained in 53 years old female with
palatum carcinoma in the upper left side. After ablation of the tumour
intraoperationaly an acrylic plate was inserted to separate the newly
postresectionally formed gap between the mouth and nose cavities. Eight
months later a change was noticed in the soft tissues manifested as a
whitish plaque. Swab was taken from the spot, as well as from the contact
surface of the suprastructure of the postresection prosthesis
Methods: Swabs were inoculated onto the Sabouraud broth, Sabouraud
dextrose agar and blood agar, and then subcultured on the same media.
P. zopﬁi was identiﬁed by its cultural and biochemical properties and
microscopic appearance, and conﬁrmed using the RapID Yeast Plus
system (Remel, Santa Fe, N.Mex., USA).
Results: After 72 hours of incubation, colonial growth was noticed in
all media; colonies were most prominent on Sabouraud dextrose agar.
In subcultures, the growth was noticed after 24 hours. Colonies were
whitish, pasty and variable in diameter – a growth typical for yeasts.
Under the light microscope (400×) surface of the colonies appeared
granular. In smears stained with methylen blue, oval organisms, 10
mm in diameter, were observed. Inside the colonies round, rosette-
like formations were apparent. Gram-staining revealed positively stained
spores and negatively stained sporangia. All isolates were sensitive
to amphotericin B and nystatin. RapID Yeast Plus system conﬁrmed
Prototheca zopﬁi by a code 730010.
Conclusion: Based upon the cultural, microscopic and biochemical
properties, presence of P. zopﬁi in the oral cavity of the immune-
compromised patient was conﬁrmed.
R2509 Chronic granulomatous disease associated with B. cepacia
complex infection in a developing country: a report of 2
cases and discussion
C. Bamford, M. Esser, H. Van der Plas (Tygerberg, ZA)
Chronic granulomatous disease (CGD) is an inherited primary immun-
odeﬁciency syndrome characterised by a defective respiratory burst,
with inadequate production of reactive oxygen molecules, resulting in
defective killing of phagocytosed micro-organisms.
A variety of genetic defects in the NADPH oxidase enzyme complex
exist: these include the commoner, more severe X-linked form due to
abnormal gp91 gene, or other autosomal recessive forms due to defects
in gp22, 27 and 67 genes.
Patients with CGD are particularly susceptible to bacterial and fungal
infections. The organisms commonly responsible for infection include
catalase-producing organisms, such as S. aureus and various Gram-
negative bacilli, as well as fungi, especially Aspergillus species.
Burkholderia cepacia complex (Bcc), a group of environmental Gram-
negative bacilli, may cause serious infections, especially pneumonia and
septicaemia, in this group of patients. Bcc bacteraemia is associated
with signiﬁcant mortality, particularly in patients receiving inappropriate
antibiotic therapy. Inappropriate antibiotic therapy is likely since
antibiotics effective against Bcc are seldom included in empiric antibiotic
regimes designed for immunocompetent patients. Increased awareness of
both CGD and Bcc could limit this situation.
We present 2 cases of Bcc infection in patients with CGD: one in a
patient known with CGD, who died of Bcc septicaemia, and one in a
10 year old boy, in whom persistent B. cepacia skin infection was the
indicator condition which lead to the diagnosis of CGD.
CGD is under-diagnosed in sub-Saharan Africa where the majority
of patients die of infection before their condition is recognised.
There are currently no other CGD patients included in the SA
Primary Immunodeﬁciency Register. In addition, little is known about
the underlying genetic proﬁles of CGD in Africa, which may be
diverse. Increased awareness of the disease is required since successful
prophylaxis and treatment with available antibacterial and antifungal
agents is possible in the local context.
R2510 Polymicrobial bacteraemia in cancer patients
G. Rodriguez, A. Safdar, G. Bodey, K. Rolston (Houston, US)
Objective: Most databases describing bacteraemias in cancer patients
focus only on monomicrobical episodes. Our objective was to describe
the microbiology of polymicrobial bacteraemia (PMB) in such patients.
Methods: Retrospective review of institutional microbiology records
(Nov. 2005 – Dec. 2006) to identify patients with PMB, and chart review
of patients with PMB.
Results: Eighty-one episodes of PMB were identiﬁed in 71 pts. (64
pts – 1 episode, 7 pts. – 2 or more episodes). There were 36
women and 35 men with a median age of 55 yrs (range 17–85).
Forty-four (62%) had haematologic malignancies and 27 (38%) had
solid tumours. Thirty-seven (46%) were neutropenic at the onset of
PMB and 48 (59%) had received prior antibiotics, primarily quinolone
prophylaxis. Thirty-eight (47%) had a deﬁnite catheter related PMB
and 21 (31%) had a high organism load (500–1000 CFU/ml) on
quantitative cultures. Multiple Gram-positive species were isolated in
20 (25%), multiple Gram-negative species in 20 (32%), both Gram-
positive and Gram-negative species in 21 (26%), bacterial and fungal
isolates in 11 (13%) and bacterial plus mycobacteria in 3 (4%). The most
common Gram-positive isolates were GNS, viridans group streptococci,
Enterococcus spp. and Corynebacterium spp. The most common Gram-
negative isolates were Escherichia coli, Klebsiella spp., Enterobacter
spp., and Pseudomonas spp. and Stenotrophomonas maltophilia. The
most common fungal isolates were Candida spp. The overall response
to therapy was 84% (68/81). Sixty-six patients (82%) received initial
concordant therapy which covered all isolated pathogens. No signiﬁcant
differences in response were noted in patients with haematologic
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malignancies compared to those with solid tumours and in neutropenic
patients compared to non-neutropenic patients.
Conclusions: PMB’s are not uncommon in cancer patients. Approx-
imately 70% of PMB have a Gram-negative component. Antibiotic
therapy is associated with an 84% overall response rate.
R2511 Pneumocystis jirovecii pneumonia – An AIDS deﬁning
illness?
C. Dierkes, S. Siebig, B. Ehrenstein, H. Linde, J. Scho¨lmerich,
B. Salzberger (Regensburg, DE)
Objective: While HIV patients were known as the most affected
collective by Pneumocystis jirovecii (carinii) pneumonia (PcP) in the
past, in recent years an increasing number of patients undergoing
immunosuppressive therapy or chemotherapy are diagnosed with PcP.
Details about the change in epidemiology, the clinical features and the
clinical outcome of these patients are little-known.
Methods: Retrospective analysis of all patients diagnosed with PcP at
the university medical centre of Regensburg during the years 2004–
2007. All patients showed clinical characteristics of PcP and had either
microscopically or molecular (PCR) proof of Pneumocystis jirovecii
infection.
Results: 67 patients were diagnosed with PcP (49 men, 18 women,
median age 52). Underlying disease was mostly malignancy (40%),
HIV (27%) and rheumatic disease (15%). Treatment at the intensive
care unit was necessary for 42 patients, respiratory therapy for 25
patients. Mortality of the whole group was 27%, considering the different
underlying diseases 1 out of 18 HIV patients died while 16 of the 49
other patients did not survive.
Summary: PcP does not seem to be the disease of HIV infected persons
any more, as most of the patients in this analysis had different underlying
disease. Especially oncologic and rheumatologic cases seem to be a
group at risk and PcP should be strongly considered as a differential
diagnosis in these patients.
The total mortality of all PcP affected patients in this study was
notably higher compared to average mortality rates of HIV patients
diagnosed with PcP published in the literature and when comparing
the mortality rate of HIV and non-HIV infected patients of our study.
Further investigations are needed in order to identify risk factors leading
to infection in non-HIV patients and to analyse differences in outcome.
R2512 Combination antifungal therapy for invasive aspergillosis
in solid organ transplant recipients
C. Cervera, J.C. Trullas, G. Soto, L. Linares, J. Puig de la Bellacasa,
M. Navasa, A. Mas, F. Cofan, M.J. Ricart, E. Roig, C. Agusti,
A. Moreno (Barcelona, ES)
Background: Invasive aspergillosis (IA) in solid-organ transplant
(SOT) recipients is still a major cause of infectious-related mortality.
Combination antifungal therapy (CAT) represents a new challenge due
to the availability of new antifungal drugs. We evaluate the clinical
characteristics and outcomes of SOT patients with IA treated with CAT.
We compared the outcomes of this cohort with an historical cohort
treated with monotherapy.
Methods: All cases of probable or proven IA in SOT treated with double
antifungal therapy were compared with those treated with antifungal
monotherapy.
Results: From 1998 to August 2007, 25 cases of deﬁnite or probable IA
in SOT were diagnosed of which 13 (52%) received combined antifungal
therapy (11 liposomal amphotericin B [lAmB] + caspofungin, 1 lAmB
+ itraconazole and 1 voriconazole + caspofungin). Monotherapy was
based in Amphotericin B in all cases but one (treated with itraconazole).
Diagnosis of IA was: 9 proven and 16 probable. Late-onset IA (more than
180 days post-transplant) represented 24% of the cases (6 cases). By type
of SOT: 6 kidney, 15 liver, 3 kidney-pancreas and 1 heart. A. fumigatus
was isolated in 19 patients, A. niger in 2, A. terreus in 1, Aspergillus spp.
in 1 and in 2 patients no microbiologic isolation was found (1 case biopsy
proven without culture and 1 case with two positive galactomannan and
suggestive radiological ﬁndings). There were no differences between both
groups of antifungal treatment and type of SOT, age, gender, number of
proven diagnosis and disseminated infection. Death occurred in 67% (8
cases) of patients treated with monotherapy vs 23% (3 cases) in those
treated with CAT (p = 0.028).
Conclusions: Our results suggest a better outcome of SOT patients with
IA treated with CAT. Randomized studies to evaluate the efﬁcacy of
CAT in IA are needed.
R2513 Two cases of fatal bacteraemia caused by unusual
pathogens in patients with haematologic malignancy
E. Hajdu, G. Terhes, J. Soki, K. Piukovics, Z. Borbenyi, E. Nagy
(Szeged, HU)
Objectives: The aim of this study was to introduce the 16S rDNA
sequencing analysis for identiﬁcation of unusual pathogens isolated from
blood and to examine the aetiological background of these infections.
Methods: During the febrile period, blood was taken from patients
into BACTEC bottles. In the case of positive ﬂuorescence signal, blood
was processed according to the standard clinical laboratory procedures.
Using conventional methods, identiﬁcation of the isolated strains was
unsuccessful, thus nucleotide sequences of partial 16S rDNA of the
isolated strains were determined and compared to all sequences in the
GenBank database.
Results: In case 1, forty-one-year-old woman with bleeding disorders,
thrombocytopenia and anaemia was admitted to haematology unit. On
the basis of laboratory ﬁndings, the results of bone marrow biopsy and
cytogenetic analysis, the diagnosis was acute promyelocitic leukaemia.
After the chemotherapy, dyspnoea, abdominal pain, and interstitial
pneumonia developed. Her blood cultures taken during the febrile period
became positive for Achromobacter xylosoxidans. In spite of the adequate
antibiotic therapy and intensive care, the patient died shortly after her
admission to the ICU. In case 2, thirty-seven-year-old man with a 9-year
history of large granular lymphocyte leukaemia was admitted to high
fever, headache and confusion. CT scan of the brain revealed multiple
hyperdense focal lesions surrounded by oedema. After 52 and 65 hours
of incubation positive signals were generated in the BACTEC blood
culture system, and two days later small colonies of Nocardia farcinica
were isolated. The patient died shortly after taking these blood cultures.
Conclusion: In the above described cases, the identiﬁed species
(A. xylosoxidans and N. farcinica) are rare causes of bloodstream
infections, but nowadays these are increasingly recognised problems in
immunocompromised patients. At the same time, because of the difﬁcult
identiﬁcation of these pathogens and the special group of patients, the
recognition of these species and the treatment of these infections are
challenging to microbiologists and physicians as well.
R2514 Blood culture statistic study in febrile neutropenic
haematology patients
M. Bronk, M. Kochowska-Bronk, J. Komarnicka, A. Sledzinska,
A. Samet (Gdansk, PL)
Objectives: The aim of study was to evaluate the frequency patterns of
bacterial pathogens isolated from blood cultures in febrile neutropenic
patients hospitalised in haematology unit over the three years period..
Methods: A total number 1322 of blood cultures were examined,
using the (automated) Bact/Alert Blood Cultures System. All isolates
from positive blood cultures, after classic subculture methods, were
characterised at species level by the Vitek system. Antibiotic suscep-
tibility testing was performed using automated Vitek system according
to CLSI recommendations. All the investigated patients were neutropenic
(WBC< 500) with fever (>38ºC) and were under antimicrobial and/or
antifungal therapy at the time of blood culture.
Results: Over the three years period (2005–2007) 1322 blood cultures
were performed on the basis of the physicians request from 321 patients
(with febrile and neutropenic) hospitalised in the haematology ward of
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our hospital. The pathogens were isolated from 363 blood cultures from
321 patients.
Among the 363 bacterial strains isolated from bloodstream infections 261
were Gram-positive strains (71.90%), 91 Gram-negative strains (25.07%)
and 11 yeast (3.03%).
In the group of Gram-positive bacteria were: S. epidermidis 147,
E. faecium 50, S. aureus 16, S. hominis 11, S. haemolyticus 9, E. fecalis
9, S. mitis 9, C. jeikeium 5, S. salivarius 2, S. sanguis 2, S. intermedius
2. In the group of Gram-negative strains were: E. coli 24, P. aeruginosa
13, E. cloacae 12, K. pneumonia 12, S. maltophilia 10, A. baumannii 7,
A. lwofﬁi 5, S. marcescens 4, C. freundii 3, S. enteritidis 1.In the group
of yeast were: Candida albicans 4, C. krusei 3, C. glabrata 2, C. famata
1, C. parapsilosis 1. In the Enterococcus isolates were 8/59 glycopeptide
resistant strains (13.56%) and 2 isolates resistant to linezolid (3.39%).
All the Staphylococcus isolates were susceptible to glycopeptide and
linezolid. All the Gram-negative rods were susceptible to imipenem and
meropenem.
Conclusion: Gram-positive bacteria are common pathogens in neu-
tropenic haematology patients. Glycopeptides (teicoplanin and van-
comycin) were effective for the treatment of infections caused by
Staphylococcus spp. and E. faecalis. Linezolid is effective in the
treatment of infections caused by Gram-positive pathogens including
glycopeptide resistant Enterococcus spp. Imipenem and meropenem
were effective for the treatment of infections caused by Gram-negative
pathogens.
R2515 Antimicrobial prophylaxis in neutropenic patients
undergoing peripheral blood stemcell or bone marrow
transplantation
M. Dettenkofer, R. Babikir, S. Wenzler-Ro¨ttele, H. Bertz, W. Kern,
A. Widmer, E. Meyer on behalf of the ONKO-KISS Study Group
Objectives: To assess antimicrobial prophylaxis in neutropenic patients
undergoing bone marrow transplantation (BMT) or peripheral blood-
stem cell transplantation (PBSCT) and analyse the data in relation
with the incidence of nosocomial infections. Data were taken from
ONKO-KISS (Hospital Infection Surveillance System for Patients
with Hematologic/Oncologic Malignancies), an ongoing multicentre
surveillance project established by the German National Reference
Centre for Surveillance of Nosocomial Infections in 2000 [CID 2005;
40: 926].
Methods: Nosocomial Infections were identiﬁed using CDC deﬁnitions
for laboratory-conﬁrmed blood stream infection (BSI) and modiﬁed cri-
teria for pneumonia in neutropenic patients [for detailed information and
reference data see http://www.nrz-hygiene.de/surveillance/onko.htm]. In-
formation on antimicrobial prophylaxis was obtained by a questionnaire
sent to all ONKO-KISS participants.
Results: 10 out of 14 centres treating patients with allogeneic BMT or
PBSCT returned the questionnaire. All routinely administered systemic
antibiotics (9/10 cotrimoxazole, 6/10 ciproﬂoxacin, 4/10 levoﬂoxacin and
2/10 other antibiotics), as well as antiviral agents. Systemic antifungal
prophylaxis was applied by 9 of the 10 centres.
14 out of 19 centres treating patients with autologous BMT or PBSCT
returned the questionnaire. 3 out of 14 did not routinely give systemic
antibiotic prophylaxis. Only 5 centres applied systemic antifungals and
half (7/14) applied antiviral agents. 3 participants had only recently
joined the ONKO-KISS system and thus reported few or no data on
nosocomial infections. 9 of the remaining 11 centres available for
analysis administered systemic antibiotics. The incidence of BSI/1000
neutropenic days was 15.7 and of pneumonia 5.8 in this group (data from
7/2002−6/2007). In contrast, the 2 centres that did not give any antibiotic
prophylaxis reported 19.4 cases of BSI and 8.1 cases of pneumonia per
1000 neutropenic days.
Conclusions: Our results offer very preliminary data suggesting that
antibiotic prophylaxis is of beneﬁt to these high risk patients in the
prevention of nosocomial infections. However, the inﬂuence on the
development of antimicrobial resistance must be closely monitored. It
might be reasonable to consider routine administration of antibiotics
also in autologous BMT/PBSCT in the case of above-average infection
rates.
R2516 Mediastinitis after heart transplantation: clinical
presentation and outcome
M.C. Farinas, E. Arnaiz, J.A. Va´zquez de Prada, P. Munoz, M. Valerio,
J. Yan˜ez, M. Gurguı´, M.L. Galvez, M.T. A´lvarez, A. Moreno,
C. Cervera, F. Pe´rez-Villa (Santander, Madrid, Barcelona, ES)
Objective: To assess the incidence, predisposing factors and outcome of
mediastinitis after heart transplantation.
Methods: From January 1997 to December 2006, a total of 774 heart
transplants were performed in four tertiary care university centres in
Spain. Those cases with possible mediastinitis were identiﬁed from the
hospital infection register and discharge register. Patients’ charts were
reviewed and cases of mediastinitis conﬁrmed based on criteria of the
Centers for Disease Control and Prevention.
Results: Mediastinitis developed in 13 (1.8%) of 774 cardiac transplant
patients. Patient’s ages ranged from 37 to 64 years (mean 54.3 y,
SD=8.1) and 9 (69.2%) patients were males. The incubation period for
mediastinitis ranged from 2 to 40 days (mean 13.1d, SD=12.2). Ten
(76.9%) patients were diagnosed in the ﬁrst 2 weeks after transplantation
and only 1 case developed longer than l month after this procedure.
Seven (53, 8%) patients were diabetic, and 1 had a previous heart
transplant. Fever (84.6%), purulent secretion through the wound (86%)
and sternal instability on palpation (76.9%) were the main clinical
ﬁndings. Bacteraemia developed in 8 (61. 5%) patients: S. aureus was the
most frequent microorganism isolated (3 patients, 1 MRSA), followed
by S. epidermidis (2 patients), K. pneumoniae (1 patient), P. aeruginosa
(1 patient) and S. viridans (1 patient). In the wound secretion or in
the mediastinum or both S. aureus was identiﬁed in 5 patients (2
MRSA), S. epidermidis in 2, and K. pneumoniae, P. aeruginosa, Serratia
marcescens and Candida glabrata in 1 patient each. All patients received
antibiotic treatment. Surgical treatment was performed in 12 (92.3%)
cases, and the extension of the debridement varied with local conditions.
In 7 (53%) patients, additional irrigation of the closed wound with
povidone-iodine was performed. Two (15.4%) patients died in the ﬁrst
month after the diagnosis, and the causes of death were related to the
infection.
Conclusion: Promptness in diagnosing mediastinitis and precocious
surgical drainage has changed the natural evolution of this disease.
Nevertheless, observance of the basic precepts of prophylaxis of infection
is still the best way to treat mediastinitis. Gram-positive organisms were
more commonly isolated than were Gram-negative bacteria.
R2517 Catheter-related bacteraemia with Methylobacterium
species
H.M. Holt, M.N. Skov (Odense, DK)
Objectives: Methylobacterium is an aerobic, slow-growing, Gram-
negative bacillus rarely found in human, clinical specimens.
We present three cases of bacteraemia with Methylobacterium species
and the results of phenotypic characterisation, antibiotic susceptibility
testing and 16S rRNA gene sequencing.
Methods: Clinical records from three patients with Methylobacterium
infections were obtained. The BacTec bloodculture system was used.
Identiﬁcation was made by standard methods, VITEK®2 GN card and
direct sequencing of the 16S rRNA gene. Susceptibility testing was
performed by direct agar diffusion with Rosco Neo-Sensitabs® and by
E-test®.
Results: Three cases of bacteraemia with four isolates of Methy-
lobacterium species in pure culture are presented. Two patients were
immunocompromised and received chemotherapy for acute leukaemia;
one patient had pancreatitis and multiorgan failure. All patients had a
central venous catheter as the most likely focus of infection. All isolates
of Methylobacterium were growing slowly with a time to detection
of 3−5 days in the BacTec® system and two days incubation after
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subculturing. Three of the four isolates were resistant to all betalactam
antibiotics inclusive meropenem but susceptible to tetracycline and
aminoglycosides. Comparison of the 16S rRNA gene sequences showed
different patterns and a common source of infection therefore was
unlikely.
Conclusion: Catheter related infections with Methylobacterium are seen
in Denmark. The infection might be under-diagnosed as Methylobac-
terium is slow-growing and not always visible in the initial Gram-
stain. The genus is often resistant to meropenem and other betalactam-
antibiotics but susceptible to aminoglycosides and tetracyclines
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R2518 Piperacillin/tazobactam versus imipenem/cilastatin for
severe diabetic foot infections: a prospective, randomised
clinical trial in a university hospital
N. Saltoglu, A. Dalkiran, T. Tetiker, H. Bayram, Y. Tasova, C. Dalay,
M. Sert (Istanbul, Adana, TR)
Objectives: In this prospective, randomised clinical trial of comparing
the effectiveness and side effects of two antibiotic regimens, we assessed
the patients with diabetic foot infections whose infection grade is
between Wagner grade 2 and 4.
Patients and Methods: Of the 62 patients enrolled the study, we
assigned patients randomly into piperacillin/tazobactam (4.5 gr IV q8 h)
or imipenem/cilastatin (0.5g IV q6 h) group.
Results: A total of 86 microorganisms were isolated from 62 patients.
Infections were polymicrobial in 40% of patients while 21% had no
bacterial growth in the culture. 61% of the isolated microorganisms
were Gram-positive while 74% were Gram-negative. 66% of the
patients had history of previous antibiotic therapy and 40% had a
previous history of hospitalisation within 3 weeks of the study. The
frequency of the microorganisms isolated from each therapy group was
similar and the most commonly isolated pathogens were Pseudomonas
aeruginosa (20%), Enterobacteriacea spp. (20%), Staphylococcus spp.
(32%) and Streptococcus spp. (13%). The presence of ESBL among
the Enterobacteriacea isolates was found in ﬁve isolates while the
meticillin resistance in Staphylococcus spp. was found in four isolates.
The amputation rate was 60% and 69% for piperacillin/tazobactam and
imipenem group, respectively. Most (64%) of the amputations due to
infection was observed in patients with Wagner grade 3. Clinical cure
rates were similar between the two treatment groups. The adverse effects
were more common in the piperacillin/tazobactam than the imipenem
group (30% vs. 9%; p = 0.055) with nephrotoxicity (20% vs 3%),
hepatotoxicity (17% vs 3%) and haematological side effects (7% vs 0)
being most frequent.
Conclusion: Our study suggests that both piperacillin/tazobactam
and imipenem/ cilastatin can be used for the empirical treatment
of severe diabetic foot infections with polymicrobial and/or resistant
microorganisms. Considering their relatively low frequency of side
effects, both agents can be used with conﬁdence
R2519 Meterological effects on the incidence of pneumococcal
bacteraemia in Denmark
T. Tvedebrink, S. Lundbye-Christensen, R.W. Thomsen, C. Dethlefsen,
H.C. Schønheyder (Aalborg, DK)
Objectives: The seasonal nature of invasive pneumococcal disease with
peak incidences during the winter months is well recognised. However,
few detailed studies of the possible temporal relationship between actual
climatic changes and subsequent pneumococcal disease are available.
Methods: We performed an 8-year longitudinal population-based
ecological study in a Danish county to examine whether foregoing
changes in climatic parameters, including temperature, relative humidity,
precipitation, and wind velocity, predicted variations in pneumococcal
bacteraemia (PB) incidence. We ﬁtted harmonic sinusoidal models to
estimate the exact phase difference in days between climatic changes
and PB activity.
Results: There was a close inverse relationship between temperature
changes and PB incidence, with an observed time lag of 16 days between
temperature peaks and troughs and PB activity (Figure). Peaks in relative
humidity preceded PB peaks by about 2 months. These relationships were
seen independently of a strong seasonal pattern of PB.
Conclusion: This study suggests that changes in temperature closely
predict PB incidence peaks, independently of seasonal patterns.
R2520 Study of community-acquired bacteraemias managed in a
medical department
C. Loupa, G. Kouppari, G. Petrou, K. Romanos, H. Antonopoulou,
M. Zoumberi, M. Tsimoranga, M. Lelekis (Athens, GR)
Objectives: To analyse clinically and microbiologically the cases of
community-acquired bacteraemias which were managed in a medical
department of a 300 bed Hellenic hospital.
Methods: We studied prospectively all consecutive cases of community-
acquired bacteraemias diagnosed (Bactec, Becton Dickinson) and
managed in our 28-bed medical department.
Results: During a 32-month period, community-acquired bacteraemia
was diagnosed in 90 patients (34 men, mean age 74.9 years), out
of which 77 were evaluable for analysis. There were 89 different
bacteria isolated, of which 68 were considered clinically signiﬁcant. The
pathogens were Gram(−) (51/68), Gram(+) (16/68) and fungi (1/68).
Among Gram(−), E. coli (31/51) and Klebsiella spp. (8/51) were the
most common pathogens, while S. aureus (7/24) and Streptococcus spp.
(7/24) were the most common among Gram(+). There was also one case
of C. albicans in an old patient with severe underlying diseases and
immunosuppression. The most common diagnoses were UTI (35/77),
biliary tract infection (15/77) and endocarditis (8/77). 71/77 patients
received empiric antibiotic treatment and 6 according to blood culture
results. The most common empiric treatment was monotherapy with
ampicillin/amoxicillin+inhibitor (33/71), while combination treatment
was given in 14/71 patients. According to pathogen sensitivity, empiric
treatment proved appropriate in 56/71 cases. Modiﬁcation of the initial
treatment was done in 41/77 cases for various reasons. Mean duration of
treatment was 12 days and the outcome was successful in 65/77 cases.
Conclusions: UTIs were the most common cause of bacteraemia in our
patients. Gram-negatives and especially E. coli were the predominant
pathogens. In most of the cases patients received empiric treatment,
appropriate in the majority of cases, and the outcome was successful in
84% of cases.
R2521 Searching the Surviving Sepsis Campaign database for
avoidable deaths
J. Koeze, V.M. Silderhuis, E. Metz, A. Halaby, G.J. Kootstra,
R.M.L. Brouwer (Enschede, NL)
Introduction: Recently it has been estimated that in the Netherlands
yearly about 1700 deaths in hospitalised patients could be prevented
by timely, accurate, diagnosis and adequate treatment. The surviving
sepsis campaign is an international campaign aiming at a reduction in
mortality with 25% in 5 years time. In March 2007 the SSC guidelines
were introduced in the ICU, ER and the departments of Internal Medicine
and Surgery of our hospital.
Aim of study: Analysis of cause of death in patients entered in the SSC
database in terms of unnecessary and untimely deaths in order to detect
possible ﬂaws in the diagnostic and therapeutic process.
Methods: Retrospective analysis of prospectively obtained data from the
SSC database a large non-academic teaching hospital.
Results: Ninety one patients (age 65±1.6 mean±s.e.m., 70% male)
were included. 46 (50%) were admitted to the ICU, 45 patients (50%)
were treated in the wards. Nineteen patients (20.7%) did not survive,
10 of these patients were not admitted to the ICU because of limits
on escalation of treatment (LOT). Nine patients were admitted to the
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ICU. Six died in the ICU, cause of death multiorgan failure (n = 4) and
withdrawal of futile treatment (n = 2). Three patients died after transfer
from the ICU to the ward (all three with LOT).
In all patients blood cultures were taken, in 18 before intravenous
empirical broad-spectrum antibiotics were started. Compliance to the
resuscitation bundle was >80%. Blood cultures were positive in only
two. Multiple sources of infection could be suspected in one patient.
A pulmonary focus was suspected in 10 patients, however, in only one
a suitable sputum specimen was obtained (Streptococcus pneumoniae,
n = 1). Six patients were suspected to have a urinary tract infection, in
ﬁve urinary cultures were taken (E. coli, n = 1; Klebsiella pneumoniae,
n = 1). An abdominal focus was suspected in ﬁve patients, urine cultures
were taken in four. In two patients the same microorganism was found
in the blood and urinary culture (E. coli, Klebsiella pneumoniae).
Microbiological data to narrow the antibiotic regimen were only available
in a limited number of patients.
Conclusion: Compliance to the SSC bundles was excellent, but more
microbiological samples of sputum should be obtained. Most patients
who died in our SSC cohort had limits on escalation of treatment and
cannot be counted as preventable deaths. Detailed analysis of cause of
death improves the diagnostic and therapeutic process.
R2522 Two cases of Lactococcus endocarditis
F. C¸okca, H. Deniz, S. O¨gu¨cu¨, H. Kutlu, O¨. Kurt-Azap (Ankara, TR)
Lactococcus species are common in the environment and they are used in
the food industry for food preservation. Although lactococcus species are
generally considered as non pathogen for humans, case reports including
serious infections such as endocarditis have been reported recently. We
report two cases of subacute endocarditis due to Lactococcus spp. in
native valves.
Case 1: A 75 years old man was admitted for fever, weight loss and
sweeting lasting for a month. Three years ago he had cardiac by pass
operation and had an ureterostomia due to urine bladder malignancy.
On cardiac examination he has got 3/6 systolic murmur and a
vegetation of 4×5mm was reported on mitral valve by transeosophageal
echocardiography. Three consecutive blood cultures grew Gram-positive
cocci which were ovoid making pairs or short chains. With the
suspicion of enterococcal endocarditis vancomycin 2 gr/day was begun.
The bacteria was identiﬁed as Lactococcus lactis ssp. lactis. He was
successfully treated medically for 6 weeks and no relaps was detected.
Case 2: A 63 years old man was admitted for fever of unknown origin.
He was hospitalised in another hospital 3 months before and was given
corticosteroids for the initial diagnosis of connective tissue disease. He
was on prednisolone therapy (10mg/day) for the last month but still
had fever and malaise. On physical examination he had 3/6 pansystolic
murmur and pretibial edema. Proteinuria and haematuria was detected.
Serum creatinine was 1.5mg/dl. Echocardiography showed 1×0.8cm
vegetation on mitral valve and blood cultures grew Gram-positive coccus
which was identiﬁed as Lactococcus rafﬁnolactis. He was treated with
ampicillin 12 gr/day. On follow up, echocardiography revealed mitral
valve rupture and there was no regression in the size of vegetation. Mitral
valve replacement was performed and medical therapy was continued for
8 weeks. Renal functions improved during therapy. He was in good health
after surgery and no relapse was detected in a year period.
There are very rare cases of lactococcus endocarditis in the literature and
to our knowledge Lactococcus rafﬁnolactis endocarditis has not been
reported before. We could not establish a clear source of infection but
both patients were older in age, and one has got malignancy. No dental
extraction history was noted.
R2523 Community-acquired urosepsis
H. Naz, F. Cevik, N. Aykin, E. Ozakin (Eskisehir, TR)
Objectives: Community acquired urinary tract infections (CAUTI) are
among the most common bacterial infections. In our study we aimed to
analyse retrospectively, the cases we followed in our clinic, diagnosed as
CAUTI, and to share the risk factors, clinic, ethiologic and laboratory
data in cases with urosepsis(US).
Methods: The cases followed in Eskis¸ehir Yunus Emre State Hospital,
Department of Infectious Diseases, during January 2005 and October
2007, diagnosed as CAUTI were analysed retrospectively. The Chi-
squared test was used for qualitative variables and independent predictors
of US were assessed using multiple logistic regression.
Results: 229 UTI and 71 (31%) US cases were determined during
the study period. Between the US cases, 43 (60.6%) were women,
28 (39.4%) were men, with a mean age of 67.4+ 15.9 (20–92)
years. The distribution of the US cases was: sepsis 65 (90.1%);
severe sepsis 5 (7%); septic shock 1(1.4%), multiple organ disfunction
1 (1.4%). When the cases with and without US were compared,
leucocytosis, thrombocytopenia, elevated sedimentation rate, elevated
CRP, pyuria, haematuria, proteinuria and leucocyte esterase positiveness
was signiﬁcantly higher in the US cases. When the risk factors of the
229 CAUTI cases were compared according to the presence of US, age
(year), diabetes mellitus (DM), neurologic disease, chronic obstructive
pulmonary disease (COPD), steroid therapy, and immunosupression were
statistically signiﬁcantly higher in patients with US (table-1). The most
frequent microorganism encountered by blood and urinary cultures, in
patients followed for CAUTI, with or without US, was E. coli, Klebsiella
sp. and Enterococcus sp. In one case it was polymicrobial. 6 of the 71
patients with US died, (mortality rate 8.5%). Of the 158 cases without
US, one patient died (mortality rate 0.6%). The mortality in cases with
US was statistically signiﬁcantly higher (p = 0.001).
Conclusion: The CAUTI cases that are elderly, have other diseases such
as DM, COPD, neurologic diseases and have received steroid therapy or
immunosupression, have a higher risk of developing US. Although ratios
may vary, the causative agents are not different in community acquired
US cases and in the cases without.
Table 1. Comparison of the risk factors according to US
OR 95%CI p
Age (year) 1.03 1.01−1.06 0.004*
Male gender 0.78 0.36−1.71 0.547
Urolithiasis 0.48 0.15−1.52 0.216
Urinary catheter 0.82 0.23−2.28 0.768
Prostatic involvement** 0.67 0.10−4.30 0.678
Incontinence 1.36 0.56−3.33 0.492
Urological abnormalities 0.16 0.01−1.64 0.126
Diabetes mellitus 0.22 0.10−0.48 0.000*
Cardiovascular disease 1.01 0.46−2.22 0.962
Neurologic disease 0.13 0.03−0.49 0.002*
Chronic renal insufﬁciency 11.7 0.82–164.5 0.069
Chronic liver disease 1.95 0.33–11.4 0.456
COPD 0.22 0.06−0.71 0.012*
Steroid therapy 27.9 1.89–409.7 0.015*
Immunosuppression 0.11 0.01−0.88 0.038*
Neoplasia 2.35 0.24–22.28 0.455
*Signiﬁcant. **Was evaluated in male patients.
R2524 Importance of pneumococcal bacteraemia for severity
scoring in community-acquired pneumonia
K. Stra˚lin, H. Holmberg (O¨rebro, SE)
Objective: The severity rules pneumonia severity index (PSI) and
CURB-65 are widely used for severity assessment in community-
acquired pneumonia (CAP). We aimed to compare the performances of
these rules in CAP patients with and without pneumococcal bacteraemia.
Methods: The records of all patients hospitalised at our 35-bed clinic
with a discharge code of pneumonia during a 4-year period were
retrospectively screened. Patients with chest X-ray inﬁltrates, at least
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two symptoms indicating pneumonia, and no hospitalisation during the
preceding month were considered to have CAP. The CAP patients who
had blood cultures obtained on admission were included in the study. The
PSI, CURB-65, and CRB-65 rules were calculated. Data on survival
at day 30 from admission was collected from the national population
register.
Results: Among 648 CAP patients, who fullﬁlled the study criteria,
46 patients (7.1%, mean age 65 years) had pneumococcal bacteraemia,
while 602 patients (mean age 66 years) had blood cultures that were
negative for Streptococcus pneumoniae. The frequencies of comorbid
illnesses were similar in the two groups. Death within 30 days was
noted in 15% (7/46) of those with and in 4.5% (27/602) of those
without pneumococcal bacteraemia (p = 0.002). The table shows the 30-
day mortality rates according to different severity scores in the CAP
patients with and without pneumococcal bacteraemia.
Death within 30 days and/or admission to intensive care unit (ICU) was
noted in 28% (13/46) of those with and in 12% (70/602) of those without
pneumococcal bacteraemia (p< 0.001). Death and/or ICU admission
among the CAP patients with high severity scores was noted as follows
(pneumococcal bacteraemia vs. no pneumococcal bacteraemia): PSI V,
80% (8/10) vs. 35% (22/63, p = 0.013); CURB-65 3−5, 47% (7/15) vs.
23% (27/119, p = 0.044); and CRB-65 2−4, 50% (9/18) vs. 20% (35/176,
p = 0.004).
Conclusion: The present study shows that pneumococcal bacteraemia is
an important severity factor in CAP. In CAP patients with high severity
scores, the outcome appears to be worse in those with than in those
without pneumococcal bacteraemia. This knowledge should be borne in
mind when severity scores are interpreted in CAP patients with known
or suspected pneumococcal bacteraemia.
Severity rule Score 30-day mortality rates
[No. dead/total no. (%)]
p-value
Pneumococcal
bacteraemia
No pneumococcal
bacteraemia
PSI I−III 0/27 (0) 1/340 (0.3) 1.0
IV 1/9 (11) 12/199 (6.0) 0.45
V 6/10 (60) 14/63 (22) 0.021
CURB-65 0−1 0/19 (0) 1/305 (0.3) 1.0
2 2/12 (17) 8/178 (4.5) 0.12
3−5 5/15 (33) 18/119 (15) 0.078
CRB-65 0 0/12 (0) 0/139 (0) 1.0
1 1/16 (6.2) 7/287 (2.4) 0.36
2−4 6/18 (33) 20/176 (11) 0.009
R2525 Usefulness of urinary Streptococcus pneumoniae test for
early aetiologic diagnostic of community-acquired pneumo-
nia admitted to a regional hospital (ATHENAS Study)
R. de la Rosa, J. Fernandez-Rivera, Y. Marin, C. Serrano, M.J. Romero,
A. Luna, A.J. Ramos, J. Delgado (Bormujos, ES)
Objective: Streptococcus pneumoniae is the main cause of community-
acquired pneumonia (CAP). The cornerstone for ethiologic diagniostic,
sputum culture, may persist negative up to 45% of cases. The aim of
the present study was to assess the usefullness of urinary Streptococcus
pneumoniae antigen test for early ethiologic diagnostic of CAP in
patients who are admitted into a secondary-hospital.
Patients and Methods: A prospective observational study, including
the whole 319 CAP diagnosed patients admitted into an Internal
Medicine Department between Novemeber 1, 2005 to April 30, 2007,
was designed. CAP diagnostic was performed when a new pulmonar
inﬁltrate in Chest X-Ray was observed, along with at least two of the
following criteria: fever >38ºC, cough, purulent sputum, crackles at chest
exploration, peripheral blood leucocites >10,000 cel/mm3). To diagnostic
pneumococcal ethiology patients underwent these tests: sputum culture,
peripheral blood culture (if patient had fever >38ºC) and urinary
Streptococcus pneumoniae antigen test (BINAX-NOW pneumonia kit).
Results: Median age of patients analysed was 72 years. During the study
were performed sputum culture in 183 patients (57.4%), blood culture
in 143 (45%) y urinary Streptococcus pneumoniae antigen test in 287
(90%). 108 cases of pneumococcal-CAP were diagnosed, by means of
urinary antigens (95 cases [88%]), sputum culture (23 [21.3%]) y blood
culture (9 [8.33%]). Streptococcus pneumoniae was isolated from sputum
in twelve patients (52.2%), although urinary test were negative. However,
all nine patients who presented with pneumococcal bacteraemia showed
a positive urinary antigen test. No statistically differences were found
when compared the rate of positivity in urinary test after stratifying
the population studied according to severity Fine criteria (p> 0.05; t de
Student).
Conclusion: Inclusion of urinary Streptococcus pneumoniae antigen test
as a part of early ethiologic study of patients with CAP at admission
into hospital is useful. This test allows increase signiﬁcantly the rate
of diagnostics of pneumococal pneumonia in our population, including
high severity cases, such as those with bacteraemia.
R2526 C-reactive protein in predicting the need for reoperation in
odontogenic maxillofacial infections requiring hospital care
L. Seppa¨nen, A. Lauhio, C. Lindqvist, R. Rautemaa (Helsinki, FI)
Objectives: Odontogenic infections may lead to hospitalisation and
severe infection complications. Although management of these infections
with antimicrobial therapy and surgical intervention has a good
prognosis, reoperation is occasionally essential for resolution of the
infection. Our aim was to ﬁnd a marker that would identify those patients
subsequently requiring reoperation.
Methods: In this retrospective study the medical records of 101
consecutive patients admitted to the Helsinki University Central Hospital
due to an odontogenic infection were analysed. This patient series covers
all cases of severe odontogenic infections in the Helsinki and Uusimaa
Hospital District during 2004 (1.4 million inhabitants). Age, gender,
occupational social class, body temperature, WBC counts, CRP levels,
focus, fascial spaces involved, need for reoperation, need for intensive
care, APACHE II score and length of stay were reviewed.
Results: CRP levels and WBC counts were higher on admission
in patients later requiring reoperation (P< 0.0001 and P = 0.0337,
respectively), and cut-off values of CRP level >120mg/L and WBC
count >14.0 103/mL were signiﬁcantly associated with a higher incidence
of reoperation (P = 0.0002 and P = 0.0019, respectively). These patients
also reached higher CRP levels and WBC counts than patients not
requiring reoperation. Interestingly, they reached the maximal body
temperature one day later, although admission body temperatures showed
no difference. The length of stay was longer and the need for and duration
of intensive care were higher in reoperated patients (all P< 0.0001). A
multiple space involvement was present more often in patients requiring
reoperation (P = 0.0006).
Conclusion: This study shows that C-reactive protein is a valuable
diagnostic marker with a cut-off value of 120mg/L on admission in
identifying patients subsequently requiring reoperation due to severe
odontogenic maxillofacial infection. A combination of CRP and WBC
measurements showed to be more reliable than measurements of WBC
only. Fever on admission was not found to be useful in identifying
patients later requiring reoperation. These patients are more often in
need of intensive care and require longer intensive care and hospital stay.
Multiple space involvement was found to predispose to reoperation.
R2527 The incidence of SIADH in acute meningitis patients ad-
mitted to a hospital in Tehran, Iran, during a 2-year period
S. Shokouhi, M. Hasanzadeh (Tehran, IR)
Objectives: Meningitis is one of the dangerous & life threatening
infections that delay in its diagnosis & management has great mortality
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& morbidity. Syndrome of inappropriate secretion of Anti Diuretic
Hormone (SIADH) is one of known complications of acute meningitis
that can change the prognosis, duration of symptoms, mortality &
morbidity of it. Hypotonic hyponatraemia is one of ﬁrst manifestations
of SIADH, but most of the patients do not have any symptoms, because
clinical manifestations usually do not occur until serum sodium reaches
below 120 meq/l.
Material and Methods: We enrolled 71 patients with diagnosis of acute
meningitis (either Bacterial or Aseptic) that admitted during 2 years
in Loghman Hakim General Hospital in our study. We checked serum
sodium, Speciﬁc gravity of urine & calculate serum & urine osmolality
of each of them in 1st & 3rd day of admission. We managed SIADH
cases with water restriction & if it didn’t work with hypertonic salin plus
lasix. The patient’s data was analysing by using SPSS Software. (Version
11.5).
Results: A total number of 71 patients were included in our study. 51
(72%) male & 20 (28%) female with an average age of 27.5±2.3 year.
Their meningitis were bacterial in 45 (63%) & Aseptic in 26 (37%).
Average length of stay of these patients in our hospital was 13.8±10.5
days. Only 5 patients (7%) had our criteria for SIADH (Serum Na <135,
serum osmolality <275 & urine osmolality >100). Without peripheral
edema or diuretic therapy. Two of them were died & the other two had
generalised seizure that one of them had serum Na <120.
Conclusion: The incidence of SIADH in patients with diagnosis of
meningitis in this study was (7%) & there was no statistical correlation
between SIADH and patient’s mortality, mental status in admission,
seizure or length of admission.
R2528 Characteristics of patients having Corynebacterium
pseudodiphtheriticum isolated in heavy growth from sputum
specimens
D. Haldane, K. Forward, R. Davidson, T. Hatchette (Halifax, CA)
Introduction: Corynebacterium pseudodiphtheriticum (Cd) has been
recognised as a respiratory tract pathogen in immunocompromised
patients infrequently. We observed sputum specimens from inpatients
that were excellent quality with numerous Gram-positive rods that
cultured Cd in high numbers. We reviewed these patients to determine
any possible clinical signiﬁcance of Cd and to determine if further
investigation of the role of Cd in respiratory infection was warranted.
Methods: A patient was included who was an in-patient in our institution
between June 1 2002 and May 31 2004, and had an excellent quality
sputum specimen showing heavy (growth in all 4 plate quadrants) and
predominate growth of Cd, with the specimen Gram stain consistent
with the culture result. Charts were reviewed retrospectively using a
standard questionnaire to determine evidence of infection and possible
predisposing factors to respiratory infection. The clinical signiﬁcance of
the isolate was assessed by author consensus.
Results: Eleven patients were identiﬁed, 9 male, aged 21–77. Seven
had a history of smoking, 3 were receiving corticosteroids, but there
were no other causes of immmunosuppression. Five had documented
fever (38ºC), 4 produced purulent sputum, 5 of 9 had cough (2 were
intubated), 8 of 10 had elevated WBC (1 not done), 4 of 10 had
radiological evidence consistant with pneumonia. Eight patients received
antimicrobials. One patient died.
Conclusions: Two patients were identiﬁed as having Cd pneumonia, and
2 with Cd acute bronchitis. The constellation of symptoms, signs and the
clinical course were not consistent with lower respiratory tract infection
in the remaining 7. Further studies are warranted to deﬁne the role of
Cd as a respiratory tract pathogen.
R2529 Aseptic meningitis in adults in a university hospital
J. Modol, M. Gimenez, S. Molinos, P. Tudela (Badalona, ES)
Objective: to determine the incidence and the epidemiological, clinical
and laboratory characteristics of aseptic meningitis (AM) in adults.
Methods: Prospective evaluation of all adult patients who have
undergone a lumbar puncture due to meningitis suspicion in a 600-
bed university hospital, serving 800,000 inhabitants in north-eastern
Spain, from February 2007 to November 2007. We assess all cases
with cerebrospinal ﬂuid (CSF) pleocytosis, and negative Gram stain and
standard bacterial cultures.
Results: A total of 237 lumbar punctures (LP) were performed,
conﬁrming acute bacterial meningitis in 16 (7%). In 39 patients
(16%) the ﬁnal diagnose was aseptic meningitis, median age 40 years
(range 19–80), 51% male. No seasonal distribution. 85% community-
acquired. 23% didn’t have underlying diseases, 26% had undergone
neurosurgery in previous 3 months, 18% infected by HIV, 18%
previous meningoencephalitis and 10% chronic ORL pathology. Clinical
presentation: 65% headache, 50% fever, 44% nausea-vomiting, 23%
decrease of consciousness, 46% neck stiffness and 13% neurological
focal deﬁcits. CSF was clear 66% of cases, haemorrhagic 23% and turbid
11%. Median CSF protein (g/L): 0.97 (82% above 0.5g/L), median CSF
glucose: 3mmol/L (38% below 2.5mmol/L). CSF leucocytes count was
less than 500/mm3 in 95%, lymphocytic predominance in 56%. CT scan
previous to LP was performed in 87%, showing abnormalities in 47%.
The ﬁnal diagnose was: 8 (21%) infections (5 Cryptococcus neoformans,
2 M. tuberculosis, 1 Herpes zoster), 7 (18%) postoperative, 5 (13%)
partially treated bacterial meningitis, 5 (13%) induced by non-steroid
anti-inﬂamatory drug (NSAID), 2 (5%) carcinomatous meningitis, 2
(5%) migraine. Other (1): parameningeal infection, retroviral rebound
syndrome and systemic lupus erithematosus. No cases of enteroviral AM
were detected. 50% patients got antibacterial agents, 25% acyclovir, 19%
antifungal and 6% tuberculostatic agents. Median stage was 12.5 days.
22% of patients required ICU, 14% endotracheal intubation and 5.4%
died. Glasgow outcome scale at discharge was: II 3%, III 13%, IV 19%,
V 60%.
Conclusion: AM is a prevalent disease that affects youngsters without
previous pathology, patients infected by HIV and who have undergone
neurosurgery. Non-enteroviral infections, postoperative and NSAID-
related are the main causes of AM in our area. Usually it has a good
outcome but sometimes requires ICU admission and has important
sequels and mortality.
R2530 Local immune response in women infected with HPV and
Chlamydia trachomatis
D. Friedek, A. Ekiel, M. Romanik, B. Wiechula, H. Dolezych,
G. Martirosian (Katowice, PL)
Objectives: Progression of HPV-dependent dysplastic changes to
cervical cancer is connected with other risk factors: immune dysfunction,
presence of biological co-cancerogens. The aim of this study was to
determine whether C. trachomatis can inﬂuence on locally produced
cytokines (INF-g, IL-1a, IL-10, TNF-a, TGF-b and sTNFR)in women
infected with high-oncogenic HPV types.
Methods: 183 women were studied: 39 with normal cytology results
(mean age 39.8), 67 with ASCUS (mean 40.5), 49 with LSIL (mean
36.6), 23 with HSIL (mean 35.8) and 5 with SCC (mean 45.2). In
each case 2 swabs: one to detect DNA of high-oncogenic HPV types
and second to detect C. trachomatis DNA (Amplicor, Roche) were
simultaneously taken. CVL samples were used for cytokine and anti-
C. trachomatis IgG detection (VIRO-Immun Labor-Diagnostika GmbH).
For statistical analysis U Mann-Whitney, Kruskal-Wallis-Anova and chi2
tests were used.
Results and Conclusions: C. trachomatis DNA was found only in
samples taken from 4 women in control group and anti-C. trachomatis
IgG in 31 out of 183 (16.5%). No statistically signiﬁcant differences
were observed in occurrence of anti-C. trachomatis IgG in women
from control group and groups with ASCUS, LSIL and HSIL.In
women with SCC these abs were signiﬁcantly more common (60%,
p = 0.0001). DNA of high-oncogenic HPV was observed signiﬁcantly
more frequently in women with LSIL (46.94%; p = 0087) and HSIL
(95.65%;p = 0.0001) compared with control group women (17.95%)
and ASCUS (23.37%). No signiﬁcant correlation was found between
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presence of anti-C. trachomatis IgG and high-oncogenic HPV. We did
not observe signiﬁcant differences in concentration of INF-g, IL-1a, LI-
10, TNF-a and TGF-b in women with or without anti-C. trachomatis
abs. Signiﬁcantly higher concentration of INF-g was observed in women
infected with HPV(p = 0.01) compared with women without HPV DNA.
Signiﬁcantly higher concentrations of TGF-b were demonstrated in HPV-
positive women with ASCUS (p = 0.004) and LSIL (p = 0.047) compared
with women with normal cytology infected with HPV. However IL-10
level was signiﬁcantly lower in HPV DNA-positive women with ASCUS,
LSIL and HSIL, compared with HPV-positive women without cytological
changes. Positive correlation in concentration of IFN-g and TGF-b and
negative correlation for IL-10 in HPV infected women with ASCUS,
LSIL and HSIL compared with women without cytological abnormalities
was detected.
R2531 Phagocyte Fcg receptors expression in bacteraemia
M.A. Escobar, A.A. Garcia-Egido, F.M. Gomez-Soto, F.J. Fernandez,
P. Ruiz, M. Rosety, C. Romero, F. Gomez (El Puerto Santa Maria, ES)
Early markers of bacteraemia are useful for prognosis and, in decision
making for i.v. antibiotic therapy.
Objectives: To assess the diagnostic power of the surface expression of
Fc receptors for IgG (FcgRs) for the prediction of bacteraemia in febrile
patients.
Methods: We performed a 5 year prospective case-control study on 193
consecutive patients (pts) with an episode of bacteraemia as compared to
198 randomly selected concurrent febrile pts with negative blood cultures
(control). Demographic and clinical data were collected by chart review
and/or questioning their attending physicians. Plasma levels of C-reactive
protein (CRP), TNFg, IL-1a, IL-6, IL-8 and IL-10 were determined. The
surface expression of Fc receptors for IgG (FcgRs): FcgRI, FcgRII and
FcgRIII on peripheral blood monocytes (M) and granulocytes (G) was
assessed by ﬂow cytometry. These studies were done concomitantly with
blood cultures.
Results: Both groups were not different for age, sex, previous
administration of immunosupressants or antibiotics, clinical severity
index or comorbid conditions. In univariate analysis, cases had
signiﬁcantly higher levels of CRP (p< 0.001), TNFg (p< 0.001), IL-1a
(p< 0.001) and IL-6 (p< 0.01) than controls. The expression of FcgRIIA
and FcgRIII by M and, that of FcgRI on G was signiﬁcantly enhanced
(p< 0.001) in bacteriemic patients as compared to culture-negative
febrile pts; while the expression of FcgRIIB by either M or G was
signiﬁcantly decreased (p< 0.03). Setting a cut-off value =25% of the
mean ﬂuorescence intensity over controls for FcgRs surface expression
and, assuming a prevalence of bacteraemia of 5–10% among hospitalised
patients undergoing blood cultures, results in a sensitivity, speciﬁcity,
positive and, negative predictive values of: 77%, 97%, 74%, and 98%,
respectively for M-FcgRIIA, 73%, 96%, 74% and 97%, respectively for
M-FcgRIII, 58%, 93%, 49% and 95%, respectively for G-FcgRI and,
71%, 91%, 57% and 83%, respectively for G-FcgRIIB.
Conclusions: Our results suggest that the surface expression of Fc
receptors for IgG on peripheral blood monocytes and granulocytes may
help clinicians to rule out bacteraemia in febrile patients.
Antimicrobial clinical trials
R2532 Clinical and bacteriological efﬁcacy of sequential
intravenous to oral moxiﬂoxacin in hospitalised patients
with community-acquired pneumonia and bacteraemia
P. Arvis, D. Haverstock, S.H. Choudri (Puteaux, FR; West Haven,
US; Toronto, CA)
Objectives: To compare the clinical and microbiological efﬁcacy of
sequential IV/PO moxiﬂoxacin (MXF) with comparator (COMP) therapy
in patients with community acquired pneumonia (CAP) and bacteraemia.
Methods: Data were pooled from 6 trials of MXF 400mg (IV/PO) in
the treatment of CAP in hospitalised patients. COMP treatments were
ceftriaxone + erythromycin, amoxicillin/clavulanate + clarithromycin,
trovaﬂoxacin, levoﬂoxacin, ceftriaxone + azithromycin + metronidazole
or ceftriaxone + levoﬂoxacin. Blood cultures were performed prior to
initiation of study drug therapy.
Results: The 6 trials randomised 3015 patients (1494 MXF, 1521
COMP) of which 2288 were valid per protocol (PP) (1141 MXF, 1147
COMP). Of the valid PP patients, 342 MXF and 361 COMP-treated
subjects were also microbiologically valid. 68 (6.0%) patients in the
MXF group and 83 (7.2%) in the COMP group had bacteraemia. Of
these, 40 (58.8%) in the MXF group and 48 (57.8%) in the COMP
group, were male, 20 (29.4%) and 17 (20.5%) were 75 years old, 12
(17.6%) and 14 (16.9%) had bilateral inﬁltrates and 28 (41.2%) and 39
(47.0%) had severe CAP (ATS 2001 criteria). S. pneumoniae was the
most common pathogen (MXF 48, COMP 64), with a range of other
pathogens occurring less often including S. aureus (5, 2), H. inﬂuenzae
(4, 4), E. coli (2, 3). Efﬁcacy data at test-of-cure for the bacteraemic
population are shown in the table. Clinical success rates in the non-
bacteraemic population were MXF 89.1% and COMP 87.7%.
MXF,
n/N (%)
COMP,
n/N (%)
Overall clinical success 54/68 (79.4) 65/83 (78.3)
Clinical success in severe CAP 19/28 (67.8) 25/39 (64.1)
Overall bacteriological success† 56/68 (82.4) 67/83 (80.7)
Bacteriological success† S. pneumoniae bacteraemia 42/48 (87.5) 50/64 (78.1)
†Eradication + presumed eradication.
Conclusions: Monotherapy with MXF (IV/PO) resulted in clinical and
overall bacteriological success rates similar to those of COMP therapy
in patients with CAP and bacteraemia. The bacteriological success rate
in bacteraemic patients with S. pneumoniae was numerically higher with
MXF.
Paediatric infections
R2533 Clinical qualitative evaluation of the diagnosis of acute
otitis media in general practice
S. Fanello, J.M. Legros, H. Hicombo, J.F. Garnier, C. Dagorne,
E. Parot-Schinkel (Angers, FR)
Objectives: Assess the quality of the diagnosis of Acute Otitis Media
(AOM) given by General Practitioners (GPs) on a daily basis and
compare it with the diagnosis of Ear, Nose and Throat specialist (ENTS)
which is considered as the gold standard.
Methodology: Every GP had to include 6 children aged 1 to 4 years for
whom he suspected or diagnosed that they were suffering from AOM.
Parents had to accept to see the ENTS participating in the survey within
48 hours.
Results: 24 GPs took part in the survey and included at least one child,
which amounts to a ﬁnal 57% acceptability rate. 208 eardrums were
included in the survey. 21.9% of assumptions or diagnosis’s of AOM
(30/137) were declared null by the ENTS. GPs diagnose AOM without
any doubt only in 54% of all cases. The diagnosis and the assumption of
AOM were respectively conﬁrmed in 83.8% of all cases and 71.4% by
the ENTS. The combination of redness and bulge, and isolated redness
accounted for respectively 44.3% and 26.2% of the main otoscopical
factors reminiscent of the AOM according to GPs. In the case of redness
and bulge, the diagnosis was conﬁrmed in 83% of all cases by the ENTS
as opposed to 75% regarding the isolated redness.
An AOM was suspected in 57.1% of the eardrums barely or not visible
or without any sign of infection and not conﬁrmed in 25% of all cases.
Conclusion: The global over diagnosis is 21.9% and 25% when the
otoscopy is hindered by the presence of cerumen or when the eardrums
are only inﬂammatory. Even though the over diagnosis is inferior to
the one mentioned in published writings, post-graduate teaching on the
various cerumen removal techniques and the use of pneumatic otoscopy
could contribute to improving the quality of diagnosing AOM.
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R2534 To determine the efﬁcacy and safety of different doses of
faropenem medoxomil in acute otitis media as measured
by double tympanocentesis
A. Arguedas, R. Dagan, E. Leibovitz, E. Wang, J. Song, I. Critchley,
R. Tosiello, R. Echols (San Jose, CR; Beer Sheva, IL; Milford,
Louisville, US)
Objectives: to determine the efﬁcacy and saftey of 4 doses of FM
in AOM and the impact of therapy on colonisation and antimicrobial
resistance development in children aged 6 months – 7 years.
Methods: Subjects with AOM were enrolled in 2 sites, Costa Rica
& Israel and randomised to receive one of following doses of FM in
cohort 1: 7.5 and 15mg/kg/dose and in cohort 2: 15, 30 or 40mg/kg/dose
bid for 10 days. Baseline tympanocentesis taken on all subjects and
repeated on day 4−6 in those with positive baseline or those who had
clinically failed. Test of cure clinical response was evaluated at d 12–14
and late follow up at d 28–32. Naso-oropharyngeal swabs were taken at
each visit.
Results: Total of 328 subjects enrolled leading to 47(7.5); 77(15), 79(30)
and 67(40) [total 270] who completed 10 days therapy (82%). 92%
of patients were enrolled in Costa Rica, 56.9% <2 years old, 28.2%
had received antibiotics in preceding 30 days. Pathogens isolated were
S. pneumoniae 113 (44.0%), H. inﬂuenzae 103 (40.2%), M. catarrhalis
28 (10.9%) & S. pyogenes 12 (5.9%), total 256. Signiﬁcant dose effect
on bacteriologic eradication. However, higher eradication seen in cohort
2 of 15mg/kg group (85% vs. 62.5%, p = 0.07), suggesting cohort effect
may be confounding. Eradication of H. inﬂuenzae accounted for dose
effect and signiﬁcantly higher even within cohort 1 (15mg vs. 7.5mg,
p = 0.01).
7.5mg/kg 15mg/kg 30mg/kg 40mg/kg
cohort 1 cohort 2
Clinical response at TOC, % 84.6 72.5 75 88.4 82.7
Clin resp. at Late FU 78.8 65 70 77.9 73.3
Bact. erad mITT 16/29 25/40 17/20 37/43 46/49
55.2% 62.5% 85% 86% 93.9%
S. pneumoniae erad., % 94.1 88.2 91.7 85.0 100
H. inﬂuenzae erad., % 0 45.5 83.3 81.0 84.2
M. catarrhalis erad., % 100 87.5 NA 83.3 100
S. pyogenes erad., % NA 100 100 100 100
Subjects with 1 AE, % 36.8 43.3 48.9 41.4
Diarrhoea, % 12.3 17.8 25.6 12.6
Vomiting, % 3.5 7.8 6.7 13.8
No FM resistance emergence. Reduction in oral or nasal colonisation
was observed for S. pneumoniae and M. catarrhalis.
Conclusions: FM was efﬁcacious and well tolerated at doses of at least
15mg/kg/dose given bid for 10 days in AOM.
R2535 Rothia dentocariosa bacteraemia in cardiosurgery patients
in a children’s hospital: report of two cases
A. Sergounioti, A. Charissiadou, E. Metaxas, I. Papavassiliou,
M. Bellou, A. Pangalis (Athens, GR)
Introduction: Rothia dentocariosa is part of the normal oral ﬂora,
particularly in patients with periodontal disease and until recently it was
not considered to be pathogenic to human. Lately, R.dentocariosa is
evaluated when isolated from blood cultures of cardiosurgery patients
and in cases of endocarditis, mainly when predisposing factors are
present, such as heart valve disease and congenital heart defects. We
present two cases of R. dentocariosa bacteraemia in children who were
treated surgically for the congenital heart disease they were suffering
from.
Case 1: A 14-month-old female infant was admitted to the Cardiosurgery
Department of our Hospital because of Ventricular Septal Defect
and Pulmonary Stenosis. She was successfully operated (Bidirectional
Glenn shunt) and was discharged from the hospital in good general
health. Ten days later, she was readmitted in the Cardiosurgery
Department with chylothorax and pleuritis. Two of the blood cultures
yielded R.dentocariosa, which was evaluated. Cefuroxime per os was
administered to the child additionally to the prescribed cardiological
medication and resulted to clinical improvement..
Case 2: A 2-month-old male infant was admitted to the cardiosurgery
clinic for surgical repair of Coarctation of the aorta and Patent ductus
arteriosus. Three days after the operation, R.dentocariosa was isolated
from the blood culture. Cefuroxime per os was administered.
Methods: Blood specimens were inoculated into Bactec Ped Plus/F
Medium (Becton-Dickinson) and were incubated in the automated blood
culture system Bactec 9240 (B-D). The positive cultures yielded a
pleomorphic Gram-positive rod which was identiﬁed as R.dentocariosa
with the BBL Crystal GP System (Becton-Dickinson). Susceptibility test
was performed with the Kirby-Bauer method. Penicillin, vancomycin,
erythromycin, clindamycin, cefotaxime and chloramphenicol were tested.
The evaluation of the results was based on the CLSI guidelines about
streptococci. Only one of the two strains isolated was resistant to
clindamycin.
Conclusions: Although R.dentocariosa bacteraemia is rarely observed,
physicians should be alert to evaluate it correctly when R.dentocariosa
is isolated from cardiosurgery patients.
R2536 Neonatal sepsis caused by Streptococcus bovis biotype II/2
E. Kenesei, K. Kelen, L. Balogh (Budapest, HU)
Objective: Streptococcus bovis is an uncommon cause of infection in
neonates. However, little is known about the clinical manifestation and
condition that predispose to S. bovis infection in this population.
Here we report a 5-day-old baby with bacteraemia and sepsis caused
Streptococcus bovis biotype II/2.
Material and Methods: A 5-day-old baby boy presented with fever (39
C), irritability and physical examination revealed 200/min heart, 60/min
respiration rate and hepatosplenomegaly.
The patient was born at term by spontaneous vaginal delivery after
an uncomplicated pregnancy, weigth 3140 g, APGAR score was 9/10.
Maternal prenatal culture was negative for group B streptococcus.
Laboratory studies showed the following: WBC: 20.9 G/l (neu-
trophils:62.8%, lymphocytes:23.8%, monocytes: 8.7%) platelets: 209
G/l, haemoglobin: 177 g/l, CRP: 55g/l. Antibiotic therapy was started
empirically with ampicillin and aminoglycoside.
The blood culture demonstrated Gram-positive coccus after 16 hour of
incubation. Subculture showed alpha-haemolytic colonies. Rapid latex
agglutination tests for grouping of Lanceﬁeld were performed (Slidex
Strepto plus, bioMerieux SA) and it appeared group D streptococcus.
Subsequently, the isolate was identiﬁed as Streptococcus bovis biotype
II/2 by the API 20 Strep system (bioMerieux SA). The strain was
sensitive for penicillin, ceftriaxon, erythromycin, clindamycin and
vancomycin. After continuing of single ampicillin administration the
patient was rapidly recovered.
Conclusion: Among group D streptococci, enterococci are well
recognised as causes of neonatal sepsis. In contrast, Streptococcus
bovis is considered an uncommon pathogen in newborn. Accurate
identiﬁcation of S. bovis has important implication for treatment.
Streptococcus bovis strains remain exquisitely sensitive for pencillin,
whereas in case of enterococcus or viridans streptococcus infection
addition of aminoglycoside or vancomycin are necessary for sufﬁcient
treatment.
R2537 Neonatal bacteraemia: bacteriological proﬁle and
antimicrobial susceptibility pattern
N. Al-Sweih, S. Khan (Kuwait, KW)
Introduction: Neonatal septicaemia remains a signiﬁcant cause of
morbidity and mortality in the new born. This study was carried out
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to determine the bacteriological proﬁle, the antimicrobial susceptibility
of the blood isolates and the change in the trends over the study period.
Methods and Materials: All blood isolates from cases of neonatal
bacteraemia (single isolate per episode) were taken over a period of 5
years (January 2002–December 2006) at the Maternity hospital, Kuwait.
Routine identiﬁcation and susceptibility testing were performed mainly
by using VITEK2 system. E test may be used for some isolates.
Results: There was 1551 episode of bacteraemia during the study
period. The most common isolated organism was coagulase-negative
Staphylococci (45%). Gram-negative organisms were isolated in 464
(30%) of cases and the most common isolate was Klebsiella pneumoniae
(37.1%). Other Gram-negative isolated were Escherichia coli (14.2%),
Enterobacter spp. (14%) and Acinetobacter spp. (15.3%). All Gram-
positive cocci were susceptible to vancomycin and most Gram-
positive cocci other than Staphylococci were susceptible to ampicillin.
No meticillin-resistant Staphylococcus aureus were isolated. Most of
the Gram-negative were sensitive to amikacin (95.7%), ciproﬂoxacin
(95.3%), tazobactam-piperacillin (95.3) and for meropenem (99.1%)
while they were more resistant to cefotaxime (46.9%), ceftazidime
(34.9%) and only 10.9% were resistant to gentamicin.
Conclusion: The bacteriological proﬁle of organism causing neonatal
bacteraemia is comparable to other reports in literature. Over the study
period we observed a trend of increasing resistance to commonly used
antibiotics among Gram-negative isolates.
R2538 ESBL-producing Enterobacteriaceae among neonates in an
academic clinical centre, Gdansk, Poland
B. Rybak, L. Naumiuk, E. Naumiuk, A. Samet, I. Domzalska-Popadiuk
(Gdansk, PL)
Objectives: The aim of this study was to analyse occurrence of ESBL
[Extended-Spectrum Beta-Lactamases] producing Enterobacteriaceae in
patients who were hospitalised in the Depart. of Neonatology Medical
University of Gdansk.
Methods: We analysed microbiological records obtained from 2003 to
2007. Strains were identiﬁed by classical method and VITEK, VITEK2
(BioMerieux). Production of ESBL was detected by double disk method.
Results: In the studied period 8632 patients were hospitalised. ESBL+
isolates were recovered from 425 patients. In 2003 ESBL+ isolates were
recovered from 216 patients, then 2004 – 48 patients, 2005 – 27 patients,
2006 – 110 patients and 2007 − 24 patients.
The most often isolated was Enterobacter aerogenes from 131 patients
(47.1%), then Klebsiella pneumoniae 96 patients (34.5%) Escherichia
coli 17 patients (6.1%); Enterobacter cloacae 16 patients (5.8%);
Klebsiella oxytoca 11 patients (4%); Citrobacter freundii 6 patients
(2.2%) and Enterobacter intermedius 1 patient.
Isolates were recovered from stools and rectal swabs (54%), respiratory
tract (37.4%), urine (3.89%) and blood (1.73%).
All strains were susceptible to carbapenems, about 90% to ﬂuoro-
quinolones and nearly 80% urine isolates to nitrofurantoin, but about
90% isolates were resistant to aminoglicosides and co-trimoxazole.
Conclusions: High percentage of ESBL carriage among children
complicates infection control measures and treatment of common
infections like urinary tract infection.
Newborns should be screened for ESBL carriage in our setting.
R2539 Diagnosis of Mycoplasma pneumoniae: results of a
prospective study in Tunisia
A. Touati, W. Achour, A. Ben Hassen (Tunis, TN)
Objectives: Mycoplasma pneumoniae is an important human respiratory
tract pathogen; it causes 15 to 20% of community-acquired pneumonia
in older children and adults and a variety of respiratory tract infection in
younger children. The aim of our study was to diagnose and to determine
the overall incidence of M. pneumoniae infection in young children.
Methods: a prospective study was conducted from November 2005 to
October 2007. It concerned 273 neonates and infants hospitalised in the
intensive care unit in children’s hospital in Tunis and suffering from
respiratory problems. We collected 285 different specimens, essentially
from respiratory tract, placed into transport medium (2SP). Samples
were tested by 16S rRNA gene- and P1 adhesin gene-based PCR and
by inoculation in Hayﬂick modiﬁed broth medium supplemented with
glucose. Two hundred and ninety-one sera obtained at the same time were
used for detection of IgM and IgG antibodies using ELISA-PLATELIA
M. pneumoniae TMB tests (BioRad®). Typing ofM. pneumoniae clinical
isolates was carried out by a PCR-RFLP method using HpaII restriction
endonuclease.
Results: samples were distributed as follow: 174 nasopharyngeal
aspirates, 42 throat swabs, 31 nose swabs, 25 tracheal aspirates, 7
bronchoalveolar lavages, 4 cerebrospinal ﬂuids, 1 sputum, 1 articular
ﬂuid and 1 pleural ﬂuid. We totally isolated 5 M. pneumoniae clinical
isolates; all strains belonged to subtype I.
Fourteen patients (10 infants and 4 neonates) could be diagnosed with
certain M. pneumoniae infection: 4 had positive culture, one had positive
nasopharyngeal aspirate by PCR and culture, one had positive throat
swab-PCR and serology (positive IgM and moderate IgG), one with
positive IgM and high IgG titer, 4 had positive IgM associated with low
or moderate or negative IgG and 3 with seroconversions.
Conclusion: our study showed a low incidence (5.12%) (14/273) of
current M. pneumoniae infection. All M. pneumoniae clinical strains
were of subtype I. Culture, PCR and serology tests are complementary
for the conﬁrmation of diagnosis.
R2540 Microbial analysis of breast milk as a tool to differentiate
infectious mastitis and Raynaud’s syndrome during lactation
M.C. Collado, S. Delgado, R. Arroyo, A. Maldonado, J.M. Rodrı´guez
(Valencia, Madrid, ES)
Objectives. Mastitis is an inﬂammation of the mammary gland that is
frequent during the lactation period and that is usually associated with
a bacterial infection. Raynaud’s phenomenon consists in a vasospasm of
peripherical blood vessels and may affect the nipples of breastfeeding
mothers. Raynaud’s syndrome is often misdiagnosed as infectious
mastitis on the solely basis of a painful lactation. In this context, our
objective was to elucidate if bacterial analysis of breast milk can be an
useful tool to differentiate both conditions.
Methods. Samples of breast milk were collected from 5 women
suffering infectious mastitis and from 5 showing symptoms of Raynaud’s
syndrome. The microbial composition of the samples was analysed by
classical plate count techniques and, also, by molecular techniques as
PCR-DGGE and real time quantitative PCR (RTi-Q-PCR).
Results. Using culture-based methods, signiﬁcant differences were
observed between the samples of mastitis-suffering women and those
provided by women with Raynaud’ phenomenon. Globally, staphylococci
and streptococci were the predominant bacterial groups in mastitic milk
while no bacteria could be detected after the plating and incubation
of Raynaud’ samples. The assessment of the bacterial composition
of breast milk by PCR-DGGE also revealed signiﬁcant differences
between mastitic and Raynaud samples. In general, more complex
proﬁles were observed in women with infectious mastitis where bands
corresponding to staphylococcal and streptococcal species were often
present. Interestingly, the intensity of the Staphylococcus aureus band
was higher in Raynaud’ samples. RTi-Q-PCR with different general
or genus-speciﬁc primer couples conﬁrmed the existence of signiﬁcant
differences in the bacterial composition of milk in both conditions. As an
example, the milk of mastitis-suffering women showed higher levels of
total bacteria (p< 0.05) than those from women with Raynaud’ syndrome
women.
Conclusions. Our results indicate that the two conditions studied
(infectious mastitis/Raynaud’ phenomenon) have a different impact
on the microbial composition of breast milk. Bacteriological analysis
of milk can be an useful tool in the differential diagnosis between
infectious mastitis and Raynaud’s phenomenon. The recognition of
the exact condition responsible for breast pain will allow a more
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appropiate treatment, avoiding the cost and side effects of unnecessary
antibiotherapy when Raynaud’s phenomenon is diagnosed.
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R2541 Levels of anti-Haemophilus inﬂuenzae type B antibody in
Turkey before routine vaccination
C. Sonmez, N. Coplu, D. Kurtoglu, B. Esen, A. Crowley-Luke,
L. Ransley (Ankara, TR; Salisbury, UK)
Objectives: Haemophilus inﬂuenzae type b (Hib) vaccine was introduced
into the routine vaccination schedule in Turkey on January 1st, 2007.
This study investigated immunity to Hib before vaccination.
Methods: Serum samples collected from Samsun, Antalya and
Diyarbakir provinces between 2000–2001 were tested in this study. A
total of 1713 serum samples from patients aged 6 months to more
than 60 years from 26 health centres were tested. A commercial ELISA
(Immunozym Hib IgG, Progen Biotechnik GmhB, Heidelberg, Germany)
test was used to measure antibody concentration of anti-Hib IgG.
For quality control, 30 sera were selected and retested at the Health
Protection Agency (HPA)(Salisbury, U.K) using an in-house ELISA. For
evaluation of the concentration of anti-Hib antibody, 0.15mg/ml was
accepted as non-protective, >0.15 to <1.0mg/ml as short term protection
and 1.0mg/ml as long term protective. Chi-square test and logistic
regression were used for statistical analysis.
Results: Results of the commercial ELISA and the HPA in-house
ELISA correlated well (correlation coeﬁcient 0.87). The distribution
of antibody concentrations according to age, gender and location by
protection levels is shown in the Table. Between 38.1 to 79.3% of
children under ﬁve years of age had antibody levels lower than those
considered protective, and 15.2 to 61.9% had antibody levels cosistent
with short term protection. These children should be considered at risk
of Hib infection. Protection against Hib infection increased by age in all
three provinces (Antalya: OR 1.028, 95.0% CI; 1.070−1.038, Diyarbakir:
OR 1.027, 95.0% CI; 1.060−1.038, Samsun: OR 1.041, 95.0% CI;
1.030−1.052). There were no statistically signiﬁcant differences between
provinces when Diyarbakir was considered as the reference province
(Samsun: OR 1.800, 95.0% CI; 0.617−1.036, Antalya: OR 1.212, 95.0%
CI; 1.930−1.579).
Conclusion: Children under ﬁve years of age in Turkey were at high
risk for Hib infection before the introduction of vaccination. The impact
of the vaccination programme should be monitored at frequent intervals
to ensure the maximum beneﬁt is obtained from immunisation.
Antalya Diyarbakır Samsun
n 0.15*,
%
>0.15–
<1**, %
1***,
%
n 0.15,
%
>0.15–
<1, %
1,
%
n 0.15,
%
>0.15–
<1, %
1,
%
Age group
0 19 42.1 52.6 5.3 26 46.2 46.2 7.7 29 79.3 17.2 3.4
1 32 53.1 34.4 12.5 16 68.8 18.8 12.5 31 67.7 19.4 12.9
2 30 50.0 36.7 13.3 21 47.6 52.4 33 75.8 15.2 9.1
3 31 48.4 41.9 9.7 21 38.1 61.9 25 72.0 28.0
4 23 56.5 34.8 8.7 29 55.2 27.6 17.2 29 58.6 31.0 10.3
5−9 130 30.0 44.6 25.4 113 37.2 38.1 24.8 122 39.3 35.2 25.4
10–14 25 32.0 40.0 28.0 27 37.0 29.6 33.3 31 35.5 32.3 32.3
15–19 27 7.4 55.6 37.0 26 30.8 50.0 19.2 24 25.0 33.3 41.7
20–29 75 18.7 41.3 40.0 60 26.7 30.0 43.3 62 14.5 50.0 35.5
30–39 68 17.6 48.5 33.8 51 17.6 51.0 31.4 60 20.0 41.7 38.3
40–49 64 18.8 50.0 31.3 50 16.0 38.0 46.0 56 10.7 41.1 48.2
50+ 85 17.6 48.2 34.1 84 19.0 44.0 36.9 78 25.6 53.8 20.5
Gender
Male 279 26.5 45.9 27.6 254 34.3 39.0 26.8 283 36.0 40.3 23.7
Female 330 29.1 43.9 27.0 270 29.3 41.5 29.3 297 38.4 33.7 27.9
Location
Rural 297 27.3 44.4 28.3 287 33.1 36.9 30.0 293 37.9 34.5 27.6
Urban 312 28.5 45.2 26.3 237 30.0 44.3 25.7 287 36.6 39.4 24.0
Total 609 27.9 44.8 27.3 524 31.7 40.3 28.1 580 37.2 36.9 25.9
R2542 Interrelation between typhoid fever process and monocytes
with expression of C3bR receptor
J. Tuychiev, S. Aripov (Tashkent, UZ)
Objectives: To reveal interrelation between typhoid fever process
(complicated and relapse ﬂow) and monocytes with expression of C3bR
receptor.
Methods: 60 patients in 16–67 of age (25 male and 35 female) with
typhoid fever, caused chloramphenicol susceptible strain of Salmonella
enterica serotype typhi, were tested for determination of C3bR receptor’s
expression of monocytes with test of rosette formation (Mendes N.F. et
al., 1973). There was evaluated the percentage index of rosette formatting
monocytes (RFM%) with C3b component of complement. Average rate
of this index was 39.0±2.6% in the control group, consisted from 45
healthy people in 17–61 of age (21 male and 24 female).
Results: Among 60 patients relapse of typhoid fever occurred
in 12 (20.0%) patients, complications in 7 (11.7%) patients [in
3 (5.0%) case of intestinal bleeding; intestinal perforation, nosebleed,
meningoencephalitis and toxic shock in 1 (1.7%) cases]. RFM% index
was in low level in 23 (38.3%) patients, in high level in 29 (48.3%)
and in the limits of control group indexes in 8 (13.3%) cases. Among 23
patients with low RFM% indexes relapse of typhoid fever was registered
in 12 (52.2%) patients, complications occurred in 5 (21.7%) patients. In
6 (26.1%) patients of this group complications and relapses did not
registered. In the group of 29 patients with high level of RFM% indexes
complications occurred only in 2 (6.9%) patients (intestinal bleeding
and toxic shock), vice-versa in majority patients – 27 (93.1%) with
high indexes of RFM% there was not any unfavourable outcome. All
8 (100%) patients with normal RFM% indexes unfavourable outcome
was not registered as well.
Conclusion: Low indexes of monocyte with C3bR receptor expression
in membrane associate with high risk of developing of typhoid fever
relapses and complications. High indexes of C3bR expression associate
with low risk of complication’s developing and absence of relapse’s risk
in typhoid fever patients. The method of identiﬁcation of monocytes
expressed C3bR receptor can be used in patients with typhoid fever both
as a revelation immunodeﬁciency persons and as a criterion of forecast
of disease’s ﬂow.
R2543 Bronchial asthma and Chlamydia pneumoniae
D. Kalikatzaros, M. Stagas, G. Hristodoulou, S. Mavrea,
E. Anastasakou (Athens, GR)
Introduction: C. pneumoniae is a known cause for respiratory diseases
such as pneumonia, bronchitis and more but it has not yet been
determined the role at the pathogenesis of bronchial asthma. The purpose
of our study was to detect the presence of C. pneumoniae antibodies to
the serum of patients of our hospital and correlate with the disease.
Material and Methods: We studied 750 patients from which 470 were
female and 280 male. All patients were nursed at the pneumonological
clinics of our hospital during the last year (2006–2007). 100 healthy
controls were also used. 165 out of the 750 patients had symptoms of
bronchial asthma following a respiratory infection. At those 165 patients
as well as at the 100 controls (IFA) was used to detect C. Pneumoniae
antibodies while the rest immunological tests were negative.
Results: All 165 patients had positive IgG antibodies for C. pneumoniae
in titles ranging from 1/16 to 1/512 with a higher percentage at titles
1/32 and 1/64. The healthy controls had a high title antibodies at 1/16
while no one had a title of 1/128 or 1/512.
Conclusions: As shown on the table the title of IgG antibodies for
C. pneumoniae is much higher to patients with bronchial asthma than
it is to the healthy individuals. Despite the fact that high titles of
IgG antibodies for C. pneumoniae can be found at countries with low
morbidity for bronchial asthma (tropical countries) it is possible that
chronic infection with C. pneumoniae can be a causing factor for the
disease.
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Positive IgG antibodies 165 Patients 100 Healthy controls
1/16 32 (19.5%) 78 (78%)
1/32 38 (23%) 16 (16%)
1/64 45 (27%) 5 (5%)
1/128 18 (11%) 0 (0%)
1/256 20 (12%) 1 (1%)
1/512 11 (6.5%) 0 (0%)
R2544 Relevance of A 2 phospholipases and matrix-
metalloproteases in the assessment of the inﬂammatory
process evolution in periodontal disease
M. Balotescu Chiﬁriuc, I. Codita, E. Ionica, A. Radulescu, S. Radu,
I. Floarea, M. Bucur, C. Larion (Bucharest, RO)
Introduction: In the oral cavity, indigenous bacteria are often associated
with the aetiology of two major oral diseases, which are endemic in
industrialised societies and are increasing in developing countries, i.e.
caries and periodontal diseases. Periodontitis involves the destruction of
the connective tissue attachment and the adjacent alveolar bone. The
induction and progression of periodontal tissue destruction is a complex
process involving plaque accumulation, release of bacterial substances,
and host inﬂammatory response.
Purpose: to investigate the levels of proteolytic enzymes and
phospholipases in inﬂammatory pocket exudates and saliva from patients
with periodontopatic disease and their correlation with the severity of
disease in order to assess their potential applications as biochemical
markers in periodontitis clinical trials.
Material and Methods: A total number of 30 adult patients
with chronic periodontal diseases of different severity degrees were
analysed. Saliva and periodontal pocket content were prelevated after
local hygenisation, before any stomatological treatment. All specimens
were submitted to qualitative and quantitative microbiological analysis
following standard oral microbiology protocols. All isolated microbial
species were investigated for the expression of soluble, enzymatic
factors. The total protein content and the level of matrix-metalloproteases
was assessed by zymographic analysis. The sPLA2 type II was analysed
using adapted NEFA C method. The samples were preserved at −200ºC
until the analysis.
Results and Discussion: Our results demonstrated the presence
of a constant high level of matrix-metalloproteases 2 and 9 (with
gelatinase activity) in all periodontal pocket samples. The highest level
of MMP-9 was correlated with the microbiological identiﬁcation of
viable, gelatinase producing Proteus vulgaris strains in the pocket
specimens. The dynamic of sPLA2 type II levels varied with the patient,
either succesively growing or remaining constant, or decreasing in
consecutively prelevated specimens, but without no speciﬁc correlation
with the clinical evolution of the disease.
Conclusion: These results are suggesting that despite its value as
inﬂammation parameter, the sPLA2 type II cannot be used as a
biochemical parameter of disease severity of evolution. In exchange,
the level of MMP-9 could be an indicator of the release of bacterial
substances with proinﬂammatory activity.
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R2545 Varicella vaccination in HIV-positive individuals, a time to
act
E. de Barra, A. Jackson, J. Mallon, S. Clarke, F. Lyons, C. Dowling,
M. Moriarty, C. Bergin (Dublin, IE)
Introduction: Varicella is a highly infectious disease with secondary
attack rates of appriximately 90% for susceptible household contacts.
HIV positive non-immune individuals represent such at risk contacts.
A 16-year old HIV positive patient originally from Africa presented to
A&E in June 2007 with primary varicella pneumonitis. Her brother, with
whom she lived, was HIV negative and recently had primary varicella.
She was known to be non-immune to varicella. She had received VZV
IgG treatment but clinically progressed to require admission. CD4 count
was 254 x 106. This case, along with recent guidelines, (MMWR 2007),
prompted us to review the prevalence of varicella non-immune patients
in our cohort. The department provides care for approximately 2400 HIV
positive patients of whom 30% have migrated from COHP where rate
of VZV non-immunity is known to be higher.
Methods: A retrospective analysis of all patients diagnosed with HIV
between 2002 and 2007 was undertaken. Patient demographics including
country of origin, VZV IgG status, CD4 count, HAART history and
family history especially for children of school-going age were recorded.
A phone survey was subsequently carried out to ascertain household
membership of all at risk individuals, including children and other
immunosuppressed household members.
Results: In the study period 594 HIV positive patients were tested for
Varicella IgG, 36.8% from COHP. 15% patients from COHP were non-
immune which compared with 4% of the European cohort, highlighting
patients from COHP as an at risk group. 50(8.4%) of all patients were
VZV IgG negative. Of the non immune patients 8(16%) had a CD4
count <200, 11(22%) had a CD4 count of 200 to 350 and 31(62%) had
a CD4 count >350. The non immune patients with CD4 counts >200
were contacted and offered vaccination in-line with recent guidelines.
The non immune patients with CD4 counts <200 were contacted and a
detailed history of their cohabitants was recorded. Vaccination of non-
immune household members was advised.
Conclusion: Primary varicella infection in the HIV positive population
poses a credible threat, especially in patients from COHP. Guidelines
published in June 2007 advise that non immune patients with CD4 counts
>200 can be vaccinated, whereas those with CD4 counts <200 should
have their household contacts vaccinated. In retrospect our individual
case would have been identiﬁed and vaccinated.
R2546 Construction of a recombinant bacmid containing
papillomavirus type16-L1 gene
A. Abdoli, H. Soleimanjahi, F. Fotouhi chahooki, A. Teimoori,
M. Fazeli, F. Farzaneh pour, M. Shenagari (Tehran, IR)
Objectives: Major capsid protein L1 of HPV-16 intrinsically of
assembling and producing viral-like particle (VLP) in vitro.
Methods: HPV16-L1 gene extracted from parafﬁn embedded infected
cervical tissues of patients who suffered from cervical cancer. This
gene was inserted into pFast HTA plasmid. After the conﬁrmation,
the recombinant plasmid was transfected into DH10 E.Coli containing
Bacmid and helper plasmid.
Results: It was observed recombinant Bacmid colonies turned to white
colonies and non-recombinant colonies remained blue in absence of
X-gal and IPTG. For conﬁrming the recombinant Bacmid production,
an in-house designed PCR was applied.
Conclusion: This research has lead to the production of recombinant
Bacmid which can replicate in insect cells and produce L1 protein. This
protein has the power of assemblage and construction of VLP.
R2547 Comparative study of serum bactericidal activity to
serogroup C and serogroup A polysaccharide meningococcal
vaccination
S.D. Siadat, N. Rezaei, D. Norouzian, A. Aghamohammadi, H. Ahmadi,
B. Tabaraie, M. Nejati (Tehran, IR)
Objective: The polysaccharide vaccine against meningococcus
serogroups A and C was the prototype vaccine for this infection, which
is safe, inexpensive and effective against the serotypes A and C. Serum
bactericidal antibody (SBA) assay, an antibody-mediated complement-
dependent method, is the gold standard surrogate of protection for
Neisseria meningitidis. This study was performed to compare serum
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bactericidal activity to serogroup C and serogroup A after polysaccharide
meningococcal vaccination.
Methods: Sixteen subjects (36 patients with primary immunodeﬁciency
diseases and 24 healthy controls) were vaccinated with meningococcal
polysaccharide vaccine A + C. The SBA assay was performed according
to the World Health Organization (WHO) expert Committee on
Biological Standardization procedure. Bactericidal antibody response to
N. meningitidis serogroups A and C in the sera of all subjects were
compared before and 3 weeks after vaccination. The geometric mean
titer (GMT) were calculated and compared.
Results: Following vaccination, the serum bactericidal antibody GMT
against N. meningitidis serogroup A and serogroup C were signiﬁcantly
increased compared to the pre-vaccination level in both patient and
control groups. The serum bactericidal GMT pre- and post-vaccination
against serogroup C were 1.49 and 12.1 while against serogroup A
were 1.32 and 16.25. Comparative studies of the serum bactericidal
GMT per-vaccination was not revealed any signiﬁcant difference between
bactericidal activity to N. meningitidis serogroup A and serogroup C
(P= 0.207), whereas the serum bactericidal GMT post-vaccination to
serogroup A were signiﬁcantly higher than the serogroup C (P= 0.006).
Conclusion: The high level of bactericidal antibody response to
N. meningitidis serogroups A is seemed to be due to differences
protective efﬁcacy of serogroup A polysaccharide (89–100%) in
comparison to serogroup C polysaccharide (85%) in clinical trials.
R2548 Factors associated with suboptimal compliance to
vaccinations
M. Falagas, E. Zarkadoulia (Athens, GR)
Objectives: We conducted a systematic review of the available evidence
in order to investigate the factors associated with suboptimal compliance
to vaccinations, focusing on children and adolescents in developed
countries.
Methods: We searched the PubMed database to identify studies
concerning suboptimal compliance to childhood vaccination. We
categorised the studies in 2 groups with regard to the presence or not of
an analytical statistical approach.
Results: We initially identiﬁed 553 potentially relevant articles and
subsequently reviewed in detail 39 that provided original data regarding
the possible association between various factors and suboptimal
compliance to childhood immunisations. Factors inﬂuencing compli-
ance to vaccinations related to parental-childhood characteristics and
healthcare structure-professionals characteristics. Speciﬁcally, among
the various parental-childhood characteristics studied, non-white race,
low socioeconomic status, paying for immunisation, lack of health
insurance, low parental education, older age of the child, younger
maternal age, large family size, late birth order, lack of knowledge about
disease and vaccination, negative beliefs/attitudes towards immunisation,
fear of side effects/risks/contraindications, not remembering vaccination
schedules and appointments, sick child delays, and delayed well child
visits were statistically signiﬁcantly associated with suboptimal com-
pliance. Also, among healthcare structure-professionals characteristics,
skepticism/doubts regarding provided medical information, inadequate
support from healthcare providers, lack of available health structures, and
problems concerning transportation and accessibility to immunisation
clinics were statistically signiﬁcant factors of suboptimal compliance to
vaccination in children population.
Conclusion: By recognising and understanding the factors associated
with suboptimal compliance to vaccinations we can better approach the
risk populations and target our efforts at stressing and reinforcing the
vital importance of immunisations. Methods to enhance compliance to
vaccinations may include reminder calls and mail notiﬁcation of parents
by providers, initiation of health education programmes for parents and
health professionals, and open communication and trust between care
takers of children and physicians.
